No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 2b7aA, 1.0000, 0.00, 1.000, 284, 284, THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY A POTENT AND SPECIFIC PAN-JANUS KINASE INHIBITOR
2, 3tjcA, 0.9986, 0.23, 0.996, 284, 284, CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 8
3, 4hgeA, 0.9975, 0.31, 0.996, 284, 284, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 8
4, 4aqcA, 0.9973, 0.33, 0.993, 289, 284, TRIAZOLOPYRIDINE-BASED INHIBITOR OF JANUS KINASE 2
5, 3fupA, 0.9971, 0.33, 1.000, 284, 284, CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
6, 5cf5A, 0.9963, 0.38, 0.996, 287, 284, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 7-[(DIMETHYL-13-THIAZOL-2-YL)AMINO]-10-ETHYL-3-METHYL-35810- TETRAAZATRICYCLO[7.3.0.026] DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
7, 3tjdA, 0.9949, 0.50, 0.996, 284, 284, CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 19
8, 4ji9A, 0.9948, 0.45, 0.996, 284, 284, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH TG101209
9, 5cf8A, 0.9943, 0.29, 0.996, 285, 283, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-35810- TETRAAZATRICYCLO[7.3.0.06] DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
10, 3q32A, 0.9938, 0.51, 0.996, 291, 284, STRUCTURE OF JANUS KINASE 2 WITH A PYRROLOTRIAZINE INHIBITOR
11, 4f08A, 0.9932, 0.53, 0.996, 288, 284, DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2
12, 4e6dA, 0.9932, 0.36, 0.986, 286, 283, JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 7
13, 5cf4A, 0.9923, 0.47, 0.993, 283, 283, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-35810- TETRAAZATRICYCLO[7.3.0.06] DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
14, 2b7aB, 0.9917, 0.58, 1.000, 287, 284, THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY A POTENT AND SPECIFIC PAN-JANUS KINASE INHIBITOR
15, 3tjcB, 0.9916, 0.59, 0.996, 287, 284, CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 8
16, 5cf4B, 0.9915, 0.60, 0.996, 291, 284, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-35810- TETRAAZATRICYCLO[7.3.0.06] DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
17, 4zimA, 0.9914, 0.48, 0.996, 285, 283, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH A 9H-CARBAZOLE-1- CARBOXAMIDE INHIBITOR
18, 3fupB, 0.9910, 0.60, 1.000, 287, 284, CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
19, 4f08B, 0.9902, 0.65, 0.996, 288, 284, DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2
20, 4hgeB, 0.9900, 0.67, 0.996, 288, 284, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 8
21, 5cf5B, 0.9898, 0.67, 0.996, 294, 284, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 7-[(DIMETHYL-13-THIAZOL-2-YL)AMINO]-10-ETHYL-3-METHYL-35810- TETRAAZATRICYCLO[7.3.0.026] DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
22, 3tjdB, 0.9898, 0.68, 0.996, 287, 284, CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 19
23, 4zimB, 0.9897, 0.67, 0.996, 294, 284, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH A 9H-CARBAZOLE-1- CARBOXAMIDE INHIBITOR
24, 4aqcB, 0.9895, 0.67, 0.993, 295, 284, TRIAZOLOPYRIDINE-BASED INHIBITOR OF JANUS KINASE 2
25, 4ji9B, 0.9889, 0.69, 0.996, 288, 284, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH TG101209
26, 4e4mE, 0.9887, 0.68, 0.993, 296, 284, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
27, 4e4mA, 0.9887, 0.67, 0.993, 296, 284, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
28, 5cf6A, 0.9885, 0.62, 0.996, 285, 283, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 10-[(2S)-23-DIHYDROXYPROPYL]-3-METHYL-7-(METHYLAMINO)-35810- TETRAAZATRICYCLO [7.3.0.026]DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
29, 3q32B, 0.9870, 0.75, 0.996, 294, 284, STRUCTURE OF JANUS KINASE 2 WITH A PYRROLOTRIAZINE INHIBITOR
30, 2w1iA, 0.9870, 0.77, 1.000, 284, 284, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
31, 5cf8B, 0.9864, 0.67, 0.996, 288, 283, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-35810- TETRAAZATRICYCLO[7.3.0.06] DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
32, 2w1iB, 0.9863, 0.80, 1.000, 284, 284, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
33, 5cf6B, 0.9860, 0.86, 0.993, 290, 284, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 10-[(2S)-23-DIHYDROXYPROPYL]-3-METHYL-7-(METHYLAMINO)-35810- TETRAAZATRICYCLO [7.3.0.026]DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
34, 4e6dB, 0.9859, 0.67, 0.986, 286, 283, JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 7
35, 4f09A, 0.9856, 0.79, 0.996, 288, 284, DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2
36, 4ivaA, 0.9855, 0.79, 0.996, 290, 284, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR TRANS-4-[(8AS)- 2-[(1R)-1-HYDROXYETHYL]IMIDAZO[45-D]PYRROLO[23-B]PYRIDIN-1(8AH)- YL]CYCLOHEXANECARBONITRILE
37, 4e6qA, 0.9842, 0.83, 0.982, 296, 284, JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 12
38, 4e4mD, 0.9842, 0.82, 0.996, 296, 284, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
39, 3krrA, 0.9841, 0.75, 0.996, 291, 283, CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT QUINOXALINE ATP SITE INHIBITOR
40, 4e4mB, 0.9840, 0.83, 0.996, 296, 284, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
41, 3e62A, 0.9840, 0.76, 0.996, 291, 283, FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
42, 4p7eA, 0.9838, 0.52, 1.000, 281, 281, TRIAZOLOPYRIDINE COMPOUNDS AS SELECTIVE JAK1 INHIBITORS: FROM HIT IDENTIFICATION TO GLPG0634
43, 3e63A, 0.9838, 0.77, 0.996, 290, 283, FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
44, 4e6qB, 0.9837, 0.85, 0.982, 296, 284, JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 12
45, 4p7eB, 0.9834, 0.63, 1.000, 285, 282, TRIAZOLOPYRIDINE COMPOUNDS AS SELECTIVE JAK1 INHIBITORS: FROM HIT IDENTIFICATION TO GLPG0634
46, 4d0xA, 0.9815, 0.83, 0.996, 291, 283, PYRROLE-3-CARBOXAMIDES AS POTENT AND SELECTIVE JAK2 INHIBITORS
47, 5aepA, 0.9808, 0.85, 0.996, 287, 283, NOVEL PYRROLE CARBOXAMIDE INHIBITORS OF JAK2 AS POTENTIAL TREATMENT OF MYELOPROLIFERATIVE DISORDERS
48, 4gfmA, 0.9808, 0.75, 0.996, 289, 282, JAK2 KINASE (JH1 DOMAIN) WITH 26-DICHLORO-N-(2-OXO-25- DIHYDROPYRIDIN-4-YL)BENZAMIDE
49, 3e64A, 0.9807, 0.87, 0.996, 291, 283, FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
50, 3lpbB, 0.9780, 0.58, 0.996, 284, 280, CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT 28-DIARYL- QUINOXALINE INHIBITOR
51, 4d0wA, 0.9766, 0.77, 0.996, 289, 281, PYRROLE-3-CARBOXAMIDES AS POTENT AND SELECTIVE JAK2 INHIBITORS
52, 4ytiA, 0.9759, 0.87, 0.996, 284, 282, DISCOVERY OF VX-509 (DECERNOTINIB): A POTENT AND SELECTIVE JANUS KINASE (JAK) 3 INHIBITOR FOR THE TREATMENT OF AUTOIMMUNE DISEASE
53, 4gmyA, 0.9746, 1.04, 0.993, 298, 284, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH 26-DICHLORO-N-{2- [(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}BENZAMIDE
54, 3rvgA, 0.9744, 0.63, 0.996, 285, 279, CRYSTALS STRUCTURE OF JAK2 WITH A 1-AMINO-5H-PYRIDO[43-B]INDOL-4- CARBOXAMIDE INHIBITOR
55, 4gl9D, 0.9742, 0.92, 0.965, 282, 282, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN
56, 4jiaA, 0.9741, 1.05, 0.993, 298, 284, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 9
57, 4ythA, 0.9740, 0.92, 0.993, 287, 282, DISCOVERY OF VX-509 (DECERNOTINIB): A POTENT AND SELECTIVE JANUS KINASE (JAK) 3 INHIBITOR FOR THE TREATMENT OF AUTOIMMUNE DISEASES
58, 4gl9C, 0.9736, 0.94, 0.965, 282, 282, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN
59, 4gl9A, 0.9729, 0.96, 0.965, 282, 282, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN
60, 6bbvA, 0.9725, 1.10, 0.986, 289, 283, CRYSTAL STRUCTURE OF JAK2 IN COMPLEX WITH COMPOUND 25
61, 4ytfA, 0.9725, 0.79, 0.996, 283, 280, DISCOVERY OF VX-509 (DECERNOTINIB): A POTENT AND SELECTIVE JANUS KINASE (JAK) 3 INHIBITOR FOR THE TREATMENT OF AUTOIMMUNE DISEASES
62, 3lpbA, 0.9725, 0.34, 0.993, 278, 277, CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT 28-DIARYL- QUINOXALINE INHIBITOR
63, 3io7A, 0.9725, 0.78, 0.996, 282, 280, 2-AMINOPYRAZOLO[15-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2
64, 3iokA, 0.9724, 0.80, 0.996, 285, 280, 2-AMINOPYRAZOLO[15-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2
65, 4ytcA, 0.9722, 0.79, 0.993, 284, 280, DISCOVERY OF VX-509 (DECERNOTINIB): A POTENT AND SELECTIVE JANUS KINASE (JAK) 3 INHIBITOR FOR THE TREATMENT OF AUTOIMMUNE DISEASE
66, 4bbfD, 0.9718, 0.83, 0.996, 288, 280, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
67, 4bbfA, 0.9713, 0.85, 0.996, 288, 280, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
68, 5tq3B, 0.9696, 1.01, 0.975, 285, 281, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
69, 5l3aA, 0.9689, 1.04, 0.993, 290, 282, FRAGMENT-BASED DISCOVERY OF 6-ARYLINDAZOLE JAK INHIBITORS
70, 3kckA, 0.9689, 0.88, 0.996, 285, 280, A NOVEL CHEMOTYPE OF KINASE INHIBITORS
71, 3jy9A, 0.9686, 0.89, 0.996, 282, 280, JANUS KINASE 2 INHIBITORS
72, 5tq8A, 0.9679, 1.25, 0.986, 291, 283, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
73, 4gl9B, 0.9664, 0.95, 0.957, 280, 280, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN
74, 5tq5A, 0.9663, 1.31, 0.986, 291, 283, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
75, 2xa4A, 0.9658, 0.50, 0.989, 276, 276, INHIBITORS OF JAK2 KINASE DOMAIN
76, 4bbeC, 0.9649, 1.00, 0.996, 288, 280, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
77, 4bbeB, 0.9649, 0.99, 0.996, 288, 280, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
78, 4bbfB, 0.9644, 1.02, 0.996, 288, 280, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
79, 4bbfC, 0.9639, 1.03, 0.996, 288, 280, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
80, 4bbeD, 0.9621, 1.07, 0.996, 288, 280, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
81, 5usyA, 0.9620, 0.98, 0.996, 287, 279, JAK2 JH1 IN COMPLEX WITH JNJ-7706621
82, 4bbeA, 0.9617, 1.08, 0.996, 288, 280, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
83, 5tq3A, 0.9614, 0.92, 0.975, 282, 278, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
84, 3pjcA, 0.9608, 1.57, 0.611, 286, 283, CRYSTAL STRUCTURE OF JAK3 COMPLEXED WITH A POTENT ATP SITE INHIBITOR SHOWING HIGH SELECTIVITY WITHIN THE JANUS KINASE FAMILY
85, 5wevA, 0.9600, 0.97, 0.989, 293, 279, IDENTIFICATION OF AN IMIDAZOPYRIDINE SCAFFOLD TO GENERATE POTENT AND SELECTIVE TYK2 INHIBITORS THAT DEMONSTRATE ACTIVITY IN AN IN VIVO PSORIASIS MODEL
86, 6drwA, 0.9597, 0.92, 0.986, 289, 278, JAK2 JH1 IN COMPLEX WITH JNJ-7706621 (CRYSTAL FORM 2) 
87, 2xa4B, 0.9585, 0.64, 0.989, 275, 275, INHIBITORS OF JAK2 KINASE DOMAIN
88, 4py1A, 0.9583, 1.20, 0.512, 289, 281, CRYSTAL STRUCTURE OF TYK2 IN COMPLEX WITH COMPOUND 15 6-((25- DIMETHOXYPHENYL)THIO)-3-(1-METHYL-1H-PYRAZOL-4-YL)-[124]TRIAZOLO[4 3-B]PYRIDAZINE
89, 5tq6A, 0.9566, 0.59, 0.989, 274, 274, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
90, 4giiA, 0.9565, 1.24, 0.505, 289, 281, TYK2 (JH1) IN COMPLEX WITH 26-DICHLORO-4-CYANO-N-{2- [(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}BENZAMIDE
91, 4gihA, 0.9561, 1.16, 0.507, 288, 280, TYK2 (JH1) IN COMPLEX WITH 26-DICHLORO-N-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}BENZAMIDE
92, 4gj2A, 0.9559, 1.17, 0.507, 288, 280, TYK2 (JH1) IN COMPLEX WITH 26-DICHLORO-N-[2-({[(1R2R)-2- FLUOROCYCLOPROPYL]CARBONYL}AMINO)PYRIDIN-4-YL]BENZAMIDE
93, 3lxnA, 0.9555, 1.09, 0.509, 287, 279, STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
94, 4gj3A, 0.9550, 1.18, 0.507, 288, 280, TYK2 (JH1) IN COMPLEX WITH 26-DICHLORO-4-CYANO-N-[2-({[(1R2R)-2- FLUOROCYCLOPROPYL]CARBONYL}AMINO)PYRIDIN-4-YL]BENZAMIDE
95, 5usyB, 0.9548, 1.21, 0.996, 287, 279, JAK2 JH1 IN COMPLEX WITH JNJ-7706621
96, 4c62A, 0.9542, 0.56, 0.989, 273, 273, INHIBITORS OF JAK2 KINASE DOMAIN
97, 4c61B, 0.9541, 0.69, 0.993, 274, 274, INHIBITORS OF JAK2 KINASE DOMAIN
98, 3zmmA, 0.9541, 0.56, 0.989, 273, 273, INHIBITORS OF JAK2 KINASE DOMAIN
99, 3zmmB, 0.9535, 0.71, 0.993, 274, 274, INHIBITORS OF JAK2 KINASE DOMAIN
100, 5lwnA, 0.9534, 1.40, 0.606, 290, 282, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 5 (FM409)
101, 4gvjA, 0.9534, 1.35, 0.509, 290, 281, TYK2 (JH1) IN COMPLEX WITH ADENOSINE DI-PHOSPHATE
102, 6gl9B, 0.9529, 1.41, 0.606, 291, 282, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 10 (FM475) 
103, 4c61A, 0.9522, 0.48, 0.993, 272, 272, INHIBITORS OF JAK2 KINASE DOMAIN
104, 4d1sA, 0.9521, 0.84, 0.993, 280, 275, PYRROLE-3-CARBOXAMIDES AS POTENT AND SELECTIVE JAK2 INHIBITORS
105, 4k77A, 0.9520, 1.03, 0.552, 282, 277, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 6
106, 1yvjA, 0.9517, 1.62, 0.610, 288, 282, CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN IN COMPLEX WITH A STAUROSPORINE ANALOGUE
107, 5lwmA, 0.9512, 1.44, 0.606, 290, 282, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 4 (FM381)
108, 6gl9A, 0.9505, 1.44, 0.606, 292, 282, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 10 (FM475) 
109, 5tq4A, 0.9499, 1.67, 0.986, 290, 284, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
110, 4k77B, 0.9491, 1.05, 0.554, 280, 276, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 6
111, 5hx8A, 0.9489, 1.02, 0.554, 291, 276, JAK1 COMPLEX WITH 4-[(4-AMINOCYCLOHEXYL)AMINO]-3-(1H-BENZIMIDAZOL-2- YL)-1H-PYRIDIN-2-ONE
112, 5wo4A, 0.9487, 1.01, 0.554, 292, 276, JAK1 COMPLEXED WITH COMPOUND 28
113, 3zc6A, 0.9481, 1.05, 0.615, 277, 275, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH AN INDAZOLE SUBSTITUTED PYRROLOPYRAZINE INHIBITOR
114, 5walA, 0.9478, 1.27, 0.498, 286, 279, IDENTIFICATION OF AN IMIDAZOPYRIDINE SCAFFOLD TO GENERATE POTENT AND SELECTIVE TYK2 INHIBITORS THAT DEMONSTRATE ACTIVITY IN AN IN VIVO PSORIASIS MODEL
115, 3eyhA, 0.9477, 1.16, 0.552, 285, 277, CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
116, 4ivbB, 0.9470, 1.09, 0.554, 280, 276, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR TRANS-4-{2- [(1R)-1-HYDROXYETHYL]IMIDAZO[45-D]PYRROLO[23-B]PYRIDIN-1(6H)- YL}CYCLOHEXANECARBONITRILE
117, 4i5cB, 0.9468, 0.98, 0.556, 291, 275, THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
118, 5wo4B, 0.9464, 1.11, 0.554, 280, 276, JAK1 COMPLEXED WITH COMPOUND 28
119, 4ivdB, 0.9462, 1.12, 0.554, 280, 276, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 34
120, 4ivcB, 0.9462, 1.11, 0.554, 280, 276, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR (TRANS-4-{2- [(1R)-1-HYDROXYETHYL]IMIDAZO[45-D]PYRROLO[23-B]PYRIDIN-1(6H)- YL}CYCLOHEXYL)ACETONITRILE
121, 6glaA, 0.9460, 1.43, 0.600, 288, 280, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 11 (FM481) 
122, 4e4nB, 0.9459, 1.15, 0.554, 280, 276, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 49
123, 5tq6B, 0.9457, 0.61, 0.989, 271, 271, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
124, 3zc6B, 0.9457, 0.83, 0.619, 276, 273, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH AN INDAZOLE SUBSTITUTED PYRROLOPYRAZINE INHIBITOR
125, 5e1eA, 0.9456, 1.04, 0.556, 279, 275, HUMAN JAK1 KINASE IN COMPLEX WITH COMPOUND 30 AT 2.30 ANGSTROMS RESOLUTION
126, 4k6zA, 0.9455, 1.01, 0.556, 279, 275, THE JAK1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 37
127, 4ivbA, 0.9454, 1.01, 0.556, 291, 275, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR TRANS-4-{2- [(1R)-1-HYDROXYETHYL]IMIDAZO[45-D]PYRROLO[23-B]PYRIDIN-1(6H)- YL}CYCLOHEXANECARBONITRILE
128, 4e1zA, 0.9453, 1.36, 0.498, 288, 279, STRUCTURE OF MOUSE TYK-2 COMPLEXED TO A 3-AMINOINDAZOLE INHIBITOR
129, 3eygA, 0.9451, 1.05, 0.556, 280, 275, CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
130, 4c62B, 0.9450, 0.65, 0.993, 271, 271, INHIBITORS OF JAK2 KINASE DOMAIN
131, 4i5cA, 0.9448, 1.07, 0.553, 279, 275, THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
132, 4ei4B, 0.9447, 1.15, 0.554, 280, 276, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 20
133, 4ivcA, 0.9446, 1.03, 0.556, 291, 275, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR (TRANS-4-{2- [(1R)-1-HYDROXYETHYL]IMIDAZO[45-D]PYRROLO[23-B]PYRIDIN-1(6H)- YL}CYCLOHEXYL)ACETONITRILE
134, 6glbB, 0.9445, 1.44, 0.600, 288, 280, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 20 (FM484) 
135, 5e1eB, 0.9444, 1.03, 0.556, 280, 275, HUMAN JAK1 KINASE IN COMPLEX WITH COMPOUND 30 AT 2.30 ANGSTROMS RESOLUTION
136, 4rioA, 0.9443, 1.41, 0.619, 285, 278, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRIDAZINE CARBOXAMIDE INHIBITOR
137, 5hx8B, 0.9440, 1.09, 0.553, 279, 275, JAK1 COMPLEX WITH 4-[(4-AMINOCYCLOHEXYL)AMINO]-3-(1H-BENZIMIDAZOL-2- YL)-1H-PYRIDIN-2-ONE
138, 4hvgA, 0.9440, 1.27, 0.617, 281, 277, JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[23- B]PYRAZINE-7-CARBOXYLIC ACID ((S)-2-HYDROXY-12-DIMETHYL-PROPYL)- AMIDE
139, 6glbA, 0.9436, 1.45, 0.600, 288, 280, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 20 (FM484) 
140, 4e5wA, 0.9434, 1.05, 0.556, 292, 275, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 26
141, 6bbuA, 0.9433, 1.15, 0.554, 279, 276, CRYSTAL STRUCTURE OF JAK1 IN COMPLEX WITH COMPOUND 25
142, 4e20A, 0.9432, 1.16, 0.507, 282, 276, STRUCTURE OF MOUSE TYK-2 COMPLEXED TO A 3-AMINOINDAZOLE INHIBITOR
143, 4fk6B, 0.9431, 1.22, 0.552, 284, 277, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 72
144, 4e4nA, 0.9431, 1.11, 0.556, 291, 275, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 49
145, 4ehzB, 0.9429, 1.17, 0.554, 280, 276, THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
146, 6glaB, 0.9424, 1.31, 0.601, 286, 278, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 11 (FM481) 
147, 4ivdA, 0.9416, 1.03, 0.558, 290, 274, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 34
148, 4e4lE, 0.9413, 1.10, 0.556, 280, 275, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
149, 4i6qA, 0.9409, 1.08, 0.624, 277, 274, JAK3 KINASE DOMAIN IN COMPLEX WITH 2-PHENOXY-5H-PYRROLO[23- B]PYRAZINE-7-CARBOXYLIC ACID ((S)-1-CYCLOPROPYL-ETHYL)-AMIDE
150, 5tq7A, 0.9407, 0.82, 0.985, 275, 271, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
151, 3nz0A, 0.9403, 1.17, 0.502, 285, 275, NON-PHOSPHORYLATED TYK2 KINASE WITH CMP6
152, 3zc6C, 0.9400, 0.99, 0.619, 275, 273, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH AN INDAZOLE SUBSTITUTED PYRROLOPYRAZINE INHIBITOR
153, 4ehzD, 0.9399, 1.23, 0.554, 280, 276, THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
154, 4ehzC, 0.9399, 1.13, 0.556, 278, 275, THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
155, 4ehzA, 0.9391, 1.16, 0.556, 290, 275, THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
156, 4e5wB, 0.9388, 1.00, 0.557, 278, 273, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 26
157, 4z16B, 0.9382, 1.13, 0.624, 276, 274, CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN COVALENTLY BOUND TO N-(3- (((5-CHLORO-2-((2-METHOXY-4-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO) PYRIMIDIN-4-YL)AMINO)METHYL)PHENYL)ACRYLAMIDE
158, 5tozA, 0.9381, 1.32, 0.622, 278, 275, JAK3 WITH COVALENT INHIBITOR PF-06651600
159, 4fk6A, 0.9378, 1.19, 0.553, 285, 275, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 72
160, 4e4lB, 0.9373, 1.11, 0.558, 279, 274, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
161, 3lxlA, 0.9365, 1.17, 0.630, 281, 273, STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
162, 4ei4A, 0.9360, 1.08, 0.560, 289, 273, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 20
163, 4hvhA, 0.9357, 1.19, 0.624, 278, 274, JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[23- B]PYRAZINE-7-CARBOXYLIC ACID ((R)-2-HYDROXY-12-DIMETHYL-PROPYL
164, 4e4lD, 0.9357, 1.17, 0.558, 281, 274, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
165, 3lxkA, 0.9352, 1.14, 0.629, 279, 272, STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
166, 3zepC, 0.9344, 1.15, 0.612, 276, 273, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRAZINE-2-PHENYL ETHER INHIBITOR
167, 3zepA, 0.9341, 1.08, 0.632, 274, 272, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRAZINE-2-PHENYL ETHER INHIBITOR
168, 3zepD, 0.9329, 0.88, 0.630, 272, 270, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRAZINE-2-PHENYL ETHER INHIBITOR
169, 4hvdA, 0.9327, 1.18, 0.626, 276, 273, JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[23- B]PYRAZINE-7-CARBOXYLIC ACID ((S)-122-TRIMETHYL-PROPYL)-AMIDE
170, 5khwB, 0.9323, 1.22, 0.560, 276, 273, CRYSTAL STRUCTURE OF JAK1 IN COMPLEX WITH ADP
171, 5f1zA, 0.9320, 1.18, 0.516, 281, 273, STRUCTURE OF TYK2 WITH INHIBITOR 16: 3-AZANYL-5-[(2~{S})-3- METHYLBUTAN-2-YL]-7-[1-METHYL-5-(2-OXIDANYLPROPAN-2-YL)PYRAZOL-3-YL]- 1~{H}-PYRAZOLO[43-C]PYRIDIN-4-ONE
172, 3lxpA, 0.9316, 1.39, 0.493, 285, 276, STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
173, 4e4lA, 0.9314, 1.17, 0.560, 277, 273, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
174, 5tq7B, 0.9309, 0.94, 0.981, 269, 269, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
175, 5khwA, 0.9307, 1.26, 0.560, 276, 273, CRYSTAL STRUCTURE OF JAK1 IN COMPLEX WITH ADP
176, 4qt1A, 0.9305, 1.21, 0.626, 277, 273, JAK3 KINASE DOMAIN IN COMPLEX WITH 1-[(3S)-1-ISOBUTYLSULFONYL-3- PIPERIDYL]-3-(5H-PYRROLO[23-B]PYRAZIN-2-YL)UREA
177, 6c7yA, 0.9303, 1.05, 0.557, 273, 271, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS1 IN COMPLEX WITH JAK1 KINASE DOMAIN 
178, 4hviA, 0.9296, 1.11, 0.620, 274, 271, JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[23- B]PYRAZINE-7-CARBOXYLIC ACID ((R)-1-METHYL-2-OXO-2-PIPERIDIN-1-YL- ETHYL)-AMIDE
179, 5ttvA, 0.9288, 1.30, 0.618, 280, 272, JAK3 WITH COVALENT INHIBITOR 6
180, 5khxA, 0.9283, 0.99, 0.556, 276, 270, CRYSTAL STRUCTURE OF JAK1 IN COMPLEX WITH PF-4950736
181, 5w86D, 0.9269, 1.10, 0.619, 272, 270, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 46-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)
182, 4v0gB, 0.9262, 1.28, 0.618, 272, 272, JAK3 IN COMPLEX WITH A COVALENT EGFR INHIBITOR
183, 5ttsA, 0.9250, 1.18, 0.626, 274, 270, JAK3 WITH COVALENT INHIBITOR 4
184, 5w86C, 0.9243, 1.34, 0.620, 273, 271, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 46-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)
185, 4z16A, 0.9243, 1.03, 0.621, 271, 269, CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN COVALENTLY BOUND TO N-(3- (((5-CHLORO-2-((2-METHOXY-4-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO) PYRIMIDIN-4-YL)AMINO)METHYL)PHENYL)ACRYLAMIDE
186, 4z16C, 0.9236, 1.06, 0.621, 271, 269, CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN COVALENTLY BOUND TO N-(3- (((5-CHLORO-2-((2-METHOXY-4-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO) PYRIMIDIN-4-YL)AMINO)METHYL)PHENYL)ACRYLAMIDE
187, 4z16D, 0.9223, 1.08, 0.621, 271, 269, CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN COVALENTLY BOUND TO N-(3- (((5-CHLORO-2-((2-METHOXY-4-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO) PYRIMIDIN-4-YL)AMINO)METHYL)PHENYL)ACRYLAMIDE
188, 5f20A, 0.9217, 1.09, 0.520, 274, 269, STRUCTURE OF TYK2 WITH INHIBITOR 4: 3-AZANYL-5-(2-METHYLPHENYL)-7-(1- METHYLPYRAZOL-3-YL)-1~{H}-PYRAZOLO[43-C]PYRIDIN-4-ONE
189, 5ttuA, 0.9203, 1.11, 0.627, 271, 268, JAK3 WITH COVALENT INHIBITOR 7
190, 4qpsC, 0.9195, 1.13, 0.617, 276, 269, CRYSTAL STRUCTURE OF JAK3 COMPLEXED TO N-[3-(6-PHENYLAMINO-PYRAZIN-2- YL)-3H-BENZOIMIDAZOL-5-YL]-ACRYLAMIDE
191, 5w86A, 0.9192, 1.01, 0.622, 269, 267, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 46-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)
192, 4oliA, 0.9190, 0.97, 0.521, 539, 267, THE PSEUDOKINASE/KINASE PROTEIN FROM JAK-FAMILY MEMBER TYK2
193, 3zc6D, 0.9190, 0.81, 0.630, 267, 265, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH AN INDAZOLE SUBSTITUTED PYRROLOPYRAZINE INHIBITOR
194, 3zepB, 0.9146, 1.01, 0.624, 268, 266, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRAZINE-2-PHENYL ETHER INHIBITOR
195, 5w86B, 0.9140, 1.25, 0.622, 267, 267, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 46-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)
196, 4gfoA, 0.9132, 1.40, 0.513, 272, 269, TYK2 KINASE (JH1 DOMAIN) WITH 26-DICHLORO-N-(2-OXO-25- DIHYDROPYRIDIN-4-YL)BENZAMIDE
197, 3nyxA, 0.9112, 1.93, 0.469, 287, 277, NON-PHOSPHORYLATED TYK2 JH1 DOMAIN WITH QUINOLINE-THIADIAZOLE- THIOPHENE INHIBITOR
198, 4v0gA, 0.9102, 1.24, 0.629, 267, 267, JAK3 IN COMPLEX WITH A COVALENT EGFR INHIBITOR
199, 4qpsA, 0.9073, 1.34, 0.607, 270, 267, CRYSTAL STRUCTURE OF JAK3 COMPLEXED TO N-[3-(6-PHENYLAMINO-PYRAZIN-2- YL)-3H-BENZOIMIDAZOL-5-YL]-ACRYLAMIDE
200, 5vo6A, 0.9061, 1.15, 0.615, 271, 265, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRIDAZINE INHIBITOR
201, 3ugcA, 0.9036, 1.56, 0.989, 274, 267, STRUCTURAL BASIS OF JAK2 INHIBITION BY THE TYPE II INHIBTOR NVP-BBT594
202, 5wfjA, 0.9006, 1.31, 0.614, 265, 264, THE JAK3 KINASE DOMAIN IN COMPLEX WITH A COVALENT INHIBITOR
203, 5hezD, 0.8919, 1.87, 0.936, 289, 267, JAK2 KINASE (JH1 DOMAIN) MUTANT P1057A IN COMPLEX WITH TG101209
204, 5hezB, 0.8895, 1.90, 0.936, 289, 267, JAK2 KINASE (JH1 DOMAIN) MUTANT P1057A IN COMPLEX WITH TG101209
205, 5hezC, 0.8887, 1.94, 0.936, 289, 267, JAK2 KINASE (JH1 DOMAIN) MUTANT P1057A IN COMPLEX WITH TG101209
206, 4lrmC, 0.8860, 1.90, 0.340, 293, 268, EGFR D770_N771INSNPG IN COMPLEX WITH PD168393
207, 5xgnA, 0.8847, 2.04, 0.340, 302, 268, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/C797S IN COMPLEX WITH GO6976
208, 4lrmE, 0.8843, 1.88, 0.332, 290, 268, EGFR D770_N771INSNPG IN COMPLEX WITH PD168393
209, 5hezA, 0.8828, 1.97, 0.906, 287, 266, JAK2 KINASE (JH1 DOMAIN) MUTANT P1057A IN COMPLEX WITH TG101209
210, 2jiuA, 0.8823, 2.05, 0.340, 303, 268, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788
211, 4rixD, 0.8822, 2.02, 0.333, 297, 267, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-Q790R MUTATION
212, 4g5pA, 0.8822, 1.98, 0.336, 299, 268, CRYSTAL STRUCTURE OF EGFR KINASE T790M IN COMPLEX WITH BIBW2992
213, 4riyD, 0.8819, 2.00, 0.337, 297, 267, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-E909G MUTATION
214, 5jebA, 0.8818, 2.02, 0.333, 299, 267, CRYSTAL STRUCTURE OF EGFR TYROSINE KINASE DOMAIN WITH NOVEL INHIBITOR OF ACTIVE STATE OF HER2
215, 5cy3A, 0.8818, 1.78, 0.342, 276, 266, SYK CATALYTIC DOMAIN COMPLEXED WITH A POTENT AND ORALLY BIOAVAILABLE BENZISOTHIAZOLE INHIBITOR
216, 4lrmD, 0.8814, 2.04, 0.332, 289, 268, EGFR D770_N771INSNPG IN COMPLEX WITH PD168393
217, 4lrmA, 0.8798, 2.03, 0.332, 307, 268, EGFR D770_N771INSNPG IN COMPLEX WITH PD168393
218, 3ikaA, 0.8797, 2.09, 0.340, 310, 268, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M MUTANT COVALENTLY BINDING TO WZ4002
219, 2jitA, 0.8776, 2.05, 0.336, 299, 268, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION
220, 4riwD, 0.8767, 2.08, 0.337, 297, 267, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER
221, 4lrmB, 0.8741, 2.18, 0.332, 293, 268, EGFR D770_N771INSNPG IN COMPLEX WITH PD168393
222, 2x2kA, 0.8737, 2.05, 0.357, 289, 266, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
223, 4wd5A, 0.8725, 2.13, 0.341, 307, 267, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH QL-X138
224, 4li5A, 0.8723, 2.29, 0.332, 306, 268, EGFR-K IN COMPLEX WITH N-[3-[[5-CHLORO-4-(1H-INDOL-3-YL)PYRIMIDIN-2- YL]AMINO]-4-METHOXY-PHENYL] PROP-2-ENAMIDE
225, 2ivuA, 0.8715, 2.03, 0.358, 288, 265, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR ZD6474
226, 4ckiA, 0.8710, 2.04, 0.358, 293, 265, CRYSTAL STRUCTURE OF ONCOGENIC RET TYROSINE KINASE M918T BOUND TO ADENOSINE
227, 3gqiA, 0.8708, 2.15, 0.386, 304, 267, CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
228, 2ivtA, 0.8704, 2.05, 0.358, 288, 265, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN
229, 4ewhA, 0.8702, 1.85, 0.395, 274, 263, CO-CRYSTAL STRUCTURE OF ACK1 WITH INHIBITOR
230, 4rixB, 0.8692, 2.09, 0.337, 293, 264, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-Q790R MUTATION
231, 3bceC, 0.8688, 2.27, 0.363, 286, 267, CRYSTAL STRUCTURE OF THE ERBB4 KINASE
232, 4riyB, 0.8681, 2.09, 0.341, 293, 264, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-E909G MUTATION
233, 3pp0A, 0.8681, 2.17, 0.337, 286, 267, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN HER2 (ERBB2).
234, 4ewhB, 0.8673, 1.85, 0.397, 273, 262, CO-CRYSTAL STRUCTURE OF ACK1 WITH INHIBITOR
235, 4ckjA, 0.8671, 2.17, 0.357, 292, 266, CRYSTAL STRUCTURE OF RET TYROSINE KINASE DOMAIN BOUND TO ADENOSINE
236, 3r7oA, 0.8670, 2.10, 0.322, 299, 264, STRUCTURE OF DUALLY PHOSPHORYLATED C-MET RECEPTOR KINASE IN COMPLEX WITH AN MK-2461 ANALOG
237, 2ivsA, 0.8670, 2.12, 0.358, 284, 265, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED RET TYROSINE KINASE DOMAIN
238, 5eg3A, 0.8662, 2.06, 0.376, 301, 266, CRYSTAL STRUCTURE OF THE ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH THE CSH2 DOMAIN OF PHOSPHOLIPASE C GAMMA (PLCGAMMA)
239, 3q6wA, 0.8662, 2.10, 0.322, 297, 264, STRUCTURE OF DUALLY-PHOSPHORYLATED MET RECEPTOR KINASE IN COMPLEX WITH AN MK-2461 ANALOG WITH SPECIFICITY FOR THE ACTIVATED RECEPTOR
240, 5cxhA, 0.8658, 1.92, 0.341, 277, 264, SYK CATALYTIC DOMAIN COMPLEXED WITH A POTENT ORALLY BIOAVAILABLE THIAZOLE INHIBITOR
241, 4jq8A, 0.8653, 2.15, 0.335, 303, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 4B
242, 3bceB, 0.8646, 2.26, 0.362, 286, 265, CRYSTAL STRUCTURE OF THE ERBB4 KINASE
243, 2x2mA, 0.8645, 2.04, 0.357, 286, 263, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
244, 3pp0B, 0.8641, 2.12, 0.341, 296, 267, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN HER2 (ERBB2).
245, 5y5uA, 0.8639, 1.93, 0.347, 266, 262, CRYSTAL STRUCTURES OF SPLEEN TYROSINE KINASE IN COMPLEX WITH A NOVEL INHIBITOR 
246, 3bkbA, 0.8638, 1.88, 0.354, 373, 263, CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES)
247, 5flfD, 0.8630, 2.37, 0.388, 290, 268, DISEASE LINKED MUTATION IN FGFR
248, 4riwB, 0.8630, 2.19, 0.341, 293, 264, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER
249, 2j6mA, 0.8630, 2.24, 0.335, 306, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AEE788
250, 2itpA, 0.8630, 2.34, 0.333, 305, 267, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AEE788
251, 3clyA, 0.8629, 2.41, 0.382, 289, 267, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAINS TRAPPED IN TRANS-PHOSPHORYLATION REACTION
252, 4gfgA, 0.8627, 2.06, 0.343, 277, 265, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH R9021
253, 2x2lA, 0.8621, 2.08, 0.361, 287, 263, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
254, 3bceA, 0.8620, 2.24, 0.362, 285, 265, CRYSTAL STRUCTURE OF THE ERBB4 KINASE
255, 3eqrA, 0.8613, 1.94, 0.398, 270, 261, CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T74
256, 4iwdA, 0.8612, 2.18, 0.322, 299, 264, STRUCTURE OF DUALLY PHOSPHORYLATED C-MET RECEPTOR KINASE IN COMPLEX WITH AN MK-8033 ANALOG
257, 4jq7A, 0.8611, 2.10, 0.336, 303, 265, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 2A
258, 2ivvA, 0.8606, 2.06, 0.363, 282, 262, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR PP1
259, 4jr3A, 0.8605, 2.12, 0.336, 303, 265, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 3G
260, 1u59A, 0.8603, 2.01, 0.337, 282, 264, CRYSTAL STRUCTURE OF THE ZAP-70 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
261, 4j96B, 0.8592, 2.19, 0.383, 305, 266, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659M MUTATION IDENTIFIED IN CERVICAL CANCER.
262, 3cblA, 0.8590, 1.96, 0.354, 356, 263, CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE
263, 2itqA, 0.8588, 2.37, 0.333, 300, 267, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AFN941
264, 1pkgA, 0.8587, 2.02, 0.347, 290, 262, STRUCTURE OF A C-KIT KINASE PRODUCT COMPLEX
265, 5ugbA, 0.8586, 2.33, 0.331, 307, 266, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN IN COMPLEX WITH 4-(4-{[2- {[(3S)-1-ACETYLPYRROLIDIN-3-YL]AMINO}-9-(PROPAN-2-YL)-9H-PURIN-6- YL]AMINO}PHENYL)-1-METHYLPIPERAZIN-1-IUM
266, 5cavA, 0.8586, 2.40, 0.333, 306, 267, EGFR KINASE DOMAIN WITH COMPOUND 41A
267, 4rx7A, 0.8583, 2.00, 0.342, 272, 263, SYK CATALYTIC DOMAIN COMPLEXED WITH A POTENT TRIAZINE INHIBITOR
268, 3eqrB, 0.8581, 1.88, 0.404, 271, 260, CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T74
269, 4jrvA, 0.8580, 2.17, 0.333, 300, 264, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 4C
270, 1m17A, 0.8580, 2.28, 0.335, 312, 266, EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE DOMAIN WITH 4-ANILINOQUINAZOLINE INHIBITOR ERLOTINIB
271, 3eqpB, 0.8579, 1.88, 0.400, 270, 260, CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T95
272, 5flfA, 0.8576, 2.15, 0.389, 296, 265, DISEASE LINKED MUTATION IN FGFR
273, 4wnmA, 0.8571, 1.96, 0.347, 273, 262, SYK CATALYTIC DOMAIN IN COMPLEX WITH A POTENT TRIAZOLOPYRIDINE INHIBITOR
274, 2j5eA, 0.8570, 2.38, 0.335, 309, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 13-JAB
275, 5cxzA, 0.8569, 2.00, 0.345, 269, 261, SYK CATALYTIC DOMAIN COMPLEXED WITH NAPHTHYRIDINE INHIBITOR
276, 5u6bB, 0.8567, 1.89, 0.313, 291, 262, STRUCTURE OF THE AXL KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC INHIBITOR
277, 4tksA, 0.8566, 2.31, 0.336, 307, 265, NATIVE-SAD PHASING FOR HUMAN EGFR KINASE DOMAIN.
278, 5ui0B, 0.8565, 2.19, 0.381, 304, 265, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 2 HARBORING AN E565A/K659M DOUBLE GAIN-OF-FUNCTION MUTATION
279, 5ui0A, 0.8564, 2.23, 0.376, 301, 266, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 2 HARBORING AN E565A/K659M DOUBLE GAIN-OF-FUNCTION MUTATION
280, 5u6bD, 0.8564, 1.90, 0.313, 291, 262, STRUCTURE OF THE AXL KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC INHIBITOR
281, 6fekA, 0.8562, 1.98, 0.364, 294, 261, ONCOGENIC POINT MUTATION OF RET RECEPTOR TYROSINE KINASE
282, 5c26A, 0.8562, 2.12, 0.341, 272, 264, CRYSTAL STRUCTURE OF SYK IN COMPLEX WITH COMPOUND 1
283, 4xg6A, 0.8561, 2.03, 0.344, 271, 262, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
284, 5tr6A, 0.8555, 2.01, 0.349, 272, 261, DISCOVERY OF TAK-659 AN ORALLY AVAILABLE INVESTIGATIONAL INHIBITOR OF SPLEEN TYROSINE KINASE (SYK)
285, 4k33A, 0.8553, 2.00, 0.373, 293, 263, CRYSTAL STRUCTURE OF FGF RECEPTOR 3 (FGFR3) KINASE DOMAIN HARBORING THE K650E MUTATION A GAIN-OF-FUNCTION MUTATION RESPONSIBLE FOR THANATOPHORIC DYSPLASIA TYPE II AND SPERMATOCYTIC SEMINOMA
286, 1m14A, 0.8552, 2.18, 0.340, 307, 265, TYROSINE KINASE DOMAIN FROM EPIDERMAL GROWTH FACTOR RECEPTOR
287, 5ugaA, 0.8551, 2.48, 0.343, 283, 268, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN (L858R T790M V948R) IN COMPLEX WITH 4-(4-{[2-{[(3S)-1-ACETYLPYRROLIDIN-3-YL]AMINO}-9- (PROPAN-2-YL)-9H-PURIN-6-YL]AMINO}PHENYL)-1-METHYLPIPERAZIN-1-IUM
288, 5c27A, 0.8548, 2.15, 0.341, 272, 264, CRYSTAL STRUCTURE OF SYK IN COMPLEX WITH COMPOUND 2
289, 5lmbA, 0.8547, 2.04, 0.349, 264, 261, HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR
290, 4j98B, 0.8546, 2.16, 0.386, 304, 264, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659Q MUTATION.
291, 1xbcA, 0.8540, 1.93, 0.346, 268, 260, CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH STAUROSPORIN
292, 5hibA, 0.8539, 2.19, 0.342, 314, 263, EGFR KINASE DOMAIN MUTANT TMLR WITH A PYRAZOLOPYRIMIDINE INHIBITOR
293, 4rx8A, 0.8538, 2.01, 0.345, 269, 261, SYK CATALYTIC DOMAIN COMPLEXED WITH A POTENT TRIAZINE INHIBITOR2
294, 5hg5A, 0.8534, 2.51, 0.343, 302, 268, EGFR (L858R T790M V948R) IN COMPLEX WITH N-{3-[(2-{[4-(4- METHYLPIPERAZIN-1-YL)PHENYL]AMINO}-7H-PYRROLO[23-D]PYRIMIDIN-4-YL) OXY]PHENYL}PROP-2-ENAMIDE
295, 5flfB, 0.8534, 2.28, 0.383, 292, 266, DISEASE LINKED MUTATION IN FGFR
296, 4rssA, 0.8534, 2.22, 0.345, 269, 264, CRYSTAL STRUCTURE OF TYROSINE-PROTEIN KINASE SYK WITH AN INHIBITOR
297, 5hg7A, 0.8533, 2.45, 0.336, 280, 265, EGFR (L858R T790M V948R) IN COMPLEX WITH 1-{(3R4R)-3-[5-CHLORO-2- (1-METHYL-1H-PYRAZOL-4-YLAMINO)-7H-PYRROLO[23-D]PYRIMIDIN-4- YLOXYMETHYL]-4-METHOXY-PYRROLIDIN-1-YL}PROPENONE (PF-06459988)
298, 2g2hB, 0.8533, 2.02, 0.359, 272, 262, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
299, 5amnA, 0.8532, 2.18, 0.363, 287, 262, THE DISCOVERY OF 2-SUBSTITUTED PHENOL QUINAZOLINES AS POTENT AND SELECTIVE RET KINASE INHIBITORS
300, 4xg3B, 0.8532, 1.96, 0.342, 267, 260, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
301, 3vf8A, 0.8530, 1.94, 0.346, 265, 260, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE SYK CATALYTIC DOMAIN WITH PYRAZOLYLBENZIMIDAZOLE INHIBITOR 416
302, 5xdkA, 0.8528, 2.52, 0.341, 307, 267, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH CO-1686
303, 3srvA, 0.8528, 1.93, 0.347, 262, 259, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITOR
304, 3eqpA, 0.8527, 1.78, 0.403, 268, 258, CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T95
305, 5u8lA, 0.8525, 2.52, 0.343, 289, 268, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH A SULFONYL FLUORIDE PROBE XO44
306, 4ll0A, 0.8525, 1.74, 0.350, 291, 257, EGFR L858R/T790M IN COMPLEX WITH PD168393
307, 4puzB, 0.8523, 1.90, 0.347, 265, 259, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH GS- 9973
308, 2itwA, 0.8523, 2.29, 0.336, 300, 265, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AFN941
309, 4i23A, 0.8522, 2.03, 0.330, 304, 261, CRYSTAL STRUCTURE OF THE WILD-TYPE EGFR KINASE DOMAIN IN COMPLEX WITH DACOMITINIB (SOAKED)
310, 5j9yA, 0.8521, 2.20, 0.341, 300, 264, EGFR-T790M IN COMPLEX WITH PYRAZOLOPYRIMIDINE INHIBITOR 1B
311, 2pvfA, 0.8521, 2.18, 0.384, 285, 263, CRYSTAL STRUCTURE OF TYROSINE PHOSPHORYLATED ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH ATP ANALOG AND SUBSTRATE PEPTIDE
312, 2qohB, 0.8520, 1.94, 0.365, 281, 260, CRYSTAL STRUCTURE OF ABL KINASE BOUND WITH PPY-A
313, 6bl8A, 0.8517, 2.14, 0.365, 270, 263, PREDICTING THE CONFORMATIONAL VARIABILITY OF ABL TYROSINE KINASE USING MOLECULAR DYNAMICS SIMULATIONS AND MARKOV STATE MODELS
314, 2gs6A, 0.8517, 2.16, 0.338, 311, 263, CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AN ATP ANALOG-PEPTIDE CONJUGATE
315, 1xbaA, 0.8516, 1.96, 0.346, 266, 260, CRYSTAL STRUCTURE OF APO SYK TYROSINE KINASE DOMAIN
316, 2j0lA, 0.8513, 2.09, 0.330, 274, 264, CRYSTAL STRUCTURE OF A THE ACTIVE CONFORMATION OF THE KINASE DOMAIN OF FOCAL ADHESION KINASE WITH A PHOSPHORYLATED ACTIVATION LOOP.
317, 3vjnA, 0.8512, 2.09, 0.332, 297, 262, CRYSTAL STRUCTURE OF THE MUTATED EGFR KINASE DOMAIN (G719S/T790M) IN COMPLEX WITH AMPPNP.
318, 1m52A, 0.8512, 2.01, 0.359, 271, 262, CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH PD173955
319, 5hg8A, 0.8511, 2.55, 0.343, 300, 268, EGFR (L858R T790M V948R) IN COMPLEX WITH N-[3-({2-[(1-METHYL-1H- PYRAZOL-4-YL)AMINO]-7H-PYRROLO[23-D]PYRIMIDIN-4-YL}OXY)PHENYL]PROP- 2-ENAMIDE
320, 4j96A, 0.8510, 2.32, 0.380, 302, 266, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659M MUTATION IDENTIFIED IN CERVICAL CANCER.
321, 3dqwC, 0.8510, 2.04, 0.305, 275, 262, C-SRC KINASE DOMAIN THR338ILE MUTANT IN COMPLEX WITH ATPGS
322, 3ue4A, 0.8509, 2.09, 0.365, 270, 263, STRUCTURAL AND SPECTROSCOPIC ANALYSIS OF THE KINASE INHIBITOR BOSUTINIB BINDING TO THE ABL TYROSINE KINASE DOMAIN
323, 3srvB, 0.8508, 1.96, 0.351, 263, 259, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITOR
324, 5tt7A, 0.8507, 1.98, 0.340, 274, 259, DISCOVERY OF TAK-659 AN ORALLY AVAILABLE INVESTIGATIONAL INHIBITOR OF SPLEEN TYROSINE KINASE (SYK)
325, 3dqwD, 0.8507, 2.06, 0.305, 276, 262, C-SRC KINASE DOMAIN THR338ILE MUTANT IN COMPLEX WITH ATPGS
326, 3kxxA, 0.8503, 2.33, 0.383, 305, 266, STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1
327, 5lmaA, 0.8501, 1.95, 0.344, 267, 259, HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR
328, 2f4jA, 0.8497, 2.15, 0.365, 287, 263, STRUCTURE OF THE KINASE DOMAIN OF AN IMATINIB-RESISTANT ABL MUTANT IN COMPLEX WITH THE AURORA KINASE INHIBITOR VX-680
329, 4ll0B, 0.8496, 1.73, 0.348, 281, 256, EGFR L858R/T790M IN COMPLEX WITH PD168393
330, 5hg9A, 0.8495, 2.47, 0.337, 280, 264, EGFR (L858R T790M V948R) IN COMPLEX WITH 1-[(3R4R)-3-[({2-[(1- METHYL-1H-PYRAZOL-4-YL)AMINO]-7H-PYRROLO[23-D]PYRIMIDIN-4-YL}OXY) METHYL]-4-(TRIFLUOROMETHYL)PYRROLIDIN-1-YL]PROP-2-EN-1-ONE
331, 4twpB, 0.8495, 2.16, 0.365, 271, 263, THE CRYSTAL STRUCTURE OF HUMAN ABL1 T315I GATEKEEPER MUTANT KINASE DOMAIN IN COMPLEX WITH AXITINIB
332, 2v7aA, 0.8495, 2.09, 0.365, 269, 263, CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH THE INHIBITOR PHA-739358
333, 5ugcA, 0.8494, 2.43, 0.337, 280, 264, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN (L858R T790M V948R) IN COMPLEX WITH A COVALENT INHIBITOR N-[(3R4R)-4-FLUORO-1-{6-[(3- METHOXY-1-METHYL-1H-PYRAZOL-4-YL)AMINO]-9-METHYL-9H-PURIN-2- YL}PYRROLIDIN-3-YL]PROPANAMIDE
334, 5ug9A, 0.8494, 2.44, 0.337, 280, 264, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN (L858R T790M V948R) IN COMPLEX WITH A COVALENT INHIBITOR N-[(3R4R)-4-FLUORO-1-{6-[(3- METHOXY-1-METHYL-1H-PYRAZOL-4-YL)AMINO]-9-(PROPAN-2-YL)-9H-PURIN-2- YL}PYRROLIDIN-3-YL]PROPANAMIDE
335, 4zogB, 0.8494, 2.04, 0.364, 268, 261, VX-680/MK-0457 BINDS TO HUMAN ABL1 ALSO IN INACTIVE DFG CONFORMATIONS.
336, 4i0sA, 0.8492, 1.92, 0.345, 267, 258, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 2-(6- CHLORO-1-METHYL-1H-INDAZOL-3-YL)-5H-PYRROLO[23-B]PYRAZINE-7- CARBOXYLIC ACID ISOPROPYLAMIDE
337, 3kulB, 0.8492, 2.15, 0.344, 271, 262, KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 8 (EPHA8)
338, 2g2fA, 0.8492, 2.15, 0.365, 275, 263, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
339, 1m52B, 0.8491, 2.08, 0.359, 272, 262, CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH PD173955
340, 4fyoA, 0.8490, 1.94, 0.345, 267, 258, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH N-{(S)-1- [7-(34-DIMETHOXY-PHENYLAMINO)-THIAZOLO[54-D]PYRIMIDIN-5-YL]- PYRROLIDIN-3-YL}-TEREPHTHALAMIC ACID
341, 3vf9A, 0.8489, 2.00, 0.346, 265, 260, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE SYK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 027
342, 3cd3A, 0.8488, 1.87, 0.363, 352, 259, CRYSTAL STRUCTURE OF PHOSPHORYLATED HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE
343, 2z60A, 0.8486, 2.02, 0.365, 281, 260, CRYSTAL STRUCTURE OF THE T315I MUTANT OF ABL KINASE BOUND WITH PPY-A
344, 2x2mB, 0.8485, 2.04, 0.357, 279, 258, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
345, 5ug8A, 0.8484, 2.45, 0.337, 280, 264, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN (L858R T790M V948R) IN COMPLEX WITH A COVALENT INHIBITOR N-[(3R4R)-4-FLUORO-1-{6-[(1- METHYL-1H-PYRAZOL-4-YL)AMINO]-9-(PROPAN-2-YL)-9H-PURIN-2- YL}PYRROLIDIN-3-YL]PROPANAMIDE
346, 4xg3A, 0.8484, 1.97, 0.333, 262, 258, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
347, 4px6A, 0.8484, 1.85, 0.345, 262, 258, SYK CATALYTIC DOMAIN IN COMPLEX WITH A POTENT PYRIDOPYRIMIDINONE INHIBITOR
348, 5em8A, 0.8483, 2.44, 0.336, 303, 265, EGFR KINASE DOMAIN WITH PYRIDONE COMPOUND 13: 4-[(2-METHOXYPHENYL) AMINO]-~{N}-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-2-OXIDANYLIDENE-1~{H}- PYRIDINE-3-CARBOXAMIDE
349, 4r3pA, 0.8483, 2.39, 0.332, 310, 265, CRYSTAL STRUCTURES OF EGFR IN COMPLEX WITH MIG6
350, 3kxxB, 0.8483, 2.37, 0.387, 305, 266, STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1
351, 4xg9B, 0.8482, 1.98, 0.347, 265, 259, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
352, 3w2qA, 0.8481, 2.36, 0.336, 307, 265, EGFR KINASE DOMAIN T790M/L858R MUTANT WITH HKI-272
353, 3w2oA, 0.8478, 2.29, 0.330, 305, 264, EGFR KINASE DOMAIN T790M/L858R MUTANT WITH TAK-285
354, 4zjvA, 0.8477, 2.38, 0.345, 282, 267, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH MITOGEN- INDUCIBLE GENE 6 PROTEIN
355, 4pv0A, 0.8477, 2.02, 0.342, 268, 260, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH AN IMIDAZOPYRAZINE INHIBITOR
356, 3fqeA, 0.8477, 1.88, 0.345, 269, 258, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH YM193306
357, 4xg7A, 0.8476, 2.15, 0.330, 266, 261, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
358, 2eb2A, 0.8475, 2.36, 0.337, 305, 264, CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (G719S)
359, 2gs2A, 0.8472, 2.47, 0.336, 305, 265, CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN
360, 2qohA, 0.8470, 1.98, 0.367, 271, 259, CRYSTAL STRUCTURE OF ABL KINASE BOUND WITH PPY-A
361, 2g2hA, 0.8467, 2.15, 0.363, 272, 262, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
362, 5czhA, 0.8466, 2.39, 0.322, 311, 264, EGFR L858R MUTANT IN COMPLEX WITH AN OPTIMAL PEPTIDE SUBSTRATE
363, 4j98A, 0.8459, 2.31, 0.383, 304, 264, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659Q MUTATION.
364, 4i21B, 0.8459, 2.56, 0.342, 302, 269, CRYSTAL STRUCTURE OF L858R + T790M EGFR KINASE DOMAIN IN COMPLEX WITH MIG6 PEPTIDE
365, 5ghvB, 0.8458, 2.09, 0.338, 265, 260, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
366, 4i21A, 0.8458, 2.56, 0.342, 290, 269, CRYSTAL STRUCTURE OF L858R + T790M EGFR KINASE DOMAIN IN COMPLEX WITH MIG6 PEPTIDE
367, 1qpjA, 0.8458, 1.99, 0.354, 265, 260, CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE.
368, 4wkqA, 0.8456, 2.19, 0.332, 296, 259, 1.85 ANGSTROM STRUCTURE OF EGFR KINASE DOMAIN WITH GEFITINIB
369, 1u4dB, 0.8455, 1.79, 0.402, 262, 254, STRUCTURE OF THE ACK1 KINASE DOMAIN BOUND TO DEBROMOHYMENIALDISINE
370, 3vjoA, 0.8454, 2.14, 0.333, 298, 261, CRYSTAL STRUCTURE OF THE WILD-TYPE EGFR KINASE DOMAIN IN COMPLEX WITH AMPPNP.
371, 5y9tA, 0.8453, 2.35, 0.345, 300, 264, CRYSTAL STRUCTURE OF EGFR T790M MUTANT IN COMPLEX WITH NAQUOTINIB 
372, 4xg4A, 0.8453, 2.02, 0.344, 264, 259, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
373, 3lcdA, 0.8453, 2.12, 0.338, 290, 260, INHIBITOR BOUND TO A DFG-IN STRUCTURE OF THE KINASE DOMAIN OF CSF-1R
374, 3b2tA, 0.8453, 2.25, 0.375, 288, 264, STRUCTURE OF PHOSPHOTRANSFERASE
375, 5gtzA, 0.8451, 2.33, 0.349, 317, 261, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH JTS-1-39
376, 5ghvA, 0.8449, 2.11, 0.338, 265, 260, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
377, 3w2pA, 0.8449, 2.42, 0.311, 308, 264, EGFR KINASE DOMAIN T790M/L858R MUTANT WITH COMPOUND 2
378, 3fqhA, 0.8449, 1.88, 0.340, 262, 256, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH A 2-SUBSTITUTED 7-AZAINDOLE
379, 4dfnA, 0.8447, 2.15, 0.345, 269, 261, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH AN ADAMANTYLPYRAZINE INHIBITOR
380, 2itxA, 0.8446, 2.40, 0.337, 307, 264, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP- PNP
381, 2g2fB, 0.8444, 1.96, 0.360, 264, 258, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
382, 4id7A, 0.8443, 2.08, 0.402, 268, 259, ACK1 KINASE IN COMPLEX WITH THE INHIBITOR CIS-3-[8-AMINO-1-(4- PHENOXYPHENYL)IMIDAZO[15-A]PYRAZIN-3-YL]CYCLOBUTANOL
383, 2fo0A, 0.8443, 2.23, 0.361, 465, 263, ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE FORMS OF THE C-ABL TYROSINE KINASE
384, 2jiuB, 0.8441, 2.38, 0.300, 309, 267, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788
385, 4puzA, 0.8440, 1.94, 0.350, 263, 257, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH GS- 9973
386, 5cziA, 0.8438, 2.45, 0.322, 310, 264, EGFR L858R MUTANT IN COMPLEX WITH A SHC PEPTIDE SUBSTRATE
387, 4i0tA, 0.8438, 1.98, 0.346, 266, 257, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 2-(5678- TETRAHYDRO-IMIDAZO[15-A]PYRIDIN-1-YL)-5H-PYRROLO[23-B]PYRAZINE-7- CARBOXYLIC ACID TERT-BUTYLAMIDE
388, 4wa9B, 0.8436, 2.15, 0.351, 276, 262, THE CRYSTAL STRUCTURE OF HUMAN ABL1 WILD TYPE KINASE DOMAIN IN COMPLEX WITH AXITINIB
389, 5lmbB, 0.8435, 1.87, 0.348, 261, 256, HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR
390, 3ug1A, 0.8435, 2.04, 0.337, 296, 258, CRYSTAL STRUCTURE OF THE MUTATED EGFR KINASE DOMAIN (G719S/T790M) IN THE APO FORM
391, 5flfC, 0.8433, 2.34, 0.371, 283, 264, DISEASE LINKED MUTATION IN FGFR
392, 4rx9A, 0.8432, 1.92, 0.339, 268, 257, SYK CATALYTIC DOMAIN COMPLEXED WITH A POTENT PYRIMIDINE INHIBITOR
393, 4j95B, 0.8429, 2.36, 0.383, 282, 264, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME IN SPACE GROUP C2.
394, 2py3B, 0.8429, 2.54, 0.373, 284, 263, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565G MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
395, 3lcsA, 0.8426, 2.38, 0.302, 304, 265, CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
396, 3kxzA, 0.8425, 2.04, 0.354, 263, 260, THE COMPLEX CRYSTAL STRUCTURE OF LCK WITH A PROBE MOLECULE W259
397, 3kulA, 0.8425, 2.26, 0.341, 267, 261, KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 8 (EPHA8)
398, 4uxlA, 0.8423, 1.92, 0.345, 288, 258, STRUCTURE OF HUMAN ROS1 KINASE DOMAIN IN COMPLEX WITH PF-06463922
399, 4r3rA, 0.8422, 2.46, 0.322, 309, 264, CRYSTAL STRUCTURES OF EGFR IN COMPLEX WITH MIG6
400, 2j5fA, 0.8421, 2.26, 0.346, 308, 260, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 34-JAB
401, 2v7aB, 0.8420, 2.23, 0.365, 268, 263, CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH THE INHIBITOR PHA-739358
402, 4j97C, 0.8419, 2.09, 0.385, 283, 260, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659E MUTATION IDENTIFIED IN ENDOMETRIAL CANCER.
403, 1oecA, 0.8419, 2.19, 0.385, 280, 262, FGFR2 KINASE DOMAIN
404, 4j99D, 0.8417, 2.09, 0.388, 281, 260, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659T MUTATION.
405, 6d8eA, 0.8416, 2.38, 0.341, 304, 261, DISCOVERY OF A HIGHLY POTENT AND BROADLY EFFECTIVE EGFR AND HER2 EXON 20 INSERTION MUTANT INHIBITOR 
406, 4zogA, 0.8416, 2.23, 0.360, 269, 261, VX-680/MK-0457 BINDS TO HUMAN ABL1 ALSO IN INACTIVE DFG CONFORMATIONS.
407, 3dk7B, 0.8414, 1.98, 0.364, 268, 258, CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
408, 3ue4B, 0.8412, 2.17, 0.364, 268, 261, STRUCTURAL AND SPECTROSCOPIC ANALYSIS OF THE KINASE INHIBITOR BOSUTINIB BINDING TO THE ABL TYROSINE KINASE DOMAIN
409, 3hmiA, 0.8412, 2.06, 0.358, 268, 260, THE CRYSTAL STRUCTURE OF HUMAN ABL2 IN COMPLEX WITH 5-AMINO-3-{[4- (AMINOSULFONYL)PHENYL]AMINO}-N-(26-DIFLUOROPHENYL)-1H-124- TRIAZOLE-1-CARBOTHIOAMIDE
410, 4j97A, 0.8410, 2.24, 0.383, 282, 261, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659E MUTATION IDENTIFIED IN ENDOMETRIAL CANCER.
411, 2z8cA, 0.8409, 2.31, 0.303, 297, 261, PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH (4-{[5-CARBAMOYL-4-(3-METHYLANILINO)PYRIMIDIN-2- YL]AMINO}PHENYL)ACETIC ACID
412, 1opkA, 0.8409, 2.36, 0.361, 449, 263, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
413, 4j99B, 0.8408, 2.37, 0.383, 291, 264, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659T MUTATION.
414, 1xbbA, 0.8408, 2.05, 0.341, 268, 258, CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH GLEEVEC
415, 6bl8B, 0.8405, 2.10, 0.362, 268, 260, PREDICTING THE CONFORMATIONAL VARIABILITY OF ABL TYROSINE KINASE USING MOLECULAR DYNAMICS SIMULATIONS AND MARKOV STATE MODELS
416, 4xeyA, 0.8405, 2.01, 0.359, 269, 259, CRYSTAL STRUCTURE OF AN SH2-KINASE DOMAIN CONSTRUCT OF C-ABL TYROSINE KINASE
417, 4fl1A, 0.8405, 2.28, 0.345, 268, 261, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH
418, 4dflA, 0.8404, 1.99, 0.339, 263, 257, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH A SULFONAMIDOPYRAZINE PIPERIDINE INHIBITOR
419, 5y5tA, 0.8403, 1.99, 0.339, 263, 257, CRYSTAL STRUCTURES OF SPLEEN TYROSINE KINASE IN COMPLEX WITH A NOVEL INHIBITOR 
420, 5x26A, 0.8403, 2.34, 0.342, 302, 260, CRYSTAL STRUCTURE OF EGFR 696-1022 L858R IN COMPLEX WITH SKLB(3)
421, 3dk3B, 0.8403, 1.98, 0.364, 269, 258, CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
422, 2jitB, 0.8403, 2.41, 0.305, 312, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION
423, 5ugxA, 0.8402, 2.33, 0.380, 297, 263, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 2 HARBORING A E565A/D650V DOUBLE GAIN-OF-FUNCTION MUTATION
424, 2pwlB, 0.8402, 2.59, 0.381, 286, 265, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549H MUTATION RESPONSIBLE FOR CROUZON SYNDROME.
425, 4fynA, 0.8401, 1.97, 0.339, 267, 257, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 3-(8-{4- [ETHYL-(2-HYDROXY-ETHYL)-AMINO]-PHENYLAMINO}-IMIDAZO[12-A]PYRAZIN-5- YL)-PHENOL
426, 4cnhB, 0.8401, 1.97, 0.309, 293, 256, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 3-((1R)-1-(5-FLUORO-2- METHOXYPHENYL)ETHOXY)-5-(1-METHYL-1H-123-TRIAZOL-5-YL) PYRIDIN-2-AMINE
427, 3fqsA, 0.8401, 2.11, 0.341, 268, 258, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH R406
428, 1gjoA, 0.8400, 2.22, 0.385, 280, 262, THE FGFR2 TYROSINE KINASE DOMAIN
429, 4i0rA, 0.8399, 1.97, 0.336, 264, 256, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 2-(345- TRIMETHOXY-PHENYL)-5H-PYRROLO[23-B]PYRAZINE-7-CARBOXYLIC ACID ISOPROPYLAMIDE
430, 1oplB, 0.8398, 2.10, 0.363, 365, 259, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
431, 4lqmA, 0.8397, 2.35, 0.350, 305, 260, EGFR L858R IN COMPLEX WITH PD168393
432, 4j97B, 0.8397, 2.16, 0.381, 283, 260, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659E MUTATION IDENTIFIED IN ENDOMETRIAL CANCER.
433, 5feqA, 0.8396, 2.20, 0.351, 290, 259, EGFR KINASE DOMAIN IN COMPLEX WITH A COVALENT AMINOBENZIMIDAZOLE
434, 2gqgB, 0.8396, 2.10, 0.369, 276, 260, X-RAY CRYSTAL STRUCTURE OF DASATINIB (BMS-354825) BOUND TO ACTIVATED ABL KINASE DOMAIN
435, 1oplA, 0.8396, 2.39, 0.361, 451, 263, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
436, 5x27A, 0.8394, 2.24, 0.340, 302, 259, CRYSTAL STRUCTURE OF EGFR 696-1022 L858R IN COMPLEX WITH SKLB(5)
437, 4twpA, 0.8394, 2.06, 0.368, 266, 258, THE CRYSTAL STRUCTURE OF HUMAN ABL1 T315I GATEKEEPER MUTANT KINASE DOMAIN IN COMPLEX WITH AXITINIB
438, 5x28A, 0.8393, 2.26, 0.340, 310, 259, CRYSTAL STRUCTURE OF EGFR 696-1022 L858R IN COMPLEX WITH SKLB(6)
439, 2py3A, 0.8392, 2.47, 0.374, 282, 262, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565G MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
440, 4xliB, 0.8391, 2.03, 0.360, 264, 258, CRYSTAL STRUCTURE OF ABL2/ARG KINASE IN COMPLEX WITH DASATINIB
441, 2xynA, 0.8389, 2.06, 0.357, 264, 258, HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680
442, 1y57A, 0.8388, 2.28, 0.313, 452, 262, STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIBITOR
443, 4zjvB, 0.8387, 2.26, 0.346, 273, 263, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH MITOGEN- INDUCIBLE GENE 6 PROTEIN
444, 2ivsB, 0.8386, 1.86, 0.370, 277, 254, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED RET TYROSINE KINASE DOMAIN
445, 3dqwA, 0.8385, 2.25, 0.309, 278, 262, C-SRC KINASE DOMAIN THR338ILE MUTANT IN COMPLEX WITH ATPGS
446, 2pwlA, 0.8384, 2.58, 0.383, 284, 264, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549H MUTATION RESPONSIBLE FOR CROUZON SYNDROME.
447, 4f4pA, 0.8381, 2.02, 0.350, 262, 257, SYK IN COMPLEX WITH LIGAND LASW836
448, 2hziB, 0.8381, 1.98, 0.370, 264, 257, ABL KINASE DOMAIN IN COMPLEX WITH PD180970
449, 1u4dA, 0.8379, 1.70, 0.410, 258, 251, STRUCTURE OF THE ACK1 KINASE DOMAIN BOUND TO DEBROMOHYMENIALDISINE
450, 5tiuA, 0.8377, 1.91, 0.341, 266, 255, CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH INHIBITOR
451, 2dq7X, 0.8374, 1.90, 0.336, 262, 256, CRYSTAL STRUCTURE OF FYN KINASE DOMAIN COMPLEXED WITH STAUROSPORINE
452, 1qpdA, 0.8374, 2.16, 0.354, 270, 260, STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
453, 3ug2A, 0.8373, 2.14, 0.333, 299, 258, CRYSTAL STRUCTURE OF THE MUTATED EGFR KINASE DOMAIN (G719S/T790M) IN COMPLEX WITH GEFITINIB
454, 5x2kA, 0.8372, 2.51, 0.347, 314, 262, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH WZ4003
455, 2itoA, 0.8369, 2.30, 0.340, 303, 259, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH IRESSA
456, 4fz6A, 0.8367, 2.08, 0.339, 266, 257, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH [6-((S)-2- METHYL-PYRROLIDIN-1-YL)-PYRIDIN-2-YL]-(6-PHENYL-IMIDAZO[12- B]PYRIDAZIN-8-YL)-AMINE
457, 2gqgA, 0.8367, 2.14, 0.365, 277, 260, X-RAY CRYSTAL STRUCTURE OF DASATINIB (BMS-354825) BOUND TO ACTIVATED ABL KINASE DOMAIN
458, 4j97D, 0.8365, 2.20, 0.382, 285, 259, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659E MUTATION IDENTIFIED IN ENDOMETRIAL CANCER.
459, 3dqwB, 0.8365, 2.29, 0.309, 278, 262, C-SRC KINASE DOMAIN THR338ILE MUTANT IN COMPLEX WITH ATPGS
460, 1u54B, 0.8364, 1.81, 0.401, 261, 252, CRYSTAL STRUCTURES OF THE PHOSPHORYLATED AND UNPHOSPHORYLATED KINASE DOMAINS OF THE CDC42-ASSOCIATED TYROSINE KINASE ACK1 BOUND TO AMP-PCP
461, 4fz7A, 0.8363, 2.03, 0.340, 265, 256, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 6-((1R2S)- 2-AMINO-CYCLOHEXYLAMINO)-4-(6-ETHYL-PYRIDIN-2-YLAMINO)-PYRIDAZINE-3- CARBOXYLIC ACID AMIDE
462, 2qu5A, 0.8361, 2.28, 0.367, 292, 256, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR
463, 2hziA, 0.8359, 2.27, 0.368, 268, 261, ABL KINASE DOMAIN IN COMPLEX WITH PD180970
464, 5x2fD, 0.8358, 2.33, 0.341, 309, 261, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(6)
465, 4j99C, 0.8358, 2.35, 0.384, 291, 263, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659T MUTATION.
466, 2pz5B, 0.8358, 2.44, 0.373, 280, 260, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549T MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
467, 4j95C, 0.8356, 2.28, 0.385, 281, 262, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME IN SPACE GROUP C2.
468, 4i20A, 0.8356, 2.50, 0.341, 287, 267, CRYSTAL STRUCTURE OF MONOMERIC (V948R) PRIMARY ONCOGENIC MUTANT L858R EGFR KINASE DOMAIN
469, 3ikaB, 0.8356, 2.46, 0.302, 310, 265, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M MUTANT COVALENTLY BINDING TO WZ4002
470, 2q0bB, 0.8356, 2.49, 0.372, 282, 261, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565A MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
471, 2ofuA, 0.8356, 2.20, 0.354, 272, 260, X-RAY CRYSTAL STRUCTURE OF 2-AMINOPYRIMIDINE CARBAMATE 43 BOUND TO LCK
472, 3zewA, 0.8354, 2.25, 0.327, 269, 260, CRYSTAL STRUCTURE OF EPHB4 IN COMPLEX WITH STAUROSPORINE
473, 2of4A, 0.8354, 2.28, 0.349, 271, 261, CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 1 BOUND TO LCK
474, 2hz0A, 0.8354, 2.20, 0.362, 265, 257, ABL KINASE DOMAIN IN COMPLEX WITH NVP-AEG082
475, 3lctA, 0.8353, 2.54, 0.306, 308, 265, CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
476, 5fedA, 0.8352, 2.28, 0.337, 288, 258, EGFR KINASE DOMAIN IN COMPLEX WITH A COVALENT AMINOBENZIMIDAZOLE INHIBITOR.
477, 4xliA, 0.8352, 2.12, 0.360, 264, 258, CRYSTAL STRUCTURE OF ABL2/ARG KINASE IN COMPLEX WITH DASATINIB
478, 3fqhB, 0.8352, 1.87, 0.336, 258, 253, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH A 2-SUBSTITUTED 7-AZAINDOLE
479, 2hz4B, 0.8352, 1.96, 0.373, 261, 255, ABL KINASE DOMAIN UNLIGATED AND IN COMPLEX WITH TETRAHYDROSTAUROSPORINE
480, 3kmmA, 0.8349, 2.22, 0.358, 270, 260, STRUCTURE OF HUMAN LCK KINASE WITH A SMALL MOLECULE INHIBITOR
481, 1qpcA, 0.8348, 2.23, 0.358, 270, 260, STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
482, 4yjoA, 0.8347, 2.19, 0.340, 267, 259, THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000222
483, 3kf4A, 0.8347, 2.15, 0.368, 281, 258, STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE
484, 3bymA, 0.8347, 2.22, 0.358, 271, 260, X-RAY CO-CRYSTAL STRUCTURE AMINOBENZIMIDAZOLE TRIAZINE 1 BOUND TO LCK
485, 3ad6A, 0.8347, 2.29, 0.356, 272, 261, CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
486, 2pzpB, 0.8346, 2.46, 0.377, 282, 260, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K526E MUTATION RESPONSIBLE FOR CROUZON SYNDROME
487, 5t68B, 0.8344, 2.11, 0.341, 264, 258, CRYSTAL STRUCTURE OF SYK CATALYTIC DOMAIN IN COMPLEX WITH A FURO[32- D]PYRIMIDINE
488, 2psqA, 0.8344, 2.68, 0.381, 287, 265, CRYSTAL STRUCTURE OF UNPHOSPHORYLATED UNACTIVATED WILD TYPE FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN
489, 2itzA, 0.8344, 2.38, 0.340, 302, 259, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSA
490, 4hzrA, 0.8343, 1.86, 0.401, 261, 252, CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN
491, 5uhnA, 0.8342, 2.37, 0.380, 282, 263, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 2 HARBORING A N549H/E565A DOUBLE GAIN-OF-FUNCTION MUTATION
492, 3ac1A, 0.8342, 2.24, 0.358, 270, 260, CRYSTAL STRUCTURE OF PYRAZIN DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
493, 1k9aB, 0.8341, 1.77, 0.371, 441, 251, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
494, 5t68A, 0.8340, 2.10, 0.341, 266, 258, CRYSTAL STRUCTURE OF SYK CATALYTIC DOMAIN IN COMPLEX WITH A FURO[32- D]PYRIMIDINE
495, 1u54A, 0.8340, 1.85, 0.401, 262, 252, CRYSTAL STRUCTURES OF THE PHOSPHORYLATED AND UNPHOSPHORYLATED KINASE DOMAINS OF THE CDC42-ASSOCIATED TYROSINE KINASE ACK1 BOUND TO AMP-PCP
496, 3kf4B, 0.8337, 2.24, 0.367, 270, 259, STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE
497, 3d7uC, 0.8337, 1.78, 0.367, 257, 251, STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
498, 3d7uA, 0.8337, 1.78, 0.367, 257, 251, STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
499, 1k9aA, 0.8337, 1.78, 0.367, 439, 251, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
500, 4mkcA, 0.8336, 2.31, 0.308, 303, 260, CRYSTAL STRUCTURE OF ANAPLASTIC LYMPHOMA KINASE COMPLEXED WITH LDK378
501, 3b2tB, 0.8335, 2.22, 0.375, 287, 259, STRUCTURE OF PHOSPHOTRANSFERASE
502, 4hzrB, 0.8334, 1.59, 0.402, 258, 249, CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN
503, 2ittA, 0.8334, 2.36, 0.344, 302, 259, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AEE788
504, 3ac5A, 0.8333, 2.25, 0.358, 270, 260, CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
505, 2pvyA, 0.8333, 2.20, 0.376, 288, 258, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME.
506, 2of2A, 0.8333, 2.32, 0.349, 271, 261, CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 8 BOUND TO LCK
507, 2pz5A, 0.8332, 2.47, 0.373, 280, 260, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549T MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
508, 1t46A, 0.8331, 2.30, 0.346, 297, 257, STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE
509, 4yjuA, 0.8330, 2.04, 0.348, 262, 256, THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000249
510, 2itnA, 0.8329, 2.36, 0.344, 304, 259, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AMP-PNP
511, 2hz4A, 0.8329, 2.12, 0.370, 262, 257, ABL KINASE DOMAIN UNLIGATED AND IN COMPLEX WITH TETRAHYDROSTAUROSPORINE
512, 4xg8A, 0.8328, 1.99, 0.341, 258, 255, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
513, 2zm1A, 0.8328, 2.26, 0.358, 270, 260, CRYSTAL STRUCTURE OF IMIDAZO PYRAZIN 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
514, 4e93A, 0.8327, 1.65, 0.371, 361, 251, CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES)IN COMPLEX WITH TAE684
515, 3ri1A, 0.8327, 2.70, 0.381, 285, 265, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR2 KINASE IN COMPLEX WITH ARQ 069
516, 3fzrA, 0.8326, 2.00, 0.345, 261, 255, CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-431396
517, 3ac2A, 0.8326, 2.27, 0.358, 270, 260, CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
518, 3dk7A, 0.8325, 2.15, 0.364, 265, 258, CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
519, 2zm4A, 0.8325, 2.27, 0.358, 270, 260, CRYSTAL STRUCTURE OF IMIDAZO QUINOXALINE 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK ACTIVATED FORM (AUTO- PHOSPHORYLATED ON TYR394)
520, 3lckA, 0.8324, 2.27, 0.358, 270, 260, THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK) ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394)
521, 3ackA, 0.8324, 2.27, 0.358, 270, 260, CRYSTAL STRUCTURE OF PYRROLO PYRAZINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
522, 3ac3A, 0.8324, 2.27, 0.358, 270, 260, CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
523, 5y5uB, 0.8323, 1.85, 0.353, 257, 252, CRYSTAL STRUCTURES OF SPLEEN TYROSINE KINASE IN COMPLEX WITH A NOVEL INHIBITOR 
524, 3w2rA, 0.8323, 2.03, 0.337, 297, 255, EGFR KINASE DOMAIN T790M/L858R MUTANT WITH COMPOUND 4
525, 2ityA, 0.8323, 2.30, 0.349, 300, 258, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH IRESSA
526, 1qpeA, 0.8323, 2.25, 0.358, 270, 260, STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
527, 2pzpA, 0.8321, 2.48, 0.377, 280, 260, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K526E MUTATION RESPONSIBLE FOR CROUZON SYNDROME
528, 4g5jA, 0.8320, 2.08, 0.335, 307, 254, CRYSTAL STRUCTURE OF EGFR KINASE IN COMPLEX WITH BIBW2992
529, 3acjA, 0.8320, 2.28, 0.358, 270, 260, CRYSTAL STRUCTURE OF IMIDAZO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
530, 2zybA, 0.8320, 2.27, 0.358, 270, 260, CRYSTAL STRUCTURE OF PHENYLIMIDAZO PYRAZIN 2 BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
531, 3ad4A, 0.8319, 2.28, 0.358, 270, 260, CRYSTAL STRUCTURE OF METHOXY BENZOFURAN DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
532, 2rf9A, 0.8319, 2.56, 0.340, 280, 265, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
533, 4xg9A, 0.8318, 1.98, 0.350, 259, 254, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
534, 3et7A, 0.8318, 2.02, 0.345, 261, 255, CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-2318841
535, 3dk3A, 0.8318, 2.18, 0.364, 266, 258, CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
536, 2q0bA, 0.8318, 2.49, 0.373, 280, 260, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565A MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
537, 2b4sD, 0.8318, 2.30, 0.308, 294, 260, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE
538, 4xeyB, 0.8317, 1.87, 0.358, 359, 254, CRYSTAL STRUCTURE OF AN SH2-KINASE DOMAIN CONSTRUCT OF C-ABL TYROSINE KINASE
539, 3kxxC, 0.8317, 2.34, 0.391, 286, 261, STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1
540, 3ac4A, 0.8317, 2.28, 0.358, 270, 260, CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
541, 2r4bA, 0.8314, 2.26, 0.366, 292, 257, ERBB4 KINASE DOMAIN COMPLEXED WITH A THIENOPYRIMIDINE INHIBITOR
542, 2b4sB, 0.8313, 2.33, 0.308, 294, 260, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE
543, 3kxxD, 0.8312, 2.37, 0.391, 288, 261, STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1
544, 3ad5A, 0.8312, 2.30, 0.358, 270, 260, CRYSTAL STRUCTURE OF TRIAZOLONE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
545, 4xg2A, 0.8311, 2.05, 0.333, 259, 255, CRYSTAL STRUCTURE OF LIGAND-FREE SYK
546, 3ac8A, 0.8310, 2.29, 0.358, 270, 260, CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
547, 2pzrB, 0.8309, 2.51, 0.369, 282, 260, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K641R MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
548, 3bu6A, 0.8308, 2.24, 0.309, 294, 259, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PHOSPHOPEPTIDE
549, 2pvyD, 0.8308, 2.24, 0.380, 283, 258, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME.
550, 2g2iB, 0.8308, 2.19, 0.370, 265, 257, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
551, 2psqB, 0.8307, 2.70, 0.385, 286, 265, CRYSTAL STRUCTURE OF UNPHOSPHORYLATED UNACTIVATED WILD TYPE FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN
552, 5x2aB, 0.8305, 2.47, 0.337, 322, 261, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(3)
553, 4u0iA, 0.8305, 2.25, 0.348, 297, 256, CRYSTAL STRUCTURE OF KIT IN COMPLEX WITH PONATINIB
554, 2itvA, 0.8305, 2.40, 0.344, 303, 259, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AMP-PNP
555, 5x2cA, 0.8304, 2.29, 0.353, 304, 258, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(5)
556, 4i1zA, 0.8303, 2.56, 0.345, 287, 267, CRYSTAL STRUCTURE OF THE MONOMERIC (V948R) FORM OF THE GEFITINIB/ERLOTINIB RESISTANT EGFR KINASE DOMAIN L858R+T790M
557, 4hjoA, 0.8302, 2.25, 0.341, 278, 258, CRYSTAL STRUCTURE OF THE INACTIVE EGFR TYROSINE KINASE DOMAIN WITH ERLOTINIB
558, 3pxkB, 0.8301, 1.74, 0.348, 258, 250, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH PYRROLO[23- D]THIAZOLE
559, 5x2aC, 0.8298, 2.27, 0.354, 303, 257, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(3)
560, 4yjtA, 0.8298, 2.34, 0.347, 268, 259, THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000233
561, 3dk6A, 0.8298, 2.08, 0.367, 262, 256, CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
562, 5x2fC, 0.8296, 2.27, 0.354, 302, 257, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(6)
563, 4zseC, 0.8296, 2.25, 0.350, 301, 257, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R CRYSTAL FORM II
564, 1u46B, 0.8296, 1.81, 0.402, 257, 249, CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED KINASE DOMAIN OF THE TYROSINE KINASE ACK1
565, 3bu3A, 0.8295, 2.26, 0.309, 294, 259, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE
566, 5d41B, 0.8292, 2.28, 0.353, 302, 258, EGFR KINASE DOMAIN IN COMPLEX WITH MUTANT SELECTIVE ALLOSTERIC INHIBITOR
567, 3zfxA, 0.8292, 2.09, 0.345, 267, 255, CRYSTAL STRUCTURE OF EPHB1
568, 2xynC, 0.8292, 2.16, 0.358, 262, 257, HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680
569, 5x2fA, 0.8291, 2.29, 0.353, 301, 258, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(6)
570, 5gmpA, 0.8291, 2.34, 0.354, 305, 257, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH XTF-262
571, 4i24B, 0.8291, 2.38, 0.355, 304, 259, STRUCTURE OF T790M EGFR KINASE DOMAIN CO-CRYSTALLIZED WITH DACOMITINIB
572, 3byoA, 0.8291, 2.33, 0.358, 270, 260, X-RAY CO-CRYSTAL STRUCTURE OF 2-AMINO-6-PHENYLPYRIMIDO[5  4 :56]PYRIMIDO[12-A]BENZIMIDAZOL-5(6H)-ONE 25 BOUND TO LCK
573, 2r4bB, 0.8290, 2.24, 0.367, 291, 256, ERBB4 KINASE DOMAIN COMPLEXED WITH A THIENOPYRIMIDINE INHIBITOR
574, 5mjbA, 0.8289, 2.52, 0.323, 276, 263, KINASE DOMAIN OF HUMAN EPHB1 G703C MUTANT COVALENTLY BOUND TO A QUINAZOLINE-BASED INHIBITOR
575, 4zseA, 0.8288, 2.35, 0.349, 297, 258, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R CRYSTAL FORM II
576, 3ri1B, 0.8288, 2.73, 0.381, 283, 265, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR2 KINASE IN COMPLEX WITH ARQ 069
577, 3mdyA, 0.8288, 2.25, 0.276, 320, 257, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-1B (BMPR1B) IN COMPLEX WITH FKBP12 AND LDN- 193189
578, 5feeA, 0.8287, 2.16, 0.341, 287, 255, EGFR KINASE DOMAIN T790M MUTANT IN COMPLEX WITH A COVALENT AMINOBENZIMIDAZOLE INHIBITOR.
579, 5gtyH, 0.8286, 2.18, 0.349, 300, 255, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
580, 4z55A, 0.8286, 2.37, 0.313, 294, 259, ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN COMPLEXED WITH PYRAZOLOPYRIMIDINE DERIVATIVE OF LDK378
581, 3mdyC, 0.8286, 2.29, 0.275, 320, 258, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-1B (BMPR1B) IN COMPLEX WITH FKBP12 AND LDN- 193189
582, 2g2iA, 0.8286, 2.18, 0.374, 271, 257, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
583, 5yu9D, 0.8285, 2.28, 0.350, 300, 257, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH IBRUTINIB
584, 4yjpA, 0.8285, 2.27, 0.341, 263, 258, THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000223
585, 3zfxD, 0.8285, 2.14, 0.345, 265, 255, CRYSTAL STRUCTURE OF EPHB1
586, 1pkgB, 0.8285, 2.04, 0.349, 277, 252, STRUCTURE OF A C-KIT KINASE PRODUCT COMPLEX
587, 4wd5B, 0.8282, 2.42, 0.298, 304, 262, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH QL-X138
588, 5hcyA, 0.8281, 2.23, 0.353, 302, 255, EGFR KINASE DOMAIN MUTANT TMLR WITH 3-CARBOXAMIDE AZAINDOLE COMPOUND 13
589, 5x2aD, 0.8279, 2.41, 0.349, 297, 258, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(3)
590, 3zfxH, 0.8279, 2.12, 0.337, 266, 255, CRYSTAL STRUCTURE OF EPHB1
591, 2xynB, 0.8279, 2.25, 0.357, 264, 258, HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680
592, 5uglA, 0.8278, 2.46, 0.388, 285, 263, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 TYROSINE KINASE DOMAIN HARBORING THE D650V ACTIVATING MUTATION
593, 5cnnB, 0.8275, 2.41, 0.351, 304, 259, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN MUTANT I682Q
594, 1k9aE, 0.8275, 1.91, 0.369, 440, 252, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
595, 4yc8B, 0.8274, 2.17, 0.362, 264, 257, C-HELIX-OUT BINDING OF DASATINIB ANALOG TO C-ABL KINASE
596, 2pzrA, 0.8272, 2.50, 0.371, 280, 259, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K641R MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
597, 3l9pA, 0.8271, 2.45, 0.307, 303, 261, CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
598, 3sxsA, 0.8266, 2.19, 0.322, 264, 258, CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEXED WITH PP2
599, 5uwdA, 0.8265, 2.36, 0.332, 271, 256, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN (L858R T790M V948R) IN COMPLEX WITH THE COVALENT INHIBITOR CO-1686
600, 4zseB, 0.8265, 2.39, 0.349, 313, 258, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R CRYSTAL FORM II
601, 5x2cB, 0.8263, 2.35, 0.341, 303, 258, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(5)
602, 4j99A, 0.8263, 2.30, 0.392, 280, 260, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659T MUTATION.
603, 2j0jA, 0.8263, 2.15, 0.332, 611, 256, CRYSTAL STRUCTURE OF A FRAGMENT OF FOCAL ADHESION KINASE CONTAINING THE FERM AND KINASE DOMAINS.
604, 5xgnB, 0.8261, 2.40, 0.314, 308, 261, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/C797S IN COMPLEX WITH GO6976
605, 4asxB, 0.8259, 2.74, 0.235, 307, 264, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH DIHYDRO-BAUERINE C
606, 4asxA, 0.8258, 2.68, 0.236, 310, 263, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH DIHYDRO-BAUERINE C
607, 5hcxA, 0.8257, 2.16, 0.352, 298, 253, EGFR KINASE DOMAIN MUTANT TMLR WITH AZABENZIMIDAZOLE COMPOUND 7
608, 2xirA, 0.8256, 2.28, 0.373, 296, 255, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH PF-00337210 (N2-DIMETHYL-6-(7-(2-MORPHOLINOETHOXY) QUINOLIN-4-YLOXY)BENZOFURAN-3-CARBOXAMIDE)
609, 2r2pA, 0.8256, 2.55, 0.352, 283, 264, KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 5 (EPHA5)
610, 5hicA, 0.8255, 2.21, 0.346, 302, 254, EGFR KINASE DOMAIN MUTANT TMLR WITH A IMIDAZOPYRIDINYL- AMINOPYRIMIDINE INHIBITOR
611, 5x2fB, 0.8253, 2.51, 0.337, 312, 261, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(6)
612, 5gtyA, 0.8253, 2.24, 0.352, 300, 256, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
613, 4u5jA, 0.8253, 2.06, 0.310, 267, 255, C-SRC IN COMPLEX WITH RUXOLITINIB
614, 4ag8A, 0.8253, 2.29, 0.373, 296, 255, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH AXITINIB (AG-013736) (N-METHYL-2-(3-((E)-2-PYRIDIN-2-YL-VINYL)-1H- INDAZOL-6- YLSULFANYL)-BENZAMIDE)
615, 4d4vA, 0.8251, 1.92, 0.347, 256, 251, FOCAL ADHESION KINASE CATALYTIC DOMAIN
616, 3zfxI, 0.8251, 2.06, 0.344, 263, 253, CRYSTAL STRUCTURE OF EPHB1
617, 1u46A, 0.8251, 1.77, 0.411, 255, 248, CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED KINASE DOMAIN OF THE TYROSINE KINASE ACK1
618, 3kcfE, 0.8247, 2.59, 0.267, 330, 262, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
619, 5e8uA, 0.8246, 2.70, 0.254, 306, 264, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204DI211VY249FS280T Y282FS287NA350CL352F)
620, 4rwkA, 0.8244, 2.50, 0.396, 308, 260, CRYSTAL STRUCTURE OF V561M FGFR1 GATEKEEPER MUTATION (C488A C584S V561M) IN COMPLEX WITH N-{3-[2-(35-DIMETHOXYPHENYL)ETHYL]-1H- PYRAZOL-5-YL}-4-[(3R5S)-35-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)
621, 5xp7B, 0.8243, 1.95, 0.313, 267, 252, C-SRC IN COMPLEX WITH ATP-CHCL
622, 3wzeA, 0.8243, 2.32, 0.366, 298, 254, KDR IN COMPLEX WITH LIGAND SORAFENIB
623, 3kcfA, 0.8243, 2.75, 0.265, 328, 264, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
624, 2ituA, 0.8243, 2.32, 0.346, 304, 257, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AFN941
625, 3socB, 0.8242, 2.71, 0.236, 309, 263, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH A QUINAZOLIN
626, 4zseD, 0.8241, 2.41, 0.350, 297, 257, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R CRYSTAL FORM II
627, 4wrgA, 0.8241, 2.05, 0.344, 289, 253, 1.9 ANGSTROM STRUCTURE OF EGFR KINASE DOMAIN
628, 3faaE, 0.8239, 2.53, 0.267, 330, 262, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A 2- AMINOIMIDAZOLE INHIBITOR
629, 5gtyG, 0.8237, 2.21, 0.354, 299, 254, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
630, 4cd0A, 0.8237, 2.36, 0.311, 295, 257, STRUCTURE OF L1196M MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 2-(5-(6-AMINO-5-((R)-1-(5-FLUORO-2-(2H-123-TRIAZOL-2-YL) PHENYL)ETHOXY)PYRIDIN-3-YL)-4-METHYLTHIAZOL-2-YL)PROPANE-12-DIOL
631, 5ugxB, 0.8236, 2.03, 0.390, 282, 254, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 2 HARBORING A E565A/D650V DOUBLE GAIN-OF-FUNCTION MUTATION
632, 4zauA, 0.8236, 2.29, 0.357, 283, 255, AZD9291 COMPLEX WITH WILD TYPE EGFR
633, 5x2aA, 0.8235, 2.39, 0.350, 297, 257, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(3)
634, 5hczA, 0.8235, 2.20, 0.348, 300, 253, EGFR KINASE DOMAIN MUTANT TMLR WITH 3-AZETIDINYL AZAINDAZOLE COMPOUND 21
635, 4j95A, 0.8235, 2.39, 0.392, 279, 260, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME IN SPACE GROUP C2.
636, 4u5jB, 0.8233, 2.09, 0.310, 267, 255, C-SRC IN COMPLEX WITH RUXOLITINIB
637, 4d58B, 0.8233, 2.31, 0.343, 261, 254, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS- ANILINO PYRIMIDINE INHIBITOR
638, 4d4sB, 0.8233, 2.31, 0.339, 260, 254, FOCAL ADHESION KINASE CATALYTIC DOMAIN
639, 3kcfC, 0.8233, 2.72, 0.261, 330, 264, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
640, 1iasD, 0.8233, 2.55, 0.267, 330, 262, CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
641, 3dk6B, 0.8232, 1.90, 0.363, 259, 251, CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
642, 5cnnA, 0.8231, 2.13, 0.354, 300, 254, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN MUTANT I682Q
643, 4qrcA, 0.8231, 2.40, 0.364, 297, 258, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 4 IN COMPLEX WITH PONATINIB
644, 3zosB, 0.8231, 2.55, 0.355, 303, 259, STRUCTURE OF THE DDR1 KINASE DOMAIN IN COMPLEX WITH PONATINIB
645, 3vntA, 0.8231, 2.32, 0.373, 301, 255, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VEGFR2 WITH A [1 3]THIAZOLO[54-B]PYRIDINE DERIVATIVE
646, 3q4tB, 0.8231, 2.68, 0.237, 308, 262, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH DORSOMORPHIN
647, 5gtyB, 0.8230, 2.26, 0.353, 299, 255, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
648, 5grnA, 0.8230, 2.46, 0.352, 285, 256, CRYSTAL STRUCTURE OF PDGFRA IN COMPLEX WITH WQ-C-159
649, 5d41A, 0.8230, 2.04, 0.348, 300, 253, EGFR KINASE DOMAIN IN COMPLEX WITH MUTANT SELECTIVE ALLOSTERIC INHIBITOR
650, 4d4yA, 0.8230, 1.91, 0.344, 255, 250, FOCAL ADHESION KINASE CATALYTIC DOMAIN
651, 2pvyB, 0.8230, 2.05, 0.375, 286, 253, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME.
652, 1iasE, 0.8230, 2.55, 0.267, 330, 262, CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
653, 1iasA, 0.8229, 2.55, 0.267, 330, 262, CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
654, 6aywB, 0.8228, 2.50, 0.222, 293, 261, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
655, 4d5kA, 0.8227, 1.91, 0.344, 255, 250, FOCAL ADHESION KINASE CATALYTIC DOMAIN
656, 3kcfB, 0.8227, 2.59, 0.260, 324, 262, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
657, 5vloB, 0.8226, 2.52, 0.222, 293, 261, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
658, 1iasC, 0.8225, 2.55, 0.267, 330, 262, CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
659, 5gtyE, 0.8223, 2.07, 0.344, 297, 253, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
660, 4asdA, 0.8223, 2.33, 0.373, 305, 255, CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SORAFENIB (BAY 43-9006)
661, 2hz4C, 0.8223, 2.07, 0.366, 259, 254, ABL KINASE DOMAIN UNLIGATED AND IN COMPLEX WITH TETRAHYDROSTAUROSPORINE
662, 3c0gB, 0.8222, 2.47, 0.218, 320, 261, CASK CAM-KINASE DOMAIN- 3 -AMP COMPLEX P1 FORM
663, 2gs7B, 0.8222, 2.65, 0.332, 288, 262, CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
664, 5canA, 0.8219, 2.26, 0.350, 301, 254, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 27
665, 3vhkA, 0.8219, 2.33, 0.370, 297, 254, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BACK POCKET BINDER
666, 2pvyC, 0.8219, 2.13, 0.378, 285, 254, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME.
667, 2g1tC, 0.8219, 2.42, 0.370, 276, 257, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
668, 4j95D, 0.8218, 2.06, 0.391, 271, 253, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME IN SPACE GROUP C2.
669, 3w32A, 0.8218, 2.71, 0.346, 317, 263, EGFR KINASE DOMAIN COMPLEXED WITH COMPOUND 20A
670, 3a4oX, 0.8218, 2.01, 0.375, 259, 253, LYN KINASE DOMAIN
671, 1iasB, 0.8218, 2.67, 0.266, 324, 263, CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
672, 6b8yA, 0.8216, 2.72, 0.261, 304, 264, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-(3- FLUOROPYRIDIN-4-YL)-2-[6-(TRIFLUOROMETHYL)PYRIDIN-2-YL]-7H-PYRROLO[2 3-D]PYRIMIDIN-4-AMINE
673, 4trlA, 0.8216, 2.25, 0.339, 268, 257, STRUCTURE OF EPHRIN TYPE-A RECEPTOR 2
674, 1rqqB, 0.8216, 2.37, 0.309, 294, 259, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS
675, 5xp5A, 0.8215, 2.14, 0.310, 267, 255, C-SRC IN COMPLEX WITH ATP-CHF
676, 4d5hA, 0.8215, 1.78, 0.341, 255, 249, FOCAL ADHESION KINASE CATALYTIC DOMAIN
677, 3faaD, 0.8215, 2.78, 0.269, 330, 264, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A 2- AMINOIMIDAZOLE INHIBITOR
678, 5j7hA, 0.8214, 2.05, 0.312, 291, 253, CRYSTAL STRUCTURE OF ANAPLASTIC LYMPHOMA KINASE (ALK) BOUND BY BRIGATINIB
679, 4d4yB, 0.8214, 2.33, 0.343, 260, 254, FOCAL ADHESION KINASE CATALYTIC DOMAIN
680, 3faaC, 0.8214, 2.71, 0.270, 330, 263, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A 2- AMINOIMIDAZOLE INHIBITOR
681, 3kcfD, 0.8213, 2.51, 0.268, 330, 261, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
682, 4rwiA, 0.8212, 2.56, 0.396, 305, 260, CRYSTAL STRUCTURE OF V561M FGFR1 GATEKEEPER MUTATION (C488A C584S V561M) APO
683, 2x7oB, 0.8212, 2.68, 0.266, 330, 263, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH AN INDOLINONE INHIBITOR
684, 5mjbB, 0.8211, 2.89, 0.323, 278, 266, KINASE DOMAIN OF HUMAN EPHB1 G703C MUTANT COVALENTLY BOUND TO A QUINAZOLINE-BASED INHIBITOR
685, 4yjqA, 0.8211, 2.38, 0.344, 264, 256, SYK KINASE DOMAIN IN COMPLEX WITH INHIBITOR GTC000224
686, 2x7oC, 0.8211, 2.68, 0.266, 330, 263, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH AN INDOLINONE INHIBITOR
687, 2gs7A, 0.8211, 2.69, 0.336, 281, 262, CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
688, 2g1tB, 0.8211, 2.44, 0.370, 273, 257, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
689, 5cnoB, 0.8210, 2.21, 0.350, 302, 254, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN MUTANT V924R
690, 4d5hB, 0.8210, 2.35, 0.343, 260, 254, FOCAL ADHESION KINASE CATALYTIC DOMAIN
691, 4aseA, 0.8210, 2.34, 0.373, 305, 255, CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH TIVOZANIB (AV-951)
692, 3faaB, 0.8210, 2.67, 0.266, 324, 263, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A 2- AMINOIMIDAZOLE INHIBITOR
693, 3bu5A, 0.8210, 2.25, 0.305, 291, 256, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE AND ATP
694, 2x7oA, 0.8209, 2.77, 0.265, 330, 264, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH AN INDOLINONE INHIBITOR
695, 5e8tA, 0.8208, 2.54, 0.261, 302, 261, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D)
696, 4xlvA, 0.8208, 2.40, 0.309, 307, 259, CRYSTAL STRUCTURE OF THE ACTIVATED INSULIN RECEPTOR TYROSINE KINASE DIMER
697, 3vo3A, 0.8208, 2.36, 0.373, 303, 255, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VEGFR2 WITH IMIDAZO[1 2-B]PYRIDAZINE DERIVATIVE
698, 2x7oE, 0.8208, 2.68, 0.266, 330, 263, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH AN INDOLINONE INHIBITOR
699, 5gnkA, 0.8207, 2.60, 0.349, 277, 258, CRYSTAL STRUCTURE OF EGFR 696-988 T790M IN COMPLEX WITH LXX-6-34
700, 4g5pB, 0.8207, 2.32, 0.310, 303, 258, CRYSTAL STRUCTURE OF EGFR KINASE T790M IN COMPLEX WITH BIBW2992
701, 5e8wA, 0.8206, 2.75, 0.261, 303, 264, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH STAUROSPORINE
702, 2x7oD, 0.8206, 2.69, 0.266, 330, 263, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH AN INDOLINONE INHIBITOR
703, 5zwjA, 0.8205, 2.31, 0.356, 267, 253, CRYSTAL STRUCTURE OF EGFR 675-1022 T790M/C797S/V948R IN COMPLEX WITH EAI045 
704, 2wotA, 0.8204, 2.67, 0.262, 303, 263, ALK5 IN COMPLEX WITH 4-((56-DIMETHYL-2-(2-PYRIDYL)-3- PYRIDYL)OXY)-N-(345-TRIMETHOXYPHENYL)PYRIDIN-2-AMINE
705, 5casA, 0.8203, 2.27, 0.356, 299, 253, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 41A
706, 2rfeA, 0.8203, 2.67, 0.331, 286, 260, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
707, 4yjvA, 0.8202, 2.35, 0.341, 263, 255, THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000250
708, 4fl2A, 0.8202, 2.38, 0.323, 555, 257, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH
709, 5aaaA, 0.8201, 2.35, 0.309, 294, 256, STRUCTURE OF L1198F MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
710, 3zfxE, 0.8201, 2.12, 0.337, 262, 252, CRYSTAL STRUCTURE OF EPHB1
711, 3vheA, 0.8201, 2.38, 0.369, 303, 255, CRYSTAL STRUCTURE OF HUMAN VEGFR2 KINASE DOMAIN WITH A NOVEL PYRROLOPYRIMIDINE INHIBITOR.
712, 5cnoA, 0.8200, 2.30, 0.349, 300, 255, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN MUTANT V924R
713, 3socA, 0.8200, 2.82, 0.231, 307, 264, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH A QUINAZOLIN
714, 5gtyD, 0.8199, 2.21, 0.354, 297, 254, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
715, 4x2nA, 0.8198, 2.67, 0.259, 303, 263, SELECTION OF FRAGMENTS FOR KINASE INHIBITOR DESIGN: DECORATION IS KEY
716, 3dqxB, 0.8198, 2.25, 0.309, 268, 256, CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH ATPGS
717, 4yc8A, 0.8196, 1.98, 0.365, 259, 252, C-HELIX-OUT BINDING OF DASATINIB ANALOG TO C-ABL KINASE
718, 2x9fA, 0.8196, 2.25, 0.329, 265, 255, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
719, 5yu9A, 0.8195, 2.30, 0.353, 302, 255, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH IBRUTINIB
720, 5caqA, 0.8195, 2.21, 0.352, 301, 253, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 33
721, 4bkjB, 0.8195, 2.76, 0.362, 297, 260, CRYSTAL STRUCTURE OF THE HUMAN DDR1 KINASE DOMAIN IN COMPLEX WITH IMATINIB
722, 3c0hB, 0.8194, 2.50, 0.218, 300, 261, CASK CAM-KINASE DOMAIN- AMPPNP COMPLEX P1 FORM
723, 4x2fA, 0.8193, 2.76, 0.261, 303, 264, SELECTION OF FRAGMENTS FOR KINASE INHIBITOR DESIGN: DECORATION IS KEY
724, 3bbtB, 0.8193, 2.48, 0.369, 274, 255, CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN COMPLEX WITH LAPATINIB
725, 5calA, 0.8192, 2.26, 0.352, 300, 253, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 24
726, 3mfsA, 0.8192, 2.54, 0.226, 303, 261, CASK-4M CAM KINASE DOMAIN AMPPNP
727, 2rf9B, 0.8192, 2.17, 0.357, 269, 255, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
728, 1rqqA, 0.8192, 2.40, 0.309, 294, 259, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS
729, 5capA, 0.8191, 2.30, 0.346, 303, 254, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 30
730, 4x2kA, 0.8191, 2.76, 0.261, 303, 264, SELECTION OF FRAGMENTS FOR KINASE INHIBITOR DESIGN: DECORATION IS KEY
731, 4x2jA, 0.8191, 2.76, 0.261, 303, 264, SELECTION OF FRAGMENTS FOR KINASE INHIBITOR DESIGN: DECORATION IS KEY
732, 5yu9C, 0.8190, 2.37, 0.349, 306, 255, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH IBRUTINIB
733, 5e90A, 0.8190, 2.64, 0.260, 303, 262, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204DI211VY249F S280T Y282FS287NA350CL352F) IN COMPLEX WITH 3-AMINO-6- [4-(2- HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL]PYRAZINE-2- CARBOXAMIDE
734, 4d55A, 0.8190, 2.04, 0.340, 260, 253, FOCAL ADHESION KINASE CATALYTIC DOMAIN
735, 3emgA, 0.8190, 2.16, 0.348, 255, 253, DISCOVERY AND SAR OF NOVEL 4-THIAZOLYL-2- PHENYLAMINOPYRIMIDINES AS POTENT INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)
736, 2i1mA, 0.8190, 2.39, 0.340, 311, 256, CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR
737, 3bbwA, 0.8189, 2.50, 0.369, 268, 255, CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN ITS INACTIVE CONFORMATION
738, 2eb3A, 0.8189, 2.21, 0.344, 294, 253, CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (L858R) IN COMPLEX WITH AMPPNP
739, 5friA, 0.8188, 2.62, 0.268, 301, 261, ALK5 IN COMPLEX WITHA AN N-(4-ANILINO-2-PYRIDYL)ACETAMIDE INHIBITOR.
740, 4x2gA, 0.8188, 2.77, 0.261, 303, 264, SELECTION OF FRAGMENTS FOR KINASE INHIBITOR DESIGN: DECORATION IS KEY
741, 4tt7A, 0.8188, 2.37, 0.306, 291, 255, CRYSTAL STRUCTURE OF HUMAN ALK WITH A COVALENT MODIFICATION
742, 3zbfA, 0.8188, 1.92, 0.347, 281, 251, STRUCTURE OF HUMAN ROS1 KINASE DOMAIN IN COMPLEX WITH CRIZOTINIB
743, 5kz0A, 0.8187, 2.29, 0.310, 293, 255, STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 2-[(1R)- 1-{[2-AMINO-5-(13-DIMETHYL-1H-PYRAZOL-4-YL)PYRIDIN-3-YL]OXY}ETHYL]- 4-FLUORO-NN-DIMETHYLBENZAMIDE
744, 5em7A, 0.8187, 2.29, 0.348, 300, 253, EGFR KINASE DOMAIN MUTANT TMLR WITH PYRIDONE COMPOUND 13: 4-[(2- METHOXYPHENYL)AMINO]-~{N}-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-2- OXIDANYLIDENE-1~{H}-PYRIDINE-3-CARBOXAMIDE
745, 4fobA, 0.8187, 2.54, 0.305, 295, 259, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH ACYLIMINOBENZIMIDAZOLE INHIBITOR 1
746, 3zzeA, 0.8187, 2.50, 0.320, 286, 256, CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH N - ((3Z)-4-CHLORO-7-METHYL-2-OXO-12-DIHYDRO-3H-INDOL-3- YLIDENE)-2-(4-HYDROXYPHENYL)PROPANOHYDRAZIDE
747, 3faaA, 0.8187, 2.78, 0.261, 328, 264, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A 2- AMINOIMIDAZOLE INHIBITOR
748, 4x0mA, 0.8186, 2.77, 0.261, 303, 264, SELECTION OF FRAGMENTS FOR KINASE INHIBITOR DESIGN: DECORATION IS KEY
749, 3bbwB, 0.8186, 2.50, 0.369, 275, 255, CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN ITS INACTIVE CONFORMATION
750, 5em6A, 0.8185, 2.29, 0.352, 301, 253, EGFR KINASE DOMAIN MUTANT TMLR WITH PYRIDONE COMPOUND 19: 4-[(2- AZANYLPYRIMIDIN-4-YL)AMINO]-~{N}-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]- 2-OXIDANYLIDENE-1~{H}-PYRIDINE-3-CARBOXAMIDE
751, 4focA, 0.8185, 2.42, 0.307, 296, 257, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH ACYLIMINOBENZIMIDAZOLE INHIBITOR 2
752, 5aa9A, 0.8184, 2.40, 0.309, 295, 256, STRUCTURE OF L1198F MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PF-06463922 ((10R)-7-AMINO-12-FLUORO-210 16-TRIMETHYL-15-OXO-10151617-TETRAHYDRO-2H-84-(METHENO) PYRAZOLO(43-H)(2511)BENZOXADIAZACYCLOTETRADECINE-3- CARBONITRILE).
753, 3mfuA, 0.8184, 2.55, 0.226, 302, 261, CASK-4M CAM KINASE DOMAIN AMPPNP-MN2+
754, 3c0hA, 0.8183, 2.52, 0.218, 300, 261, CASK CAM-KINASE DOMAIN- AMPPNP COMPLEX P1 FORM
755, 2g1tA, 0.8183, 2.36, 0.371, 271, 256, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
756, 1xkkA, 0.8183, 2.32, 0.350, 289, 254, EGFR KINASE DOMAIN COMPLEXED WITH A QUINAZOLINE INHIBITOR- GW572016
757, 3c0iA, 0.8182, 2.59, 0.218, 298, 261, CASK CAM-KINASE DOMAIN- 3 -AMP COMPLEX P212121 FORM
758, 1py5A, 0.8182, 2.81, 0.261, 301, 264, CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH INHIBITOR
759, 5aabA, 0.8181, 2.31, 0.307, 293, 254, STRUCTURE OF C1156YL1198F MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
760, 4zsaA, 0.8181, 2.67, 0.391, 289, 261, CRYSTAL STRUCTURE OF FGFR1 KINASE DOMAIN IN COMPLEX WITH 7N
761, 4ccuA, 0.8181, 2.26, 0.304, 292, 253, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 2-(5-(6-AMINO-5-((R)-1-(5-FLUORO-2-(2H-123-TRIAZOL-2-YL) PHENYL)ETHOXY)PYRIDIN-3-YL)-4-METHYLTHIAZOL-2-YL)PROPAN-2-OL
762, 1rw8A, 0.8181, 2.81, 0.258, 301, 264, CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH ATP SITE INHIBITOR
763, 5e8zA, 0.8180, 2.65, 0.263, 303, 262, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 3- AMINO-6-[4-(2-HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3- YL]PYRAZINE-2-CARBOXAMIDE
764, 4rwjA, 0.8180, 2.62, 0.388, 307, 260, CRYSTAL STRUCTURE OF FGFR1 (C488A C584S) IN COMPLEX WITH AZD4547 (N- {3-[2-(35-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R5S)-35- DIMETHYLPIPERAZIN-1-YL]BENZAMIDE)
765, 4d58A, 0.8180, 1.79, 0.343, 255, 248, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS- ANILINO PYRIMIDINE INHIBITOR
766, 1yi6B, 0.8180, 2.46, 0.273, 274, 260, C-TERM TAIL SEGMENT OF HUMAN TYROSINE KINASE (258-533)
767, 4ccbA, 0.8179, 2.23, 0.312, 287, 253, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 3-((R)-1-(5-FLUORO-2-(2H-123-TRIAZOL-2-YL) PHENYL)ETHOXY)-5-(5-METHYL-1H-PYRAZOL-4-YL)PYRIDIN-2-AMINE
768, 4aoiA, 0.8178, 2.26, 0.324, 289, 253, CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-( 3-((1H- PYRROLO(23-B)PYRIDIN-3-YL)METHYL)-(124)TRIAZOLO( 43-B)(124) TRIAZIN-6-YL)BENZONITRILE
769, 3c0gA, 0.8178, 2.47, 0.215, 309, 260, CASK CAM-KINASE DOMAIN- 3 -AMP COMPLEX P1 FORM
770, 2rfdA, 0.8178, 2.49, 0.328, 288, 256, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
771, 2jivB, 0.8178, 2.59, 0.351, 272, 259, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPEX WITH HKI-272
772, 5cauA, 0.8177, 2.26, 0.353, 297, 252, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 41B
773, 5c8nA, 0.8177, 2.28, 0.352, 300, 253, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 23
774, 4gu6A, 0.8177, 2.58, 0.337, 271, 258, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-{3-[(5-CYANO- 2-PHENYL-1H-PYRROLO[23-B]PYRIDIN-4-YLAMINO)- METHYL]-PYRIDIN-2-YL}- N-METHYL-METHANESULFONAMIDE
775, 4ap7A, 0.8176, 2.39, 0.323, 289, 254, CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-( (6-(4- FLUOROPHENYL)-(124)TRIAZOLO(43-B)(124)TRIAZIN-3-YL)METHYL) PHENOL
776, 4agcA, 0.8176, 2.39, 0.373, 304, 255, CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH AXITINIB (AG-013736) (N-METHYL-2-( 3-((E)-2-PYRIDIN-2-YL-VINYL)-1H-INDAZOL-6-YLSULFANYL)- BENZAMIDE)
777, 5ew3A, 0.8175, 2.11, 0.372, 274, 250, HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN IN COMPLEX WITH AAL993
778, 3h3cA, 0.8175, 2.17, 0.352, 263, 253, CRYSTAL STRUCTURE OF PYK2 IN COMPLEX WITH SULFOXIMINE- SUBSTITUTED TRIFLUOROMETHYLPYRIMIDINE ANALOG
779, 2g1tD, 0.8175, 2.49, 0.370, 277, 257, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
780, 3ky2A, 0.8174, 2.40, 0.385, 307, 257, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN
781, 3c4fB, 0.8174, 2.48, 0.386, 290, 259, FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3- METHOXYBENZYL)-7-AZAINDOLE
782, 2p2iA, 0.8174, 1.99, 0.373, 289, 249, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NICOTINAMIDE INHIBITOR
783, 3zosA, 0.8173, 2.76, 0.358, 301, 260, STRUCTURE OF THE DDR1 KINASE DOMAIN IN COMPLEX WITH PONATINIB
784, 1vjyA, 0.8173, 2.62, 0.258, 299, 260, CRYSTAL STRUCTURE OF A NAPHTHYRIDINE INHIBITOR OF HUMAN TGF- BETA TYPE I RECEPTOR
785, 5j9zA, 0.8172, 2.23, 0.356, 291, 253, EGFR-T790M IN COMPLEX WITH PYRAZOLOPYRIMIDINE INHIBITOR 1A
786, 4d4sA, 0.8172, 1.85, 0.341, 255, 249, FOCAL ADHESION KINASE CATALYTIC DOMAIN
787, 4cliA, 0.8172, 2.39, 0.309, 294, 256, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PF-06463922 ((10R)-7-AMINO-12-FLUORO-21016-TRIMETHYL-15 -OXO-10151617-TETRAHYDRO-2H-84-(METHENO)PYRAZOLO(43-H) (2511)BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE).
788, 5xp5B, 0.8171, 2.23, 0.310, 267, 255, C-SRC IN COMPLEX WITH ATP-CHF
789, 3q4tA, 0.8171, 2.78, 0.233, 305, 262, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH DORSOMORPHIN
790, 2rfeB, 0.8171, 2.64, 0.329, 273, 258, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
791, 4i22A, 0.8170, 2.25, 0.352, 297, 253, STRUCTURE OF THE MONOMERIC (V948R)GEFITINIB/ERLOTINIB RESISTANT DOUBLE MUTANT (L858R+T790M) EGFR KINASE DOMAIN CO-CRYSTALLIZED WITH GEFITINIB
792, 4cmoA, 0.8170, 2.40, 0.309, 295, 256, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 2-((1R)-1-((3-AMINO-6-(2- METHOXYPYRIDIN- -YL)PYRAZIN-2-YL)OXY)ETHYL)-4-FLUORO-N-METHYLBENZAMIDE
793, 3zclA, 0.8170, 2.28, 0.324, 289, 253, X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR ( S)-3-(1-(1H-PYRROLO(23-B)PYRIDIN-3-YL)ETHYL)-N-ISOPROPYL-( 124)TRIAZOLO(43-B)PYRIDAZIN-6-AMINE
794, 3w2sA, 0.8170, 2.59, 0.346, 307, 257, EGFR KINASE DOMAIN WITH COMPOUND4
795, 3g2fA, 0.8170, 2.85, 0.256, 302, 262, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE II (BMPR2) AT 2.35 A RESOLUTION
796, 3c4fA, 0.8170, 2.48, 0.394, 290, 259, FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3- METHOXYBENZYL)-7-AZAINDOLE
797, 5gtyF, 0.8169, 2.26, 0.350, 297, 254, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
798, 2jivA, 0.8169, 2.45, 0.352, 270, 256, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPEX WITH HKI-272
799, 1b6cD, 0.8169, 2.82, 0.268, 326, 265, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12
800, 5t8pA, 0.8168, 2.44, 0.205, 327, 259, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO BENZOXEPIN COMPOUND 2
801, 3mfrA, 0.8168, 2.58, 0.226, 302, 261, CASK-4M CAM KINASE DOMAIN NATIVE
802, 4qqjA, 0.8167, 2.42, 0.358, 282, 257, CRYSTAL STRUCTURE OF FGF RECEPTOR (FGFR) 4 KINASE DOMAIN HARBORING THE V550L GATE-KEEPER MUTATION
803, 1yi6A, 0.8167, 2.61, 0.299, 274, 261, C-TERM TAIL SEGMENT OF HUMAN TYROSINE KINASE (258-533)
804, 4xg8C, 0.8166, 1.83, 0.355, 254, 248, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
805, 4cmuA, 0.8166, 2.40, 0.309, 294, 256, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR (10R)-7-AMINO-12-FLUORO-1310 16-TETRAMETHYL-1617-DIHYDRO-1H-84-(METHENO)PYRAZOLO(43- H)(2511)BENZOXADIAZACYCLOTETRADECIN-15(10H)-ONE
806, 3geqB, 0.8166, 1.96, 0.316, 273, 250, STRUCTURAL BASIS FOR THE CHEMICAL RESCUE OF SRC KINASE ACTIVITY
807, 3zbxA, 0.8165, 2.28, 0.324, 282, 253, X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR 6- ((6-(4-FLUOROPHENYL)-(124)TRIAZOLO(43-B)(124)TRIAZIN- 3-YL)METHYL)QUINOLINE.
808, 2j0kA, 0.8165, 1.97, 0.339, 598, 251, CRYSTAL STRUCTURE OF A FRAGMENT OF FOCAL ADHESION KINASE CONTAINING THE FERM AND KINASE DOMAINS.
809, 5fm3A, 0.8164, 2.31, 0.361, 276, 255, CRYSTAL STRUCTURE OF HYPER-PHOSPHORYLATED RET KINASE DOMAIN WITH (PROXIMAL) JUXTAMEMBRANE SEGMENT
810, 3js2A, 0.8164, 2.46, 0.390, 295, 259, CRYSTAL STRUCTURE OF MINIMAL KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH 5-(2-THIENYL) NICOTINIC ACID
811, 4ogrI, 0.8163, 2.63, 0.202, 318, 262, CRYSTAL STRUCTURE OF P-TEFB COMPLEX WITH AFF4 AND TAT
812, 3beaA, 0.8163, 2.45, 0.336, 310, 256, CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH A PYRIMIDINOPYRIDONE INHIBITOR
813, 5t8pB, 0.8162, 2.44, 0.205, 328, 259, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO BENZOXEPIN COMPOUND 2
814, 5fm2A, 0.8162, 2.31, 0.361, 273, 255, CRYSTAL STRUCTURE OF HYPER-PHOSPHORYLATED RET KINASE DOMAIN WITH (PROXIMAL) JUXTAMEMBRANE SEGMENT
815, 2hk5A, 0.8162, 2.40, 0.366, 269, 257, HCK KINASE IN COMPLEX WITH LCK TARGETTED INHIBITOR PG-1009247
816, 5c8kA, 0.8161, 2.32, 0.352, 300, 253, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 1
817, 2etmA, 0.8161, 2.34, 0.332, 262, 256, CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN COMPLEXED WITH 7H-PYRROLO [23-D] PYRIMIDINE DERIVATIVE
818, 5mjaA, 0.8160, 2.46, 0.329, 271, 258, KINASE DOMAIN OF HUMAN EPHB1 BOUND TO A QUINAZOLINE-BASED INHIBITOR
819, 5iuiA, 0.8160, 2.70, 0.287, 303, 261, CRYSTAL STRUCTURE OF ANAPLASTIC LYPHOMA KINASE (ALK) IN COMPLEX WITH 4
820, 2j0mB, 0.8160, 1.95, 0.340, 257, 250, CRYSTAL STRUCTURE A TWO-CHAIN COMPLEX BETWEEN THE FERM AND KINASE DOMAINS OF FOCAL ADHESION KINASE.
821, 1mqbB, 0.8159, 2.20, 0.346, 265, 254, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE
822, 5e8sA, 0.8158, 2.58, 0.262, 301, 260, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (WT)
823, 4bkjA, 0.8158, 2.79, 0.363, 295, 259, CRYSTAL STRUCTURE OF THE HUMAN DDR1 KINASE DOMAIN IN COMPLEX WITH IMATINIB
824, 5am7A, 0.8157, 2.56, 0.395, 294, 258, FGFR1 MUTANT WITH AN INHIBITOR
825, 1b6cH, 0.8157, 2.76, 0.265, 326, 264, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12
826, 1ir3A, 0.8155, 2.45, 0.305, 300, 259, PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG
827, 4rj8A, 0.8154, 2.29, 0.353, 298, 252, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 8
828, 3zxzA, 0.8154, 2.30, 0.324, 289, 253, X-RAY STRUCTURE OF PF-04217903 BOUND TO THE KINASE DOMAIN OF C-MET
829, 1gagA, 0.8154, 2.47, 0.305, 300, 259, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR
830, 4yjrA, 0.8153, 2.31, 0.339, 263, 254, SYK KINASE DOMAIN IN COMPLEX WITH INHIBITOR GTC000225
831, 4rj4A, 0.8153, 2.34, 0.348, 299, 253, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 6
832, 4d5kB, 0.8153, 1.97, 0.345, 256, 249, FOCAL ADHESION KINASE CATALYTIC DOMAIN
833, 3mftA, 0.8153, 2.59, 0.226, 302, 261, CASK-4M CAM KINASE DOMAIN MN2+
834, 3gt8C, 0.8153, 2.53, 0.346, 296, 257, CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
835, 5c8mA, 0.8152, 2.38, 0.350, 302, 254, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 17
836, 4rj7A, 0.8152, 2.22, 0.355, 295, 251, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 1
837, 5ng0B, 0.8151, 2.55, 0.259, 282, 259, STRUCTURE OF RIP2K(L294F) WITH BOUND AMPPCP
838, 5ew8A, 0.8151, 2.50, 0.390, 291, 259, FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693
839, 5am6A, 0.8151, 2.57, 0.391, 295, 258, NATIVE FGFR1 WITH AN INHIBITOR
840, 2wgjA, 0.8151, 2.43, 0.323, 289, 254, X-RAY STRUCTURE OF PF-02341066 BOUND TO THE KINASE DOMAIN OF C-MET
841, 6g4yB, 0.8148, 2.47, 0.205, 328, 259, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK) IN COMPLEX WITH COMPOUND 1A 
842, 4uwcA, 0.8148, 2.53, 0.386, 300, 259, FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE IN COMPLEX WITH JK-P3
843, 4fodA, 0.8148, 2.53, 0.306, 308, 258, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH ACYLIMINOBENZIMIDAZOLE INHIBITOR 36
844, 3s95B, 0.8148, 2.23, 0.295, 290, 254, CRYSTAL STRUCTURE OF THE HUMAN LIMK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
845, 3dqxA, 0.8148, 2.27, 0.310, 267, 255, CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH ATPGS
846, 2xb7A, 0.8147, 1.98, 0.316, 286, 250, STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH NVP- TAE684
847, 5usqA, 0.8146, 2.54, 0.255, 299, 259, ALK-5 KINASE INHIBITOR COMPLEX
848, 4g3cB, 0.8146, 2.45, 0.205, 327, 259, CRYSTAL STRUCTURE OF APO MURINE NF-KAPPAB INDUCING KINASE (NIK)
849, 5a9uA, 0.8144, 2.30, 0.304, 292, 253, STRUCTURE OF C1156Y MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PF-06463922 ((10R)-7-AMINO-12-FLUORO-210 16-TRIMETHYL-15-OXO-10151617-TETRAHYDRO-2H-84-(METHENO) PYRAZOLO(43-H)(2511)BENZOXADIAZACYCLOTETRADECINE-3- CARBONITRILE).
850, 4mneB, 0.8144, 2.31, 0.300, 270, 257, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
851, 4d4vB, 0.8144, 1.99, 0.345, 255, 249, FOCAL ADHESION KINASE CATALYTIC DOMAIN
852, 4cljA, 0.8144, 2.48, 0.311, 295, 257, STRUCTURE OF L1196M MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PF-06463922 ((10R)-7-AMINO-12-FLUORO-210 16-TRIMETHYL-15-OXO-10151617-TETRAHYDRO-2H-84-(METHENO) PYRAZOLO(43-H)(2511)BENZOXADIAZACYCLOTETRADECINE-3- CARBONITRILE).
853, 2rgpA, 0.8144, 2.34, 0.352, 284, 253, STRUCTURE OF EGFR IN COMPLEX WITH HYDRAZONE A POTENT DUAL INHIBITOR
854, 2j0kB, 0.8144, 2.11, 0.337, 612, 252, CRYSTAL STRUCTURE OF A FRAGMENT OF FOCAL ADHESION KINASE CONTAINING THE FERM AND KINASE DOMAINS.
855, 1b6cB, 0.8143, 2.85, 0.268, 326, 265, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12
856, 3en4B, 0.8142, 2.09, 0.310, 266, 252, TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP121 A MULTITARGETED KINASE INHIBITOR
857, 1fgiA, 0.8142, 2.52, 0.390, 283, 259, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU5402 INHIBITOR
858, 3b2wA, 0.8141, 2.20, 0.352, 261, 253, CRYSTAL STRUCTURE OF PYRIMIDINE AMIDE 11 BOUND TO LCK
859, 1t45A, 0.8141, 2.61, 0.339, 331, 257, STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C- KIT TYROSINE KINASE
860, 5wilA, 0.8139, 2.16, 0.250, 274, 252, JAK2 PSEUDOKINASE IN COMPLEX WITH AZD7762 
861, 4anqA, 0.8139, 2.34, 0.303, 293, 254, STRUCTURE OF G1269A MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
862, 3kexB, 0.8139, 2.72, 0.330, 283, 261, CRYSTAL STRUCTURE OF THE CATALYTICALLY INACTIVE KINASE DOMAIN OF THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3)
863, 5winA, 0.8138, 2.16, 0.250, 274, 252, JAK2 PSEUDOKINASE IN COMPLEX WITH JNJ7706621 
864, 5aa8A, 0.8138, 2.30, 0.304, 292, 253, STRUCTURE OF C1156YL1198F MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PF-06463922 ((10R)-7-AMINO-12- FLUORO-21016-TRIMETHYL-15-OXO-10151617-TETRAHYDRO-2H- 84-(METHENO)PYRAZOLO(43-H)(2511) BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE).
865, 3gt8A, 0.8138, 2.39, 0.353, 300, 255, CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
866, 2rfeD, 0.8136, 2.74, 0.339, 278, 257, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
867, 5i9vA, 0.8135, 2.37, 0.341, 279, 255, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH AGS
868, 4yhfB, 0.8135, 2.19, 0.324, 269, 253, BRUTON S TYROSINE KINASE IN COMPLEX WITH A T-BUTYL CYANOACRYLAMIDE INHIBITOR
869, 3zc5A, 0.8135, 2.34, 0.324, 289, 253, X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR ( S)-6-(1-(6-(1-METHYL-1H-PYRAZOL-4-YL)-(124)TRIAZOLO(43- B)PYRIDAZIN-3-YL)ETHYL)QUINOLINE.
870, 3gt8D, 0.8135, 2.41, 0.349, 295, 255, CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
871, 2xvdA, 0.8135, 2.49, 0.327, 270, 257, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
872, 2qluA, 0.8135, 2.61, 0.233, 297, 257, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE II KINASE DOMAIN FROM HUMAN
873, 5yu9B, 0.8134, 2.35, 0.352, 295, 253, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH IBRUTINIB
874, 5ftoA, 0.8134, 2.65, 0.304, 298, 260, CRYSTAL STRUCTURE OF THE ALK KINASE DOMAIN IN COMPLEX WITH ENTRECTINIB
875, 4rj6A, 0.8134, 2.32, 0.349, 297, 252, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 4
876, 3js2B, 0.8134, 2.44, 0.388, 291, 258, CRYSTAL STRUCTURE OF MINIMAL KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH 5-(2-THIENYL) NICOTINIC ACID
877, 4qqtA, 0.8133, 2.34, 0.362, 283, 254, CRYSTAL STRUCTURE OF FGF RECEPTOR (FGFR) 4 TYROSINE KINASE DOMAIN
878, 3kexA, 0.8133, 2.72, 0.330, 292, 261, CRYSTAL STRUCTURE OF THE CATALYTICALLY INACTIVE KINASE DOMAIN OF THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3)
879, 5wijA, 0.8132, 2.17, 0.250, 274, 252, JAK2 PSEUDOKINASE IN COMPLEX WITH NU6140 
880, 4fvrA, 0.8132, 2.16, 0.250, 274, 252, CRYSTAL STRUCTURE OF THE JAK2 PSEUDOKINASE DOMAIN MUTANT V617F (MG- ATP-BOUND FORM)
881, 3g2fB, 0.8132, 2.59, 0.261, 300, 257, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE II (BMPR2) AT 2.35 A RESOLUTION
882, 5mjaB, 0.8131, 2.83, 0.327, 274, 263, KINASE DOMAIN OF HUMAN EPHB1 BOUND TO A QUINAZOLINE-BASED INHIBITOR
883, 4r5sA, 0.8131, 2.57, 0.345, 299, 258, CRYSTAL STRUCTURE OF EGFR 696-1022 L858R IN COMPLEX WITH FIIN-3
884, 3ppzB, 0.8131, 2.08, 0.319, 264, 251, CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
885, 6eixA, 0.8130, 2.81, 0.278, 312, 263, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE Q207E MUTANT OF ACVR1 (ALK2) IN COMPLEX WITH A 2-AMINOPYRIDINE INHIBITOR K02288
886, 4ctcA, 0.8130, 2.19, 0.307, 288, 251, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 7-AMINO-3-CYCLOPROPYL-12-FLUORO- 11016-TRIMETHYL-1617-DIHYDRO-1H-84-(METHENO)PYRAZOLO(4 3-H)(2511)BENZOXADIAZACYCLOTETRADECIN-15(10H)-ONE
887, 3ppzA, 0.8130, 2.19, 0.328, 264, 253, CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
888, 3geqA, 0.8130, 1.97, 0.317, 272, 249, STRUCTURAL BASIS FOR THE CHEMICAL RESCUE OF SRC KINASE ACTIVITY
889, 5wikB, 0.8129, 2.18, 0.250, 274, 252, JAK2 PSEUDOKINASE IN COMPLEX WITH BI-D1870 
890, 4i24A, 0.8129, 2.20, 0.359, 295, 251, STRUCTURE OF T790M EGFR KINASE DOMAIN CO-CRYSTALLIZED WITH DACOMITINIB
891, 6babD, 0.8128, 2.51, 0.220, 291, 259, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
892, 3b8qA, 0.8128, 2.02, 0.365, 292, 249, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
893, 5o49A, 0.8127, 2.53, 0.390, 289, 259, HUMAN FGF IN COMPLEX WITH A COVALENT INHIBITOR
894, 3gt8B, 0.8126, 2.41, 0.349, 292, 255, CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
895, 5zj6B, 0.8125, 2.37, 0.366, 270, 254, CRYSTAL STRUCTURE OF HCK KINASE COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4- PHENOXYPHENYL)-7H-PYRROLO[2;3-D]PYRIMIDIN-4-AMINE 
896, 5zj6A, 0.8125, 2.36, 0.366, 271, 254, CRYSTAL STRUCTURE OF HCK KINASE COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4- PHENOXYPHENYL)-7H-PYRROLO[2;3-D]PYRIMIDIN-4-AMINE 
897, 5e8xA, 0.8125, 2.96, 0.253, 304, 265, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204DI211VY249FS280T Y282FS287NA350CL352F) IN COMPLEX WITH STAUROSPORINE
898, 4uwyA, 0.8125, 2.26, 0.387, 296, 253, FGFR1 APO STRUCTURE
899, 3tt0A, 0.8124, 2.52, 0.390, 305, 259, CO-STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN WITH 3-(26-DICHLORO-35-DIMETHOXY-PHENYL)-1-{6-[4-(4-ETHYL-PIPERAZIN-1- YL)-PHENYLAMINO]-PYRIMIDIN-4-YL}-1-METHYL-UREA (BGJ398)
900, 2bdjA, 0.8124, 1.86, 0.319, 254, 248, SRC KINASE IN COMPLEX WITH INHIBITOR AP23464
901, 5xdlA, 0.8123, 2.27, 0.347, 292, 251, CRYSTAL STRUCTURE OF EGFR 696-1022 L858R IN COMPLEX WITH CO-1686
902, 4uwcB, 0.8123, 2.58, 0.386, 301, 259, FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE IN COMPLEX WITH JK-P3
903, 4ogrA, 0.8123, 2.71, 0.202, 314, 263, CRYSTAL STRUCTURE OF P-TEFB COMPLEX WITH AFF4 AND TAT
904, 2zvaA, 0.8123, 2.30, 0.369, 261, 255, LYN TYROSINE KINASE DOMAIN-DASATINIB COMPLEX
905, 4mxzA, 0.8122, 2.14, 0.321, 266, 252, SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
906, 4mxyA, 0.8122, 2.14, 0.321, 266, 252, SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
907, 5nkeA, 0.8121, 2.89, 0.335, 292, 263, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 3A
908, 4yjsA, 0.8121, 2.13, 0.343, 257, 251, THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000226
909, 4uwbA, 0.8121, 2.49, 0.391, 299, 258, FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE IN COMPLEX WITH JK-P5
910, 4l7sA, 0.8121, 1.81, 0.325, 250, 246, KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH AN AMINOBENZOTHIAZOLE INHIBITOR
911, 2xp2A, 0.8121, 2.23, 0.311, 285, 251, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB (PF-02341066)
912, 1b6cF, 0.8121, 2.85, 0.268, 326, 265, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12
913, 5wimA, 0.8120, 2.19, 0.250, 274, 252, JAK2 PSEUDOKINASE IN COMPLEX WITH AT9283 
914, 5i4nA, 0.8120, 2.19, 0.250, 275, 252, CRYSTAL STRUCTURE OF THE E596A V617F MUTANT JAK2 PSEUDOKINASE DOMAIN BOUND TO MG-ATP
915, 4fvqA, 0.8120, 2.18, 0.250, 274, 252, CRYSTAL STRUCTURE OF THE JAK2 PSEUDOKINASE DOMAIN (MG-ATP-BOUND FORM)
916, 3g6hA, 0.8120, 2.19, 0.312, 266, 253, SRC THR338ILE INHIBITED IN THE DFG-ASP-OUT CONFORMATION
917, 4ansA, 0.8119, 2.37, 0.307, 293, 254, STRUCTURE OF L1196MG1269A DOUBLE MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
918, 5a46B, 0.8118, 2.56, 0.386, 297, 259, FGFR1 IN COMPLEX WITH DOVITINIB
919, 5t8oB, 0.8117, 2.49, 0.208, 328, 259, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO IMIDAZOBENZOXEPIN COMPOUND 3
920, 3l8pA, 0.8117, 2.32, 0.339, 292, 251, CRYSTAL STRUCTURE OF CYTOPLASMIC KINASE DOMAIN OF TIE2 COMPLEXED WITH INHIBITOR CEP11207
921, 5ut4A, 0.8116, 2.18, 0.250, 273, 252, JAK2 JH2 IN COMPLEX WITH NVP-BSK805
922, 5gtyC, 0.8116, 2.21, 0.353, 295, 252, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
923, 3kfaB, 0.8116, 2.37, 0.379, 284, 253, STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE
924, 2jkmA, 0.8116, 2.25, 0.340, 260, 253, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS- ANILINO PYRIMIDINE INHIBITOR
925, 5t8qB, 0.8115, 2.51, 0.205, 328, 259, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO ARYL PYRROLE FRAGMENT 17
926, 5bmmA, 0.8115, 2.42, 0.309, 275, 256, SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC25B
927, 3plsA, 0.8115, 2.49, 0.333, 298, 258, RON IN COMPLEX WITH LIGAND AMP-PNP
928, 3kfaA, 0.8115, 2.37, 0.379, 284, 253, STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE
929, 4agdA, 0.8114, 2.47, 0.373, 303, 255, CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SUNITINIB (SU11248) (N-2- DIETHYLAMINOETHYL)-5-((Z)-(5-FLUORO-2-OXO-1H-INDOL-3- YLIDENE)METHYL)-24-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE)
930, 3sxrA, 0.8114, 2.28, 0.315, 260, 254, CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEX WITH DASATINIB
931, 4l7sB, 0.8113, 1.82, 0.325, 250, 246, KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH AN AMINOBENZOTHIAZOLE INHIBITOR
932, 1ql6A, 0.8113, 2.54, 0.205, 281, 258, THE CATALYTIC MECHANISM OF PHOSPHORYLASE KINASE PROBED BY MUTATIONAL STUDIES
933, 5o4aA, 0.8112, 2.66, 0.392, 290, 260, HUMAN FGF IN COMPLEX WITH A COVALENT INHIBITOR
934, 3f6xD, 0.8112, 2.21, 0.316, 267, 253, C-SRC KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE INHIBITOR
935, 4kabB, 0.8111, 2.30, 0.344, 258, 253, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 3-METHYL-14- DIHYDRO-PYRAZOLO[45-C]PYRAZOLE
936, 4e26A, 0.8110, 2.42, 0.295, 270, 258, BRAF IN COMPLEX WITH AN ORGANIC INHIBITOR 7898734
937, 4idvD, 0.8109, 2.51, 0.208, 335, 259, CRYSTAL STRUCTURE OF NIK WITH COMPOUND 4-{3-[2-AMINO-5-(2- METHOXYETHOXY)PYRIMIDIN-4-YL]-1H-INDOL-5-YL}-2-METHYLBUT-3-YN-2-OL (13V)
938, 3l8vA, 0.8109, 2.62, 0.320, 293, 256, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A BIARYLAMINE BASED INHIBITOR
939, 2wouA, 0.8109, 2.55, 0.260, 299, 258, ALK5 IN COMPLEX WITH 4-((4-((26-DIMETHYL-3-PYRIDYL)OXY)-2- PYRIDYL)AMINO)BENZENESULFONAMIDE
940, 5e8yA, 0.8108, 2.65, 0.248, 298, 258, TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431AR433AE485AK488AR493A R495A) IN COMPLEX WITH STAUROSPORINE
941, 3rhxA, 0.8108, 2.56, 0.390, 289, 259, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR1 KINASE IN COMPLEX WITH ARQ 069
942, 3lzbA, 0.8108, 2.39, 0.343, 265, 254, EGFR KINASE DOMAIN COMPLEXED WITH AN IMIDAZO[21-B]THIAZOLE INHIBITOR
943, 5aacA, 0.8107, 2.34, 0.304, 292, 253, STRUCTURE OF C1156Y MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
944, 3lzbB, 0.8107, 2.39, 0.346, 265, 254, EGFR KINASE DOMAIN COMPLEXED WITH AN IMIDAZO[21-B]THIAZOLE INHIBITOR
945, 3d4qB, 0.8107, 2.12, 0.310, 264, 252, PYRAZOLE-BASED INHIBITORS OF B-RAF KINASE
946, 3belA, 0.8107, 2.38, 0.353, 280, 252, X-RAY STRUCTURE OF EGFR IN COMPLEX WITH OXIME INHIBITOR
947, 2vz6A, 0.8107, 2.51, 0.213, 291, 258, STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE II ALPHA (CAMK2A) IN COMPLEX WITH INDIRUBIN E804
948, 2etmB, 0.8107, 2.24, 0.341, 263, 252, CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN COMPLEXED WITH 7H-PYRROLO [23-D] PYRIMIDINE DERIVATIVE
949, 4y95B, 0.8106, 2.17, 0.344, 266, 253, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BRUTON S TYROSINE KINASE WITH MUTATIONS IN THE ACTIVATION LOOP
950, 1qcfA, 0.8106, 2.40, 0.353, 449, 255, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY- SELECTIVE TYROSINE KINASE INHIBITOR
951, 1k2pA, 0.8106, 2.39, 0.332, 258, 256, CRYSTAL STRUCTURE OF BRUTON S TYROSINE KINASE DOMAIN
952, 4y95C, 0.8105, 2.17, 0.344, 266, 253, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BRUTON S TYROSINE KINASE WITH MUTATIONS IN THE ACTIVATION LOOP
953, 3eflA, 0.8105, 1.91, 0.370, 286, 246, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH MOTESANIB
954, 5e92A, 0.8103, 2.87, 0.246, 298, 260, TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431AR433AE485AK488AR493A R495A) IN COMPLEX WITH AMPPNP
955, 5bmmB, 0.8103, 2.43, 0.309, 275, 256, SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC25B
956, 4ec8A, 0.8103, 2.78, 0.209, 325, 263, STRUCTURE OF FULL LENGTH CDK9 IN COMPLEX WITH CYCLINT AND DRB
957, 3d4qA, 0.8103, 2.13, 0.310, 264, 252, PYRAZOLE-BASED INHIBITORS OF B-RAF KINASE
958, 5nkhA, 0.8102, 2.92, 0.338, 295, 263, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 3E
959, 4idvC, 0.8102, 2.51, 0.208, 335, 259, CRYSTAL STRUCTURE OF NIK WITH COMPOUND 4-{3-[2-AMINO-5-(2- METHOXYETHOXY)PYRIMIDIN-4-YL]-1H-INDOL-5-YL}-2-METHYLBUT-3-YN-2-OL (13V)
960, 4idvB, 0.8102, 2.50, 0.212, 335, 259, CRYSTAL STRUCTURE OF NIK WITH COMPOUND 4-{3-[2-AMINO-5-(2- METHOXYETHOXY)PYRIMIDIN-4-YL]-1H-INDOL-5-YL}-2-METHYLBUT-3-YN-2-OL (13V)
961, 4hvsA, 0.8102, 2.44, 0.346, 326, 254, CRYSTAL STRUCTURE OF KIT KINASE DOMAIN WITH A SMALL MOLECULE INHIBITOR PLX647
962, 2yfxA, 0.8102, 2.39, 0.307, 292, 254, STRUCTURE OF L1196M MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
963, 4qmpA, 0.8101, 2.43, 0.273, 289, 256, MST3 IN COMPLEX WITH CDK1/2 INHIBITOR III 5-AMINO-3-{[4- (AMINOSULFONYL)PHENYL]AMINO}-N-(26-DIFLUOROPHENYL)-1H-124- TRIAZOLE-1-CARBOTHIOAMIDE
964, 3ppkB, 0.8098, 2.14, 0.302, 264, 252, HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
965, 3fzpA, 0.8098, 2.22, 0.353, 259, 252, CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH ATPGS
966, 5vndB, 0.8097, 2.59, 0.382, 295, 259, CRYSTAL STRUCTURE OF FGFR1-Y563C (FGFR4 SURROGATE) COVALENTLY BOUND TO H3B-6527
967, 2bdfB, 0.8097, 2.26, 0.311, 265, 254, SRC KINASE IN COMPLEX WITH INHIBITOR AP23451
968, 4pp9B, 0.8096, 1.67, 0.324, 247, 244, ITK KINASE DOMAIN WITH COMPOUND 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4- YL]-2H-INDAZOLE-3-CARBOXAMIDE)
969, 3pxkA, 0.8096, 1.98, 0.341, 256, 249, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH PYRROLO[23- D]THIAZOLE
970, 3ppjB, 0.8096, 2.14, 0.302, 264, 252, HUMAN B-RAF KINASE IN COMPLEX WITH A FUROPYRIDINE INHIBITOR
971, 3bbtD, 0.8096, 2.35, 0.376, 259, 250, CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN COMPLEX WITH LAPATINIB
972, 4uwbB, 0.8094, 2.51, 0.389, 299, 257, FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE IN COMPLEX WITH JK-P5
973, 3priB, 0.8094, 2.14, 0.310, 264, 252, CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
974, 3priA, 0.8094, 2.14, 0.310, 264, 252, CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
975, 1phkA, 0.8094, 2.36, 0.208, 277, 255, TWO STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHORYLASE KINASE: AN ACTIVE PROTEIN KINASE COMPLEXED WITH NUCLEOTIDE SUBSTRATE-ANALOGUE AND PRODUCT
976, 5uhnB, 0.8093, 2.16, 0.389, 269, 252, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 2 HARBORING A N549H/E565A DOUBLE GAIN-OF-FUNCTION MUTATION
977, 3tzmA, 0.8093, 2.47, 0.258, 295, 256, TGF-BETA RECEPTOR TYPE 1 IN COMPLEX WITH SB431542
978, 2ijmA, 0.8093, 2.08, 0.343, 260, 251, CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN WITH 2 MOLECULES IN THE ASYMMETRIC UNIT COMPLEXED WITH ADP AND ATP
979, 1opjA, 0.8093, 2.29, 0.377, 287, 252, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
980, 5kvtA, 0.8092, 2.45, 0.395, 287, 256, THE STRUCTURE OF TRKA KINASE DOMAIN BOUND TO THE INHIBITOR ENTRECTINIB
981, 3rcdB, 0.8091, 2.25, 0.341, 271, 249, HER2 KINASE DOMAIN COMPLEXED WITH TAK-285
982, 3q4uD, 0.8091, 2.70, 0.282, 299, 259, CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH LDN- 193189
983, 5nk5A, 0.8090, 2.75, 0.335, 287, 260, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 1M
984, 4ueuA, 0.8090, 2.05, 0.382, 256, 249, TYROSINE KINASE AS - A COMMON ANCESTOR OF SRC AND ABL
985, 4idvA, 0.8090, 2.53, 0.208, 335, 259, CRYSTAL STRUCTURE OF NIK WITH COMPOUND 4-{3-[2-AMINO-5-(2- METHOXYETHOXY)PYRIMIDIN-4-YL]-1H-INDOL-5-YL}-2-METHYLBUT-3-YN-2-OL (13V)
986, 5l6wL, 0.8089, 2.61, 0.292, 290, 257, STRUCTURE OF THE LIMK1-ATPGAMMAS-CFL1 COMPLEX
987, 4ctbA, 0.8089, 2.36, 0.308, 292, 253, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR (5R)-8-AMINO-3-FLUORO-519-DIMETHYL-20-OXO-5181920- TETRAHYDRO-711-(AZENO)PYRIDO(2 1 :23)IMIDAZO(45-H)(2511) BENZOXADIAZACYCLOTETRADECINE-14-CARBONITRILE
988, 3rcdD, 0.8089, 2.26, 0.341, 271, 249, HER2 KINASE DOMAIN COMPLEXED WITH TAK-285
989, 1fpuB, 0.8089, 2.27, 0.384, 270, 250, CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
990, 5ng2B, 0.8088, 2.24, 0.261, 278, 253, STRUCTURE OF RIP2K(D146N) WITH BOUND STAUROSPORINE
991, 5caoA, 0.8088, 2.29, 0.347, 300, 251, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 29
992, 4qmmA, 0.8087, 2.45, 0.273, 288, 256, MST3 IN COMPLEX WITH AT-9283 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]- 1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM
993, 3u6jA, 0.8087, 2.45, 0.373, 308, 255, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRAZOLONE INHIBITOR
994, 5edqA, 0.8085, 2.42, 0.348, 298, 253, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 15: ~{N}-(7- CHLORANYL-1~{H}-INDAZOL-3-YL)-77-DIMETHYL-2-(1~{H}-PYRAZOL-4-YL)- 5~{H}-FURO[34-D]PYRIMIDIN-4-AMINE
995, 3lzbC, 0.8085, 2.18, 0.348, 259, 250, EGFR KINASE DOMAIN COMPLEXED WITH AN IMIDAZO[21-B]THIAZOLE INHIBITOR
996, 2rfdB, 0.8085, 2.61, 0.335, 286, 257, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
997, 5zv2A, 0.8084, 2.46, 0.385, 284, 257, FGFR-1 IN COMPLEX WITH LIGAND LENVATINIB 
998, 4qmoA, 0.8084, 2.45, 0.273, 288, 256, MST3 IN COMPLEX WITH IMIDAZOLO-OXINDOLE PKR INHIBITOR C16
999, 4nw6A, 0.8084, 2.69, 0.224, 302, 259, RSK2 N-TERMINAL KINASE IN COMPLEX WITH 2-AMINO-7-SUBSTITUTED BENZOXAZOLE COMPOUND 27
1000, 3psbB, 0.8084, 2.14, 0.310, 264, 252, FURO[23-C]PYRIDINE-BASED INDANONE OXIMES AS POTENT AND SELECTIVE B- RAF INHIBITORS
1001, 2oiqB, 0.8084, 2.19, 0.313, 265, 252, CRYSTAL STRUCTURE OF CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH THE CANCER DRUG IMATINIB.
1002, 5ew8B, 0.8083, 2.57, 0.388, 290, 258, FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693
1003, 4mxcA, 0.8083, 2.58, 0.322, 290, 255, CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR
1004, 4fvpA, 0.8081, 2.24, 0.250, 274, 252, CRYSTAL STRUCTURE OF THE JAK2 PSEUDOKINASE DOMAIN (APO FORM)
1005, 3psdB, 0.8081, 2.15, 0.310, 264, 252, NON-OXIME PYRAZOLE BASED INHIBITORS OF B-RAF KINASE
1006, 3oy3B, 0.8081, 2.42, 0.379, 284, 253, CRYSTAL STRUCTURE OF ABL T315I MUTANT KINASE DOMAIN BOUND WITH A DFG- OUT INHIBITOR AP24589
1007, 2wd1A, 0.8081, 2.78, 0.326, 289, 258, HUMAN C-MET KINASE IN COMPLEX WITH AZAINDOLE INHIBITOR
1008, 5e91A, 0.8080, 2.85, 0.247, 297, 259, TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431AR433AE485AK488AR493A R495A) IN COMPLEX WITH 3-AMINO-6-[4-(2- HYDROXYETHYL)PHENYL]-N-[4- (MORPHOLIN-4-YL)PYRIDIN-3-YL] PYRAZINE-2-CARBOXAMIDE
1009, 4nw5A, 0.8080, 2.69, 0.220, 302, 259, RSK2 N-TERMINAL KINASE IN COMPLEX WITH 2-AMINO-7-SUBSTITUTED BENZOXAZOLE COMPOUND 8
1010, 3oy3A, 0.8080, 2.41, 0.379, 284, 253, CRYSTAL STRUCTURE OF ABL T315I MUTANT KINASE DOMAIN BOUND WITH A DFG- OUT INHIBITOR AP24589
1011, 5h0bA, 0.8079, 2.66, 0.367, 446, 256, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-4-METHYLPENTANOIC ACID
1012, 4g3dA, 0.8079, 2.51, 0.214, 324, 257, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK)
1013, 3lmgB, 0.8079, 2.80, 0.332, 268, 259, CRYSTAL STRUCTURE OF THE ERBB3 KINASE DOMAIN IN COMPLEX WITH AMP-PNP
1014, 6babA, 0.8078, 2.54, 0.221, 290, 258, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
1015, 4qmqA, 0.8078, 2.47, 0.273, 289, 256, MST3 IN COMPLEX WITH CP-673451
1016, 3hmmA, 0.8078, 2.62, 0.262, 293, 256, STRUCTURE OF ALK5 + GW855857
1017, 3f6xC, 0.8078, 2.05, 0.309, 265, 249, C-SRC KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1018, 2ijmB, 0.8078, 2.17, 0.347, 261, 251, CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN WITH 2 MOLECULES IN THE ASYMMETRIC UNIT COMPLEXED WITH ADP AND ATP
1019, 4r7hA, 0.8077, 2.31, 0.343, 308, 251, CRYSTAL STRUCTURE OF FMS KINASE DOMAIN WITH A SMALL MOLECULAR INHIBITOR PLX3397
1020, 4bb4A, 0.8077, 2.32, 0.332, 265, 253, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1021, 3w33A, 0.8077, 2.51, 0.348, 297, 253, EGFR KINASE DOMAIN COMPLEXED WITH COMPOUND 19B
1022, 2wkmA, 0.8077, 2.61, 0.322, 286, 255, X-RAY STRUCTURE OF PHA-00665752 BOUND TO THE KINASE DOMAIN OF C-MET
1023, 1fvrB, 0.8077, 2.45, 0.324, 300, 256, TIE2 KINASE DOMAIN
1024, 5imxA, 0.8076, 1.96, 0.317, 266, 246, ANAPLASTIC LYMPHOMA KINASE (ALK) CATALYTIC DOMAIN COMPLEXED WITH NOVEL INHIBITOR 3-SULFONYLPYRAZOL-4-AMINO PYRIMIDINE
1025, 4v05B, 0.8076, 2.46, 0.398, 286, 256, FGFR1 IN COMPLEX WITH AZD4547.
1026, 3ik3A, 0.8075, 2.34, 0.377, 280, 252, AP24534 A PAN-BCR-ABL INHIBITOR FOR CHRONIC MYELOID LEUKEMIA POTENTLY INHIBITS THE T315I MUTANT AND OVERCOMES MUTATION-BASED RESISTANCE
1027, 2hckA, 0.8075, 2.33, 0.361, 437, 252, SRC FAMILY KINASE HCK-QUERCETIN COMPLEX
1028, 5vndA, 0.8074, 2.53, 0.388, 302, 258, CRYSTAL STRUCTURE OF FGFR1-Y563C (FGFR4 SURROGATE) COVALENTLY BOUND TO H3B-6527
1029, 5ut1A, 0.8074, 2.20, 0.251, 272, 251, JAK2 JH2 IN COMPLEX WITH BI-D1870
1030, 5p9fA, 0.8073, 2.23, 0.340, 266, 253, BTK IN COMPLEX WITH GDC-0834
1031, 5ng2A, 0.8073, 2.12, 0.259, 274, 251, STRUCTURE OF RIP2K(D146N) WITH BOUND STAUROSPORINE
1032, 5h0hA, 0.8073, 2.66, 0.367, 446, 256, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-NN4-TRIMETHYLPENTANAMIDE
1033, 4kioC, 0.8073, 1.95, 0.324, 251, 247, KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH A COVALENTLY-BINDING INHIBITOR
1034, 4fl3A, 0.8073, 2.50, 0.339, 538, 254, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH
1035, 3lmgA, 0.8073, 2.81, 0.332, 268, 259, CRYSTAL STRUCTURE OF THE ERBB3 KINASE DOMAIN IN COMPLEX WITH AMP-PNP
1036, 2h8hA, 0.8073, 2.50, 0.298, 444, 255, SRC KINASE IN COMPLEX WITH A QUINAZOLINE INHIBITOR
1037, 5ut5A, 0.8072, 2.19, 0.251, 272, 251, JAK2 JH2 IN COMPLEX WITH GLPG0634
1038, 5ut0A, 0.8072, 2.20, 0.251, 272, 251, JAK2 JH2 IN COMPLEX WITH AT9283
1039, 5a46A, 0.8072, 2.65, 0.391, 289, 258, FGFR1 IN COMPLEX WITH DOVITINIB
1040, 4xcuA, 0.8072, 2.46, 0.355, 288, 256, CRYSTAL STRUCTURE OF FGFR4 WITH AN IRREVERSIBLE INHIBITOR
1041, 4w8dA, 0.8072, 2.46, 0.273, 289, 256, CRYSTAL STRUCTURE OF MST3 WITH A PYRROLOPYRIMIDINE INHIBITOR (PF- 06454589).
1042, 5ut3A, 0.8071, 2.20, 0.251, 272, 251, JAK2 JH2 IN COMPLEX WITH IKK-2 INHIBITOR VI
1043, 5h09A, 0.8071, 2.68, 0.367, 446, 256, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-ETHYL2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-4-METHYLPENTANOATE
1044, 5ftqA, 0.8071, 2.49, 0.310, 293, 255, CRYSTAL STRUCTURE OF THE ALK KINASE DOMAIN IN COMPLEX WITH CMPD 17
1045, 4y85B, 0.8071, 2.47, 0.202, 306, 257, CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(5-(1H-INDOL- 3-YL)-1H-PYRROLO[23-B]PYRIDIN-3-YL)-134-OXADIAZOL-2-AMINE
1046, 5xs2A, 0.8070, 3.04, 0.195, 366, 266, CDK8-CYCC IN COMPLEX WITH COMPOUND 17:3-CHLORO-4-(4-PYRIDYL)-1H- PYRROLE-2-CARBOXAMIDE
1047, 4y95A, 0.8070, 2.23, 0.340, 266, 253, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BRUTON S TYROSINE KINASE WITH MUTATIONS IN THE ACTIVATION LOOP
1048, 3g0fA, 0.8070, 2.57, 0.350, 291, 254, KIT KINASE DOMAIN MUTANT D816H IN COMPLEX WITH SUNITINIB
1049, 4k11A, 0.8069, 2.49, 0.302, 447, 255, THE STRUCTURE OF 1NA IN COMPLEX WITH SRC T338G
1050, 4fnyA, 0.8069, 1.98, 0.305, 273, 246, CRYSTAL STRUCTURE OF THE R1275Q ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR
1051, 2vz6B, 0.8069, 2.65, 0.215, 294, 260, STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE II ALPHA (CAMK2A) IN COMPLEX WITH INDIRUBIN E804
1052, 5htiA, 0.8068, 2.63, 0.325, 290, 255, CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH LXM108
1053, 5am7B, 0.8068, 2.29, 0.395, 287, 253, FGFR1 MUTANT WITH AN INHIBITOR
1054, 3f6xB, 0.8068, 2.15, 0.311, 267, 251, C-SRC KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1055, 3cc6A, 0.8068, 2.61, 0.353, 269, 258, CRYSTAL STRUCTURE OF KINASE DOMAIN OF PROTEIN TYROSINE KINASE 2 BETA (PTK2B)
1056, 5hvkA, 0.8067, 2.62, 0.283, 297, 258, CRYSTAL STRUCTURE OF LIMK1 MUTANT D460N IN COMPLEX WITH FULL-LENGTH COFILIN-1
1057, 4uxqA, 0.8067, 2.35, 0.366, 286, 254, FGFR4 IN COMPLEX WITH PONATINIB
1058, 4idtB, 0.8067, 2.39, 0.220, 335, 255, CRYSTAL STRUCTURE OF NIK WITH 11-BROMO-5678-TETRAHYDROPYRIMIDO[4  5 :34]CYCLOHEPTA[12-B]INDOL-2-AMINE (T28)
1059, 3omvA, 0.8067, 2.17, 0.286, 264, 252, CRYSTAL STRUCTURE OF C-RAF (RAF-1)
1060, 3f6xA, 0.8066, 2.00, 0.315, 264, 248, C-SRC KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1061, 3dtwA, 0.8066, 2.05, 0.356, 288, 247, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZISOXAZOLE INHIBITOR
1062, 5hvkC, 0.8065, 2.64, 0.283, 291, 258, CRYSTAL STRUCTURE OF LIMK1 MUTANT D460N IN COMPLEX WITH FULL-LENGTH COFILIN-1
1063, 4y95D, 0.8065, 2.24, 0.344, 265, 253, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BRUTON S TYROSINE KINASE WITH MUTATIONS IN THE ACTIVATION LOOP
1064, 4u8zA, 0.8065, 2.48, 0.273, 289, 256, CRYSTAL STRUCTURE OF MST3 WITH A PYRROLOPYRIMIDINE INHIBITOR (PF- 06447475)
1065, 5uszA, 0.8064, 2.20, 0.251, 272, 251, JAK2 JH2 IN COMPLEX WITH JNJ-7706621
1066, 5h0eA, 0.8064, 2.61, 0.357, 446, 255, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-4-METHYLPENTANAMIDE
1067, 5dg5B, 0.8064, 2.62, 0.325, 297, 255, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH ALTIRATINIB ANALOG DP- 4157
1068, 4otwA, 0.8064, 2.87, 0.327, 272, 260, HER3 PSEUDOKINASE DOMAIN BOUND TO BOSUTINIB
1069, 4g3eB, 0.8064, 2.45, 0.211, 325, 256, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO A 6-ALKYNYLINDOLINE (CMP1)
1070, 6gi6A, 0.8063, 2.72, 0.282, 298, 259, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH A QUINAZOLINONE BASED ALK2 INHIBITOR WITH A 5-METHYL CORE. 
1071, 5ar5A, 0.8063, 2.23, 0.266, 284, 252, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH BENZIMIDAZOLE
1072, 4y85A, 0.8063, 2.49, 0.202, 307, 257, CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(5-(1H-INDOL- 3-YL)-1H-PYRROLO[23-B]PYRIDIN-3-YL)-134-OXADIAZOL-2-AMINE
1073, 3lzbD, 0.8063, 2.28, 0.347, 261, 251, EGFR KINASE DOMAIN COMPLEXED WITH AN IMIDAZO[21-B]THIAZOLE INHIBITOR
1074, 5ut6A, 0.8062, 2.22, 0.251, 272, 251, JAK2 JH2 IN COMPLEX WITH A DIAMINOPYRIMIDINE
1075, 3dkcA, 0.8062, 2.75, 0.309, 312, 259, STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH ATP
1076, 2hckB, 0.8062, 2.36, 0.361, 437, 252, SRC FAMILY KINASE HCK-QUERCETIN COMPLEX
1077, 4mxzB, 0.8061, 2.23, 0.323, 264, 251, SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
1078, 4mxyB, 0.8061, 2.23, 0.323, 264, 251, SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
1079, 3vs3B, 0.8061, 2.38, 0.365, 431, 252, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)- 7H-PYRROLO[23-D]PYRIMIDIN-4-AMINE
1080, 6aywA, 0.8060, 2.72, 0.222, 293, 261, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
1081, 5y25A, 0.8060, 2.37, 0.347, 292, 251, EGFR KINASE DOMAIN MUTANT (T790M/L858R) WITH COVALENT LIGAND NS-062 
1082, 5vilC, 0.8060, 2.76, 0.253, 271, 257, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 6)
1083, 5i9uA, 0.8060, 2.57, 0.341, 281, 255, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE
1084, 4z3vA, 0.8060, 2.24, 0.340, 271, 253, FRAGMENT-BASED DISCOVERY OF A SMALL MOLECULE REVERSIBLE INHIBITOR OF BRUTON S TYROSINE KINASE
1085, 4pp9A, 0.8060, 1.67, 0.325, 246, 243, ITK KINASE DOMAIN WITH COMPOUND 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4- YL]-2H-INDAZOLE-3-CARBOXAMIDE)
1086, 3zfxF, 0.8060, 1.87, 0.343, 254, 245, CRYSTAL STRUCTURE OF EPHB1
1087, 3pozA, 0.8060, 2.34, 0.351, 293, 251, EGFR KINASE DOMAIN COMPLEXED WITH TAK-285
1088, 6g4zB, 0.8059, 2.45, 0.207, 325, 256, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK) IN COMPLEX WITH COMPOUND 2F 
1089, 4yznA, 0.8059, 2.43, 0.277, 269, 256, HUMANIZED ROCO4 BOUND TO COMPOUND 19
1090, 3q4uC, 0.8059, 2.62, 0.280, 296, 257, CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH LDN- 193189
1091, 4yhfA, 0.8058, 2.39, 0.335, 268, 254, BRUTON S TYROSINE KINASE IN COMPLEX WITH A T-BUTYL CYANOACRYLAMIDE INHIBITOR
1092, 4ckrA, 0.8058, 2.82, 0.364, 295, 258, CRYSTAL STRUCTURE OF THE HUMAN DDR1 KINASE DOMAIN IN COMPLEX WITH DDR1-IN-1
1093, 3vrzB, 0.8058, 2.30, 0.368, 430, 250, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL)PHENYL]- 3-BENZYLUREA
1094, 2vx0A, 0.8058, 2.55, 0.323, 273, 257, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1095, 2hznA, 0.8058, 2.00, 0.381, 272, 247, ABL KINASE DOMAIN IN COMPLEX WITH NVP-AFG210
1096, 5ut2A, 0.8057, 2.22, 0.251, 273, 251, JAK2 JH2 IN COMPLEX WITH PRT062607
1097, 4r1vA, 0.8057, 2.82, 0.322, 289, 258, IDENTIFICATION AND OPTIMIZATION OF PYRIDAZINONES AS POTENT AND SELECTIVE C-MET KINASE INHIBITORS
1098, 4mxxA, 0.8057, 2.25, 0.313, 266, 252, HUMAN SRC A403T MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
1099, 4k8aB, 0.8057, 2.29, 0.341, 258, 252, FRAGMENT-BASED DISCOVERY OF FOCAL ADHESION KINASE INHIBITORS
1100, 5vioC, 0.8056, 2.73, 0.253, 271, 257, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 13)
1101, 5t0pA, 0.8056, 2.13, 0.316, 264, 250, C-SRC KINASE DOMAIN IN COMPLEX WITH RAO-IV-151
1102, 3omvB, 0.8056, 2.18, 0.286, 264, 252, CRYSTAL STRUCTURE OF C-RAF (RAF-1)
1103, 4mxoA, 0.8055, 2.25, 0.313, 266, 252, HUMAN SRC KINASE BOUND TO KINASE INHIBITOR BOSUTINIB
1104, 5zv2B, 0.8054, 2.50, 0.388, 282, 255, FGFR-1 IN COMPLEX WITH LIGAND LENVATINIB 
1105, 4bggA, 0.8054, 2.66, 0.280, 296, 257, CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH LDN-213844
1106, 3ik3B, 0.8054, 2.36, 0.377, 286, 252, AP24534 A PAN-BCR-ABL INHIBITOR FOR CHRONIC MYELOID LEUKEMIA POTENTLY INHIBITS THE T315I MUTANT AND OVERCOMES MUTATION-BASED RESISTANCE
1107, 5fg8A, 0.8053, 2.59, 0.222, 269, 257, DROSOPHILA CAMKII-WT IN COMPLEX WITH A FRAGMENT OF THE EAG POTASSIUM CHANNEL AND MG2+/ADP
1108, 4cmtA, 0.8053, 2.27, 0.308, 284, 250, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 3-((1R)-1-(5-FLUORO-2-(2H-123-TRIAZOL-2-YL) PHENYL)ETHOXY)-5-(3-(METHYLSULFONYL)PHENYL)PYRIDIN-2-AMINE
1109, 3mtfB, 0.8053, 2.72, 0.283, 298, 258, CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH A 2- AMINOPYRIDINE INHIBITOR
1110, 2rfeC, 0.8053, 2.34, 0.336, 262, 250, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
1111, 2f2uB, 0.8053, 2.80, 0.187, 383, 262, CRYSTAL STRUCTURE OF THE RHO-KINASE KINASE DOMAIN
1112, 1opjB, 0.8052, 2.49, 0.379, 288, 253, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
1113, 5h9bA, 0.8051, 2.58, 0.222, 269, 257, DROSOPHILA CAMKII-WT IN COMPLEX WITH A FRAGMENT OF THE EAG POTASSIUM CHANNEL AND MG2+/AMPPN
1114, 5b7vA, 0.8051, 2.58, 0.388, 282, 255, HUMAN FGFR1 KINASE IN COMPLEX WITH CH5183284
1115, 4rwlB, 0.8051, 2.51, 0.384, 285, 255, CRYSTAL STRUCTURE OF FGFR1 (C488A C584C) IN COMPLEX WITH 6-(7-((1- AMINOCYCLOPROPYL) METHOXY)-6-METHOXYQUINOLIN-4-YLOXY)-N-METHYL-1- NAPHTHAMIDE (E3810)
1116, 4qmvA, 0.8051, 2.50, 0.273, 288, 256, MST3 IN COMPLEX WITH PF-03814735 N-{2-[(1S4R)-6-{[4- (CYCLOBUTYLAMINO)-5-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]AMINO}-1234- TETRAHYDRO-14-EPIMINONAPHTHALEN-9-YL]-2-OXOETHYL}ACETAMIDE
1117, 3my1A, 0.8051, 2.88, 0.209, 314, 263, STRUCTURE OF CDK9/CYCLINT1 IN COMPLEX WITH DRB
1118, 3b8rA, 0.8051, 2.00, 0.370, 289, 246, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
1119, 2ckeA, 0.8051, 2.68, 0.231, 301, 260, HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR
1120, 5t8qA, 0.8050, 2.56, 0.202, 323, 257, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO ARYL PYRROLE FRAGMENT 17
1121, 4rj5A, 0.8050, 2.36, 0.348, 296, 250, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 5
1122, 3oomA, 0.8049, 2.68, 0.276, 297, 257, CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH THE IMIDAZO[12-B]PYRIDAZINE INHIBITOR K00507
1123, 1k9aF, 0.8049, 2.08, 0.336, 436, 247, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
1124, 5wr7A, 0.8048, 2.65, 0.396, 301, 255, CRYSTAL STRUCTURE OF TRK-A COMPLEXED WITH A SELECTIVE INHIBITOR CH7057288
1125, 4v05A, 0.8048, 2.59, 0.397, 287, 257, FGFR1 IN COMPLEX WITH AZD4547.
1126, 4bggB, 0.8048, 2.66, 0.280, 293, 257, CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH LDN-213844
1127, 3gvuA, 0.8048, 2.29, 0.369, 271, 249, THE CRYSTAL STRUCTURE OF HUMAN ABL2 IN COMPLEX WITH GLEEVEC
1128, 5h0gA, 0.8047, 2.67, 0.367, 446, 256, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-N4-DIMETHYLPENTANAMIDE
1129, 5am6B, 0.8047, 2.32, 0.401, 280, 252, NATIVE FGFR1 WITH AN INHIBITOR
1130, 3orxD, 0.8047, 2.59, 0.241, 282, 257, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
1131, 3orxC, 0.8047, 2.59, 0.241, 283, 257, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
1132, 5oxgC, 0.8046, 2.74, 0.282, 301, 259, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH LDN- 212854
1133, 5o49B, 0.8046, 2.44, 0.392, 286, 255, HUMAN FGF IN COMPLEX WITH A COVALENT INHIBITOR
1134, 5hznE, 0.8046, 2.49, 0.319, 296, 254, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1135, 3vs4A, 0.8046, 2.36, 0.367, 429, 251, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 5-(4-PHENOXYPHENYL)-7-(TETRAHYDRO-2H-PYRAN-4-YL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE
1136, 5hznA, 0.8045, 2.49, 0.319, 296, 254, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1137, 4y85C, 0.8045, 2.51, 0.202, 303, 257, CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(5-(1H-INDOL- 3-YL)-1H-PYRROLO[23-B]PYRIDIN-3-YL)-134-OXADIAZOL-2-AMINE
1138, 4bciA, 0.8045, 2.70, 0.208, 308, 259, STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
1139, 3orxA, 0.8045, 2.60, 0.241, 283, 257, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
1140, 1kswA, 0.8045, 2.54, 0.302, 449, 255, STRUCTURE OF HUMAN C-SRC TYROSINE KINASE (THR338GLY MUTANT) IN COMPLEX WITH N6-BENZYL ADP
1141, 4bcfA, 0.8044, 2.62, 0.209, 307, 258, STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
1142, 4anlA, 0.8044, 2.47, 0.303, 292, 254, STRUCTURE OF G1269A MUTANT ANAPLASTIC LYMPHOMA KINASE
1143, 5vfiA, 0.8043, 2.27, 0.340, 271, 253, BRUTON S TYROSINE KINASE (BTK) WITH GDC-0853
1144, 2ckeC, 0.8043, 2.68, 0.231, 300, 260, HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR
1145, 5i9yA, 0.8042, 2.80, 0.337, 287, 258, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH DASATINIB
1146, 2srcA, 0.8042, 2.58, 0.302, 449, 255, CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC IN COMPLEX WITH AMP-PNP
1147, 1fvrA, 0.8042, 2.45, 0.325, 299, 255, TIE2 KINASE DOMAIN
1148, 5edpA, 0.8041, 2.49, 0.348, 295, 253, EGFR KINASE (T790M/L858R) APO
1149, 4tyjA, 0.8041, 2.23, 0.369, 278, 249, STRUCTURAL ANALYSIS OF THE HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE
1150, 4nkaB, 0.8041, 2.44, 0.386, 287, 254, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 2
1151, 3vs1A, 0.8041, 2.30, 0.369, 424, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL)PHENYL]- 3-PHENYLUREA
1152, 3v8sD, 0.8041, 2.82, 0.202, 397, 262, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH INDAZOLE DERIVATIVE (COMPOUND 18)
1153, 2yhvA, 0.8041, 2.43, 0.308, 291, 253, STRUCTURE OF L1196M MUTANT ANAPLASTIC LYMPHOMA KINASE
1154, 2zv8A, 0.8040, 2.21, 0.375, 257, 251, LYN TYROSINE KINASE DOMAIN-AMP-PNP COMPLEX
1155, 4nk9B, 0.8039, 2.52, 0.386, 282, 254, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 1
1156, 4idtA, 0.8039, 2.41, 0.220, 334, 255, CRYSTAL STRUCTURE OF NIK WITH 11-BROMO-5678-TETRAHYDROPYRIMIDO[4  5 :34]CYCLOHEPTA[12-B]INDOL-2-AMINE (T28)
1157, 4eolC, 0.8039, 2.63, 0.268, 299, 257, THR 160 PHOSPHORYLATED CDK2 H84S Q85M K89D - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
1158, 3thbA, 0.8039, 2.82, 0.263, 287, 259, STRUCTURE OF PLK1 KINASE DOMAIN IN COMPLEX WITH A BENZOLACTAM-DERIVED INHIBITOR
1159, 2xuuA, 0.8039, 2.69, 0.242, 301, 260, CRYSTAL STRUCTURE OF A DAP-KINASE 1 MUTANT
1160, 2biyA, 0.8039, 2.71, 0.239, 287, 259, STRUCTURE OF PDK1-S241A MUTANT KINASE DOMAIN
1161, 5iugA, 0.8038, 2.20, 0.310, 285, 248, CRYSTAL STRUCTURE OF ANAPLASTIC LYMPHOMA KINASE (ALK) IN COMPLEX WITH 5A
1162, 2a2aA, 0.8038, 2.70, 0.223, 304, 260, HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE
1163, 6g4yA, 0.8037, 2.54, 0.211, 322, 256, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK) IN COMPLEX WITH COMPOUND 1A 
1164, 5nkgA, 0.8037, 3.01, 0.331, 292, 260, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 3D
1165, 5hznC, 0.8037, 2.49, 0.319, 296, 254, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1166, 5e8vA, 0.8037, 2.87, 0.248, 296, 258, TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431AR433AE485AK488AR493A R495A)
1167, 4nk9A, 0.8037, 2.48, 0.390, 281, 254, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 1
1168, 3zfxB, 0.8037, 1.93, 0.339, 254, 245, CRYSTAL STRUCTURE OF EPHB1
1169, 2vwyA, 0.8037, 2.74, 0.328, 274, 259, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1170, 5hznG, 0.8036, 2.49, 0.319, 296, 254, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1171, 4mxoB, 0.8036, 2.18, 0.312, 264, 250, HUMAN SRC KINASE BOUND TO KINASE INHIBITOR BOSUTINIB
1172, 3ppkA, 0.8036, 2.14, 0.304, 262, 250, HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
1173, 3hngA, 0.8036, 2.29, 0.373, 288, 249, CRYSTAL STRUCTURE OF VEGFR1 IN COMPLEX WITH N-(4-CHLOROPHENYL)-2- ((PYRIDIN-4-YLMETHYL)AMINO)BENZAMIDE
1174, 5t8oA, 0.8035, 2.54, 0.206, 324, 257, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO IMIDAZOBENZOXEPIN COMPOUND 3
1175, 5hznF, 0.8035, 2.50, 0.319, 296, 254, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1176, 5hznB, 0.8035, 2.50, 0.319, 296, 254, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1177, 4bcgA, 0.8035, 2.86, 0.209, 312, 263, STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
1178, 3ppjA, 0.8035, 2.13, 0.304, 262, 250, HUMAN B-RAF KINASE IN COMPLEX WITH A FUROPYRIDINE INHIBITOR
1179, 4h1jA, 0.8034, 2.68, 0.345, 263, 258, CRYSTAL STRUCTURE OF PYK2 WITH THE PYRAZOLE 13A
1180, 3vryA, 0.8034, 2.33, 0.368, 428, 250, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23-D]PYRIMIDIN-7-YL- CYCLOPENTANE
1181, 3sxrB, 0.8034, 2.28, 0.313, 258, 252, CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEX WITH DASATINIB
1182, 3q4uA, 0.8034, 2.76, 0.283, 298, 258, CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH LDN- 193189
1183, 2yabB, 0.8034, 2.72, 0.230, 299, 261, CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH AMP
1184, 5xy1A, 0.8033, 1.99, 0.381, 253, 247, CRYSTAL STRUCTURE OF LYN KINASE DOMAIN IN COMPLEX WITH N-(1H-INDAZOL- 6-YL)-8-(PIPERIDIN-4-YLOXY)-6-PROPYLQUINAZOLIN-2-AMINE
1185, 4gu9B, 0.8033, 2.40, 0.345, 255, 252, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH (2-FLUORO- PHENYL)-(1H-PYRAZOLO[34-D]PYRIMIDIN-4-YL)-AMINE
1186, 2ckeB, 0.8033, 2.67, 0.231, 300, 260, HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR
1187, 4fnwA, 0.8032, 2.46, 0.308, 304, 253, CRYSTAL STRUCTURE OF THE APO F1174L ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
1188, 6ginA, 0.8031, 2.65, 0.281, 296, 256, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH AN QUINAZOLINONE BASED ALK2 INHIBITOR WITH A 4-MORPHOLINOPHENYL SOLVENT ACCESSIBLE GROUP. 
1189, 6f3fA, 0.8031, 2.51, 0.302, 448, 255, AUTOINHIBITED SRC KINASE BOUND TO ADP
1190, 5p9gA, 0.8031, 2.27, 0.333, 265, 252, STRUCTURE OF BTK WITH RN486
1191, 5ia2A, 0.8031, 2.73, 0.336, 287, 256, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 66
1192, 4v01B, 0.8031, 2.38, 0.378, 275, 251, FGFR1 IN COMPLEX WITH PONATINIB (CO-CRYSTALLISATION).
1193, 4g3dB, 0.8031, 2.63, 0.214, 318, 257, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK)
1194, 3zfxG, 0.8031, 1.86, 0.344, 253, 244, CRYSTAL STRUCTURE OF EPHB1
1195, 3rcdC, 0.8031, 2.18, 0.351, 281, 248, HER2 KINASE DOMAIN COMPLEXED WITH TAK-285
1196, 3lq5A, 0.8031, 2.65, 0.209, 307, 258, STRUCTURE OF CDK9/CYCLINT IN COMPLEX WITH S-CR8
1197, 3g0fB, 0.8031, 2.48, 0.344, 293, 253, KIT KINASE DOMAIN MUTANT D816H IN COMPLEX WITH SUNITINIB
1198, 1z9xB, 0.8031, 2.71, 0.227, 303, 260, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 3 MONOMERS IN THE ASYMMETRIC UNIT
1199, 1z9xA, 0.8031, 2.71, 0.227, 303, 260, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 3 MONOMERS IN THE ASYMMETRIC UNIT
1200, 4ymjB, 0.8030, 2.28, 0.385, 275, 252, (R)-2-PHENYLPYRROLIDINE SUBSTITUTE IMIDAZOPYRIDAZINES: A NEW CLASS OF POTENT AND SELECTIVE PAN-TRK INHIBITORS
1201, 4ot6A, 0.8030, 2.29, 0.329, 265, 252, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 4- METHANESULFONYL-N-(3-{8-[4-(MORPHOLINE-4-CARBONYL)-PHENYLAMINO]- IMIDAZO[12-A]PYRAZIN-6-YL}-PHENYL)-BENZAMIDE
1202, 3tn8A, 0.8030, 2.69, 0.208, 304, 259, CDK9/CYCLIN T IN COMPLEX WITH CAN508
1203, 3rcdA, 0.8030, 2.18, 0.351, 281, 248, HER2 KINASE DOMAIN COMPLEXED WITH TAK-285
1204, 4bcjA, 0.8029, 2.93, 0.205, 309, 263, STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
1205, 5p9iA, 0.8028, 2.36, 0.304, 271, 253, BTK1 SOAKED WITH IBRUTINIB-REV
1206, 5bvkA, 0.8028, 2.53, 0.361, 278, 255, FRAGMENT-BASED DISCOVERY OF POTENT AND SELECTIVE DDR1/2 INHIBITORS
1207, 4pmmA, 0.8028, 2.42, 0.397, 285, 252, THE STRUCTURE OF TRKA KINASE BOUND TO THE INHIBITOR N-(3-CYCLOPROPYL- 1-PHENYL-1H-PYRAZOL-5-YL)-2-{4-[3-METHOXY-4-(4-METHYL-1H-IMIDAZOL-1- YL)PHENYL]-1H-123-TRIAZOL-1-YL}ACETAMIDE
1208, 4bchA, 0.8028, 2.64, 0.209, 308, 258, STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
1209, 4b4lA, 0.8028, 2.70, 0.246, 299, 260, CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT
1210, 2i0yA, 0.8028, 2.49, 0.345, 289, 252, CFMS TYROSINE KINASE (FGF KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR
1211, 2ckeD, 0.8028, 2.71, 0.231, 300, 260, HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR
1212, 5dg5A, 0.8027, 2.71, 0.322, 297, 255, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH ALTIRATINIB ANALOG DP- 4157
1213, 2yabA, 0.8027, 2.70, 0.231, 299, 260, CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH AMP
1214, 2jkqA, 0.8027, 2.27, 0.343, 258, 251, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS- ANILINO PYRIMIDINE INHIBITOR
1215, 4wnkA, 0.8026, 2.79, 0.204, 499, 260, CRYSTAL STRUCTURE OF BOVINE G PROTEIN COUPLED-RECEPTOR KINASE 5 IN COMPLEX WITH CCG215022
1216, 4otqA, 0.8026, 2.29, 0.329, 263, 252, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 1-[5-[3-(7-TERT- BUTYL-4-OXO-QUINAZOLIN-3-YL)-2-METHYL-PHENYL]-1-METHYL-2-OXO-3- PYRIDYL]-3-METHYL-UREA
1217, 3vs4B, 0.8026, 2.33, 0.368, 434, 250, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 5-(4-PHENOXYPHENYL)-7-(TETRAHYDRO-2H-PYRAN-4-YL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE
1218, 3my0M, 0.8026, 2.88, 0.264, 298, 261, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1219, 2wtkB, 0.8026, 2.49, 0.220, 311, 254, STRUCTURE OF THE HETEROTRIMERIC LKB1-STRADALPHA-MO25ALPHA COMPLEX
1220, 2vx1A, 0.8026, 2.76, 0.328, 274, 259, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1221, 1ad5B, 0.8026, 2.41, 0.361, 437, 252, SRC FAMILY KINASE HCK-AMP-PNP COMPLEX
1222, 1ad5A, 0.8026, 2.40, 0.361, 437, 252, SRC FAMILY KINASE HCK-AMP-PNP COMPLEX
1223, 5l1zA, 0.8025, 2.67, 0.198, 310, 258, TAR COMPLEX WITH HIV-1 TAT-AFF4-P-TEFB
1224, 4y93A, 0.8025, 2.26, 0.345, 429, 252, CRYSTAL STRUCTURE OF THE PH-TH-KINASE CONSTRUCT OF BRUTON S TYROSINE KINASE (BTK)
1225, 3vryB, 0.8025, 2.31, 0.368, 434, 250, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23-D]PYRIMIDIN-7-YL- CYCLOPENTANE
1226, 3psdA, 0.8025, 2.15, 0.304, 262, 250, NON-OXIME PYRAZOLE BASED INHIBITORS OF B-RAF KINASE
1227, 6fnhB, 0.8024, 2.81, 0.338, 271, 260, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH A PYRAZOLO[3;4-D]PYRIMIDINE FRAGMENT OF NVP-BHG712 
1228, 5p9jA, 0.8024, 2.30, 0.336, 263, 253, BTK1 COCRYSTALLIZED WITH IBRUTINIB
1229, 4l00A, 0.8024, 2.24, 0.254, 277, 252, CRYSTAL STRUCTURE OF THE APO JAK1 PSEUDOKINASE DOMAIN
1230, 4h58A, 0.8024, 2.15, 0.304, 263, 250, BRAF IN COMPLEX WITH COMPOUND 3
1231, 3qhwC, 0.8024, 2.60, 0.258, 297, 256, STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC
1232, 2c0tA, 0.8024, 2.23, 0.359, 427, 248, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359
1233, 2bdfA, 0.8024, 2.27, 0.313, 261, 252, SRC KINASE IN COMPLEX WITH INHIBITOR AP23451
1234, 5vilA, 0.8023, 2.81, 0.253, 271, 257, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 6)
1235, 5nk7A, 0.8023, 2.70, 0.340, 284, 256, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2A
1236, 4zlzA, 0.8023, 2.25, 0.341, 270, 252, CRYSTAL STRUCTURE OF BRUTON S TYROSINE KINASE IN COMPLEX WITH A SUBSTITUTED CINNOLINE
1237, 4rx5A, 0.8023, 2.29, 0.329, 265, 252, BRUTON S TYROSINE KINASE (BTK) WITH PYRIDAZINONE COMPOUND 23
1238, 4rfyA, 0.8023, 2.29, 0.329, 263, 252, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6- (DIMETHYLAMINO)-2-[2-(HYDROXYMETHYL)-3-[1-METHYL-5-[[5-(MORPHOLINE-4- CARBONYL)-2-PYRIDYL]AMINO]-6-OXO-3-PYRIDYL]PHENYL]-34- DIHYDROISOQUINOLIN-1-ONE
1239, 4gg5A, 0.8023, 2.39, 0.315, 274, 251, CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR
1240, 3s95A, 0.8023, 2.52, 0.291, 290, 254, CRYSTAL STRUCTURE OF THE HUMAN LIMK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
1241, 6fnkA, 0.8022, 2.59, 0.327, 274, 257, CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE WITH A PYRAZOLO[3;4-D]PYRIMIDINE FRAGMENT OF NVP-BHG712 
1242, 5ng0A, 0.8022, 2.25, 0.263, 274, 251, STRUCTURE OF RIP2K(L294F) WITH BOUND AMPPCP
1243, 4rt7A, 0.8022, 2.39, 0.351, 274, 251, CRYSTAL STRUCTURE OF FLT3 WITH A SMALL MOLECULE INHIBITOR
1244, 4c02A, 0.8022, 2.63, 0.288, 313, 257, CRYSTAL STRUCTURE OF HUMAN ACVR1 (ALK2) IN COMPLEX WITH FKBP12.6 AND DORSOMORPHIN
1245, 3vs6A, 0.8022, 2.35, 0.368, 434, 250, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR TERT-BUTYL {4-[4-AMINO-1-(PROPAN-2-YL)-1H-PYRAZOLO[34- D]PYRIMIDIN-3-YL]-2-METHOXYPHENYL}CARBAMATE
1246, 3prfB, 0.8022, 2.15, 0.296, 262, 250, CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A NON- OXIME FUROPYRIDINE INHIBITOR
1247, 3orxB, 0.8022, 2.53, 0.243, 280, 255, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
1248, 3mtfA, 0.8022, 2.68, 0.281, 296, 256, CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH A 2- AMINOPYRIDINE INHIBITOR
1249, 2c0oA, 0.8022, 2.22, 0.359, 433, 248, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041
1250, 6g4zA, 0.8021, 2.56, 0.207, 322, 256, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK) IN COMPLEX WITH COMPOUND 2F 
1251, 5p9kA, 0.8021, 2.39, 0.327, 271, 254, CRYSTAL STRUCTURE OF BTK WITH CNX 774
1252, 5nkfA, 0.8021, 2.98, 0.332, 291, 259, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 3B
1253, 5k9iB, 0.8021, 2.17, 0.316, 262, 250, CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH A COVALENT LYSINE PROBE
1254, 5ig1A, 0.8021, 2.76, 0.257, 300, 261, CRYSTAL STRUCTURE OF S. ROSETTA CAMKII KINASE DOMAIN
1255, 4ogrE, 0.8021, 2.70, 0.197, 310, 259, CRYSTAL STRUCTURE OF P-TEFB COMPLEX WITH AFF4 AND TAT
1256, 3tv7B, 0.8021, 2.84, 0.198, 397, 262, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1342
1257, 3k5vA, 0.8021, 2.37, 0.375, 286, 251, STRUCTURE OF ABL KINASE IN COMPLEX WITH IMATINIB AND GNF-2
1258, 3fxxA, 0.8021, 2.57, 0.339, 288, 257, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRATE KQWDNYE[PTYR]IW
1259, 2vwzA, 0.8021, 2.76, 0.328, 274, 259, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1260, 3psbA, 0.8020, 2.14, 0.312, 262, 250, FURO[23-C]PYRIDINE-BASED INDANONE OXIMES AS POTENT AND SELECTIVE B- RAF INHIBITORS
1261, 3prfA, 0.8020, 2.17, 0.296, 262, 250, CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A NON- OXIME FUROPYRIDINE INHIBITOR
1262, 2hiwA, 0.8020, 2.32, 0.384, 274, 250, CRYSTAL STRUCTURE OF INACTIVE CONFORMATION ABL KINASE CATALYTIC DOMAIN COMPLEXED WITH TYPE II INHIBITOR
1263, 5xvfA, 0.8019, 2.59, 0.195, 289, 257, CRYSTAL STRUCTURE OF PAK4 IN COMPLEX WITH INHIBITOR CZH062
1264, 3vs6B, 0.8019, 2.35, 0.368, 434, 250, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR TERT-BUTYL {4-[4-AMINO-1-(PROPAN-2-YL)-1H-PYRAZOLO[34- D]PYRIMIDIN-3-YL]-2-METHOXYPHENYL}CARBAMATE
1265, 3qhwA, 0.8019, 2.61, 0.258, 297, 256, STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC
1266, 3cp9A, 0.8019, 2.09, 0.359, 288, 245, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
1267, 2c0iA, 0.8019, 2.23, 0.359, 433, 248, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983
1268, 4o27B, 0.8018, 2.55, 0.273, 281, 256, CRYSTAL STRUCTURE OF MST3-MO25 COMPLEX WITH WIF MOTIF
1269, 4eokC, 0.8018, 2.64, 0.268, 299, 257, THR 160 PHOSPHORYLATED CDK2 H84S Q85M K89D - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR NU6102
1270, 3gqlA, 0.8018, 2.71, 0.401, 287, 257, CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
1271, 3fy2A, 0.8018, 2.58, 0.348, 285, 256, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRATE KQWDNYEFIW
1272, 2yaaA, 0.8018, 2.70, 0.231, 300, 260, CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH ATP
1273, 2a2aD, 0.8018, 2.69, 0.231, 303, 260, HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE
1274, 6fd3A, 0.8017, 2.60, 0.218, 296, 257, THIOPHOSPHORYLATED PAK3 KINASE DOMAIN
1275, 3qgyB, 0.8017, 1.62, 0.336, 245, 241, CRYSTAL STRUCTURE OF ITK INHIBITOR COMPLEX
1276, 3q4uB, 0.8017, 2.85, 0.291, 300, 258, CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH LDN- 193189
1277, 5iuhA, 0.8016, 2.14, 0.308, 285, 247, CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE (ALK) IN COMPLEX WITH 5D
1278, 4o2pB, 0.8016, 2.18, 0.316, 265, 250, KINASE DOMAIN OF CSRC IN COMPLEX WITH A SUBSTITUTED PYRAZOLOPYRIMIDINE
1279, 4c7tA, 0.8016, 2.45, 0.336, 259, 253, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH A DIARYLAMINO-135-TRIAZINE INHIBITOR
1280, 2xikA, 0.8016, 2.56, 0.266, 288, 256, STRUCTURE OF HUMAN YSK1 (YEAST SPS1-STE20-RELATED KINASE 1)
1281, 1k3aA, 0.8016, 2.63, 0.304, 288, 257, STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR KINASE
1282, 1fpuA, 0.8016, 2.39, 0.384, 275, 250, CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1283, 5xp7A, 0.8015, 2.28, 0.315, 265, 251, C-SRC IN COMPLEX WITH ATP-CHCL
1284, 5a4cB, 0.8015, 2.62, 0.391, 286, 256, FGFR1 LIGAND COMPLEX
1285, 4v04B, 0.8015, 2.48, 0.383, 287, 253, FGFR1 IN COMPLEX WITH PONATINIB.
1286, 3v8sB, 0.8015, 2.86, 0.202, 397, 262, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH INDAZOLE DERIVATIVE (COMPOUND 18)
1287, 3cpbA, 0.8015, 2.05, 0.352, 285, 244, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BISAMIDE INHIBITOR
1288, 5lxmA, 0.8014, 2.50, 0.263, 266, 255, CRYSTAL STRUCTURE OF AURORA-A BOUND TO A HYDROCARBON-STAPLED PROTEOMIMETIC OF TPX2
1289, 5b7vB, 0.8014, 2.50, 0.395, 277, 253, HUMAN FGFR1 KINASE IN COMPLEX WITH CH5183284
1290, 4zsaB, 0.8014, 2.41, 0.399, 282, 253, CRYSTAL STRUCTURE OF FGFR1 KINASE DOMAIN IN COMPLEX WITH 7N
1291, 3twjA, 0.8014, 2.79, 0.199, 396, 261, RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1447
1292, 2zv9A, 0.8014, 2.17, 0.376, 256, 250, LYN TYROSINE KINASE DOMAIN-PP2 COMPLEX
1293, 2e2bA, 0.8014, 2.16, 0.379, 270, 248, CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH INNO-406
1294, 3uqgA, 0.8013, 2.21, 0.316, 263, 250, C-SRC KINASE DOMAIN IN COMPLEX WITH BUMPLESS BKI ANALOG UW1243
1295, 3lcoA, 0.8013, 2.38, 0.336, 293, 250, INHIBITOR BOUND TO A DFG-OUT STRUCTURE OF THE KINASE DOMAIN OF CSF-1R
1296, 2yaaB, 0.8013, 2.70, 0.231, 299, 260, CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH ATP
1297, 5oxgB, 0.8012, 2.70, 0.280, 296, 257, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH LDN- 212854
1298, 5oxgA, 0.8012, 2.69, 0.281, 293, 256, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH LDN- 212854
1299, 5ar2B, 0.8012, 2.32, 0.270, 285, 252, RIP2 KINASE CATALYTIC DOMAIN (1 - 310)
1300, 4ebvA, 0.8012, 2.51, 0.339, 262, 251, STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH NOVEL ALLOSTERIC INHIBITOR
1301, 3my0L, 0.8012, 2.92, 0.268, 296, 261, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1302, 4eonA, 0.8011, 2.63, 0.262, 299, 256, THR 160 PHOSPHORYLATED CDK2 H84S Q85M Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
1303, 4brxA, 0.8011, 2.58, 0.339, 259, 254, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH A DIARYLAMINO-135-TRIAZINE INHIBITOR
1304, 3vs1B, 0.8011, 2.35, 0.369, 433, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL)PHENYL]- 3-PHENYLUREA
1305, 3vrzA, 0.8011, 2.35, 0.369, 429, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL)PHENYL]- 3-BENZYLUREA
1306, 3tacA, 0.8011, 2.73, 0.208, 324, 260, CRYSTAL STRUCTURE OF THE LIPRIN-ALPHA/CASK COMPLEX
1307, 3my0B, 0.8011, 2.87, 0.264, 295, 261, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1308, 5vioA, 0.8010, 2.81, 0.253, 271, 257, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 13)
1309, 5t0pB, 0.8010, 2.15, 0.313, 263, 249, C-SRC KINASE DOMAIN IN COMPLEX WITH RAO-IV-151
1310, 4r7iA, 0.8010, 2.35, 0.344, 290, 250, CRYSTAL STRUCTURE OF FMS KINASE DOMAIN WITH A SMALL MOLECULAR INHIBITOR GLEEVEC
1311, 4otrA, 0.8010, 2.31, 0.329, 263, 252, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6-CYCLOPROPYL-2- [3-[5-[[5-(4-ETHYLPIPERAZIN-1-YL)-2-PYRIDYL]AMINO]-1-METHYL-6-OXO-3- PYRIDYL]-2-(HYDROXYMETHYL)PHENYL]-8-FLUORO-ISOQUINOLIN-1-ONE
1312, 3vs0B, 0.8010, 2.33, 0.369, 433, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR N-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL) PHENYL]BENZAMIDE
1313, 3tkuB, 0.8010, 2.82, 0.188, 395, 260, MRCK BETA IN COMPLEX WITH FASUDIL
1314, 3rwqA, 0.8010, 2.55, 0.243, 283, 255, DISCOVERY OF A NOVEL POTENT AND SELECTIVE INHIBITOR OF 3- PHOSPHOINOSITIDE DEPENDENT KINASE (PDK1)
1315, 2a2aC, 0.8010, 2.73, 0.231, 303, 260, HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE
1316, 6gipA, 0.8009, 2.70, 0.280, 296, 257, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH A QUINAZOLINONE BASED ALK2 INHIBITOR WITH A 2; 5-DIMETHYL CORE. 
1317, 5fbnC, 0.8009, 2.39, 0.336, 256, 253, BTK KINASE DOMAIN WITH INHIBITOR 1
1318, 5edrA, 0.8009, 2.50, 0.349, 299, 252, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 27: ~{N}-(1~{H}- INDAZOL-3-YL)-77-DIMETHYL-2-(2-METHYLPYRAZOL-3-YL)-5~{H}-FURO[34- D]PYRIMIDIN-4-AMINE
1319, 3tkuA, 0.8009, 2.83, 0.188, 395, 260, MRCK BETA IN COMPLEX WITH FASUDIL
1320, 3lvpC, 0.8009, 2.63, 0.302, 293, 258, CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR
1321, 2a2aB, 0.8009, 2.72, 0.227, 303, 260, HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE
1322, 5uglB, 0.8008, 2.31, 0.397, 271, 252, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 TYROSINE KINASE DOMAIN HARBORING THE D650V ACTIVATING MUTATION
1323, 5i9xA, 0.8008, 2.72, 0.340, 284, 256, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH BOSUTINIB (SKI-606)
1324, 5eobA, 0.8008, 2.81, 0.319, 288, 257, CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR
1325, 5dh3B, 0.8008, 2.70, 0.272, 283, 257, CRYSTAL STRUCTURE OF MST2 IN COMPLEX WITH XMU-MP-1
1326, 3vs3A, 0.8008, 2.36, 0.368, 434, 250, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)- 7H-PYRROLO[23-D]PYRIMIDIN-4-AMINE
1327, 3qhrA, 0.8008, 2.63, 0.258, 297, 256, STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC
1328, 3aoxA, 0.8008, 2.50, 0.304, 298, 253, X-RAY CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CH5424802
1329, 5vilB, 0.8007, 2.75, 0.254, 271, 256, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 6)
1330, 4hzsA, 0.8007, 2.57, 0.394, 319, 254, CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN WITH C-TERMINAL SH3 DOMAIN
1331, 4hw7A, 0.8007, 2.37, 0.344, 289, 250, CRYSTAL STRUCTURE OF FMS KINASE DOMAIN WITH A SMALL MOLECULAR INHIBITOR PLX647-OME
1332, 4a4lA, 0.8007, 2.75, 0.260, 290, 258, CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 5-(2-AMINO-PYRIMIDIN-4-YL)-1H-PYRROLE INHIBITOR
1333, 3qhrC, 0.8007, 2.63, 0.258, 297, 256, STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC
1334, 3ocsA, 0.8007, 2.32, 0.329, 264, 252, CRYSTAL STRUCTURE OF BRUTON S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI1746
1335, 2etkB, 0.8007, 2.86, 0.198, 398, 262, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO HYDROXYFASUDIL
1336, 1fgkA, 0.8007, 2.37, 0.391, 278, 253, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1
1337, 1agwA, 0.8007, 2.38, 0.387, 278, 253, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU4984 INHIBITOR
1338, 4hzsD, 0.8006, 2.57, 0.394, 319, 254, CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN WITH C-TERMINAL SH3 DOMAIN
1339, 4hzsC, 0.8006, 2.57, 0.394, 319, 254, CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN WITH C-TERMINAL SH3 DOMAIN
1340, 4hzsB, 0.8006, 2.57, 0.394, 319, 254, CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN WITH C-TERMINAL SH3 DOMAIN
1341, 3vs0A, 0.8006, 2.35, 0.369, 428, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR N-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL) PHENYL]BENZAMIDE
1342, 2vwxA, 0.8006, 2.78, 0.328, 274, 259, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1343, 2qu6A, 0.8006, 1.84, 0.368, 283, 242, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR
1344, 2c0tB, 0.8006, 2.38, 0.369, 429, 249, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359
1345, 4ks8A, 0.8005, 2.57, 0.207, 286, 256, PAK6 KINASE DOMAIN IN COMPLEX WITH SUNITINIB
1346, 4f64A, 0.8005, 2.38, 0.383, 278, 253, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 6
1347, 3lvpB, 0.8005, 2.63, 0.300, 295, 257, CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR
1348, 3kb7A, 0.8005, 2.76, 0.260, 289, 258, CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
1349, 5hu9A, 0.8004, 2.43, 0.376, 266, 250, CRYSTAL STRUCTURE OF ABL1 IN COMPLEX WITH CHMFL-074
1350, 3blrA, 0.8004, 2.63, 0.213, 300, 258, CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH FLAVOPIRIDOL
1351, 2c0oB, 0.8004, 2.35, 0.369, 433, 249, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041
1352, 5u6bC, 0.8003, 2.45, 0.317, 270, 252, STRUCTURE OF THE AXL KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC INHIBITOR
1353, 5nkcA, 0.8003, 2.72, 0.340, 286, 256, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2H
1354, 3tv7D, 0.8003, 2.88, 0.202, 397, 262, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1342
1355, 3my0N, 0.8003, 2.83, 0.270, 300, 259, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1356, 2jkkA, 0.8003, 2.56, 0.340, 258, 253, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS- ANILINO PYRIMIDINE INHIBITOR
1357, 4imyE, 0.8002, 2.78, 0.208, 313, 260, THE AFF4 SCAFFOLD BINDS HUMAN P-TEFB ADJACENT TO HIV TAT
1358, 4f63A, 0.8002, 2.39, 0.383, 278, 253, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 1
1359, 4aojA, 0.8002, 2.01, 0.399, 260, 248, HUMAN TRKA IN COMPLEX WITH THE INHIBITOR AZ-23
1360, 3vw8A, 0.8002, 2.52, 0.328, 303, 250, CRYSTAL STRUCTURE OF HUMAN C-MET KINASE DOMAIN WITH ITS INHIBITOR
1361, 2phkA, 0.8002, 2.51, 0.208, 277, 255, THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION
1362, 1lufA, 0.8002, 2.34, 0.341, 275, 249, CRYSTAL STRUCTURE OF THE MUSK TYROSINE KINASE: INSIGHTS INTO RECEPTOR AUTOREGULATION
1363, 5oy6B, 0.8001, 2.76, 0.284, 292, 257, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH CYCLICAL INHIBITOR OD36.
1364, 5d7vB, 0.8001, 2.49, 0.312, 264, 253, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN
1365, 4hctA, 0.8001, 2.47, 0.324, 265, 253, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 52
1366, 5vioB, 0.8000, 2.76, 0.254, 271, 256, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 13)
1367, 4rwlA, 0.8000, 2.44, 0.387, 282, 253, CRYSTAL STRUCTURE OF FGFR1 (C488A C584C) IN COMPLEX WITH 6-(7-((1- AMINOCYCLOPROPYL) METHOXY)-6-METHOXYQUINOLIN-4-YLOXY)-N-METHYL-1- NAPHTHAMIDE (E3810)
1368, 4l00B, 0.8000, 2.33, 0.249, 278, 253, CRYSTAL STRUCTURE OF THE APO JAK1 PSEUDOKINASE DOMAIN
1369, 4a4oA, 0.8000, 2.77, 0.260, 290, 258, CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 2- (2-AMINO-PYRIMIDIN-4-YL)-1567-TETRAHYDRO-PYRROLOPYRIDIN- 4-ONE INHIBITOR
1370, 5j87A, 0.7999, 2.30, 0.341, 263, 252, DISCOVERY OF N-(3-(5-((3-ACRYLAMIDO-4-(MORPHOLINE-4-CARBONYL)PHENYL) AMINO)-1-METHYL-6-OXO-16-DIHYDROPYRIDIN-3-YL)-2-METHYLPHENYL)-4- (TERT-BUTYL)BENZAMIDE (CHMFL-BTK-01) AS A HIGHLY SELECTIVE IRREVERSIBLE BTK KINASE INHIBITOR
1371, 4f65A, 0.7999, 2.52, 0.385, 279, 252, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 8
1372, 4aw2A, 0.7999, 2.80, 0.200, 398, 260, CRYSTAL STRUCTURE OF CDC42 BINDING PROTEIN KINASE ALPHA (MRCK ALPHA)
1373, 3k5vB, 0.7999, 2.29, 0.378, 283, 249, STRUCTURE OF ABL KINASE IN COMPLEX WITH IMATINIB AND GNF-2
1374, 2vn9B, 0.7999, 2.75, 0.204, 301, 260, CRYSTAL STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA ISOFORM 1 CAMKD
1375, 2fgiA, 0.7999, 2.33, 0.381, 274, 252, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074
1376, 1k2pB, 0.7999, 2.52, 0.325, 258, 255, CRYSTAL STRUCTURE OF BRUTON S TYROSINE KINASE DOMAIN
1377, 3gxlA, 0.7998, 2.50, 0.249, 285, 253, ALK-5 KINASE COMPLEX WITH GW857175
1378, 1unlB, 0.7998, 2.72, 0.230, 292, 256, STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE ALOISINE AND INDIRUBIN.
1379, 5u6bA, 0.7997, 2.47, 0.317, 270, 252, STRUCTURE OF THE AXL KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC INHIBITOR
1380, 5d7vA, 0.7997, 2.58, 0.306, 268, 255, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN
1381, 3nynB, 0.7997, 2.71, 0.217, 553, 258, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 6 IN COMPLEX WITH SANGIVAMYCIN
1382, 6fnmA, 0.7996, 2.62, 0.327, 270, 257, CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE WITH DASATINIB 
1383, 6c0tA, 0.7996, 2.58, 0.214, 334, 257, CRYSTAL STRUCTURE OF CGMP-DEPENDENT PROTEIN KINASE IALPHA (PKG IALPHA) CATALYTIC DOMAIN BOUND WITH N46 
1384, 4or5F, 0.7996, 2.83, 0.205, 324, 259, CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH HUMAN P-TEFB AND AFF4
1385, 3v5lD, 0.7996, 1.77, 0.326, 246, 242, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 542
1386, 2vn9A, 0.7996, 2.75, 0.204, 301, 260, CRYSTAL STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA ISOFORM 1 CAMKD
1387, 2oiqA, 0.7996, 2.31, 0.312, 265, 250, CRYSTAL STRUCTURE OF CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH THE CANCER DRUG IMATINIB.
1388, 1iepB, 0.7996, 2.19, 0.383, 274, 248, CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.
1389, 5u9dA, 0.7995, 2.41, 0.335, 271, 254, DISCOVERY OF A POTENT BTK INHIBITOR WITH A NOVEL BINDING MODE USING PARALLEL SELECTIONS WITH A DNA-ENCODED CHEMICAL LIBRARY
1390, 5u7qB, 0.7995, 2.87, 0.191, 385, 262, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1391, 5nkbA, 0.7995, 2.74, 0.340, 285, 256, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 4A
1392, 5hznH, 0.7995, 2.57, 0.319, 303, 254, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1393, 5hznD, 0.7995, 2.57, 0.319, 304, 254, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1394, 3my0G, 0.7995, 2.96, 0.261, 294, 261, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1395, 3my0F, 0.7995, 2.87, 0.269, 294, 260, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1396, 3my0A, 0.7995, 2.85, 0.269, 296, 260, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1397, 5p9hA, 0.7994, 2.32, 0.333, 264, 252, BTK1 COCRYSTALLIZED WITH RN983
1398, 5kktB, 0.7994, 2.88, 0.198, 394, 262, ROCK 1 BOUND TO AZAINDOLE THIOZOLE PIPERAZINE INHIBITOR
1399, 5kksB, 0.7994, 2.88, 0.198, 395, 262, ROCK 1 BOUND TO AZAINDOLE THIOZOLE INHIBITOR
1400, 4mneG, 0.7994, 2.07, 0.298, 259, 248, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
1401, 4fnxA, 0.7994, 2.37, 0.299, 292, 251, CRYSTAL STRUCTURE OF THE APO R1275Q ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
1402, 3vs2A, 0.7994, 2.34, 0.369, 430, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[CIS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H- PYRROLO[23-D]PYRIMIDIN-4-AMINE
1403, 5wnoA, 0.7993, 2.70, 0.337, 302, 255, CRYSTAL STRUCTURE OF C. ELEGANS LET-23 KINASE DOMAIN COMPLEXED WITH AMP-PNP
1404, 5wnjA, 0.7993, 1.95, 0.248, 264, 246, CRYSTAL STRUCTURE OF MURINE RECEPTOR-INTERACTING PROTEIN KINASE 4 (RIPK4) D143N IN COMPLEX WITH LESTAURTINIB 
1405, 5d7vC, 0.7993, 2.46, 0.308, 264, 253, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN
1406, 3vs5A, 0.7993, 2.34, 0.369, 429, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-(1-METHYLPIPERIDIN-4-YL)-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE
1407, 3my0R, 0.7993, 2.95, 0.264, 294, 261, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1408, 4or5A, 0.7992, 2.95, 0.202, 319, 262, CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH HUMAN P-TEFB AND AFF4
1409, 6fnhA, 0.7991, 2.69, 0.342, 277, 257, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH A PYRAZOLO[3;4-D]PYRIMIDINE FRAGMENT OF NVP-BHG712 
1410, 5p9mA, 0.7991, 2.43, 0.320, 271, 253, BTK1 BINDS COVALENTLY TO HY-15771 ONO-4059
1411, 5o4aB, 0.7991, 2.51, 0.392, 291, 255, HUMAN FGF IN COMPLEX WITH A COVALENT INHIBITOR
1412, 5nk1A, 0.7991, 2.74, 0.337, 284, 255, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 1K
1413, 5h2uA, 0.7991, 2.71, 0.316, 265, 256, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN COMPLEXED WITH DASATINIB
1414, 5eydA, 0.7991, 2.76, 0.331, 289, 254, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH AMG 337
1415, 4hcvA, 0.7991, 2.40, 0.317, 263, 252, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 53
1416, 4gk3A, 0.7991, 2.43, 0.364, 275, 253, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 87
1417, 4degA, 0.7991, 2.75, 0.331, 286, 254, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH TRIAZOLOPYRIDAZINE INHIBITOR 2
1418, 4b6lA, 0.7991, 2.84, 0.232, 281, 259, DISCOVERY OF ORAL POLO-LIKE KINASE (PLK) INHIBITORS WITH ENHANCED SELECTIVITY PROFILE USING RESIDUE TARGETED DRUG DESIGN
1419, 3my0U, 0.7991, 2.88, 0.269, 285, 260, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1420, 5osdA, 0.7990, 2.53, 0.251, 266, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1421, 3vs7A, 0.7990, 2.31, 0.367, 432, 248, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR 1-CYCLOPENTYL-3-(1H-PYRROLO[23-B]PYRIDIN-5-YL)-1H- PYRAZOLO[34-D]PYRIMIDIN-4-AMINE
1422, 3qfvA, 0.7990, 2.88, 0.188, 395, 261, MRCK BETA IN COMPLEX WITH TPCA-1
1423, 2c0iB, 0.7990, 2.39, 0.369, 433, 249, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983
1424, 1h1pC, 0.7990, 2.79, 0.267, 296, 258, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058
1425, 6g33B, 0.7989, 2.83, 0.195, 337, 256, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH 5-IODOTUBERCIDIN 
1426, 4h58B, 0.7989, 2.22, 0.300, 262, 250, BRAF IN COMPLEX WITH COMPOUND 3
1427, 2qu6B, 0.7989, 1.97, 0.360, 260, 242, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR
1428, 5oryA, 0.7988, 2.53, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1429, 5hu3A, 0.7988, 2.56, 0.213, 266, 254, DROSOPHILA CAMKII-D136N IN COMPLEX WITH A PHOSPHORYLATED FRAGMENT OF THE EAG POTASSIUM CHANNEL AND MG2+/ADP
1430, 5bpyA, 0.7988, 2.30, 0.335, 263, 251, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-824171 AKA 6-[(3R)-3-(4-TERT-BU TYLBENZAMIDO) PIPERIDIN-1-YL]-2-{[4-(MORPHOLINE-4-CARBONYL) PHENYL]AMINO}PYRIDINE- 3-CARBOXAMIDE
1431, 3tnhA, 0.7988, 2.61, 0.211, 288, 256, CDK9/CYCLIN T IN COMPLEX WITH CAN508
1432, 3krjA, 0.7988, 2.43, 0.336, 304, 250, CFMS TYROSINE KINASE IN COMPLEX WITH 4-CYANO-1H-IMIDAZOLE-2-CARBOXYLIC ACID (2-CYCLOHEX-1-ENYL-4-PIPERIDIN-4-YL-PHENYL)-AMIDE
1433, 3b8qB, 0.7988, 1.90, 0.369, 271, 244, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
1434, 2qocA, 0.7988, 2.55, 0.335, 283, 254, HUMAN EPHA3 KINASE DOMAIN PHOSPHORYLATED AMP-PNP BOUND STRUCTURE
1435, 2etrB, 0.7988, 2.88, 0.198, 398, 262, CRYSTAL STRUCTURE OF ROCK I BOUND TO Y-27632
1436, 5u6yL, 0.7987, 2.56, 0.219, 459, 256, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1437, 5u6yK, 0.7987, 2.56, 0.219, 459, 256, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1438, 5u6yJ, 0.7987, 2.56, 0.219, 459, 256, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1439, 5u6yI, 0.7987, 2.56, 0.219, 459, 256, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1440, 5u6yH, 0.7987, 2.56, 0.219, 459, 256, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1441, 5u6yG, 0.7987, 2.56, 0.219, 459, 256, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1442, 5u6yF, 0.7987, 2.56, 0.219, 459, 256, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1443, 5u6yE, 0.7987, 2.56, 0.219, 459, 256, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1444, 5u6yD, 0.7987, 2.56, 0.219, 459, 256, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1445, 5u6yC, 0.7987, 2.56, 0.219, 459, 256, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1446, 5u6yB, 0.7987, 2.56, 0.219, 459, 256, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1447, 5u6yA, 0.7987, 2.56, 0.219, 459, 256, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1448, 3my0E, 0.7987, 2.90, 0.265, 294, 260, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1449, 2yjsA, 0.7987, 2.30, 0.305, 286, 249, STRUCTURE OF C1156Y MUTANT ANAPLASTIC LYMPHOMA KINASE
1450, 2w4kA, 0.7987, 2.76, 0.242, 301, 260, X-RAY STRUCTURE OF A DAP-KINASE 2-302
1451, 5u6cA, 0.7986, 2.45, 0.323, 272, 251, CRYSTAL STRUCTURE OF THE MER KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC INHIBITOR
1452, 5orpA, 0.7986, 2.54, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1453, 3nynA, 0.7986, 2.72, 0.217, 553, 258, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 6 IN COMPLEX WITH SANGIVAMYCIN
1454, 2q0nA, 0.7986, 2.64, 0.195, 293, 257, STRUCTURE OF HUMAN P21 ACTIVATING KINASE 4 (PAK4) IN COMPLEX WITH A CONSENSUS PEPTIDE
1455, 5osfA, 0.7985, 2.54, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1456, 5orzA, 0.7985, 2.54, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1457, 5nk2A, 0.7985, 2.73, 0.337, 290, 255, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2B
1458, 4xyfA, 0.7985, 2.80, 0.329, 290, 255, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH (S)-5-(8-FLUORO-3-(1-(3-(2- METHOXYETHOXY)QUINOLIN-6-YL)ETHYL)-[124]TRIAZOLO[43-A]PYRIDIN-6- YL)-3-METHYLISOXAZOLE
1459, 4o0yA, 0.7985, 2.57, 0.195, 290, 256, BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
1460, 4ib5A, 0.7985, 2.75, 0.190, 331, 258, STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH A CK2BETA-COMPETITIVE CYCLIC PEPTIDE
1461, 3vs5B, 0.7985, 2.34, 0.369, 427, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-(1-METHYLPIPERIDIN-4-YL)-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE
1462, 3up2A, 0.7985, 2.64, 0.237, 266, 257, AURORA A IN COMPLEX WITH RPM1686
1463, 2i0vA, 0.7985, 2.46, 0.339, 303, 251, C-FMS TYROSINE KINASE IN COMPLEX WITH A QUINOLONE INHIBITOR
1464, 2hyyA, 0.7985, 2.15, 0.385, 263, 247, HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571 GLIVEC)
1465, 5vgoA, 0.7984, 2.34, 0.333, 265, 252, BRUTON S TYROSINE KINASE (BTK) WITH COMPOUND G-744
1466, 5eycA, 0.7984, 2.62, 0.328, 288, 253, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH NAPHTHYRIDINONE INHIBITOR 5
1467, 4g3fA, 0.7984, 2.30, 0.222, 312, 252, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO A 2-(AMINOTHIAZOLY)PHENOL (CMP2)
1468, 5u7rC, 0.7983, 2.88, 0.191, 387, 262, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1469, 5orvA, 0.7983, 2.54, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1470, 5ornA, 0.7983, 2.54, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1471, 5nk6A, 0.7983, 2.79, 0.337, 284, 255, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2D
1472, 5j87B, 0.7983, 2.52, 0.335, 274, 254, DISCOVERY OF N-(3-(5-((3-ACRYLAMIDO-4-(MORPHOLINE-4-CARBONYL)PHENYL) AMINO)-1-METHYL-6-OXO-16-DIHYDROPYRIDIN-3-YL)-2-METHYLPHENYL)-4- (TERT-BUTYL)BENZAMIDE (CHMFL-BTK-01) AS A HIGHLY SELECTIVE IRREVERSIBLE BTK KINASE INHIBITOR
1473, 5dr2A, 0.7983, 2.64, 0.257, 264, 257, AURORA A KINASE IN COMPLEX WITH AA30 AND ATP IN SPACE GROUP P6122
1474, 5bmlB, 0.7983, 2.89, 0.198, 395, 262, ROCK 1 BOUND TO A PYRIDINE THIAZOLE INHIBITOR
1475, 4xufB, 0.7983, 2.55, 0.351, 274, 251, CRYSTAL STRUCTURE OF THE FLT3 KINASE DOMAIN BOUND TO THE INHIBITOR QUIZARTINIB (AC220)
1476, 4dceB, 0.7983, 2.06, 0.301, 284, 246, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH A PIPERIDINE-CARBOXAMIDE INHIBITOR
1477, 3uodA, 0.7983, 2.68, 0.253, 266, 257, AURORA A IN COMPLEX WITH RPM1693
1478, 3qfvB, 0.7983, 2.86, 0.188, 396, 260, MRCK BETA IN COMPLEX WITH TPCA-1
1479, 3hgkB, 0.7983, 2.76, 0.245, 286, 257, CRYSTAL STRUCTURE OF EFFECT PROTEIN AVRPTOB COMPLEXED WITH KINASE PTO
1480, 3el8A, 0.7983, 2.27, 0.316, 263, 250, CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDINE 5
1481, 2zv7A, 0.7983, 2.28, 0.375, 257, 251, LYN TYROSINE KINASE DOMAIN APO FORM
1482, 5oy6A, 0.7982, 2.63, 0.286, 291, 255, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH CYCLICAL INHIBITOR OD36.
1483, 5oxgD, 0.7982, 2.75, 0.280, 293, 257, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH LDN- 212854
1484, 5oseA, 0.7982, 2.55, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1485, 5os5A, 0.7982, 2.55, 0.251, 267, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1486, 5iu2B, 0.7982, 2.58, 0.203, 313, 256, DISCOVERY OF IMIDAZOQUINOLINES AS A NOVEL CLASS OF POTENT SELECTIVE AND IN VIVO EFFICACIOUS COT KINASE INHIBITORS
1487, 5bq0A, 0.7982, 2.51, 0.308, 265, 253, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-824171 AKA 6-[(3R)-3-(4-TERT-BU TYLBENZAMIDO) PIPERIDIN-1-YL]-2-{[4-(MORPHOLINE-4-CARBONYL) PHENYL]AMINO}PYRIDINE- 3-CARBOXAMIDE
1488, 5a4cA, 0.7982, 2.51, 0.391, 294, 253, FGFR1 LIGAND COMPLEX
1489, 4o0xA, 0.7982, 2.56, 0.195, 290, 256, BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
1490, 4hcuA, 0.7982, 2.49, 0.324, 263, 253, CRYSTAL STRUCTURE OF ITK IN COMPLEXT WITH COMPOUND 40
1491, 3cp9B, 0.7982, 2.01, 0.374, 269, 243, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
1492, 3bhhB, 0.7982, 2.59, 0.207, 289, 256, CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 1 (CAMK2B)
1493, 2ogvA, 0.7982, 2.60, 0.335, 317, 254, CRYSTAL STRUCTURE OF THE AUTOINHIBITED HUMAN C-FMS KINASE DOMAIN
1494, 5kupA, 0.7981, 2.34, 0.333, 265, 252, BRUTON S TYROSINE KINASE (BTK) WITH PYRIDAZINONE COMPOUND 9
1495, 5h2uC, 0.7981, 2.62, 0.315, 264, 254, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN COMPLEXED WITH DASATINIB
1496, 4gk4A, 0.7981, 2.49, 0.362, 275, 254, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 90
1497, 3u4wA, 0.7981, 2.56, 0.314, 275, 255, SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC4B
1498, 3svvA, 0.7981, 2.10, 0.312, 261, 247, CRYSTAL STRUCTURE OF T338C C-SRC COVALENTLY BOUND TO VINYLSULFONAMIDE- PYRAZOLOPYRIMIDINE 9
1499, 2ya9A, 0.7981, 2.75, 0.235, 299, 260, CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2
1500, 2wtkE, 0.7981, 2.53, 0.221, 308, 253, STRUCTURE OF THE HETEROTRIMERIC LKB1-STRADALPHA-MO25ALPHA COMPLEX
1501, 5os4A, 0.7980, 2.55, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1502, 5orrA, 0.7980, 2.54, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1503, 5ig1B, 0.7980, 2.80, 0.257, 304, 261, CRYSTAL STRUCTURE OF S. ROSETTA CAMKII KINASE DOMAIN
1504, 4zlyA, 0.7980, 2.41, 0.320, 270, 253, CRYSTAL STRUCTURE OF BRUTON S TYROSINE KINASE BOUND TO A CINNOLINE FRAGMENT
1505, 4yhtB, 0.7980, 2.16, 0.309, 258, 249, BRAF COMPLEXED WITH AN INHIBITOR
1506, 4rwkB, 0.7980, 2.65, 0.396, 282, 255, CRYSTAL STRUCTURE OF V561M FGFR1 GATEKEEPER MUTATION (C488A C584S V561M) IN COMPLEX WITH N-{3-[2-(35-DIMETHOXYPHENYL)ETHYL]-1H- PYRAZOL-5-YL}-4-[(3R5S)-35-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)
1507, 4jdiA, 0.7980, 2.57, 0.195, 289, 256, CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 IN COMPLEX WITH PAKTIDE S PEPTIDE SUBSTRATE
1508, 2yjrA, 0.7980, 2.16, 0.323, 278, 248, STRUCTURE OF F1174L MUTANT ANAPLASTIC LYMPHOMA KINASE
1509, 6ginB, 0.7979, 2.74, 0.281, 296, 256, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH AN QUINAZOLINONE BASED ALK2 INHIBITOR WITH A 4-MORPHOLINOPHENYL SOLVENT ACCESSIBLE GROUP. 
1510, 5vloA, 0.7979, 2.71, 0.213, 290, 258, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
1511, 4ot5A, 0.7979, 2.36, 0.329, 263, 252, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 4-TERT-BUTYL-N- (3-{8-[4-(4-METHYL-PIPERAZINE-1-CARBONYL)-PHENYLAMINO]-IMIDAZO[12- A]PYRAZIN-6-YL}-PHENYL)-BENZAMIDE
1512, 4g3gA, 0.7979, 2.31, 0.226, 312, 252, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) V408L BOUND TO A 2-(AMINOTHIAZOLYL)PHENOL (CMP3)
1513, 4f0iB, 0.7979, 2.78, 0.395, 294, 256, CRYSTAL STRUCTURE OF APO TRKA
1514, 5os1A, 0.7978, 2.55, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1515, 5os0A, 0.7978, 2.55, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1516, 5orwA, 0.7978, 2.55, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1517, 3my0Q, 0.7978, 2.92, 0.265, 294, 260, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1518, 3f82A, 0.7978, 1.99, 0.332, 278, 244, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH N- (4-(2-AMINO-3-CHLOROPYRIDIN-4-YLOXY)-3-FLUOROPHENYL)-4- ETHOXY-1-(4-FLUOROPHENYL)-2-OXO-12-DIHYDROPYRIDINE-3- CARBOXAMIDE
1519, 3b8rB, 0.7978, 1.94, 0.374, 267, 243, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
1520, 5os3A, 0.7977, 2.55, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1521, 5d7vD, 0.7977, 2.53, 0.316, 264, 253, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN
1522, 4tyiA, 0.7977, 2.34, 0.375, 277, 251, STRUCTURAL ANALYSIS OF THE HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 4
1523, 4mcvA, 0.7977, 2.30, 0.283, 267, 251, STAR 12 BOUND TO ANALOG-SENSITIVE SRC KINASE
1524, 4ludB, 0.7977, 2.26, 0.372, 409, 247, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH THE FLUORESCENT COMPOUND SKF86002
1525, 4imyA, 0.7977, 2.85, 0.208, 314, 259, THE AFF4 SCAFFOLD BINDS HUMAN P-TEFB ADJACENT TO HIV TAT
1526, 4eopA, 0.7977, 2.69, 0.265, 297, 257, THR 160 PHOSPHORYLATED CDK2 Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
1527, 4deaA, 0.7977, 2.65, 0.237, 266, 257, AURORA A IN COMPLEX WITH YL1-038-18
1528, 3vs2B, 0.7977, 2.35, 0.369, 433, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[CIS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H- PYRROLO[23-D]PYRIMIDIN-4-AMINE
1529, 3v8tB, 0.7977, 1.65, 0.329, 244, 240, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 477
1530, 3v8sA, 0.7977, 2.93, 0.198, 395, 262, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH INDAZOLE DERIVATIVE (COMPOUND 18)
1531, 1h1wA, 0.7977, 2.59, 0.243, 284, 255, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PDK1 CATALYTIC DOMAIN
1532, 5os6A, 0.7976, 2.55, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1533, 3uo5A, 0.7976, 2.68, 0.253, 267, 257, AURORA A IN COMPLEX WITH YL1-038-31
1534, 1iepA, 0.7976, 2.23, 0.383, 274, 248, CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.
1535, 6d20A, 0.7975, 2.83, 0.395, 296, 256, CRYSTAL STRUCTURE OF TYROSINE-PROTEIN KINASE RECEPTOR IN COMPLEX WITH 5-(4-FLUOROPHENYL)THIENO[2;3-D]PYRIMIDIN-4(3H)-ONE AND 5-{[2;4- DICHLORO-5-(PYRIDIN-2-YL)BENZENE-1-CARBONYL]AMINO}-N-(2-HYDROXY-2- METHYLPROPYL)-1-PHENYL-1H-PYRAZOLE-3-CARBOXAMIDE INHIBITORS 
1536, 5tobA, 0.7975, 1.93, 0.366, 245, 243, SELECTIVITY SWITCH BETWEEN FAK AND PYK2: MACROCYCLIZATION OF FAK INHIBITORS IMPROVES PYK2 POTENCY
1537, 5orxA, 0.7975, 2.56, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1538, 5nk9A, 0.7975, 2.79, 0.337, 285, 255, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2E
1539, 5m0bA, 0.7975, 2.53, 0.228, 350, 254, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A SHORT-CHAINED N-(2-AMINOETHYL)ISOQUINOLINE-5-SULFONAMIDE) FASUDIL-DERIVATIVE (LIGAND 03) 
1540, 5lcqA, 0.7975, 2.54, 0.228, 350, 254, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH LONG-CHAIN FASUDIL-DERIVATIVE (LIGAND 05)
1541, 4nksB, 0.7975, 2.48, 0.393, 271, 252, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 3
1542, 4kabA, 0.7975, 2.18, 0.339, 255, 248, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 3-METHYL-14- DIHYDRO-PYRAZOLO[45-C]PYRAZOLE
1543, 3v8sC, 0.7975, 2.93, 0.198, 395, 262, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH INDAZOLE DERIVATIVE (COMPOUND 18)
1544, 2auhA, 0.7975, 2.75, 0.309, 297, 259, CRYSTAL STRUCTURE OF THE GRB14 BPS REGION IN COMPLEX WITH THE INSULIN RECEPTOR TYROSINE KINASE
1545, 5x02A, 0.7974, 2.45, 0.351, 305, 251, CRYSTAL STRUCTURE OF THE FLT3 KINASE DOMAIN BOUND TO THE INHIBITOR FF- 10101
1546, 5upkB, 0.7974, 2.57, 0.195, 288, 256, CDC42 BINDS PAK4 VIA AN EXTENDED GTPASE-EFFECTOR INTERFACE - 3 PEPTIDE: PAK4CAT PAK4-N45 CDC42
1547, 5orsA, 0.7974, 2.55, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1548, 5oroA, 0.7974, 2.53, 0.259, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1549, 5l2qB, 0.7974, 2.68, 0.194, 282, 258, SERINE/THREONINE-PROTEIN KINASE 40 (STK40) KINASE HOMOLOGY DOMAIN
1550, 5j87D, 0.7974, 2.35, 0.333, 263, 252, DISCOVERY OF N-(3-(5-((3-ACRYLAMIDO-4-(MORPHOLINE-4-CARBONYL)PHENYL) AMINO)-1-METHYL-6-OXO-16-DIHYDROPYRIDIN-3-YL)-2-METHYLPHENYL)-4- (TERT-BUTYL)BENZAMIDE (CHMFL-BTK-01) AS A HIGHLY SELECTIVE IRREVERSIBLE BTK KINASE INHIBITOR
1551, 4yveB, 0.7974, 2.90, 0.198, 393, 262, ROCK 1 BOUND TO METHOXYPHENYL THIAZOLE INHIBITOR
1552, 4yvcB, 0.7974, 2.90, 0.198, 392, 262, ROCK 1 BOUND TO THIAZOLE INHIBITOR
1553, 3twjC, 0.7974, 2.88, 0.198, 396, 262, RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1447
1554, 3nrmA, 0.7974, 2.68, 0.249, 263, 257, IMIDAZO[12-A]PYRAZINE-BASED AURORA KINASE INHIBITORS
1555, 2helA, 0.7974, 2.30, 0.332, 256, 250, CRYSTAL STRUCTURE OF A MUTANT EPHA4 KINASE DOMAIN (Y742A)
1556, 1fgiB, 0.7974, 2.52, 0.395, 272, 253, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU5402 INHIBITOR
1557, 5wngA, 0.7973, 2.90, 0.195, 395, 262, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1558, 4ymjA, 0.7973, 2.29, 0.388, 270, 250, (R)-2-PHENYLPYRROLIDINE SUBSTITUTE IMIDAZOPYRIDAZINES: A NEW CLASS OF POTENT AND SELECTIVE PAN-TRK INHIBITORS
1559, 4bggD, 0.7973, 2.72, 0.277, 286, 256, CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH LDN-213844
1560, 5iu2A, 0.7972, 2.60, 0.203, 312, 256, DISCOVERY OF IMIDAZOQUINOLINES AS A NOVEL CLASS OF POTENT SELECTIVE AND IN VIVO EFFICACIOUS COT KINASE INHIBITORS
1561, 4rfzA, 0.7972, 2.37, 0.329, 263, 252, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6- (DIMETHYLAMINO)-8-FLUORO-2-[2-(HYDROXYMETHYL)-3-[1-METHYL-5-[[5- (MORPHOLINE-4-CARBONYL)-2-PYRIDYL]AMINO]-6-OXO-3- PYRIDYL]PHENYL]ISOQUINOLIN-1-ONE
1562, 4gu9A, 0.7972, 2.19, 0.343, 252, 248, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH (2-FLUORO- PHENYL)-(1H-PYRAZOLO[34-D]PYRIMIDIN-4-YL)-AMINE
1563, 3u51A, 0.7972, 2.02, 0.309, 256, 246, SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC1
1564, 2hyyB, 0.7972, 2.17, 0.385, 265, 247, HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571 GLIVEC)
1565, 1xo2B, 0.7972, 2.67, 0.239, 289, 255, CRYSTAL STRUCTURE OF A HUMAN CYCLIN-DEPENDENT KINASE 6 COMPLEX WITH A FLAVONOL INHIBITOR FISETIN
1566, 6ft9C, 0.7971, 2.84, 0.199, 337, 256, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH INHIBITOR 16 
1567, 5k5xA, 0.7971, 2.68, 0.350, 345, 254, CRYSTAL STRUCTURE OF HUMAN PDGFRA
1568, 4tl0A, 0.7971, 2.78, 0.242, 300, 260, CRYSTAL STRUCTURE OF DEATH-ASSOCIATED PROTEIN KINASE 1 WITH A CRUCIAL PHOSPHOMIMICKING MUTATION
1569, 4eonC, 0.7971, 2.70, 0.266, 298, 256, THR 160 PHOSPHORYLATED CDK2 H84S Q85M Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
1570, 4cegA, 0.7971, 2.54, 0.259, 264, 255, CRYSTAL STRUCTURE OF AURORA A 122-403 C290A C393A BOUND TO ADP
1571, 3u6iA, 0.7971, 2.42, 0.317, 281, 249, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH PYRAZOLONE INHIBITOR 58A
1572, 3q6uA, 0.7971, 2.49, 0.324, 287, 250, STRUCTURE OF THE APO MET RECEPTOR KINASE IN THE DUALLY-PHOSPHORYLATED ACTIVATED STATE
1573, 3cpcA, 0.7971, 2.12, 0.357, 284, 244, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
1574, 2zm3D, 0.7971, 2.74, 0.314, 293, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR
1575, 2hiwB, 0.7971, 2.40, 0.384, 274, 250, CRYSTAL STRUCTURE OF INACTIVE CONFORMATION ABL KINASE CATALYTIC DOMAIN COMPLEXED WITH TYPE II INHIBITOR
1576, 1agwB, 0.7971, 2.56, 0.395, 272, 253, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU4984 INHIBITOR
1577, 5h2uB, 0.7970, 2.56, 0.312, 263, 253, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN COMPLEXED WITH DASATINIB
1578, 4wotC, 0.7970, 2.93, 0.191, 392, 262, ROCK2 IN COMPLEX WITH 1426382-07-1
1579, 3rhxB, 0.7970, 2.55, 0.395, 275, 253, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR1 KINASE IN COMPLEX WITH ARQ 069
1580, 2zm3C, 0.7970, 2.76, 0.313, 296, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR
1581, 2zm3B, 0.7970, 2.79, 0.313, 296, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR
1582, 2yacA, 0.7970, 2.80, 0.260, 290, 258, CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH NMS-P937
1583, 2esmB, 0.7970, 2.90, 0.198, 398, 262, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO FASUDIL
1584, 5vioD, 0.7969, 2.85, 0.253, 271, 257, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 13)
1585, 5orlA, 0.7969, 2.55, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1586, 4l01A, 0.7969, 2.26, 0.251, 274, 251, CRYSTAL STRUCTURE OF THE V658F APO JAK1 PSEUDOKINASE DOMAIN
1587, 4f64B, 0.7969, 2.54, 0.399, 272, 253, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 6
1588, 4a06A, 0.7969, 2.64, 0.246, 282, 256, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC ACTIVATOR PS114 BOUND TO THE PIF-POCKET
1589, 3oxzA, 0.7969, 1.98, 0.385, 268, 244, CRYSTAL STRUCTURE OF ABL KINASE DOMAIN BOUND WITH A DFG-OUT INHIBITOR AP24534
1590, 3my0S, 0.7969, 2.95, 0.265, 294, 260, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1591, 5j1wC, 0.7968, 2.90, 0.195, 316, 257, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH PYRIDO[34- G]QUINAZOLINE DERIVATIVE ZW31 (COMPOUND 14)
1592, 4yzmB, 0.7968, 2.26, 0.281, 262, 249, HUMANIZED ROCO4 BOUND TO LRRK2-IN1
1593, 4rg0A, 0.7968, 2.34, 0.337, 263, 252, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-[8-FLUORO-2- [2-(HYDROXYMETHYL)-3-[1-METHYL-5-[[5-(4-METHYLPIPERAZIN-1-YL)-2- PYRIDYL]AMINO]-6-OXO-3-PYRIDYL]PHENYL]-1-OXO-34-DIHYDROISOQUINOLIN- 6-YL]-2-METHYL-PROPANENITRILE
1594, 4mcvB, 0.7968, 2.24, 0.300, 265, 250, STAR 12 BOUND TO ANALOG-SENSITIVE SRC KINASE
1595, 4dehA, 0.7968, 2.66, 0.332, 286, 253, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH TRIAZOLOPYRIDINONE INHIBITOR 3
1596, 3miaA, 0.7968, 2.87, 0.205, 324, 259, CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH ATP-BOUND HUMAN P-TEFB
1597, 2qkwB, 0.7968, 2.79, 0.245, 290, 257, STRUCTURAL BASIS FOR ACTIVATION OF PLANT IMMUNITY BY BACTERIAL EFFECTOR PROTEIN AVRPTO
1598, 1oguC, 0.7968, 2.76, 0.265, 272, 257, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR
1599, 5wnkA, 0.7967, 1.94, 0.245, 263, 245, CRYSTAL STRUCTURE OF MURINE RECEPTOR-INTERACTING PROTEIN 4 (RIPK4) D143N BOUND TO TG100-115 
1600, 5vilD, 0.7967, 2.87, 0.253, 271, 257, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 6)
1601, 5lvlA, 0.7967, 2.64, 0.246, 285, 256, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH COMPOUND PS653 BOUND TO THE ATP-BINDING SITE
1602, 5l2qA, 0.7967, 2.62, 0.195, 293, 257, SERINE/THREONINE-PROTEIN KINASE 40 (STK40) KINASE HOMOLOGY DOMAIN
1603, 5h2uD, 0.7967, 2.56, 0.312, 263, 253, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN COMPLEXED WITH DASATINIB
1604, 4uakA, 0.7967, 2.90, 0.192, 404, 261, MRCK BETA IN COMPLEX WITH ADP
1605, 4eolA, 0.7967, 2.65, 0.271, 294, 255, THR 160 PHOSPHORYLATED CDK2 H84S Q85M K89D - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
1606, 3c51A, 0.7967, 2.89, 0.234, 487, 261, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ADP AND MAGNESIUM CHLORIDE AT 3.55A
1607, 3a4pA, 0.7967, 2.67, 0.328, 285, 253, HUMAN C-MET KINASE DOMAIN COMPLEXED WITH 6-BENZYLOXYQUINOLINE INHIBITOR
1608, 2g15A, 0.7967, 2.94, 0.323, 301, 257, STRUCTURAL CHARACTERIZATION OF AUTOINHIBITED C-MET KINASE
1609, 5dt3A, 0.7966, 2.60, 0.258, 263, 256, AURORA A KINASE IN COMPLEX WITH ATP IN SPACE GROUP P6122
1610, 4deeA, 0.7966, 2.61, 0.250, 271, 256, AURORA A IN COMPLEX WITH ADP
1611, 3my0I, 0.7966, 2.89, 0.266, 293, 259, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1612, 3g6gB, 0.7966, 2.18, 0.306, 263, 248, EQUALLY POTENT INHIBITION OF C-SRC AND ABL BY COMPOUNDS THAT RECOGNIZE INACTIVE KINASE CONFORMATIONS
1613, 3cs9A, 0.7966, 2.15, 0.382, 264, 246, HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB
1614, 2x4fB, 0.7966, 2.67, 0.205, 288, 259, THE CRYSTAL STRUCTURE OF THE HUMAN MYOSIN LIGHT CHAIN KINASE LOC340156.
1615, 1sm2A, 0.7966, 1.79, 0.326, 245, 242, CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1616, 5dn3A, 0.7965, 2.62, 0.250, 264, 256, AURORA A IN COMPLEX WITH ATP AND AA35.
1617, 4aojC, 0.7965, 2.12, 0.402, 261, 249, HUMAN TRKA IN COMPLEX WITH THE INHIBITOR AZ-23
1618, 2zm3A, 0.7965, 2.76, 0.313, 300, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR
1619, 2eufB, 0.7965, 2.74, 0.238, 282, 256, X-RAY STRUCTURE OF HUMAN CDK6-VCYCLIN IN COMPLEX WITH THE INHIBITOR PD0332991
1620, 5xvgA, 0.7964, 2.69, 0.195, 292, 257, CRYSTAL STRUCTURE OF PAK4 IN COMPLEX WITH INHIBITOR CZH226
1621, 5j1vA, 0.7964, 2.95, 0.195, 338, 257, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH PYRIDO[34- G]QUINAZOLINE DERIVATIVE ZW29 (COMPOUND 13)
1622, 5fbnD, 0.7964, 2.31, 0.339, 255, 251, BTK KINASE DOMAIN WITH INHIBITOR 1
1623, 4xi2A, 0.7964, 2.45, 0.340, 421, 253, CRYSTAL STRUCTURE OF AN AUTO-INHIBITED FORM OF BRUTON S TRYROSINE KINASE
1624, 4wboC, 0.7964, 2.94, 0.234, 481, 261, BOVINE G PROTEIN COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH AMLEXANOX
1625, 4otfA, 0.7964, 2.34, 0.331, 262, 251, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BRUTON S TYROSINE KINASE WITH GDC0834
1626, 4deiA, 0.7964, 2.81, 0.335, 287, 254, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH TRIAZOLOPYRIDINONE INHIBITOR 24
1627, 3my0H, 0.7964, 2.87, 0.270, 294, 259, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1628, 3c4zA, 0.7964, 2.89, 0.218, 493, 261, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ADP AND MAGNESIUM CHLORIDE AT 1.84A
1629, 1bkxA, 0.7964, 2.54, 0.217, 337, 254, A BINARY COMPLEX OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE AND ADENOSINE FURTHER DEFINES CONFORMATIONAL FLEXIBILITY
1630, 5vefA, 0.7963, 2.58, 0.195, 289, 256, PAK4 KINASE DOMAIN IN COMPLEX WITH FASUDIL
1631, 5otfA, 0.7963, 2.87, 0.192, 411, 261, MRCK BETA IN COMPLEX WITH BDP-00009066
1632, 3t9tA, 0.7963, 2.43, 0.295, 263, 251, CRYSTAL STRUCTURE OF BTK MUTANT (F435TK596R) COMPLEXED WITH IMIDAZO[15-A]QUINOXALINE
1633, 2p2iB, 0.7963, 1.68, 0.367, 263, 240, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NICOTINAMIDE INHIBITOR
1634, 5wnlA, 0.7962, 2.02, 0.252, 262, 246, CRYSTAL STRUCTURE OF MURINE RECEPTOR-INTERACTING PROTEIN 4 (RIPK4) D143N BOUND TO STAUROSPORINE 
1635, 5dnrA, 0.7962, 2.63, 0.250, 264, 256, AURORA A KINASE IN COMPLEX WITH ATP IN SPACE GROUP P41212
1636, 4jajA, 0.7962, 2.67, 0.249, 265, 257, CRYSTAL STRUCTURE OF AURORA KINASE A IN COMPLEX WITH BENZO[C][1 8]NAPHTHYRIDIN-6(5H)-ONE
1637, 4gu6B, 0.7962, 2.48, 0.337, 258, 252, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-{3-[(5-CYANO- 2-PHENYL-1H-PYRROLO[23-B]PYRIDIN-4-YLAMINO)- METHYL]-PYRIDIN-2-YL}- N-METHYL-METHANESULFONAMIDE
1638, 1uvrA, 0.7962, 2.63, 0.243, 284, 255, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-8
1639, 5vedA, 0.7961, 2.57, 0.195, 289, 256, PAK4 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
1640, 5ia3A, 0.7961, 2.52, 0.339, 275, 251, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH PD173955
1641, 3vs7B, 0.7961, 2.27, 0.368, 426, 247, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR 1-CYCLOPENTYL-3-(1H-PYRROLO[23-B]PYRIDIN-5-YL)-1H- PYRAZOLO[34-D]PYRIMIDIN-4-AMINE
1642, 1smhA, 0.7961, 2.55, 0.224, 348, 254, PROTEIN KINASE A VARIANT COMPLEX WITH COMPLETELY ORDERED N- TERMINAL HELIX
1643, 5i9zA, 0.7960, 2.42, 0.335, 273, 251, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH DANUSERTIB (PHA739358)
1644, 5bmsA, 0.7960, 2.59, 0.195, 290, 256, CRYSTAL STRUCTURE OF P21-ACTIVATED KINASE 4 IN COMPLEX WITH AN INHIBITOR COMPOUND 29
1645, 4md8G, 0.7960, 2.70, 0.180, 332, 255, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E)
1646, 4f63B, 0.7960, 2.51, 0.393, 271, 252, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 1
1647, 2gcdB, 0.7960, 2.64, 0.273, 308, 256, TAO2 KINASE DOMAIN-STAUROSPORINE STRUCTURE
1648, 1bx6A, 0.7960, 2.54, 0.217, 337, 254, CRYSTAL STRUCTURE OF THE POTENT NATURAL PRODUCT INHIBITOR BALANOL IN COMPLEX WITH THE CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE
1649, 5wneA, 0.7959, 2.94, 0.195, 384, 262, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1650, 5ortA, 0.7959, 2.57, 0.255, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1651, 4md7H, 0.7959, 2.80, 0.190, 330, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME
1652, 4md7F, 0.7959, 2.80, 0.190, 332, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME
1653, 4fijA, 0.7959, 2.57, 0.195, 291, 256, CATALYTIC DOMAIN OF HUMAN PAK4
1654, 3v8wA, 0.7959, 1.60, 0.326, 243, 239, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 469
1655, 3nyoA, 0.7959, 2.76, 0.221, 553, 258, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 6 IN COMPLEX WITH AMP
1656, 2gnjA, 0.7959, 2.55, 0.224, 335, 254, PKA THREE FOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632
1657, 6d1zA, 0.7958, 2.69, 0.398, 290, 254, CRYSTAL STRUCTURE OF TYROSINE-PROTEIN KINASE RECEPTOR IN COMPLEX WITH 5-(4-FLUOROPHENYL)THIENO[2;3-D]PYRIMIDIN-4(3H)-ONE INHIBITOR 
1658, 5nkdA, 0.7958, 2.72, 0.339, 287, 254, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2I
1659, 4xmoA, 0.7958, 2.73, 0.316, 289, 253, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH (R)-5-(8-FLUORO-3-(1- FLUORO-1-(3-METHOXYQUINOLIN-6-YL)ETHYL)-[124]TRIAZOLO[43- A]PYRIDIN-6-YL)-3-METHYLISOXAZOLE
1660, 4md7G, 0.7958, 2.80, 0.190, 332, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME
1661, 3my0C, 0.7958, 2.85, 0.271, 299, 258, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1662, 3lq8A, 0.7958, 2.60, 0.327, 278, 251, STRUCTURE OF THE KINASE DOMAIN OF C-MET BOUND TO XL880 (GSK1363089)
1663, 3iw4A, 0.7958, 2.62, 0.230, 330, 256, CRYSTAL STRUCTURE OF PKC ALPHA IN COMPLEX WITH NVP-AEB071
1664, 3c50A, 0.7958, 2.80, 0.219, 499, 260, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ADP AND MAGNESIUM CHLORIDE AT 2.6A
1665, 1okyA, 0.7958, 2.54, 0.245, 281, 253, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
1666, 1fgkB, 0.7958, 2.58, 0.395, 272, 253, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1
1667, 4wunA, 0.7957, 2.26, 0.406, 282, 249, STRUCTURE OF FGFR1 IN COMPLEX WITH AZD4547 (N-{3-[2-(35- DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R5S)-35- DIMETHYLPIPERAZIN-1-YL]BENZAMIDE) AT 1.65 ANGSTROM
1668, 4rqvA, 0.7957, 2.65, 0.246, 288, 256, CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH ATP AND THE PIF-POCKET LIGAND RS2
1669, 4e26B, 0.7957, 2.35, 0.302, 264, 252, BRAF IN COMPLEX WITH AN ORGANIC INHIBITOR 7898734
1670, 3nyoB, 0.7957, 2.76, 0.221, 553, 258, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 6 IN COMPLEX WITH AMP
1671, 6dkiA, 0.7956, 2.61, 0.395, 279, 253, CRYSTAL STRUCTURE OF TRK-A IN COMPLEX WITH THE PAN-TRK KINASE INHIBITOR; COMPOUND 19. 
1672, 4md9K, 0.7956, 2.62, 0.185, 328, 254, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
1673, 3tv7C, 0.7956, 2.96, 0.198, 394, 262, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1342
1674, 3q9zB, 0.7956, 2.79, 0.186, 332, 258, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH QUINALIZARIN AT PH 6.5
1675, 3hgkD, 0.7956, 2.72, 0.251, 286, 255, CRYSTAL STRUCTURE OF EFFECT PROTEIN AVRPTOB COMPLEXED WITH KINASE PTO
1676, 3eflB, 0.7956, 2.08, 0.370, 263, 243, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH MOTESANIB
1677, 5kksA, 0.7955, 2.99, 0.198, 395, 262, ROCK 1 BOUND TO AZAINDOLE THIOZOLE INHIBITOR
1678, 4jdhA, 0.7955, 2.60, 0.195, 289, 256, CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 IN COMPLEX WITH PAKTIDE T PEPTIDE SUBSTRATE
1679, 5u7rA, 0.7954, 2.97, 0.191, 387, 262, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1680, 3lvpA, 0.7954, 2.54, 0.311, 289, 254, CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR
1681, 3hgkA, 0.7954, 2.72, 0.251, 286, 255, CRYSTAL STRUCTURE OF EFFECT PROTEIN AVRPTOB COMPLEXED WITH KINASE PTO
1682, 3cthA, 0.7954, 2.65, 0.312, 295, 253, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A AMINOPYRIDINE BASED INHIBITOR
1683, 2a27C, 0.7954, 2.78, 0.235, 303, 260, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1684, 1h1pA, 0.7954, 2.83, 0.267, 296, 258, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058
1685, 5wnhA, 0.7953, 2.93, 0.195, 394, 262, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1686, 5bvwA, 0.7953, 2.42, 0.364, 274, 253, FRAGMENT-BASED DISCOVERY OF POTENT AND SELECTIVE DDR1/2 INHIBITORS
1687, 2y7jB, 0.7953, 2.60, 0.196, 281, 255, STRUCTURE OF HUMAN PHOSPHORYLASE KINASE GAMMA 2
1688, 2a27E, 0.7953, 2.78, 0.231, 303, 260, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1689, 1rejA, 0.7953, 2.53, 0.217, 333, 254, CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 1
1690, 5wnmA, 0.7952, 1.96, 0.249, 263, 245, CRYSTAL STRUCTURE OF MURINE RECEPTOR-INTERACTING PROTEIN 4 (RIPK4) D143N BOUND TO TOZASERTIB (VX-680) 
1691, 5nk4A, 0.7952, 2.76, 0.339, 290, 254, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2C
1692, 5njzA, 0.7952, 2.47, 0.339, 273, 251, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 1G
1693, 5l2wA, 0.7952, 2.75, 0.266, 297, 256, THE X-RAY CO-CRYSTAL STRUCTURE OF HUMAN CDK2/CYCLINE AND DINACICLIB.
1694, 4wotD, 0.7952, 2.90, 0.192, 389, 261, ROCK2 IN COMPLEX WITH 1426382-07-1
1695, 4rwiB, 0.7952, 2.55, 0.395, 280, 253, CRYSTAL STRUCTURE OF V561M FGFR1 GATEKEEPER MUTATION (C488A C584S V561M) APO
1696, 4rqkA, 0.7952, 2.66, 0.246, 285, 256, CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH ATP AND THE PIF-POCKET LIGAND RS1
1697, 4debA, 0.7952, 2.68, 0.237, 264, 257, AURORA A IN COMPLEX WITH RK2-17-01
1698, 3cjgA, 0.7952, 2.19, 0.363, 280, 248, CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 345-TRIMETHOXY ANILINE CONTAINING PYRIMIDINE
1699, 2gfcA, 0.7952, 2.56, 0.224, 335, 254, CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
1700, 2a27A, 0.7952, 2.81, 0.231, 304, 260, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1701, 6d1yA, 0.7951, 2.70, 0.398, 300, 254, CRYSTAL STRUCTURE OF TYROSINE-PROTEIN KINASE RECEPTOR IN COMPLEX WITH 2;4-DICHLORO-N-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)BENZAMIDE INHIBITOR 
1702, 5xvaA, 0.7951, 2.72, 0.195, 292, 257, CRYSTAL STRUCTURE OF PAK4 IN COMPLEX WITH INHIBITOR CZH216
1703, 5oteA, 0.7951, 2.90, 0.192, 407, 261, MRCK BETA IN COMPLEX WITH BDP-00008900
1704, 5jfxA, 0.7951, 2.31, 0.402, 277, 249, CRYSTAL STRUCTURE OF TRKA IN COMPLEX WITH PF-06273340
1705, 5j1wA, 0.7951, 2.96, 0.202, 338, 257, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH PYRIDO[34- G]QUINAZOLINE DERIVATIVE ZW31 (COMPOUND 14)
1706, 4wotB, 0.7951, 2.90, 0.192, 394, 261, ROCK2 IN COMPLEX WITH 1426382-07-1
1707, 4utdA, 0.7951, 2.60, 0.255, 266, 255, STRUCTURE OF DEPHOSPHORYLATED AURORA A (122-403) BOUND TO AMPPCP IN AN ACTIVE CONFORMATION
1708, 4riyC, 0.7951, 2.70, 0.341, 275, 255, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-E909G MUTATION
1709, 4l6qA, 0.7951, 2.97, 0.191, 388, 262, ROCK2 IN COMPLEX WITH BENZOXABOROLE
1710, 4g2fA, 0.7951, 2.44, 0.361, 275, 252, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH COMPOUND 7
1711, 4fiiA, 0.7951, 2.65, 0.206, 291, 257, CATALYTIC DOMAIN OF HUMAN PAK4 WITH RPKPLVDP PEPTIDE
1712, 4dglD, 0.7951, 2.74, 0.187, 328, 257, CRYSTAL STRUCTURE OF THE CK2 TETRAMERIC HOLOENZYME
1713, 4dceA, 0.7951, 2.32, 0.301, 288, 249, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH A PIPERIDINE-CARBOXAMIDE INHIBITOR
1714, 4cfnC, 0.7951, 2.73, 0.265, 296, 257, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6-CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
1715, 3q4cA, 0.7951, 2.35, 0.302, 264, 252, CRYSTAL STRUCTURE OF WILD TYPE BRAF KINASE DOMAIN IN COMPLEX WITH ORGANOMETALLIC INHIBITOR CNS292
1716, 3iw4B, 0.7951, 2.65, 0.230, 325, 256, CRYSTAL STRUCTURE OF PKC ALPHA IN COMPLEX WITH NVP-AEB071
1717, 2y7jC, 0.7951, 2.63, 0.195, 284, 256, STRUCTURE OF HUMAN PHOSPHORYLASE KINASE GAMMA 2
1718, 1re8A, 0.7951, 2.54, 0.217, 337, 254, CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 2
1719, 5oy6C, 0.7950, 2.83, 0.285, 291, 256, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH CYCLICAL INHIBITOR OD36.
1720, 4xx9A, 0.7950, 2.66, 0.246, 288, 256, CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH ATP AND THE PIF-POCKET LIGAND RF4
1721, 4pniA, 0.7950, 2.95, 0.234, 492, 261, BOVINE G PROTEIN-COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH GSK2163632A
1722, 4mf1B, 0.7950, 1.81, 0.326, 246, 242, ITK KINASE DOMAIN IN COMPLEX WITH BENZOTHIAZOLE INHIBITOR 12B (1S2S)- 2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(1H-PYRAZOL-4-YL)-13- BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE
1723, 3zewB, 0.7950, 2.16, 0.333, 252, 246, CRYSTAL STRUCTURE OF EPHB4 IN COMPLEX WITH STAUROSPORINE
1724, 3tv7A, 0.7950, 2.97, 0.198, 394, 262, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1342
1725, 3bz3A, 0.7950, 2.44, 0.339, 259, 251, CRYSTAL STRUCTURE ANALYSIS OF FOCAL ADHESION KINASE WITH A METHANESULFONAMIDE DIAMINOPYRIMIDINE INHIBITOR
1726, 1xjdA, 0.7950, 2.49, 0.250, 280, 252, CRYSTAL STRUCTURE OF PKC-THETA COMPLEXED WITH STAUROSPORINE AT 2A RESOLUTION
1727, 5m0lA, 0.7949, 2.56, 0.228, 338, 254, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH THE METHYLATED FASUDIL-DERIVED FRAGMENT N-METHYLISOQUINOLINE-5- SULFONAMIDE (LIGAND 02) 
1728, 5hq0A, 0.7949, 2.88, 0.257, 292, 257, TERNARY COMPLEX OF HUMAN PROTEINS CDK1 CYCLIN B AND CKS2 BOUND TO AN INHIBITOR
1729, 5em5A, 0.7949, 2.52, 0.348, 298, 250, EGFR KINASE DOMAIN MUTANT TMLR WITH PYRIDONE COMPOUND 2: 4-[2-(4- CHLOROPHENYL)ETHYLAMINO]-~{N}-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-2- OXIDANYLIDENE-1~{H}-PYRIDINE-3-CARBOXAMIDE
1730, 4y72A, 0.7949, 2.88, 0.257, 292, 257, HUMAN CDK1/CYCLINB1/CKS2 WITH INHIBITOR
1731, 2uztA, 0.7949, 2.63, 0.224, 336, 255, PKA STRUCTURES OF AKT INDAZOLE-PYRIDINE INHIBITORS
1732, 2fb8A, 0.7949, 2.15, 0.306, 259, 248, STRUCTURE OF THE B-RAF KINASE DOMAIN BOUND TO SB-590885
1733, 5u7qD, 0.7948, 2.86, 0.192, 383, 260, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1734, 5m75A, 0.7948, 2.57, 0.228, 350, 254, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A (S)-METHYL SUBSTITUED FASUDIL-DERIVATIVE 
1735, 4v01A, 0.7948, 2.39, 0.382, 273, 249, FGFR1 IN COMPLEX WITH PONATINIB (CO-CRYSTALLISATION).
1736, 4md9H, 0.7948, 2.77, 0.187, 328, 257, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
1737, 4l01B, 0.7948, 2.23, 0.252, 274, 250, CRYSTAL STRUCTURE OF THE V658F APO JAK1 PSEUDOKINASE DOMAIN
1738, 4fihA, 0.7948, 2.65, 0.206, 291, 257, CATALYTIC DOMAIN OF HUMAN PAK4 WITH QKFTGLPRQW PEPTIDE
1739, 1snuA, 0.7948, 1.82, 0.326, 245, 242, CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1740, 1jbpE, 0.7948, 2.56, 0.217, 339, 254, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE COMPLEXED WITH A SUBSTRATE PEPTIDE ADP AND DETERGENT
1741, 4md7E, 0.7947, 2.82, 0.190, 332, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME
1742, 4bn1A, 0.7947, 2.62, 0.255, 261, 255, CRYSTAL STRUCTURE OF V174M MUTANT OF AURORA-A KINASE
1743, 3fhiA, 0.7947, 2.55, 0.217, 336, 254, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE CATALYTIC AND REGULATORY (RI{ALPHA}) SUBUNITS OF PKA
1744, 3ewhA, 0.7947, 2.68, 0.366, 300, 254, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDYL-PYRIMIDINE BENZIMIDAZOLE INHIBITOR
1745, 2gniA, 0.7947, 2.56, 0.224, 338, 254, PKA FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITOR FASUDIL (HA1077)
1746, 2f2uA, 0.7947, 2.99, 0.187, 386, 262, CRYSTAL STRUCTURE OF THE RHO-KINASE KINASE DOMAIN
1747, 1q61A, 0.7947, 2.57, 0.224, 335, 254, PKA TRIPLE MUTANT MODEL OF PKB
1748, 5nk3A, 0.7946, 2.72, 0.336, 281, 256, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 1L
1749, 5l2qD, 0.7946, 2.69, 0.190, 294, 258, SERINE/THREONINE-PROTEIN KINASE 40 (STK40) KINASE HOMOLOGY DOMAIN
1750, 5jfsA, 0.7946, 2.20, 0.403, 277, 248, CRYSTAL STRUCTURE OF TRKA IN COMPLEX WITH PF-00593174
1751, 4nwmB, 0.7946, 2.33, 0.328, 261, 250, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-809959 AKA 4-TERT-BUTYL-N-[2-ME THYL-3-(6-{[4- (MORPHOLINE-4-CARBONYL)PHENYL]AMINO}-9H- PURIN-2-YL)PHENYL]BENZAMIDE
1752, 4eopC, 0.7946, 2.69, 0.267, 296, 255, THR 160 PHOSPHORYLATED CDK2 Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
1753, 3bhhA, 0.7946, 2.64, 0.203, 289, 256, CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 1 (CAMK2B)
1754, 5x8iA, 0.7945, 2.84, 0.200, 328, 255, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH COMPOUND 25
1755, 4o0vA, 0.7945, 2.64, 0.206, 290, 257, BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
1756, 4f1oA, 0.7945, 2.59, 0.259, 276, 255, CRYSTAL STRUCTURE OF THE L1180T MUTANT ROCO4 KINASE DOMAIN FROM D. DISCOIDEUM BOUND TO APPCP
1757, 3d9vB, 0.7945, 2.92, 0.198, 398, 262, CRYSTAL STRUCTURE OF ROCK I BOUND TO H-1152P A DI- METHYLATED VARIANT OF FASUDIL
1758, 2a27H, 0.7945, 2.79, 0.235, 304, 260, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1759, 1rdqE, 0.7945, 2.57, 0.217, 340, 254, HYDROLYSIS OF ATP IN THE CRYSTAL OF Y204A MUTANT OF CAMP-DEPENDENT PROTEIN KINASE
1760, 5x8iB, 0.7944, 2.83, 0.200, 327, 255, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH COMPOUND 25
1761, 4wotA, 0.7944, 2.85, 0.192, 389, 260, ROCK2 IN COMPLEX WITH 1426382-07-1
1762, 3ndmD, 0.7944, 2.90, 0.195, 396, 261, CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT ISOQUINOLONE DERIVATIVE
1763, 2ya9B, 0.7944, 2.81, 0.231, 299, 260, CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2
1764, 2vd5A, 0.7944, 2.84, 0.220, 390, 259, STRUCTURE OF HUMAN MYOTONIC DYSTROPHY PROTEIN KINASE IN COMPLEX WITH THE BISINDOYLMALEIDE INHIBITOR BIM VIII
1765, 2a27G, 0.7944, 2.81, 0.235, 303, 260, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1766, 2a27B, 0.7944, 2.79, 0.235, 303, 260, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1767, 1uu7A, 0.7944, 2.66, 0.244, 280, 254, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-2
1768, 1snxA, 0.7944, 1.83, 0.326, 245, 242, CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1769, 6g33A, 0.7943, 2.81, 0.197, 335, 254, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH 5-IODOTUBERCIDIN 
1770, 5dh3A, 0.7943, 2.80, 0.265, 287, 257, CRYSTAL STRUCTURE OF MST2 IN COMPLEX WITH XMU-MP-1
1771, 4rixC, 0.7943, 2.70, 0.337, 275, 255, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-Q790R MUTATION
1772, 4o0sA, 0.7943, 2.62, 0.251, 265, 255, CRYSTAL STRUCTURES OF HUMAN KINASE AURORA A
1773, 4f1mA, 0.7943, 2.62, 0.247, 278, 255, CRYSTAL STRUCTURE OF THE G1179S ROCO4 KINASE DOMAIN BOUND TO APPCP FROM D. DISCOIDEUM.
1774, 3ndmB, 0.7943, 2.96, 0.195, 396, 262, CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT ISOQUINOLONE DERIVATIVE
1775, 1xh8A, 0.7943, 2.57, 0.224, 337, 254, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1776, 4wboD, 0.7942, 2.96, 0.234, 491, 261, BOVINE G PROTEIN COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH AMLEXANOX
1777, 4md9E, 0.7942, 2.64, 0.181, 329, 254, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
1778, 4jboA, 0.7942, 2.63, 0.254, 266, 256, NOVEL AURORA KINASE INHIBITORS REVEAL MECHANISMS OF HURP IN NUCLEATION OF CENTROSOMAL AND KINETOCHORE MICROTUBULES
1779, 3my0P, 0.7942, 2.89, 0.266, 290, 259, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1780, 2a27F, 0.7942, 2.86, 0.230, 303, 261, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1781, 1xhaA, 0.7942, 2.58, 0.224, 348, 254, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1782, 4mf1A, 0.7941, 1.63, 0.326, 243, 239, ITK KINASE DOMAIN IN COMPLEX WITH BENZOTHIAZOLE INHIBITOR 12B (1S2S)- 2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(1H-PYRAZOL-4-YL)-13- BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE
1783, 4md8F, 0.7941, 2.83, 0.190, 332, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E)
1784, 4j52A, 0.7941, 2.84, 0.264, 293, 258, CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH A PYRIMIDODIAZEPINONE INHIBITOR
1785, 4eosA, 0.7941, 2.69, 0.262, 296, 256, THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
1786, 3pvbA, 0.7941, 2.50, 0.217, 341, 253, CRYSTAL STRUCTURE OF (73-244)RIA:C HOLOENZYME OF CAMP-DEPENDENT PROTEIN KINASE
1787, 3genA, 0.7941, 2.33, 0.328, 264, 250, THE 1.6 A CRYSTAL STRUCTURE OF HUMAN BRUTON S TYROSINE KINASE BOUND TO A PYRROLOPYRIMIDINE-CONTAINING COMPOUND
1788, 3g0eA, 0.7941, 2.82, 0.345, 332, 255, KIT KINASE DOMAIN IN COMPLEX WITH SUNITINIB
1789, 3byuA, 0.7941, 2.13, 0.366, 256, 246, CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE REVERSE AMIDE 23
1790, 1u5qB, 0.7941, 2.68, 0.273, 308, 256, CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K
1791, 1snxB, 0.7941, 1.85, 0.326, 245, 242, CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1792, 3u51B, 0.7940, 2.02, 0.310, 255, 245, SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC1
1793, 3qc9D, 0.7940, 2.91, 0.218, 486, 261, CRYSTAL STRUCTURE OF CROSS-LINKED BOVINE GRK1 T8C/N480C DOUBLE MUTANT COMPLEXED WITH ADP AND MG
1794, 3qc9B, 0.7940, 2.90, 0.218, 481, 261, CRYSTAL STRUCTURE OF CROSS-LINKED BOVINE GRK1 T8C/N480C DOUBLE MUTANT COMPLEXED WITH ADP AND MG
1795, 2a27D, 0.7940, 2.82, 0.235, 304, 260, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1796, 6ft9A, 0.7939, 2.92, 0.199, 336, 256, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH INHIBITOR 16 
1797, 5d12A, 0.7939, 2.09, 0.313, 260, 246, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL40
1798, 5ackA, 0.7939, 2.68, 0.246, 286, 256, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC COMPOUND 7 BOUND TO THE PIF-POCKET
1799, 4l6qB, 0.7939, 2.92, 0.192, 388, 261, ROCK2 IN COMPLEX WITH BENZOXABOROLE
1800, 3tnpF, 0.7939, 2.50, 0.217, 334, 253, STRUCTURE AND ALLOSTERY OF THE PKA RIIB TETRAMERIC HOLOENZYME
1801, 3tnpC, 0.7939, 2.50, 0.217, 334, 253, STRUCTURE AND ALLOSTERY OF THE PKA RIIB TETRAMERIC HOLOENZYME
1802, 3rhkA, 0.7939, 2.69, 0.311, 298, 254, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF C-MET KINASE IN COMPLEX WITH ARQ 197
1803, 3qc9C, 0.7939, 2.91, 0.218, 482, 261, CRYSTAL STRUCTURE OF CROSS-LINKED BOVINE GRK1 T8C/N480C DOUBLE MUTANT COMPLEXED WITH ADP AND MG
1804, 3mj2A, 0.7939, 2.26, 0.333, 259, 249, X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR BMS-509744
1805, 1z57A, 0.7939, 2.85, 0.208, 333, 255, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH 10Z-HYMENIALDISINE
1806, 5uq0A, 0.7938, 2.19, 0.405, 266, 247, FGFR1 KINASE DOMAIN COMPLEX WITH FRAGMENT 22-DIMETHYL-23- DIHYDROBENZOFURAN-7-CARBOXAMIDE
1807, 5ar3A, 0.7938, 2.27, 0.269, 279, 249, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH AMP-PCP
1808, 4w8eA, 0.7938, 2.66, 0.270, 290, 256, STRUCTURE OF MST3 WITH A PYRROLOPYRIMIDINE INHIBITOR (PF-06645342)
1809, 4mneC, 0.7938, 2.22, 0.289, 260, 249, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
1810, 4k8aA, 0.7938, 2.16, 0.348, 251, 247, FRAGMENT-BASED DISCOVERY OF FOCAL ADHESION KINASE INHIBITORS
1811, 4aw1A, 0.7938, 2.57, 0.249, 283, 253, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC COMPOUND PS210 BOUND TO THE PIF-POCKET
1812, 3qlgB, 0.7938, 2.04, 0.310, 260, 245, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH DASATINIB
1813, 3qc9A, 0.7938, 2.91, 0.218, 486, 261, CRYSTAL STRUCTURE OF CROSS-LINKED BOVINE GRK1 T8C/N480C DOUBLE MUTANT COMPLEXED WITH ADP AND MG
1814, 3oxtA, 0.7938, 2.48, 0.225, 335, 253, HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
1815, 3my0V, 0.7938, 2.65, 0.272, 282, 254, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1816, 2owbA, 0.7938, 2.85, 0.264, 294, 258, STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1
1817, 1ol7A, 0.7938, 2.62, 0.255, 261, 255, STRUCTURE OF HUMAN AURORA-A 122-403 PHOSPHORYLATED ON THR287 THR288
1818, 3zfxC, 0.7937, 1.89, 0.349, 248, 241, CRYSTAL STRUCTURE OF EPHB1
1819, 3qgwB, 0.7937, 1.52, 0.333, 240, 237, CRYSTAL STRUCTURE OF ITK KINASE BOUND TO AN INHIBITOR
1820, 3mi9A, 0.7937, 3.03, 0.202, 328, 262, CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH HUMAN P-TEFB
1821, 2cdzA, 0.7937, 2.55, 0.197, 289, 254, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH CGP74514A
1822, 6ft8A, 0.7936, 2.94, 0.202, 338, 257, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH INHIBITOR 8G 
1823, 5wnfA, 0.7936, 2.95, 0.195, 395, 262, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1824, 5m0cA, 0.7936, 2.58, 0.228, 336, 254, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH THE FASUDIL-FRAGMENT ISOQUINOLINE-5-SULFONAMIDE 
1825, 4ualA, 0.7936, 2.85, 0.193, 403, 259, MRCK BETA IN COMPLEX WITH BDP00005290
1826, 4pmpA, 0.7936, 2.51, 0.396, 280, 250, THE STRUCTURE OF TRKA KINASE BOUND TO THE INHIBITOR 1-CYCLOPROPYL-1- [3-(13-THIAZOL-2-YL)BENZYL]-3-[4-(TRIFLUOROMETHOXY)PHENYL]UREA
1827, 3q9xB, 0.7936, 2.73, 0.187, 330, 257, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH EMODIN AT PH 6.5
1828, 3nczA, 0.7936, 2.98, 0.198, 399, 262, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT 2H-ISOQUINOLIN-1-ONE INHIBITOR
1829, 3f3tB, 0.7936, 1.99, 0.307, 259, 244, KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL38 (TYPE III)
1830, 3dtwB, 0.7936, 1.98, 0.370, 269, 243, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZISOXAZOLE INHIBITOR
1831, 6g33C, 0.7935, 2.92, 0.199, 336, 256, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH 5-IODOTUBERCIDIN 
1832, 5wngD, 0.7935, 2.97, 0.195, 396, 262, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1833, 5tehB, 0.7935, 2.25, 0.308, 262, 247, C-SRC V281C KINASE DOMAIN IN COMPLEX WITH RAO-IV-156
1834, 5ek7B, 0.7935, 2.51, 0.353, 286, 252, STRUCTURE OF THE AUTOINHIBITED EPHA2 JMS-KD
1835, 4yveA, 0.7935, 3.00, 0.198, 390, 262, ROCK 1 BOUND TO METHOXYPHENYL THIAZOLE INHIBITOR
1836, 4yhtA, 0.7935, 2.13, 0.312, 256, 247, BRAF COMPLEXED WITH AN INHIBITOR
1837, 4md9M, 0.7935, 2.83, 0.190, 331, 258, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
1838, 4m0yA, 0.7935, 2.61, 0.294, 263, 252, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 1 [4- (CARBAMOYLAMINO)-1-(NAPHTHALEN-1-YL)-1H-PYRAZOLE-3-CARBOXAMIDE]
1839, 3my0D, 0.7935, 2.87, 0.267, 298, 258, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1840, 3hrfA, 0.7935, 2.68, 0.246, 284, 256, CRYSTAL STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN ALLOSTERIC ACTIVATOR BOUND TO THE PIF-POCKET
1841, 3fjqE, 0.7935, 2.59, 0.213, 334, 254, CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA IN COMPLEX WITH PEPTIDE INHIBITOR PKI ALPHA (6-25)
1842, 3eknA, 0.7935, 2.53, 0.315, 297, 254, INSULIN RECEPTOR KINASE COMPLEXED WITH AN INHIBITOR
1843, 3aglB, 0.7935, 2.57, 0.224, 335, 254, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1039
1844, 5hvuA, 0.7934, 3.00, 0.198, 394, 262, RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH A PYRIDINE THIAZOLE PIPERIDINE INHIBITOR
1845, 4rixA, 0.7934, 2.76, 0.337, 269, 255, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-Q790R MUTATION
1846, 4o2pA, 0.7934, 2.44, 0.316, 265, 250, KINASE DOMAIN OF CSRC IN COMPLEX WITH A SUBSTITUTED PYRAZOLOPYRIMIDINE
1847, 4kaoB, 0.7934, 2.30, 0.329, 254, 249, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 1-(5-TERT- BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-(4-PYRIDIN-3- YL-PHENYL)-UREA
1848, 3uqfA, 0.7934, 2.18, 0.320, 260, 247, C-SRC KINASE DOMAIN IN COMPLEX WITH BKI RM-1-89
1849, 3uo4A, 0.7934, 2.71, 0.237, 266, 257, AURORA A IN COMPLEX WITH RPM1680
1850, 3qamE, 0.7934, 2.58, 0.213, 348, 254, CRYSTAL STRUCTURE OF GLU208ALA MUTANT OF CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE
1851, 3c50B, 0.7934, 2.91, 0.218, 496, 261, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ADP AND MAGNESIUM CHLORIDE AT 2.6A
1852, 2y7jD, 0.7934, 2.64, 0.196, 281, 255, STRUCTURE OF HUMAN PHOSPHORYLASE KINASE GAMMA 2
1853, 5oy6D, 0.7933, 2.84, 0.284, 292, 257, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH CYCLICAL INHIBITOR OD36.
1854, 4yneA, 0.7933, 2.42, 0.402, 281, 249, (R)-2-PHENYLPYRROLIDINE SUBSTITUTE IMIDAZOPYRIDAZINES: A NEW CLASS OF POTENT AND SELECTIVE PAN-TRK INHIBITORS
1855, 4riyA, 0.7933, 2.75, 0.341, 269, 255, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-E909G MUTATION
1856, 4md9P, 0.7933, 2.61, 0.181, 328, 254, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
1857, 4eoiC, 0.7933, 2.72, 0.267, 296, 255, THR 160 PHOSPHORYLATED CDK2 K89D Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
1858, 3v8wB, 0.7933, 1.59, 0.328, 242, 238, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 469
1859, 3qalE, 0.7933, 2.60, 0.213, 339, 254, CRYSTAL STRUCTURE OF ARG280ALA MUTANT OF CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE
1860, 3my0T, 0.7933, 2.87, 0.267, 292, 258, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1861, 3hgkC, 0.7933, 2.74, 0.251, 284, 255, CRYSTAL STRUCTURE OF EFFECT PROTEIN AVRPTOB COMPLEXED WITH KINASE PTO
1862, 5jfwA, 0.7932, 2.34, 0.402, 277, 249, CRYSTAL STRUCTURE OF TRKA IN COMPLEX WITH PF-05247452
1863, 4md8H, 0.7932, 2.84, 0.190, 331, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E)
1864, 4g3cA, 0.7932, 2.33, 0.212, 315, 250, CRYSTAL STRUCTURE OF APO MURINE NF-KAPPAB INDUCING KINASE (NIK)
1865, 3gniB, 0.7932, 2.48, 0.232, 304, 250, STRUCTURE OF STRAD AND MO25
1866, 3c4wB, 0.7932, 2.94, 0.218, 518, 261, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ATP AND MAGNESIUM CHLORIDE AT 2.7A
1867, 2y7jA, 0.7932, 2.66, 0.195, 284, 256, STRUCTURE OF HUMAN PHOSPHORYLASE KINASE GAMMA 2
1868, 2hyyC, 0.7932, 2.30, 0.385, 262, 247, HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571 GLIVEC)
1869, 6c0uA, 0.7931, 2.59, 0.228, 338, 254, CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE CALPHA SUBUNIT BOUND WITH N46 
1870, 4x6qC, 0.7931, 2.51, 0.217, 334, 253, AN ISOFORM-SPECIFIC MYRISTYLATION SWITCH TARGETS RIIB PKA HOLOENZYMES TO MEMBRANES
1871, 4j8nD, 0.7931, 2.75, 0.237, 265, 257, AURORA A KINASE APO
1872, 4i4fA, 0.7931, 2.41, 0.341, 255, 249, STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH AN ALLOSTERIC BINDING PYRAZOLOBENZOTHIAZINE COMPOUND.
1873, 3fzoA, 0.7931, 2.75, 0.355, 262, 256, CRYSTAL STRUCTURE OF PYK2-APO PROLINE-RICH TYROSINE KINASE
1874, 3a7fA, 0.7931, 2.44, 0.279, 283, 251, HUMAN MST3 KINASE
1875, 1stcE, 0.7931, 2.60, 0.224, 334, 254, CAMP-DEPENDENT PROTEIN KINASE ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH STAUROSPORINE
1876, 6fyvA, 0.7930, 2.76, 0.201, 329, 254, X-RAY STRUCTURE OF CLK4-KD(146-480)/CX-4945 AT 2.46A 
1877, 5ta8A, 0.7930, 2.85, 0.264, 294, 258, CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH A NOVEL 56- DIHYDROIMIDAZOLO[15-F]PTERIDINE INHIBITOR
1878, 5ta6A, 0.7930, 2.85, 0.264, 294, 258, CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH A NOVEL 56- DIHYDROIMIDAZOLO[15-F]PTERIDINE INHIBITOR.
1879, 5n1dA, 0.7930, 2.59, 0.228, 348, 254, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-METHYL-1-(5-PYRIDIN-3-YLOXYFURAN-2-YL) METHANAMINE
1880, 4mnfB, 0.7930, 2.10, 0.305, 257, 246, CRYSTAL STRUCTURE OF BRAF-V600E BOUND TO GDC0879
1881, 4md8E, 0.7930, 2.94, 0.189, 332, 259, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E)
1882, 4l9iB, 0.7930, 2.85, 0.219, 493, 260, BOVINE G PROTEIN COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH PAROXETINE
1883, 4jdkA, 0.7930, 2.59, 0.196, 288, 255, CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 F461V MUTANT IN COMPLEX WITH PAKTIDE S PEPTIDE SUBSTRATE
1884, 4j8nC, 0.7930, 2.75, 0.237, 266, 257, AURORA A KINASE APO
1885, 4imyC, 0.7930, 2.64, 0.204, 310, 255, THE AFF4 SCAFFOLD BINDS HUMAN P-TEFB ADJACENT TO HIV TAT
1886, 4eokA, 0.7930, 2.57, 0.265, 293, 253, THR 160 PHOSPHORYLATED CDK2 H84S Q85M K89D - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR NU6102
1887, 2fgiB, 0.7930, 2.60, 0.399, 272, 253, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074
1888, 1vebA, 0.7930, 2.59, 0.224, 338, 254, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 5
1889, 1u5rB, 0.7930, 2.69, 0.273, 308, 256, CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K
1890, 1q24A, 0.7930, 2.60, 0.220, 335, 254, PKA DOUBLE MUTANT MODEL OF PKB IN COMPLEX WITH MGATP
1891, 6babB, 0.7929, 2.48, 0.214, 285, 252, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
1892, 5u7rB, 0.7929, 3.01, 0.191, 387, 262, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1893, 4xw6A, 0.7929, 2.54, 0.217, 334, 253, X-RAY STRUCTURE OF PKAC WITH ADP FREE PHOSPHATE ION CP20 MAGNESIUM IONS
1894, 4ubaA, 0.7929, 2.94, 0.185, 333, 259, LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH 4 - CARBOXY-68-BROMO-FLAVONOL (FLC26)
1895, 4j8nB, 0.7929, 2.75, 0.237, 266, 257, AURORA A KINASE APO
1896, 3v5lC, 0.7929, 1.75, 0.325, 244, 240, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 542
1897, 3u9cB, 0.7929, 2.83, 0.194, 331, 258, STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH THE ATP-COMPETITIVE INHIBITOR RESORUFIN
1898, 3mvjE, 0.7929, 2.59, 0.224, 334, 254, HUMAN CYCLIC AMP-DEPENDENT PROTEIN KINASE PKA INHIBITOR COMPLEX
1899, 3iw4C, 0.7929, 2.68, 0.230, 332, 256, CRYSTAL STRUCTURE OF PKC ALPHA IN COMPLEX WITH NVP-AEB071
1900, 3bhuC, 0.7929, 2.77, 0.266, 271, 256, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 5
1901, 2vd5B, 0.7929, 2.79, 0.218, 380, 257, STRUCTURE OF HUMAN MYOTONIC DYSTROPHY PROTEIN KINASE IN COMPLEX WITH THE BISINDOYLMALEIDE INHIBITOR BIM VIII
1902, 2v5qA, 0.7929, 2.74, 0.250, 285, 256, CRYSTAL STRUCTURE OF WILD-TYPE PLK-1 KINASE DOMAIN IN COMPLEX WITH A SELECTIVE DARPIN
1903, 5lvnA, 0.7928, 2.69, 0.246, 283, 256, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ADENOSINE BOUND TO THE ATP- BINDING SITE
1904, 5ar5B, 0.7928, 2.18, 0.271, 279, 247, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH BENZIMIDAZOLE
1905, 4mxxB, 0.7928, 2.23, 0.316, 260, 247, HUMAN SRC A403T MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
1906, 4j8nA, 0.7928, 2.75, 0.237, 266, 257, AURORA A KINASE APO
1907, 4ij9A, 0.7928, 2.60, 0.224, 335, 254, BOVINE PKA C-ALPHA IN COMPLEX WITH 2-[[5-(4-PYRIDYL)-1H-124-TRIAZOL- 3-YL]SULFANYL]-1-(2-THIOPHENYL)ETHANONE
1908, 4hptE, 0.7928, 2.59, 0.217, 335, 254, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE DISPLAYING COMPLETE PHOSPHORYL TRANSFER OF AMP-PNP ONTO A SUBSTRATE PEPTIDE
1909, 4dn5B, 0.7928, 2.38, 0.223, 330, 251, CRYSTAL STRUCTURE OF NF-KB-INDUCING KINASE (NIK)
1910, 2bdwB, 0.7928, 2.82, 0.208, 309, 259, CRYSTAL STRUCTURE OF THE AUTO-INHIBITED KINASE DOMAIN OF CALCIUM/CALMODULIN ACTIVATED KINASE II
1911, 1q62A, 0.7928, 2.60, 0.220, 336, 254, PKA DOUBLE MUTANT MODEL OF PKB
1912, 1mq4A, 0.7928, 2.64, 0.251, 261, 255, CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE
1913, 1fmoE, 0.7928, 2.58, 0.217, 336, 254, CRYSTAL STRUCTURE OF A POLYHISTIDINE-TAGGED RECOMBINANT CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH THE PEPTIDE INHIBITOR PKI(5-24) AND ADENOSINE
1914, 4wsqA, 0.7927, 2.82, 0.198, 317, 253, CRYSTAL STRUCTURE OF ADAPTOR PROTEIN 2 ASSOCIATED KINASE (AAK1) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1915, 4jdjA, 0.7927, 2.63, 0.207, 288, 256, CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 F461V MUTANT IN COMPLEX WITH PAKTIDE T PEPTIDE SUBSTRATE
1916, 4dh1A, 0.7927, 2.56, 0.217, 333, 253, LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH LOW MG2+ ATP AND IP20
1917, 3qa0B, 0.7927, 2.75, 0.191, 330, 257, CRYSTAL STRUCTURE OF THE APO-FORM OF HUMAN CK2 ALPHA AT PH 6.5
1918, 3nx8A, 0.7927, 2.61, 0.220, 333, 254, HUMAN CAMP DEPENDENT PROTEIN KINASE IN COMPLEX WITH PHENOL
1919, 2f7zE, 0.7927, 2.64, 0.224, 336, 255, PROTEIN KINASE A BOUND TO (R)-1-(1H-INDOL-3-YLMETHYL)-2-(2- PYRIDIN-4-YL-[17]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE
1920, 1svhA, 0.7927, 2.60, 0.224, 335, 254, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 8
1921, 1svgA, 0.7927, 2.59, 0.224, 338, 254, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 4
1922, 1apmE, 0.7927, 2.59, 0.217, 338, 254, 2.0 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND DETERGENT
1923, 5u7qC, 0.7926, 2.96, 0.192, 390, 261, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1924, 5ia0C, 0.7926, 2.33, 0.345, 269, 249, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH ALISERTIB (MLN8237)
1925, 5f9eA, 0.7926, 2.64, 0.235, 334, 255, STRUCTURE OF PROTEIN KINASE C THETA WITH COMPOUND 10: 22-DIMETHYL-7- (2-OXIDANYLIDENE-3~{H}-IMIDAZO[45-B]PYRIDIN-1-YL)-1-(PHENYLMETHYL)- 3~{H}-QUINAZOLIN-4-ONE
1926, 4z83E, 0.7926, 2.59, 0.224, 335, 254, PKAB3 IN COMPLEX WITH PYRROLIDINE INHIBITOR 47A
1927, 4riwC, 0.7926, 2.77, 0.336, 275, 256, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER
1928, 4md9G, 0.7926, 2.80, 0.191, 329, 257, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
1929, 4ec9A, 0.7926, 2.71, 0.207, 306, 256, CRYSTAL STRUCTURE OF FULL-LENGTH CDK9 IN COMPLEX WITH CYCLIN T
1930, 3fc2A, 0.7926, 2.86, 0.264, 293, 258, PLK1 IN COMPLEX WITH BI6727
1931, 3c4xA, 0.7926, 2.95, 0.218, 496, 261, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ATP AND MAGNESIUM CHLORIDE AT 2.9A
1932, 4j53A, 0.7925, 2.86, 0.264, 293, 258, CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH TAK-960
1933, 4dh7A, 0.7925, 2.58, 0.217, 333, 253, LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH HIGH MG2+ AMP-PNP AND IP20 
1934, 3u6hA, 0.7925, 2.44, 0.319, 280, 248, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH PYRAZOLONE INHIBITOR 26
1935, 1sveA, 0.7925, 2.60, 0.224, 341, 254, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 1
1936, 6gt1B, 0.7924, 2.44, 0.251, 269, 251, NEK7 BOUND TO PURINE INHIBITOR 
1937, 5wniA, 0.7924, 1.96, 0.242, 263, 244, CRYSTAL STRUCTURE OF MURINE RECEPTOR-INTERACTING PROTEIN KINASE 4 (RIPK4) D143N IN COMPLEX WITH ATP 
1938, 5wneD, 0.7924, 2.94, 0.195, 396, 261, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1939, 5vjaB, 0.7924, 2.61, 0.242, 266, 256, CRYSTAL STRUCTURE OF HUMAN ZIPPER-INTERACTING PROTEIN KINASE (ZIPK; ALIAS DAPK3) IN COMPLEX WITH A PYRAZOLO[3;4-D]PYRIMIDINONE LIGAND (HS38) 
1940, 5owlB, 0.7924, 2.94, 0.189, 332, 259, LOW SALT STRUCTURE OF HUMAN PROTEIN KINASE CK2ALPHA IN COMPLEX WITH 3- AMINOPROPYL-4;5;6;7-TETRABROMOBENZIMIDAZOL 
1941, 5j1vB, 0.7924, 2.94, 0.195, 337, 256, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH PYRIDO[34- G]QUINAZOLINE DERIVATIVE ZW29 (COMPOUND 13)
1942, 5ci7A, 0.7924, 2.71, 0.261, 276, 257, STRUCTURE OF ULK1 BOUND TO A SELECTIVE INHIBITOR
1943, 4wboA, 0.7924, 2.89, 0.235, 497, 260, BOVINE G PROTEIN COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH AMLEXANOX
1944, 4ujbA, 0.7924, 2.59, 0.224, 344, 254, PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR
1945, 4uj2A, 0.7924, 2.59, 0.224, 335, 254, PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR
1946, 4md9F, 0.7924, 2.71, 0.187, 327, 256, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
1947, 4ib3A, 0.7924, 2.55, 0.217, 336, 253, STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH ADP PHOSPHORYLATED PEPTIDE PSP20 AND NO METAL
1948, 4eosC, 0.7924, 2.73, 0.263, 296, 255, THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
1949, 4bggC, 0.7924, 2.77, 0.287, 279, 254, CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH LDN-213844
1950, 3oogA, 0.7924, 2.60, 0.224, 333, 254, HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH A SMALL FRAGMENT
1951, 3l9nA, 0.7924, 2.50, 0.225, 332, 253, CRYSTAL STRUCTURE OF PKAB3 (PKA TRIPLE MUTANT V123A L173M Q181K) WITH COMPOUND 27
1952, 3c4xB, 0.7924, 2.95, 0.234, 475, 261, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ATP AND MAGNESIUM CHLORIDE AT 2.9A
1953, 1jluE, 0.7924, 2.59, 0.217, 337, 254, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PHOSPHORYLATED SUBSTRATE PEPTIDE AND DETERGENT
1954, 1atpE, 0.7924, 2.58, 0.217, 334, 254, 2.2 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH MNATP AND A PEPTIDE INHIBITOR
1955, 5wnhD, 0.7923, 2.92, 0.195, 397, 261, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1956, 4ybkA, 0.7923, 2.44, 0.311, 266, 251, C-HELIX-OUT DASATINIB ANALOG CRYSTALLIZED WITH C-SRC KINASE
1957, 4u45A, 0.7923, 2.64, 0.245, 289, 253, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 25)
1958, 4dh3A, 0.7923, 2.56, 0.217, 333, 253, LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH HIGH MG2+ ATP AND IP20
1959, 4dc2A, 0.7923, 2.77, 0.191, 328, 257, STRUCTURE OF PKC IN COMPLEX WITH A SUBSTRATE PEPTIDE FROM PAR-3
1960, 3nczD, 0.7923, 2.95, 0.199, 397, 261, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT 2H-ISOQUINOLIN-1-ONE INHIBITOR
1961, 2uzvA, 0.7923, 2.64, 0.224, 336, 255, PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS
1962, 5u7qA, 0.7922, 2.97, 0.192, 388, 261, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1963, 5lcpA, 0.7922, 2.48, 0.229, 350, 253, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH FASUDIL (M77)
1964, 5ew3B, 0.7922, 1.89, 0.365, 266, 241, HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN IN COMPLEX WITH AAL993
1965, 5bmlA, 0.7922, 2.99, 0.203, 393, 261, ROCK 1 BOUND TO A PYRIDINE THIAZOLE INHIBITOR
1966, 4xbuA, 0.7922, 2.80, 0.205, 292, 258, IN VITRO CRYSTAL STRUCTURE OF PAK4 IN COMPLEX WITH INKA PEPTIDE
1967, 4f0fA, 0.7922, 2.66, 0.247, 276, 255, CRYSTAL STRUCTURE OF THE ROCO4 KINASE DOMAIN BOUND TO APPCP FROM D. DISCOIDEUM
1968, 4dgnA, 0.7922, 2.88, 0.190, 325, 258, CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH THE INHIBITOR LUTEOLIN
1969, 3g5dB, 0.7922, 1.99, 0.307, 257, 244, KINASE DOMAIN OF CSRC IN COMPLEX WITH DASATINIB
1970, 2ou7A, 0.7922, 2.83, 0.249, 292, 257, STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1
1971, 2ojfE, 0.7922, 2.65, 0.224, 336, 255, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH PYRIDINE-PYRAZOLOPYRIDINE BASED INHIBITORS
1972, 2f7eE, 0.7922, 2.65, 0.224, 336, 255, PKA COMPLEXED WITH (S)-2-(1H-INDOL-3-YL)-1-(5-ISOQUINOLIN-6- YL-PYRIDIN-3-YLOXYMETHYL-ETYLAMINE
1973, 5xgmA, 0.7921, 2.41, 0.355, 288, 248, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH GO6976
1974, 5uzjB, 0.7921, 2.88, 0.204, 386, 260, CRYSTAL STRUCTURE OF ROCK1 BOUND TO AN AMINOPYRIDINE INHIBITOR
1975, 4ujaA, 0.7921, 2.60, 0.224, 336, 254, PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR
1976, 4dgoA, 0.7921, 2.77, 0.191, 325, 257, CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH TYRPHOSTIN AG99
1977, 3cquA, 0.7921, 2.61, 0.235, 318, 255, CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR
1978, 5h8eA, 0.7920, 2.86, 0.190, 331, 258, CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 7H
1979, 3u9cA, 0.7920, 2.85, 0.194, 331, 258, STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH THE ATP-COMPETITIVE INHIBITOR RESORUFIN
1980, 3q4cB, 0.7920, 2.41, 0.302, 264, 252, CRYSTAL STRUCTURE OF WILD TYPE BRAF KINASE DOMAIN IN COMPLEX WITH ORGANOMETALLIC INHIBITOR CNS292
1981, 2gnfA, 0.7920, 2.60, 0.224, 339, 254, PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH Y- 27632
1982, 2cchC, 0.7920, 2.71, 0.263, 296, 255, THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA- LINKED ATP ANALOGUE
1983, 1wvxA, 0.7920, 2.54, 0.248, 275, 254, CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1984, 5li1A, 0.7919, 2.50, 0.202, 331, 253, STRUCTURE OF A PAR3-INHIBITORY PEPTIDE BOUND TO PKCIOTA CORE KINASE DOMAIN
1985, 5cyiC, 0.7919, 2.71, 0.263, 296, 255, CDK2/CYCLIN A COVALENT COMPLEX WITH 6-(CYCLOHEXYLMETHOXY)-N-(4- (VINYLSULFONYL)PHENYL)-9H-PURIN-2-AMINE (NU6300)
1986, 4uv0A, 0.7919, 2.82, 0.242, 300, 260, STRUCTURE OF A SEMISYNTHETIC PHOSPHORYLATED DAPK
1987, 4krcA, 0.7919, 2.83, 0.238, 297, 256, CRYSTAL STRUCTURE OF PHO85-PCL10-ATP-GAMMA-S COMPLEX
1988, 4fzfB, 0.7919, 2.60, 0.265, 279, 253, CRYSTAL STRUCTURE OF MST4-MO25 COMPLEX WITH DKI
1989, 4eojC, 0.7919, 2.84, 0.265, 282, 257, THR 160 PHOSPHORYLATED CDK2 H84S Q85M K89D - HUMAN CYCLIN A3 COMPLEX WITH ATP
1990, 4dh5A, 0.7919, 2.54, 0.217, 333, 253, ROOM TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH HIGH MG2+ ADP PHOSPHATE AND IP20
1991, 3en4A, 0.7919, 2.02, 0.316, 257, 244, TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP121 A MULTITARGETED KINASE INHIBITOR
1992, 2qcsA, 0.7919, 2.54, 0.217, 335, 253, A COMPLEX STRUCTURE BETWEEN THE CATALYTIC AND REGULATORY SUBUNIT OF PROTEIN KINASE A THAT REPRESENTS THE INHIBITED STATE
1993, 6fnfA, 0.7918, 2.36, 0.349, 267, 249, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH NVP-BHG712 
1994, 5jr7A, 0.7918, 2.53, 0.217, 335, 253, CRYSTAL STRUCTURE OF AN ACRDYS HETERODIMER [RIA(92-365):C] OF PKA
1995, 5j79A, 0.7918, 2.28, 0.270, 283, 248, THE IDENTIFICATION AND PHARMACOLOGICAL CHARACTERIZATION OF 6-(TERT- BUTYLSULFONYL)-N-(5-FLUORO-1H-INDAZOL-3-YL)QUINOLIN-4-AMINE (GSK583) A HIGHLY POTENT AND SELECTIVE INHIBITOR OF RIP2 KINASE COMPOUND 3 COMPLEX
1996, 5g1xA, 0.7918, 2.69, 0.258, 262, 256, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH N-MYC
1997, 4x6rA, 0.7918, 2.54, 0.217, 347, 253, AN ISOFORM-SPECIFIC MYRISTYLATION SWITCH TARGETS RIIB PKA HOLOENZYMES TO MEMBRANES
1998, 4riwA, 0.7918, 2.78, 0.337, 269, 255, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER
1999, 4dgmA, 0.7918, 2.88, 0.190, 326, 258, CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH THE INHIBITOR APIGENIN
2000, 3zo4A, 0.7918, 2.60, 0.224, 335, 254, THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE INHIBITORS
2001, 3sc1A, 0.7918, 2.50, 0.247, 278, 251, NOVEL ISOQUINOLONE PDK1 INHIBITORS DISCOVERED THROUGH FRAGMENT-BASED LEAD DISCOVERY
2002, 3el8B, 0.7918, 2.02, 0.320, 259, 244, CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDINE 5
2003, 2v55C, 0.7918, 2.98, 0.198, 396, 262, MECHANISM OF MULTI-SITE PHOSPHORYLATION FROM A ROCK-I:RHOE COMPLEX STRUCTURE
2004, 5wnfD, 0.7917, 2.93, 0.195, 396, 261, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
2005, 5ia0B, 0.7917, 2.62, 0.335, 266, 254, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH ALISERTIB (MLN8237)
2006, 4yxrA, 0.7917, 2.60, 0.224, 334, 254, CRYSTAL STRUCTURE OF PKA IN COMPLEX WITH INHIBITOR.
2007, 4w9xA, 0.7917, 2.81, 0.218, 300, 252, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH BARICITINIB
2008, 4uj1A, 0.7917, 2.60, 0.224, 335, 254, PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR
2009, 4o21A, 0.7917, 2.56, 0.217, 333, 253, PRODUCT COMPLEX OF METAL-FREE PKAC ATP-GAMMA-S AND SP20.
2010, 4ct1A, 0.7917, 2.70, 0.246, 283, 256, HUMAN PDK1-PKCZETA KINASE CHIMERA IN COMPLEX WITH ALLOSTERIC COMPOUND PS315 BOUND TO THE PIF-POCKET
2011, 4axaA, 0.7917, 2.60, 0.220, 335, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1S)-2-AMINO-1-( 4-CHLOROPHENYL)-1-(4-(1H-PYRAZOL-4-YL)PHENYL)ETHAN-1-OL
2012, 2w1cA, 0.7917, 2.64, 0.239, 261, 255, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2013, 2rkuA, 0.7917, 2.87, 0.264, 294, 258, STRUCTURE OF PLK1 IN COMPLEX WITH BI2536
2014, 1xh9A, 0.7917, 2.61, 0.228, 336, 254, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
2015, 1cdkB, 0.7917, 2.62, 0.224, 342, 254, CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (E.C.2.7.1.37) (PROTEIN KINASE A) COMPLEXED WITH PROTEIN KINASE INHIBITOR PEPTIDE FRAGMENT 5-24 (PKI(5-24) ISOELECTRIC VARIANT CA) AND MN2+ ADENYLYL IMIDODIPHOSPHATE (MNAMP-PNP) AT PH 5.6 AND 7C AND 4C
2016, 5jgbA, 0.7916, 2.06, 0.286, 295, 245, CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH LIGAND 10
2017, 4mneF, 0.7916, 2.14, 0.300, 258, 247, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
2018, 4ib0A, 0.7916, 2.60, 0.217, 334, 253, X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH NA+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2019, 3my0W, 0.7916, 2.70, 0.272, 281, 254, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
2020, 3mvjA, 0.7916, 2.60, 0.224, 334, 254, HUMAN CYCLIC AMP-DEPENDENT PROTEIN KINASE PKA INHIBITOR COMPLEX
2021, 3idcA, 0.7916, 2.62, 0.213, 341, 254, CRYSTAL STRUCTURE OF (102-265)RIIB:C HOLOENZYME OF CAMP- DEPENDENT PROTEIN KINASE
2022, 3e5aA, 0.7916, 2.70, 0.227, 264, 255, CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH VX-680 AND TPX2
2023, 3aglA, 0.7916, 2.58, 0.220, 338, 254, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1039
2024, 2uvxA, 0.7916, 2.61, 0.220, 335, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 7-AZAINDOLE
2025, 2evaA, 0.7916, 2.15, 0.285, 295, 246, STRUCTURAL BASIS FOR THE INTERACTION OF TAK1 KINASE WITH ITS ACTIVATING PROTEIN TAB1
2026, 1cdkA, 0.7916, 2.62, 0.220, 342, 254, CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (E.C.2.7.1.37) (PROTEIN KINASE A) COMPLEXED WITH PROTEIN KINASE INHIBITOR PEPTIDE FRAGMENT 5-24 (PKI(5-24) ISOELECTRIC VARIANT CA) AND MN2+ ADENYLYL IMIDODIPHOSPHATE (MNAMP-PNP) AT PH 5.6 AND 7C AND 4C
2027, 5vibA, 0.7915, 2.61, 0.224, 308, 254, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH THE PKI PEPTIDE AND AMINOBENZOTHIAZOLE BASED INHIBITORS
2028, 5bx7A, 0.7915, 2.60, 0.224, 343, 254, PKA IN COMPLEX WITH A BENZOTHIOPHENE FRAGMENT COMPOUND.
2029, 4uj9A, 0.7915, 2.61, 0.224, 339, 254, PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR
2030, 4rzvB, 0.7915, 2.90, 0.298, 271, 258, CRYSTAL STRUCTURE OF THE BRAF (R509H) KINASE DOMAIN MONOMER BOUND TO VEMURAFENIB
2031, 4rrvA, 0.7915, 2.70, 0.246, 283, 256, CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH ATP AND PIFTIDE
2032, 3u87B, 0.7915, 2.75, 0.195, 329, 257, STRUCTURE OF A CHIMERIC CONSTRUCT OF HUMAN CK2ALPHA AND HUMAN CK2ALPHA  IN COMPLEX WITH A NON-HYDROLYSABLE ATP-ANALOGUE
2033, 3rcjA, 0.7915, 2.68, 0.243, 281, 255, RAPID PREPARATION OF TRIAZOLYL SUBSTITUTED NH-HETEROCYCLIC KINASE INHIBITORS VIA ONE-POT SONOGASHIRA COUPLING TMS-DEPROTECTION CUAAC SEQUENCE
2034, 2esmA, 0.7915, 3.04, 0.198, 400, 262, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO FASUDIL
2035, 1snuB, 0.7915, 1.71, 0.331, 241, 239, CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
2036, 1rekA, 0.7915, 2.59, 0.217, 336, 254, CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 8
2037, 6gt1A, 0.7914, 2.43, 0.251, 267, 251, NEK7 BOUND TO PURINE INHIBITOR 
2038, 5uplA, 0.7914, 2.66, 0.195, 290, 256, CDC42 BINDS PAK4 VIA AN EXTENDED GTPASE-EFFECTOR INTEFACE - 2 PEPTIDE: PAK4FL CDC42 - UNREFINED
2039, 4uwyB, 0.7914, 2.34, 0.402, 273, 249, FGFR1 APO STRUCTURE
2040, 4txcA, 0.7914, 2.55, 0.247, 276, 255, CRYSTAL STRUCTURE OF DAPK1 KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
2041, 4ib1A, 0.7914, 2.59, 0.217, 335, 253, STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH K+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2042, 4iadA, 0.7914, 2.59, 0.217, 334, 253, LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH MG2+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2043, 4fnzA, 0.7914, 2.28, 0.302, 287, 248, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PIPERIDINE-CARBOXAMIDE INHIBITOR 2
2044, 3l9mB, 0.7914, 2.62, 0.224, 336, 254, CRYSTAL STRUCTURE OF PKAB3 (PKA TRIPLE MUTANT V123A L173M Q181K) WITH COMPOUND 18
2045, 2qo9A, 0.7914, 2.55, 0.340, 277, 253, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION PHOSPHORYLATED AMP-PNP BOUND
2046, 2fb8B, 0.7914, 2.23, 0.306, 259, 248, STRUCTURE OF THE B-RAF KINASE DOMAIN BOUND TO SB-590885
2047, 2f7xE, 0.7914, 2.65, 0.224, 336, 255, PROTEIN KINASE A BOUND TO (S)-2-(1H-INDOL-3-YL)-1-[5-((E)-2- PYRIDIN-4-YL-VINYL)-PYRIDIN-3-YLOXYMETHYL]-ETHYLAMINE
2048, 1qmzC, 0.7914, 2.72, 0.263, 296, 255, PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX
2049, 5lvoA, 0.7913, 2.70, 0.238, 285, 256, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC COMPOUND PSE10 BOUND TO THE PIF-POCKET
2050, 5lcuA, 0.7913, 2.49, 0.229, 350, 253, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A S-METHYL-PIPERAZINE SUBSTITUTED FASUDIL-DERIVATIVE (LIGAND 01)
2051, 5kmnA, 0.7913, 2.58, 0.395, 296, 253, TRKA JM-KINASE WITH 1-(2-METHYL-4-PHENYL-PYRIMIDIN-5-YL)-3-[[2- (TRIFLUOROMETHYL)PHENYL]METHYL]UREA
2052, 5hngA, 0.7913, 2.51, 0.247, 280, 251, DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS
2053, 4yo4A, 0.7913, 2.64, 0.239, 280, 255, CRYSTAL STRUCTURE OF DAPK1 CATALYTIC DOMAIN IN COMPLEX WITH THE HINGE BINDING FRAGMENT PHTHALAZINE
2054, 4v04A, 0.7913, 2.46, 0.384, 290, 250, FGFR1 IN COMPLEX WITH PONATINIB.
2055, 4tygA, 0.7913, 2.71, 0.353, 293, 255, STRUCTURAL ANALYSIS OF THE HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE
2056, 4neuA, 0.7913, 2.55, 0.296, 286, 253, X-RAY STRUCTURE OF RECEPTOR INTERACTING PROTEIN 1 (RIP1)KINASE DOMAIN WITH A 1-AMINOISOQUINOLINE INHIBITOR
2057, 4iaiA, 0.7913, 2.59, 0.217, 333, 253, X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH CA2+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2058, 3vqhA, 0.7913, 2.61, 0.224, 344, 254, BROMINE SAD PARTIALLY RESOLVES MULTIPLE BINDING MODES FOR PKA INHIBITOR H-89
2059, 3up7A, 0.7913, 2.70, 0.250, 264, 256, AURORA A IN COMPLEX WITH YL1-038-09
2060, 3owpA, 0.7913, 2.61, 0.224, 334, 254, HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
2061, 3ky2B, 0.7913, 2.63, 0.389, 280, 252, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN
2062, 3ddpC, 0.7913, 2.71, 0.263, 298, 255, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR CR8
2063, 2hyyD, 0.7913, 2.26, 0.382, 264, 246, HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571 GLIVEC)
2064, 2g9xC, 0.7913, 2.77, 0.267, 274, 255, STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR NU6271
2065, 5jr7C, 0.7912, 2.53, 0.217, 335, 253, CRYSTAL STRUCTURE OF AN ACRDYS HETERODIMER [RIA(92-365):C] OF PKA
2066, 4ypdA, 0.7912, 2.60, 0.240, 281, 254, CRYSTAL STRUCTURE OF DAPK1 CATALYTIC DOMAIN IN COMPLEX WITH THE HINGE BINDING FRAGMENT 4-METHYLPYRIDAZINE
2067, 4nkaA, 0.7912, 2.47, 0.384, 279, 250, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 2
2068, 4l67A, 0.7912, 2.66, 0.195, 289, 256, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF PAK4
2069, 4f1tA, 0.7912, 2.75, 0.251, 269, 255, CRYSTAL STRUCTURE OF THE ROCO4 KINASE DOMAIN FROM D. DISCOIDEUM BOUND TO THE ROCK INHIBITOR H1152
2070, 4cfhA, 0.7912, 2.62, 0.256, 401, 254, STRUCTURE OF AN ACTIVE FORM OF MAMMALIAN AMPK
2071, 3my0O, 0.7912, 2.93, 0.267, 297, 258, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
2072, 3dgkA, 0.7912, 2.64, 0.243, 278, 255, CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN
2073, 3c4wA, 0.7912, 2.97, 0.234, 494, 261, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ATP AND MAGNESIUM CHLORIDE AT 2.7A
2074, 2v7oA, 0.7912, 2.88, 0.208, 305, 260, CRYSTAL STRUCTURE OF HUMAN CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE II GAMMA
2075, 1oiuA, 0.7912, 2.73, 0.262, 296, 256, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
2076, 1dawA, 0.7912, 2.97, 0.185, 327, 259, CRYSTAL STRUCTURE OF A BINARY COMPLEX OF PROTEIN KINASE CK2 (ALPHA-SUBUNIT) AND MG-AMPPNP
2077, 6b1uA, 0.7911, 2.50, 0.249, 441, 253, STRUCTURE OF FULL-LENGTH HUMAN AMPK (A2B1G1) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR SC4 
2078, 5oniB, 0.7911, 2.96, 0.189, 334, 259, LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR 4P
2079, 5i0bA, 0.7911, 2.70, 0.206, 288, 257, STRUCTURE OF PAK4
2080, 4at3A, 0.7911, 2.71, 0.372, 289, 253, CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH CPD5N
2081, 3l9lB, 0.7911, 2.62, 0.224, 337, 254, CRYSTAL STRUCTURE OF PKA WITH COMPOUND 36
2082, 3gu8A, 0.7911, 2.63, 0.239, 278, 255, CRYSTAL STRUCTURE OF DAPKL93G WITH N6-CYCLOPENTYLADENOSINE
2083, 3bprA, 0.7911, 2.35, 0.332, 261, 247, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE- PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR C52
2084, 2rl5A, 0.7911, 2.50, 0.368, 294, 250, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A 23-DIHYDRO-14-BENZOXAZINE INHIBITOR
2085, 2gnhA, 0.7911, 2.60, 0.224, 338, 254, PKA FIVE FOLD MUTANT MODEL OF RHO-KINASE WITH H1152P
2086, 1sm2B, 0.7911, 1.72, 0.331, 241, 239, CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
2087, 1ol5A, 0.7911, 2.59, 0.260, 263, 254, STRUCTURE OF AURORA-A 122-403 PHOSPHORYLATED ON THR287 THR288 AND BOUND TO TPX2 1-43
2088, 5jgaA, 0.7910, 2.13, 0.285, 296, 246, CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH LIGAND 11C
2089, 4f65B, 0.7910, 2.71, 0.382, 279, 254, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 8
2090, 3t8oA, 0.7910, 2.98, 0.218, 493, 261, RHODOPSIN KINASE (GRK1) L166K MUTANT AT 2.5A RESOLUTION
2091, 3gu5A, 0.7910, 2.59, 0.244, 280, 254, CRYSTAL STRUCTURE OF DAPKQ23V-AMPPNP-MG2+
2092, 2uzwE, 0.7910, 2.66, 0.224, 336, 255, PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS
2093, 2uzdA, 0.7910, 2.84, 0.268, 295, 257, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2094, 2gcdA, 0.7910, 2.72, 0.270, 308, 256, TAO2 KINASE DOMAIN-STAUROSPORINE STRUCTURE
2095, 1oiyC, 0.7910, 2.72, 0.267, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
2096, 1h1sC, 0.7910, 2.71, 0.263, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102
2097, 5n3oA, 0.7909, 2.56, 0.229, 335, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3-(13-OXAZOL-5-YL)ANILINE
2098, 5m56A, 0.7909, 2.77, 0.187, 331, 257, MONOCLINIC COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA ) WITH THE INHIBITOR 4 -CARBOXY-68-CHLORO- FLAVONOL (FLC21)
2099, 5da3A, 0.7909, 2.66, 0.316, 263, 253, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN WITH INHIBITOR
2100, 5bx6A, 0.7909, 2.61, 0.224, 343, 254, PKA IN COMPLEX WITH A HALOGENATED PHTHALAZINONE FRAGMENT COMPOUND.
2101, 4wb8A, 0.7909, 2.60, 0.225, 334, 253, CRYSTAL STRUCTURE OF HUMAN CAMP-DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT) EXON 1 DELETION
2102, 4iw0A, 0.7909, 3.11, 0.219, 647, 265, CRYSTAL STRUCTURE AND MECHANISM OF ACTIVATION OF TBK1
2103, 4eomC, 0.7909, 2.86, 0.261, 275, 257, THR 160 PHOSPHORYLATED CDK2 H84S Q85M Q131E - HUMAN CYCLIN A3 COMPLEX WITH ATP
2104, 4dn5A, 0.7909, 2.40, 0.223, 331, 251, CRYSTAL STRUCTURE OF NF-KB-INDUCING KINASE (NIK)
2105, 4c37A, 0.7909, 2.56, 0.221, 335, 253, PKA-S6K1 CHIMERA WITH COMPOUND 21A (CCT196539) BOUND
2106, 4at5A, 0.7909, 2.90, 0.369, 294, 255, CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH GW2580
2107, 3pooA, 0.7909, 2.61, 0.224, 331, 254, HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
2108, 3fztA, 0.7909, 2.59, 0.352, 259, 253, CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-4618433
2109, 2w4jA, 0.7909, 2.64, 0.243, 276, 255, X-RAY STRUCTURE OF A DAP-KINASE 2-277
2110, 2v55A, 0.7909, 2.98, 0.198, 393, 262, MECHANISM OF MULTI-SITE PHOSPHORYLATION FROM A ROCK-I:RHOE COMPLEX STRUCTURE
2111, 2rfsA, 0.7909, 2.53, 0.333, 264, 249, X-RAY STRUCTURE OF SU11274 BOUND TO C-MET
2112, 2jdrA, 0.7909, 2.65, 0.235, 316, 255, STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A- 443654
2113, 2gngA, 0.7909, 2.61, 0.224, 338, 254, PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE
2114, 2etkA, 0.7909, 3.04, 0.198, 400, 262, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO HYDROXYFASUDIL
2115, 1qmzA, 0.7909, 2.73, 0.263, 296, 255, PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX
2116, 6dkgA, 0.7908, 2.58, 0.397, 276, 252, CRYSTAL STRUCTURE OF TRK-A IN COMPLEX WITH THE PAN-TRK KINASE INHIBITOR; COMPOUND 13B. 
2117, 5vjaC, 0.7908, 2.59, 0.245, 265, 253, CRYSTAL STRUCTURE OF HUMAN ZIPPER-INTERACTING PROTEIN KINASE (ZIPK; ALIAS DAPK3) IN COMPLEX WITH A PYRAZOLO[3;4-D]PYRIMIDINONE LIGAND (HS38) 
2118, 5u7rD, 0.7908, 2.80, 0.194, 382, 258, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
2119, 5kktA, 0.7908, 3.02, 0.199, 389, 261, ROCK 1 BOUND TO AZAINDOLE THIOZOLE PIPERAZINE INHIBITOR
2120, 5i9wA, 0.7908, 2.23, 0.340, 267, 247, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH ANP
2121, 4wsqB, 0.7908, 2.84, 0.198, 310, 253, CRYSTAL STRUCTURE OF ADAPTOR PROTEIN 2 ASSOCIATED KINASE (AAK1) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
2122, 4wb5A, 0.7908, 2.57, 0.225, 335, 253, CRYSTAL STRUCTURE OF HUMAN CAMP-DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)
2123, 4iafA, 0.7908, 2.57, 0.217, 333, 253, ROOM TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH MG2+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2124, 4dh8A, 0.7908, 2.59, 0.217, 333, 253, ROOM TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH HIGH MG2+ AMP-PNP AND IP20
2125, 2vo7A, 0.7908, 2.62, 0.224, 335, 254, STRUCTURE OF PKA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H- PYRROLO(23-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE
2126, 2erzE, 0.7908, 2.61, 0.217, 334, 254, CRYSTAL STRUCTURE OF C-AMP DEPENDENT KINASE (PKA) BOUND TO HYDROXYFASUDIL
2127, 1eh4A, 0.7908, 3.17, 0.169, 293, 266, BINARY COMPLEX OF CASEIN KINASE-1 FROM S. POMBE WITH AN ATP COMPETITIVE INHIBITOR IC261
2128, 4xw5A, 0.7907, 2.56, 0.217, 334, 253, X-RAY STRUCTURE OF PKAC WITH ATP CP20 CALCIUM IONS
2129, 4ubaB, 0.7907, 2.96, 0.189, 333, 259, LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH 4 - CARBOXY-68-BROMO-FLAVONOL (FLC26)
2130, 4cfuC, 0.7907, 2.84, 0.261, 272, 257, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
2131, 2uw4A, 0.7907, 2.58, 0.217, 334, 253, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-(5-METHYL- 1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE
2132, 1lp4A, 0.7907, 2.91, 0.190, 327, 258, CRYSTAL STRUCTURE OF A BINARY COMPLEX OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 WITH MG-AMPPNP
2133, 5ur1A, 0.7906, 2.27, 0.407, 278, 248, FGFR1 KINASE DOMAIN COMPLEX WITH SN37333 IN REVERSIBLE BINDING MODE
2134, 5os2A, 0.7906, 2.52, 0.258, 261, 252, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
2135, 5n3lA, 0.7906, 2.59, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-[(1R)-2-AMINO-1-HYDROXYETHYL]BENZENE-1 2-DIOL
2136, 4z84A, 0.7906, 2.62, 0.224, 335, 254, PKAB3 IN COMPLEX WITH PYRROLIDINE INHIBITOR 34A
2137, 4wb7B, 0.7906, 2.58, 0.225, 402, 253, CRYSTAL STRUCTURE OF A CHIMERIC FUSION OF HUMAN DNAJ (HSP40) AND CAMP- DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)
2138, 4wb6B, 0.7906, 2.62, 0.224, 340, 254, CRYSTAL STRUCTURE OF A L205R MUTANT OF HUMAN CAMP-DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)
2139, 4ekkB, 0.7906, 2.64, 0.235, 318, 255, AKT1 WITH AMP-PNP
2140, 4ebwA, 0.7906, 2.46, 0.337, 259, 249, STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH NOVEL ALLOSTERIC INHIBITOR
2141, 4dedA, 0.7906, 2.75, 0.237, 265, 257, AURORA A IN COMPLEX WITH YL1-038-21
2142, 3u87A, 0.7906, 2.78, 0.191, 329, 257, STRUCTURE OF A CHIMERIC CONSTRUCT OF HUMAN CK2ALPHA AND HUMAN CK2ALPHA  IN COMPLEX WITH A NON-HYDROLYSABLE ATP-ANALOGUE
2143, 3q9zA, 0.7906, 2.88, 0.186, 332, 258, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH QUINALIZARIN AT PH 6.5
2144, 3kxmA, 0.7906, 2.88, 0.186, 326, 258, CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR K74
2145, 2reiA, 0.7906, 2.42, 0.341, 277, 249, KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7)
2146, 2oxdA, 0.7906, 2.77, 0.191, 325, 257, PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE K17 K22 AND K32 INHIBITORS
2147, 2oh0E, 0.7906, 2.66, 0.224, 336, 255, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH PYRIDINE-PYRAZOLOPYRIDINE BASED INHIBITORS
2148, 5v24B, 0.7905, 2.52, 0.260, 263, 250, STRUCTURE-BASED DRUG DESIGN OF NOVEL ASK1 INHIBITORS USING A FULLY INTEGRATED LEAD OPTIMIZATION STRATEGY
2149, 5j5xA, 0.7905, 2.62, 0.224, 340, 254, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1416
2150, 4xbrA, 0.7905, 2.66, 0.195, 315, 256, IN CELLULO CRYSTAL STRUCTURE OF PAK4 IN COMPLEX WITH INKA
2151, 4wboB, 0.7905, 3.01, 0.234, 495, 261, BOVINE G PROTEIN COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH AMLEXANOX
2152, 4w7pC, 0.7905, 3.08, 0.198, 383, 262, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO YB-15-QD37
2153, 4md9L, 0.7905, 2.66, 0.181, 328, 254, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
2154, 4gg7A, 0.7905, 2.66, 0.321, 278, 252, CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR
2155, 4fx3C, 0.7905, 2.73, 0.259, 298, 255, CRYSTAL STRUCTURE OF THE CDK2/CYCLIN A COMPLEX WITH OXINDOLE INHIBITOR
2156, 4fieB, 0.7905, 2.76, 0.195, 300, 257, FULL-LENGTH HUMAN PAK4
2157, 4fieA, 0.7905, 2.76, 0.195, 300, 257, FULL-LENGTH HUMAN PAK4
2158, 3ow3A, 0.7905, 2.62, 0.217, 334, 254, DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS POTENT PAN AKT INHIBITORS
2159, 3gubA, 0.7905, 2.60, 0.240, 278, 254, CRYSTAL STRUCTURE OF DAPKL93G COMPLEXED WITH N6-(2- PHENYLETHYL)ADENOSINE
2160, 3gqlB, 0.7905, 2.45, 0.402, 276, 251, CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
2161, 3amaA, 0.7905, 2.62, 0.220, 342, 254, PROTEIN KINASE A SIXFOLD MUTANT MODEL OF AURORA B WITH INHIBITOR JNJ- 7706621
2162, 2pvnA, 0.7905, 2.88, 0.182, 327, 258, STRUCTURE-BASED DESIGN OF PYRAZOLO[15-A][135]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2163, 5jfvA, 0.7904, 2.26, 0.403, 277, 248, CRYSTAL STRUCTURE OF TRKA IN COMPLEX WITH PF-05206283
2164, 5ikwA, 0.7904, 2.85, 0.217, 297, 253, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH AN INDAZOLE INHIBITOR
2165, 4rerA, 0.7904, 2.49, 0.257, 458, 253, CRYSTAL STRUCTURE OF THE PHOSPHORYLATED HUMAN ALPHA1 BETA2 GAMMA1 HOLO-AMPK COMPLEX BOUND TO AMP AND CYCLODEXTRIN
2166, 4l53A, 0.7904, 2.22, 0.283, 296, 247, CRYSTAL STRUCTURE OF (1R4R)-4-{4-[7-AMINO-2-(123-BENZOTHIADIAZOL-7- YL)-3-CHLOROFURO[23-C]PYRIDIN-4-YL]-1H-PYRAZOL-1-YL}CYCLOHEXAN-1-OL BOUND TO TAK1-TAB1
2167, 1oguA, 0.7904, 2.73, 0.262, 296, 256, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR
2168, 6babC, 0.7903, 2.52, 0.222, 284, 252, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
2169, 5m6vA, 0.7903, 2.51, 0.229, 350, 253, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A DOUBLE METHYLATED FASUDIL-DERIVATIVE 
2170, 5i3oA, 0.7903, 2.90, 0.217, 302, 253, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH AN INDAZOLE INHIBITOR
2171, 5fboA, 0.7903, 2.23, 0.319, 255, 248, BTK-INHIBITOR CO-STRUCTURE
2172, 4w7pD, 0.7903, 3.01, 0.207, 387, 261, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO YB-15-QD37
2173, 4w7pB, 0.7903, 3.09, 0.202, 387, 262, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO YB-15-QD37
2174, 4mnfA, 0.7903, 2.14, 0.305, 257, 246, CRYSTAL STRUCTURE OF BRAF-V600E BOUND TO GDC0879
2175, 4ie9A, 0.7903, 2.61, 0.224, 335, 254, BOVINE PKA C-ALPHA IN COMPLEX WITH 3-PYRIDYLMETHYL-5-METHYL-1H- PYRAZOLE-3-CARBOXYLATE
2176, 4fzaB, 0.7903, 2.73, 0.263, 281, 255, CRYSTAL STRUCTURE OF MST4-MO25 COMPLEX
2177, 3zo2A, 0.7903, 2.58, 0.225, 340, 253, THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE INHIBITORS
2178, 3x2wA, 0.7903, 2.59, 0.217, 336, 253, MICHAELIS COMPLEX OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT
2179, 3tv6B, 0.7903, 2.71, 0.302, 276, 255, HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A METHOXYPYRAZOLOPYRIDINYL BENZAMIDE INHIBITOR
2180, 3mpmA, 0.7903, 2.50, 0.345, 257, 249, LCK COMPLEXED WITH A PYRAZOLOPYRIMIDINE
2181, 3idbA, 0.7903, 2.63, 0.217, 341, 254, CRYSTAL STRUCTURE OF (108-268)RIIB:C HOLOENZYME OF CAMP- DEPENDENT PROTEIN KINASE
2182, 3gu4A, 0.7903, 2.60, 0.244, 280, 254, CRYSTAL STRUCTURE OF DAPKQ23V-AMPPNP
2183, 2x39A, 0.7903, 2.66, 0.235, 316, 255, STRUCTURE OF 4-AMINO-N-(4-CHLOROBENZYL)-1-(7H-PYRROLO(23-D) PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE BOUND TO PKB
2184, 1u5qA, 0.7903, 2.73, 0.270, 308, 256, CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K
2185, 1h1qC, 0.7903, 2.72, 0.263, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094
2186, 5n1eA, 0.7902, 2.62, 0.228, 347, 254, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-(13-BENZODIOXOL-5-YL)-2-PIPERIDIN-1- YLACETAMIDE
2187, 5j1wB, 0.7902, 2.97, 0.199, 337, 256, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH PYRIDO[34- G]QUINAZOLINE DERIVATIVE ZW31 (COMPOUND 14)
2188, 5cu3B, 0.7902, 2.55, 0.183, 324, 252, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 10 BOUND
2189, 4rlkA, 0.7902, 2.91, 0.186, 327, 258, CRYSTAL STRUCTURE OF Z. MAYS CK2ALPHA IN COMPLEX WITH THE ATP- COMPETITIVE INHIBITOR 4-[(E)-(FLUOREN-9-YLIDENEHYDRAZINYLIDENE)- METHYL] BENZOATE
2190, 4g3eA, 0.7902, 2.35, 0.217, 314, 249, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO A 6-ALKYNYLINDOLINE (CMP1)
2191, 3dneA, 0.7902, 2.63, 0.224, 336, 254, CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
2192, 3d94A, 0.7902, 2.42, 0.325, 288, 249, CRYSTAL STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE IN COMPLEX WITH PQIP
2193, 3d7tB, 0.7902, 2.38, 0.283, 265, 251, STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
2194, 2uw8A, 0.7902, 2.59, 0.221, 334, 253, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-CHLORO- PHENYL)-2-PHENYL-ETHYLAMINE
2195, 2qc6A, 0.7902, 2.92, 0.186, 326, 258, PROTEIN KINASE CK2 IN COMPLEX WITH DBC
2196, 1l3rE, 0.7902, 2.59, 0.217, 338, 253, CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE
2197, 1jamA, 0.7902, 2.91, 0.186, 327, 258, CRYSTAL STRUCTURE OF APO-FORM OF Z. MAYS CK2 PROTEIN KINASE ALPHA SUBUNIT
2198, 5uoxA, 0.7901, 2.53, 0.260, 263, 250, STRUCTURE-BASED DESIGN OF ASK1 INHIBITORS AS POTENTIAL FIRST-IN-CLASS AGENTS FOR HEART FAILURE
2199, 3ms9B, 0.7901, 2.22, 0.384, 272, 245, ABL KINASE IN COMPLEX WITH IMATINIB AND A FRAGMENT (FRAG1) IN THE MYRISTATE POCKET
2200, 2uzuE, 0.7901, 2.67, 0.224, 336, 255, PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS
2201, 2uw3A, 0.7901, 2.58, 0.221, 334, 253, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 5-METHYL-4- PHENYL-1H-PYRAZOLE
2202, 2jdtA, 0.7901, 2.63, 0.220, 334, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH ISOQUINOLINE-5- SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE
2203, 1q8tA, 0.7901, 2.62, 0.224, 338, 254, THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH RHO-KINASE INHIBITOR Y-27632
2204, 1o6kA, 0.7901, 2.67, 0.235, 317, 255, STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3 PEPTIDE AND AMP-PNP
2205, 1ds5C, 0.7901, 2.98, 0.185, 328, 259, DIMERIC CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT IN COMPLEX WITH TWO BETA PEPTIDES MIMICKING THE ARCHITECTURE OF THE TETRAMERIC PROTEIN KINASE CK2 HOLOENZYME.
2206, 6fyoA, 0.7900, 2.87, 0.204, 331, 255, X-RAY STRUCTURE OF CLK1-KD(148-484)/CPD-2 AT 2.32A 
2207, 5m71A, 0.7900, 2.51, 0.229, 350, 253, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH AN (R)-METHYL SUBSTITUED FASUDIL-DERIVATIVE. 
2208, 5m6yA, 0.7900, 2.62, 0.228, 350, 254, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A METHYLISOQUINOLINE FASUDIL-DERIVATIVE 
2209, 5ek7A, 0.7900, 2.55, 0.353, 286, 252, STRUCTURE OF THE AUTOINHIBITED EPHA2 JMS-KD
2210, 4m13A, 0.7900, 2.51, 0.295, 264, 251, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 8 [4- (CARBAMOYLAMINO)-1-(7-PROPOXYNAPHTHALEN-1-YL)-1H-PYRAZOLE-3- CARBOXAMIDE]
2211, 4lfiB, 0.7900, 2.89, 0.182, 371, 258, CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH GMPPNP
2212, 2c1bA, 0.7900, 2.63, 0.224, 335, 254, STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH ( 4R2S)-5 -(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2- YLMETHANESULFONYL)ISOQUINOLINE
2213, 1xh5A, 0.7900, 2.65, 0.220, 335, 254, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
2214, 1m2qA, 0.7900, 2.89, 0.190, 327, 258, CRYSTAL STRUCTURE OF 18-DI-HYDROXY-4-NITRO-XANTEN-9- ONE/CK2 KINASE COMPLEX
2215, 1jwhB, 0.7900, 2.89, 0.190, 335, 258, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 HOLOENZYME
2216, 6eiiA, 0.7899, 2.70, 0.192, 326, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 18
2217, 6ehuB, 0.7899, 2.78, 0.195, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 32
2218, 5ts8A, 0.7899, 2.84, 0.198, 332, 257, Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 56-DIBROMOBENZOTRIAZOLE
2219, 5owhA, 0.7899, 2.81, 0.184, 334, 256, HIGH SALT STRUCTURE OF HUMAN PROTEIN KINASE CK2ALPHA IN COMPLEX WITH 3-AMINOPROPYL-4;5;6;7-TETRABROMOBENZIMIDAZOL 
2220, 5ooiA, 0.7899, 2.88, 0.182, 329, 258, STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA ) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR 4P
2221, 5k9iA, 0.7899, 2.22, 0.317, 258, 246, CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH A COVALENT LYSINE PROBE
2222, 5ho8A, 0.7899, 2.48, 0.248, 278, 250, DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS
2223, 5ezvA, 0.7899, 2.52, 0.249, 441, 253, X-RAY CRYSTAL STRUCTURE OF AMP-ACTIVATED PROTEIN KINASE ALPHA-2/ALPHA- 1 RIM CHIMAERA (ALPHA-2(1-347)/ALPHA-1(349-401)/ALPHA-2(397-END) BETA-1 GAMMA-1) CO-CRYSTALLIZED WITH C2 (5-(5-HYDROXYL-ISOXAZOL-3- YL)-FURAN-2-PHOSPHONIC ACID)
2224, 5cqwB, 0.7899, 2.89, 0.194, 331, 258, TETRAGONAL COMPLEX STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A BENZOTRIAZOLE-BASED INHIBITOR GENERATED BY CLICK-CHEMISTRY
2225, 4otdA, 0.7899, 2.62, 0.260, 334, 254, CRYSTAL STRUCTURE OF PRK1 CATALYTIC DOMAIN
2226, 4nwmA, 0.7899, 2.33, 0.329, 261, 249, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-809959 AKA 4-TERT-BUTYL-N-[2-ME THYL-3-(6-{[4- (MORPHOLINE-4-CARBONYL)PHENYL]AMINO}-9H- PURIN-2-YL)PHENYL]BENZAMIDE
2227, 4m0zA, 0.7899, 2.52, 0.295, 264, 251, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 5 {4- (CARBAMOYLAMINO)-1-(7-METHOXYNAPHTHALEN-1-YL)-1H-PYRAZOLE-3- CARBOXAMIDE}
2228, 4dggA, 0.7899, 2.17, 0.313, 261, 246, C-SRC KINASE DOMAIN IN COMPLEX WITH RM-1-176
2229, 3ovvA, 0.7899, 2.63, 0.224, 335, 254, HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
2230, 3bhtC, 0.7899, 2.76, 0.267, 270, 255, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 3
2231, 2uw7A, 0.7899, 2.63, 0.220, 335, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  4-(4-CHLORO- PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE
2232, 1ydrE, 0.7899, 2.61, 0.220, 334, 254, STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H7 PROTEIN KINASE INHIBITOR 1-(5- ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE
2233, 1ds5A, 0.7899, 2.99, 0.185, 328, 259, DIMERIC CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT IN COMPLEX WITH TWO BETA PEPTIDES MIMICKING THE ARCHITECTURE OF THE TETRAMERIC PROTEIN KINASE CK2 HOLOENZYME.
2234, 6gmdB, 0.7898, 2.77, 0.184, 326, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 3 
2235, 5uzkA, 0.7898, 2.64, 0.224, 335, 254, CRYSTAL STRUCTURE OF PKA BOUND TO AN PYRROLO PYRIDINE INHIBITOR
2236, 5os7A, 0.7898, 2.77, 0.187, 326, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 4
2237, 4wb6A, 0.7898, 2.59, 0.221, 336, 253, CRYSTAL STRUCTURE OF A L205R MUTANT OF HUMAN CAMP-DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)
2238, 2jedA, 0.7898, 2.69, 0.247, 324, 255, THE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE PROTEIN KINASE C THETA IN COMPLEX WITH NVP-XAA228 AT 2.32A RESOLUTION.
2239, 1wmkD, 0.7898, 2.89, 0.227, 314, 260, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
2240, 1wmkB, 0.7898, 2.89, 0.227, 314, 260, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
2241, 1oi9C, 0.7898, 2.75, 0.263, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
2242, 5o0eA, 0.7897, 2.47, 0.230, 349, 252, CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP120 AND FASUDIL 
2243, 5j1vC, 0.7897, 2.88, 0.197, 314, 254, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH PYRIDO[34- G]QUINAZOLINE DERIVATIVE ZW29 (COMPOUND 13)
2244, 4yhjB, 0.7897, 3.06, 0.195, 490, 261, STRUCTURE AND FUNCTION OF THE HYPERTENSION VARIANT A486V OF G PROTEIN- COUPLED RECEPTOR KINASE 4 (GRK4)
2245, 4w7pA, 0.7897, 3.07, 0.202, 388, 262, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO YB-15-QD37
2246, 4lfiA, 0.7897, 2.90, 0.182, 370, 258, CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH GMPPNP
2247, 4l9iA, 0.7897, 2.91, 0.219, 504, 260, BOVINE G PROTEIN COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH PAROXETINE
2248, 4cfxC, 0.7897, 2.74, 0.263, 298, 255, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6-CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
2249, 3gu6A, 0.7897, 2.66, 0.243, 280, 255, CRYSTAL STRUCTURE OF DAPKQ23V-ADP
2250, 2j0iA, 0.7897, 2.85, 0.205, 289, 258, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4
2251, 2etrA, 0.7897, 3.05, 0.198, 400, 262, CRYSTAL STRUCTURE OF ROCK I BOUND TO Y-27632
2252, 2c6tA, 0.7897, 2.71, 0.264, 295, 254, CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2253, 2c1aA, 0.7897, 2.63, 0.224, 335, 254, STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE
2254, 1ydsE, 0.7897, 2.62, 0.220, 334, 254, STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H8 PROTEIN KINASE INHIBITOR [N-(2-METHYLAMINO)ETHYL]-5- ISOQUINOLINESULFONAMIDE
2255, 1xh7A, 0.7897, 2.61, 0.225, 337, 253, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
2256, 6ehuA, 0.7896, 2.77, 0.195, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 32
2257, 5lcrA, 0.7896, 2.53, 0.229, 350, 253, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH OPEN-CHAIN FASUDIL-DERIVATIVE (LIGAND 04)
2258, 5kwhB, 0.7896, 2.90, 0.190, 331, 258, CRYSTAL STRUCTURE OF CK2
2259, 5kmlA, 0.7896, 2.59, 0.395, 296, 253, TRKA JM-KINASE WITH 1-(5-METHYL-3-PHENYL-12-OXAZOL-4-YL)-3-[[2- (TRIFLUOROMETHYL)PHENYL]METHYL]UREA
2260, 4yxsA, 0.7896, 2.63, 0.224, 335, 254, CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
2261, 4rwjB, 0.7896, 2.79, 0.394, 282, 254, CRYSTAL STRUCTURE OF FGFR1 (C488A C584S) IN COMPLEX WITH AZD4547 (N- {3-[2-(35-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R5S)-35- DIMETHYLPIPERAZIN-1-YL]BENZAMIDE)
2262, 3rawA, 0.7896, 3.00, 0.180, 351, 256, CRYSTAL STRUCTURE OF HUMAN CDC-LIKE KINASE 3 ISOFORM IN COMPLEX WITH LEUCETTINE L41
2263, 3kxgA, 0.7896, 2.90, 0.190, 326, 258, CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR 34567-PENTABROMO-1H-INDAZOLE (K64)
2264, 3e8eA, 0.7896, 2.63, 0.224, 341, 254, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2265, 2wxvA, 0.7896, 2.87, 0.252, 302, 258, STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(43-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR
2266, 5h8bA, 0.7895, 2.89, 0.190, 331, 258, CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 2
2267, 4q9zA, 0.7895, 2.63, 0.236, 331, 254, HUMAN PROTEIN KINASE C THETA IN COMPLEX WITH COMPOUND35 ((1R)-9- (AZETIDIN-3-YLAMINO)-18-DIMETHYL-35-DIHYDRO[124]TRIAZINO[34- C][14]BENZOXAZIN-2(1H)-ONE)
2268, 4o22A, 0.7895, 2.60, 0.217, 336, 253, BINARY COMPLEX OF METAL-FREE PKAC WITH SP20.
2269, 4nifB, 0.7895, 2.74, 0.196, 349, 255, HETERODIMERIC STRUCTURE OF ERK2 AND RSK1
2270, 4ii5A, 0.7895, 2.71, 0.264, 295, 254, STRUCTURE OF PCDK2/CYCLINA BOUND TO ADP AND 1 MAGNESIUM ION
2271, 4fx3A, 0.7895, 2.75, 0.259, 298, 255, CRYSTAL STRUCTURE OF THE CDK2/CYCLIN A COMPLEX WITH OXINDOLE INHIBITOR
2272, 4c38A, 0.7895, 2.58, 0.221, 334, 253, PKA-S6K1 CHIMERA WITH COMPOUND 21E (CCT239066) BOUND
2273, 4c36A, 0.7895, 2.58, 0.221, 335, 253, PKA-S6K1 CHIMERA WITH COMPOUND 15E (CCT147581) BOUND
2274, 3wzdA, 0.7895, 2.11, 0.371, 278, 245, KDR IN COMPLEX WITH LIGAND LENVATINIB
2275, 3pwdA, 0.7895, 2.91, 0.190, 327, 258, CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH NBC (Z1)
2276, 3g5dA, 0.7895, 1.94, 0.310, 256, 242, KINASE DOMAIN OF CSRC IN COMPLEX WITH DASATINIB
2277, 2hy81, 0.7895, 2.73, 0.214, 293, 257, PAK1 COMPLEX WITH ST2001
2278, 1ydtE, 0.7895, 2.63, 0.220, 334, 254, STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2- (4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE
2279, 1wmkG, 0.7895, 2.89, 0.227, 313, 260, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
2280, 1wmkF, 0.7895, 2.89, 0.227, 303, 260, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
2281, 1wmkE, 0.7895, 2.89, 0.227, 313, 260, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
2282, 1wmkC, 0.7895, 2.89, 0.227, 303, 260, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
2283, 5vjaA, 0.7894, 2.66, 0.242, 266, 256, CRYSTAL STRUCTURE OF HUMAN ZIPPER-INTERACTING PROTEIN KINASE (ZIPK; ALIAS DAPK3) IN COMPLEX WITH A PYRAZOLO[3;4-D]PYRIMIDINONE LIGAND (HS38) 
2284, 5lctA, 0.7894, 2.63, 0.228, 350, 254, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A R-METHYL-PIPERAZINE SUBSTITUTED FASUDIL-DERIVATIVE (LIGAND 02)
2285, 5jrsA, 0.7894, 2.26, 0.332, 258, 247, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -34-DIHYDROQUINAZOLIN-3-YL) PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE
2286, 4wbbB, 0.7894, 2.57, 0.217, 334, 253, SINGLE TURNOVER AUTOPHOSPHORYLATION CYCLE OF THE PKA RIIB HOLOENZYME
2287, 4ii5C, 0.7894, 2.71, 0.264, 295, 254, STRUCTURE OF PCDK2/CYCLINA BOUND TO ADP AND 1 MAGNESIUM ION
2288, 4iakA, 0.7894, 2.60, 0.217, 334, 253, LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH SR2+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2289, 4fifB, 0.7894, 2.78, 0.195, 292, 257, CATALYTIC DOMAIN OF HUMAN PAK4 WITH RPKPLVDP PEPTIDE
2290, 4bcoC, 0.7894, 2.79, 0.267, 269, 255, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
2291, 3ngaB, 0.7894, 2.89, 0.186, 331, 258, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH CX-4945
2292, 2uvyA, 0.7894, 2.59, 0.221, 333, 253, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH METHYL-(4-(9H- PURIN-6-YL)-BENZYL)-AMINE
2293, 2h9vA, 0.7894, 3.07, 0.187, 383, 262, STRUCTURAL BASIS FOR INDUCED-FIT BINDING OF RHO-KINASE TO THE INHIBITOR Y27632
2294, 1xh4A, 0.7894, 2.59, 0.225, 334, 253, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
2295, 1wmkH, 0.7894, 2.89, 0.227, 304, 260, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
2296, 1o6lA, 0.7894, 2.68, 0.235, 316, 255, CRYSTAL STRUCTURE OF AN ACTIVATED AKT/PROTEIN KINASE B (PKB-PIF CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE
2297, 1ds5D, 0.7894, 3.00, 0.185, 328, 259, DIMERIC CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT IN COMPLEX WITH TWO BETA PEPTIDES MIMICKING THE ARCHITECTURE OF THE TETRAMERIC PROTEIN KINASE CK2 HOLOENZYME.
2298, 5n7uA, 0.7893, 2.66, 0.224, 350, 254, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-BROMO-35-DIMETHYL-1H-PYRAZOLE
2299, 5n7pA, 0.7893, 2.64, 0.228, 350, 254, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3-AMINO-5-(PYRROLIDIN-1-YL)-1H-PYRAZOLE- 4-CARBONITRILE
2300, 5h8eB, 0.7893, 2.91, 0.190, 331, 258, CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 7H
2301, 5cqwA, 0.7893, 2.90, 0.194, 331, 258, TETRAGONAL COMPLEX STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A BENZOTRIAZOLE-BASED INHIBITOR GENERATED BY CLICK-CHEMISTRY
2302, 4wihA, 0.7893, 2.66, 0.228, 350, 254, CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS
2303, 4wb7A, 0.7893, 2.60, 0.225, 402, 253, CRYSTAL STRUCTURE OF A CHIMERIC FUSION OF HUMAN DNAJ (HSP40) AND CAMP- DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)
2304, 4fifA, 0.7893, 2.68, 0.195, 293, 256, CATALYTIC DOMAIN OF HUMAN PAK4 WITH RPKPLVDP PEPTIDE
2305, 4c34A, 0.7893, 2.63, 0.221, 336, 253, PKA-S6K1 CHIMERA WITH STAUROSPORINE BOUND
2306, 2uw5A, 0.7893, 2.60, 0.221, 333, 253, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  (R)-2-(4- CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE
2307, 2gu8A, 0.7893, 2.63, 0.217, 335, 254, DISCOVERY OF 2-PYRIMIDYL-5-AMIDOTHIOPHENES AS NOVEL AND POTENT INHIBITORS FOR AKT: SYNTHESIS AND SAR STUDIES
2308, 1wmkA, 0.7893, 2.89, 0.227, 303, 260, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
2309, 1h1rC, 0.7893, 2.76, 0.263, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086
2310, 6cd6C, 0.7892, 2.75, 0.261, 265, 253, CRYSTAL STRUCTURE OF THE HUMAN CAMKK1A IN COMPLEX WITH GSK650394
2311, 5jgdA, 0.7892, 2.14, 0.285, 295, 246, CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH LIGAND 12
2312, 4nh1B, 0.7892, 2.90, 0.182, 332, 258, CRYSTAL STRUCTURE OF A HETEROTETRAMERIC CK2 HOLOENZYME COMPLEX CARRYING THE ANDANTE-MUTATION IN CK2BETA AND CONSISTENT WITH PROPOSED MODELS OF AUTOINHIBITION AND TRANS-AUTOPHOSPHORYLATION
2313, 3v5lB, 0.7892, 1.61, 0.325, 241, 237, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 542
2314, 3v5jA, 0.7892, 1.61, 0.329, 241, 237, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 090
2315, 3pzhA, 0.7892, 2.92, 0.186, 327, 258, CRYSTAL STRUCTURE OF MAIZE CK2 ALPHA IN COMPLEX WITH EMODIN AT 1.92 A RESOLUTION
2316, 3l9lA, 0.7892, 2.54, 0.225, 338, 253, CRYSTAL STRUCTURE OF PKA WITH COMPOUND 36
2317, 3cpcB, 0.7892, 1.73, 0.370, 262, 238, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
2318, 2pvhA, 0.7892, 2.92, 0.186, 327, 258, STRUCTURE-BASED DESIGN OF PYRAZOLO[15-A][135]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2319, 1ds5B, 0.7892, 3.02, 0.189, 328, 259, DIMERIC CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT IN COMPLEX WITH TWO BETA PEPTIDES MIMICKING THE ARCHITECTURE OF THE TETRAMERIC PROTEIN KINASE CK2 HOLOENZYME.
2320, 6fnhC, 0.7891, 2.41, 0.345, 270, 249, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH A PYRAZOLO[3;4-D]PYRIMIDINE FRAGMENT OF NVP-BHG712 
2321, 5ooiB, 0.7891, 2.90, 0.186, 325, 258, STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA ) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR 4P
2322, 5n3sA, 0.7891, 2.59, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-HYDROXYBENZAMIDE
2323, 5n3kA, 0.7891, 2.58, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE O-GUANIDINO-L-HOMOSERINE
2324, 4iacA, 0.7891, 2.62, 0.213, 333, 253, X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH MG2+ CONCENTRATION AMP-PCP AND PSEUDO-SUBSTRATE PEPTIDE SP20
2325, 3bhvC, 0.7891, 2.80, 0.266, 271, 256, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR VARIOLIN B
2326, 2cpkE, 0.7891, 2.59, 0.217, 333, 253, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CYCLIC ADENOSINE MONOPHOSPHATE-DEPENDENT PROTEIN KINASE
2327, 1lr4A, 0.7891, 2.93, 0.186, 327, 258, ROOM TEMPERATURE CRYSTAL STRUCTURE OF THE APO-FORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM ZEA MAYS
2328, 5w5oO, 0.7890, 2.15, 0.273, 276, 245, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2329, 5ia1A, 0.7890, 2.26, 0.343, 261, 248, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH MLN8054
2330, 4zhxA, 0.7890, 2.53, 0.249, 408, 253, NOVEL BINDING SITE FOR ALLOSTERIC ACTIVATION OF AMPK
2331, 4xw4A, 0.7890, 2.61, 0.217, 334, 253, X-RAY STRUCTURE OF PKAC WITH AMPPNP SP20 CALCIUM IONS
2332, 4wnoA, 0.7890, 2.81, 0.256, 272, 258, STRUCTURE OF ULK1 BOUND TO AN INHIBITOR
2333, 4njdA, 0.7890, 2.84, 0.205, 290, 258, STRUCTURE OF P21-ACTIVATED KINASE 4 WITH A NOVEL INHIBITOR KY-04031
2334, 4nifE, 0.7890, 2.74, 0.196, 348, 255, HETERODIMERIC STRUCTURE OF ERK2 AND RSK1
2335, 4m12A, 0.7890, 2.54, 0.295, 264, 251, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 7 [4- (CARBAMOYLAMINO)-1-(7-ETHOXYNAPHTHALEN-1-YL)-1H-PYRAZOLE-3- CARBOXAMIDE]
2336, 4gt5A, 0.7890, 2.65, 0.391, 290, 253, CRYSTAL STRUCTURE OF THE INACTIVE TRKA KINASE DOMAIN
2337, 3lm0A, 0.7890, 2.69, 0.213, 278, 253, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE 17B (STK17B)
2338, 3e8eP, 0.7890, 2.63, 0.224, 341, 254, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2339, 2gnlA, 0.7890, 2.64, 0.224, 338, 254, PKA THREEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITOR H- 1152P
2340, 1zogA, 0.7890, 2.78, 0.187, 325, 257, CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- DERIVATIVES
2341, 6fykB, 0.7889, 2.94, 0.200, 349, 255, X-RAY STRUCTURE OF CLK2-KD(136-496)/INDAZOLE1 AT 2.39A 
2342, 5nw8A, 0.7889, 2.60, 0.229, 337, 253, CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP032 AND FASUDIL 
2343, 5n37A, 0.7889, 2.59, 0.229, 347, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-(13-BENZODIOXOL-5-YLMETHYL) CYCLOPENTANAMINE
2344, 5kwhA, 0.7889, 2.89, 0.190, 331, 258, CRYSTAL STRUCTURE OF CK2
2345, 5ku8A, 0.7889, 2.90, 0.194, 328, 258, CRYSTAL STRUCTURE OF CK2
2346, 5i3oB, 0.7889, 2.97, 0.217, 302, 254, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH AN INDAZOLE INHIBITOR
2347, 4mwhA, 0.7889, 2.90, 0.182, 371, 258, CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH ATP
2348, 4fi1A, 0.7889, 2.90, 0.182, 371, 258, CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH ATP
2349, 4dymA, 0.7889, 2.72, 0.281, 293, 253, CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH THE IMIDAZO[12-B]PYRIDAZINE INHIBITOR K00135
2350, 4c35A, 0.7889, 2.62, 0.221, 337, 253, PKA-S6K1 CHIMERA WITH COMPOUND 1 (NU1085) BOUND
2351, 3mv5A, 0.7889, 2.70, 0.235, 315, 255, CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES
2352, 3l9mA, 0.7889, 2.54, 0.225, 338, 253, CRYSTAL STRUCTURE OF PKAB3 (PKA TRIPLE MUTANT V123A L173M Q181K) WITH COMPOUND 18
2353, 3h9rA, 0.7889, 2.47, 0.292, 312, 250, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TYPE I ACTIVIN RECEPTOR (ACVR1) IN COMPLEX WITH FKBP12 AND DORSOMORPHIN
2354, 3d9vA, 0.7889, 3.06, 0.198, 400, 262, CRYSTAL STRUCTURE OF ROCK I BOUND TO H-1152P A DI- METHYLATED VARIANT OF FASUDIL
2355, 2wmbC, 0.7889, 2.64, 0.269, 266, 253, STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OF PEPTIDE LIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A
2356, 2oxxA, 0.7889, 2.81, 0.191, 325, 257, PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17 K22 AND K32
2357, 2oh4A, 0.7889, 2.55, 0.371, 297, 251, CRYSTAL STRUCTURE OF VEGFR2 WITH A BENZIMIDAZOLE-UREA INHIBITOR
2358, 1ckjA, 0.7889, 3.10, 0.197, 296, 264, CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317 COMPLEX WITH BOUND TUNGSTATE
2359, 5veeA, 0.7888, 2.69, 0.199, 289, 256, PAK4 KINASE DOMAIN IN COMPLEX WITH FRAX486
2360, 5ot5A, 0.7888, 2.79, 0.195, 326, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 24
2361, 5oniA, 0.7888, 2.99, 0.189, 334, 259, LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR 4P
2362, 5n3pA, 0.7888, 2.61, 0.229, 336, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 1H-INDOL-5-OL
2363, 5mo8A, 0.7888, 2.79, 0.191, 325, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2364, 5izfA, 0.7888, 2.62, 0.224, 336, 254, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1408
2365, 5isoC, 0.7888, 2.59, 0.248, 429, 254, STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR A BENZIMIDAZOLE DERIVATIVE (991)
2366, 5h8bB, 0.7888, 2.92, 0.190, 331, 258, CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 2
2367, 4nh1A, 0.7888, 2.91, 0.186, 330, 258, CRYSTAL STRUCTURE OF A HETEROTETRAMERIC CK2 HOLOENZYME COMPLEX CARRYING THE ANDANTE-MUTATION IN CK2BETA AND CONSISTENT WITH PROPOSED MODELS OF AUTOINHIBITION AND TRANS-AUTOPHOSPHORYLATION
2368, 4i3zC, 0.7888, 2.72, 0.264, 295, 254, STRUCTURE OF PCDK2/CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS
2369, 4i3zA, 0.7888, 2.72, 0.264, 295, 254, STRUCTURE OF PCDK2/CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS
2370, 4fmqA, 0.7888, 2.82, 0.199, 350, 256, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE
2371, 3tudA, 0.7888, 2.47, 0.336, 256, 250, CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH N-(4-METHYL-3-(8-METHYL-7- OXO-2-(PHENYLAMINO)-78-DIHYDROPYRIDO[23-D]PYRIMIDIN-6-YL)PHENYL)-3- (TRIFLUOROMETHYL)BENZAMIDE
2372, 3nieA, 0.7888, 3.09, 0.185, 369, 260, CRYSTAL STRUCTURE OF PF11_0147
2373, 3e8eB, 0.7888, 2.64, 0.224, 337, 254, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2374, 2xbaA, 0.7888, 2.33, 0.304, 283, 247, STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PHA-E429
2375, 2uzlA, 0.7888, 2.70, 0.268, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2376, 2jkoA, 0.7888, 2.41, 0.344, 256, 250, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS- ANILINO PYRIMIDINE INHIBITOR
2377, 1xh6A, 0.7888, 2.66, 0.224, 331, 254, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
2378, 1m2rA, 0.7888, 2.91, 0.190, 327, 258, CRYSTAL STRUCTURE OF 58-DI-AMINO-14-DI-HYDROXY- ANTHRAQUINONE/CK2 KINASE COMPLEX
2379, 5wngC, 0.7887, 2.80, 0.198, 387, 257, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
2380, 5n3hA, 0.7887, 2.59, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE PYRIDINE-3-CARBOXAMIDE
2381, 5lvmA, 0.7887, 2.75, 0.246, 283, 256, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ADENINE BOUND TO THE ATP- BINDING SITE
2382, 4qfgA, 0.7887, 2.51, 0.257, 365, 253, STRUCTURE OF AMPK IN COMPLEX WITH STAUROSPORINE INHIBITOR AND IN THE ABSENCE OF A SYNTHETIC ACTIVATOR
2383, 4ks7A, 0.7887, 2.83, 0.198, 286, 257, PAK6 KINASE DOMAIN IN COMPLEX WITH PF-3758309
2384, 4hpuE, 0.7887, 2.63, 0.217, 336, 253, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE DISPLAYING PARTIAL PHOSPHORYL TRANSFER OF AMP-PNP ONTO A SUBSTRATE PEPTIDE
2385, 4figB, 0.7887, 2.69, 0.195, 292, 256, CATALYTIC DOMAIN OF HUMAN PAK4
2386, 4eoqC, 0.7887, 2.86, 0.261, 275, 257, THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH ATP
2387, 4cnhA, 0.7887, 2.43, 0.302, 285, 248, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 3-((1R)-1-(5-FLUORO-2- METHOXYPHENYL)ETHOXY)-5-(1-METHYL-1H-123-TRIAZOL-5-YL) PYRIDIN-2-AMINE
2388, 3zo3A, 0.7887, 2.59, 0.225, 337, 253, THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE INHIBITORS
2389, 3qlgA, 0.7887, 2.20, 0.313, 259, 246, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH DASATINIB
2390, 3qlfB, 0.7887, 2.13, 0.306, 258, 245, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH PYRAZOLOPYRIMIDINE 5
2391, 3pyyB, 0.7887, 1.89, 0.382, 257, 241, DISCOVERY AND CHARACTERIZATION OF A CELL-PERMEABLE SMALL-MOLECULE C- ABL KINASE ACTIVATOR THAT BINDS TO THE MYRISTOYL BINDING SITE
2392, 3e8cA, 0.7887, 2.63, 0.224, 341, 254, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2393, 2xchA, 0.7887, 2.55, 0.247, 278, 251, CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
2394, 2uw9A, 0.7887, 2.67, 0.235, 316, 255, STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4-CHLORO- PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE
2395, 1lpuA, 0.7887, 2.93, 0.186, 327, 258, LOW TEMPERATURE CRYSTAL STRUCTURE OF THE APO-FORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM ZEA MAYS
2396, 1dayA, 0.7887, 2.93, 0.182, 327, 258, CRYSTAL STRUCTURE OF A BINARY COMPLEX OF PROTEIN KINASE CK2 (ALPHA-SUBUNIT) AND MG-GMPPNP
2397, 5w5oM, 0.7886, 2.16, 0.273, 276, 245, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2398, 5ot5B, 0.7886, 2.72, 0.196, 325, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 24
2399, 5nkaA, 0.7886, 2.62, 0.336, 271, 250, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2G
2400, 5n3tA, 0.7886, 2.62, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 5-CHLOROTHIOPHENE-2-SULFONAMIDE
2401, 5n32A, 0.7886, 2.62, 0.221, 345, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-CHLOROBENZYL CARBAMIMIDOTHIOATE
2402, 5mmrA, 0.7886, 2.80, 0.191, 326, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-((2-CHLORO-[11 -BIPHENYL]-4-YL) METHYL)BUTANE-14-DIAMINE BOUND
2403, 4rewA, 0.7886, 2.67, 0.259, 411, 255, CRYSTAL STRUCTURE OF THE NON-PHOSPHORYLATED HUMAN ALPHA1 BETA2 GAMMA1 HOLO-AMPK COMPLEX
2404, 4eklA, 0.7886, 2.67, 0.235, 329, 255, AKT1 WITH GDC0068
2405, 4c3fA, 0.7886, 2.41, 0.347, 257, 248, STRUCTURE OF LCK IN COMPLEX WITH A COMPOUND DISCOVERED BY VIRTUAL FRAGMENT LINKING
2406, 3warA, 0.7886, 2.94, 0.186, 334, 258, CRYSTAL STRUCTURE OF HUMAN CK2A
2407, 3qcsA, 0.7886, 2.50, 0.248, 276, 250, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 6-[2- AMINO-6-(4-MORPHOLINYL)-4-PYRIMIDINYL]-1H-INDAZOL-3-AMINE
2408, 3qcqA, 0.7886, 2.50, 0.248, 276, 250, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 6-(3- AMINO-1H-INDAZOL-6-YL)-N4-ETHYL-24-PYRIMIDINEDIAMINE
2409, 3o2mB, 0.7886, 2.73, 0.224, 358, 255, CRYSTAL STRUCTURE OF JNK1-ALPHA1 ISOFORM COMPLEX WITH A BIARYL TETRAZOL (A-82118)
2410, 3efkA, 0.7886, 2.34, 0.314, 276, 245, STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 50
2411, 3e8cC, 0.7886, 2.63, 0.224, 341, 254, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2412, 3dfcB, 0.7886, 2.63, 0.240, 280, 254, CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH AMPPNP
2413, 2vnyA, 0.7886, 2.60, 0.221, 334, 253, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6- YL)PIPERIDIN-4-YL)AMINE
2414, 6fypA, 0.7885, 3.03, 0.180, 348, 256, X-RAY STRUCTURE OF CLK3-KD(GP-[275-632]; NON-PHOS.)/CX-4945 AT 2.29A 
2415, 5n3nA, 0.7885, 2.59, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE [(2R)-24-DIHYDROXY-4-OXOBUTYL]- TRIMETHYLAZANIUM
2416, 5n3mA, 0.7885, 2.60, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE D-ARGININE
2417, 5i3rA, 0.7885, 2.92, 0.217, 302, 253, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH AN INDAZOLE INHIBITOR
2418, 5ho7A, 0.7885, 2.54, 0.247, 280, 251, DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS
2419, 4dg3E, 0.7885, 2.63, 0.213, 335, 253, CRYSTAL STRUCTURE OF R336A MUTANT OF CAMP-DEPENDENT PROTEIN KINASE WITH UNPHOSPHORYLATED TURN MOTIF.
2420, 3uqgB, 0.7885, 1.95, 0.306, 257, 242, C-SRC KINASE DOMAIN IN COMPLEX WITH BUMPLESS BKI ANALOG UW1243
2421, 3ngaA, 0.7885, 2.91, 0.190, 331, 258, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH CX-4945
2422, 3h9oA, 0.7885, 2.51, 0.248, 275, 250, PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK-1) IN COMPLEX WITH COMPOUND 9
2423, 3e8cF, 0.7885, 2.63, 0.224, 341, 254, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2424, 3bysA, 0.7885, 2.13, 0.361, 255, 244, CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE AMIDE 10B
2425, 2y0aA, 0.7885, 2.89, 0.246, 300, 260, STRUCTURE OF DAPK1 CONSTRUCT RESIDUES 1-304
2426, 2uvzA, 0.7885, 2.61, 0.221, 334, 253, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-PHENYL-C-(4-( 9H-PURIN-6-YL)-PHENYL)-METHYLAMINE
2427, 1fq1B, 0.7885, 2.70, 0.260, 295, 254, CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN COMPLEX WITH PHOSPHO-CDK2
2428, 5ot6A, 0.7884, 2.79, 0.191, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 19
2429, 5ok3A, 0.7884, 2.48, 0.230, 349, 252, CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP241 AND FASUDIL 
2430, 5mhiA, 0.7884, 2.68, 0.224, 348, 254, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE (5-CHLORO-2-METHOXYPHENYL)METHANAMINE
2431, 3qgwA, 0.7884, 1.95, 0.326, 244, 242, CRYSTAL STRUCTURE OF ITK KINASE BOUND TO AN INHIBITOR
2432, 3nunA, 0.7884, 2.51, 0.248, 278, 250, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) WITH LEAD COMPOUND
2433, 3nczC, 0.7884, 2.91, 0.193, 389, 259, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT 2H-ISOQUINOLIN-1-ONE INHIBITOR
2434, 3gopA, 0.7884, 2.04, 0.310, 300, 242, CRYSTAL STRUCTURE OF THE EGF RECEPTOR JUXTAMEMBRANE AND KINASE DOMAINS
2435, 3e8cE, 0.7884, 2.63, 0.224, 336, 254, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2436, 2iw8A, 0.7884, 2.76, 0.259, 297, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V- H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR
2437, 1jklA, 0.7884, 2.68, 0.239, 280, 255, 1.6A X-RAY STRUCTURE OF BINARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE
2438, 5n3cA, 0.7883, 2.60, 0.229, 348, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE THIOPHENE-3-CARBOXIMIDAMIDE
2439, 4yu2A, 0.7883, 2.72, 0.230, 348, 252, CRYSTAL STRUCTURE OF DYRK1A WITH HARMINE-DERIVATIZED ANNH-75 INHIBITOR
2440, 4yhjA, 0.7883, 3.09, 0.195, 501, 261, STRUCTURE AND FUNCTION OF THE HYPERTENSION VARIANT A486V OF G PROTEIN- COUPLED RECEPTOR KINASE 4 (GRK4)
2441, 4otgA, 0.7883, 2.63, 0.260, 322, 254, CRYSTAL STRUCTURE OF PRK1 CATALYTIC DOMAIN IN COMPLEX WITH LESTAURTINIB
2442, 4knbC, 0.7883, 2.66, 0.333, 271, 249, C-MET IN COMPLEX WITH OSI LIGAND
2443, 4figA, 0.7883, 2.70, 0.195, 292, 256, CATALYTIC DOMAIN OF HUMAN PAK4
2444, 3tt0B, 0.7883, 2.41, 0.402, 272, 249, CO-STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN WITH 3-(26-DICHLORO-35-DIMETHOXY-PHENYL)-1-{6-[4-(4-ETHYL-PIPERAZIN-1- YL)-PHENYLAMINO]-PYRIMIDIN-4-YL}-1-METHYL-UREA (BGJ398)
2445, 3soaA, 0.7883, 2.87, 0.190, 436, 258, FULL-LENGTH HUMAN CAMKII
2446, 3ddpA, 0.7883, 2.74, 0.263, 297, 255, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR CR8
2447, 2jdoA, 0.7883, 2.69, 0.235, 314, 255, STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5- SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE
2448, 1yrpA, 0.7883, 2.56, 0.241, 275, 253, CATALYTIC DOMAIN OF HUMAN ZIP KINASE PHOSPHORYLATED AT THR265
2449, 1ig1A, 0.7883, 2.62, 0.240, 280, 254, 1.8A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MN.
2450, 5wnhC, 0.7882, 2.82, 0.198, 388, 258, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
2451, 5w5oD, 0.7882, 2.12, 0.266, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2452, 5orhB, 0.7882, 2.72, 0.188, 325, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 2
2453, 5n1lA, 0.7882, 2.62, 0.225, 347, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 25-DIMETHYL-N-PYRIDIN-4-YLFURAN-3- CARBOXAMIDE
2454, 4dg2E, 0.7882, 2.61, 0.217, 347, 253, CRYSTAL STRUCTURE OF MYRISTOYLATED WT CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE IN COMPLEX WITH SP20
2455, 3x2vA, 0.7882, 2.62, 0.217, 331, 253, MICHAELIS-LIKE COMPLEX OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT
2456, 3tv4B, 0.7882, 2.86, 0.293, 276, 256, HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH AN BROMOPYRIDINE BENZAMIDE INHIBITOR
2457, 3rhkB, 0.7882, 2.54, 0.304, 299, 250, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF C-MET KINASE IN COMPLEX WITH ARQ 197
2458, 3q9xA, 0.7882, 2.82, 0.187, 330, 257, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH EMODIN AT PH 6.5
2459, 3nayA, 0.7882, 2.56, 0.251, 278, 251, PDK1 IN COMPLEX WITH INHIBITOR MP6
2460, 3kxnA, 0.7882, 2.93, 0.190, 327, 258, CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR TETRAIODOBENZIMIDAZOLE (K88)
2461, 3e8cD, 0.7882, 2.64, 0.224, 344, 254, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2462, 3e8cB, 0.7882, 2.64, 0.224, 344, 254, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2463, 3bwjA, 0.7882, 2.62, 0.221, 338, 253, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR LEAD COMPOUND ARC-1034
2464, 1yrpB, 0.7882, 2.56, 0.241, 275, 253, CATALYTIC DOMAIN OF HUMAN ZIP KINASE PHOSPHORYLATED AT THR265
2465, 6gmdA, 0.7881, 2.71, 0.188, 325, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 3 
2466, 6d22A, 0.7881, 2.77, 0.396, 299, 255, CRYSTAL STRUCTURE OF TYROSINE-PROTEIN KINASE RECEPTOR 
2467, 5w5oJ, 0.7881, 2.11, 0.266, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2468, 5os7B, 0.7881, 2.72, 0.188, 325, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 4
2469, 5n3qA, 0.7881, 2.60, 0.229, 336, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3-AMINOBENZAMIDE
2470, 5n39A, 0.7881, 2.63, 0.225, 347, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-(23-DIHYDROBENZO[B][14]DIOXIN-6-YL) PYRROLIDINE
2471, 5mo7A, 0.7881, 2.80, 0.191, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2472, 5ku8B, 0.7881, 2.92, 0.190, 331, 258, CRYSTAL STRUCTURE OF CK2
2473, 4w9wA, 0.7881, 2.87, 0.218, 306, 252, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH SMALL MOLECULE AZD-7762
2474, 3nayB, 0.7881, 2.55, 0.251, 278, 251, PDK1 IN COMPLEX WITH INHIBITOR MP6
2475, 3bhuA, 0.7881, 2.79, 0.262, 297, 256, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 5
2476, 2uzlC, 0.7881, 2.72, 0.264, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2477, 2pe0A, 0.7881, 2.46, 0.249, 275, 249, CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-HYDROXY-3-[1-(1H-PYRROL-2-YL)-ETH-(Z)-YLIDENE]-13-DIHYDRO- INDOL-2-ONE COMPLEX
2478, 1uu8A, 0.7881, 2.56, 0.247, 277, 251, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-1
2479, 5w5oK, 0.7880, 2.12, 0.266, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2480, 5t5tA, 0.7880, 2.53, 0.257, 368, 253, AMPK BOUND TO ALLOSTERIC ACTIVATOR
2481, 5othA, 0.7880, 2.80, 0.191, 326, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 26
2482, 5n23A, 0.7880, 2.61, 0.221, 333, 253, PROTEIN KINASE A MUTANTS AS SURROGATE MODEL FOR AURORA B WITH AT9283 INHIBITOR
2483, 5mo8B, 0.7880, 2.73, 0.192, 324, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2484, 5cx9A, 0.7880, 2.80, 0.191, 328, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH (METHYL 4-((3-(3-CHLORO-4-(PHENYL) BENZYLAMINO)PROPYL)AMINO)-4-OXOBUTANOATE BOUND
2485, 4qmzA, 0.7880, 2.72, 0.259, 286, 255, MST3 IN COMPLEX WITH SUNITINIB
2486, 4qmyA, 0.7880, 2.75, 0.270, 287, 256, MST3 IN COMPLEX WITH STAUROSPORINE
2487, 4p2kA, 0.7880, 2.31, 0.335, 259, 248, STRUCTURE OF EPHRIN TYPE-A RECEPTOR 2
2488, 4ekkA, 0.7880, 2.69, 0.235, 318, 255, AKT1 WITH AMP-PNP
2489, 4a07A, 0.7880, 2.72, 0.247, 282, 255, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC ACTIVATOR PS171 BOUND TO THE PIF-POCKET
2490, 3tz8B, 0.7880, 2.29, 0.312, 263, 247, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL104
2491, 3pvgA, 0.7880, 2.93, 0.186, 326, 258, CRYSTAL STRUCTURE OF Z. MAYS CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR 4567-TETRABROMO-1-CARBOXYMETHYLBENZIMIDAZOLE (K68)
2492, 3p0mA, 0.7880, 2.66, 0.224, 335, 254, HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
2493, 3nr9C, 0.7880, 2.96, 0.200, 347, 255, STRUCTURE OF HUMAN CDC2-LIKE KINASE 2 (CLK2)
2494, 2vo6A, 0.7880, 2.61, 0.221, 335, 253, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  4-(4- CHLOROBENZYL)-1-(7H-PYRROLO(23-D)PYRIMIDIN-4-YL)PIPERIDIN- 4-YLAMINE
2495, 2uw6A, 0.7880, 2.63, 0.221, 334, 253, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  (S)-2-(4- CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE
2496, 2jedB, 0.7880, 2.74, 0.247, 320, 255, THE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE PROTEIN KINASE C THETA IN COMPLEX WITH NVP-XAA228 AT 2.32A RESOLUTION.
2497, 1m2pA, 0.7880, 2.82, 0.191, 325, 257, CRYSTAL STRUCTURE OF 18-DI-HYDROXY-4-NITRO- ANTHRAQUINONE/CK2 KINASE COMPLEX
2498, 5otlB, 0.7879, 2.81, 0.191, 326, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 29
2499, 5othB, 0.7879, 2.73, 0.184, 324, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 26
2500, 5n3iA, 0.7879, 2.64, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE METHYL (2S)-2-AMINO-3-PHENYLPROPANOATE
2501, 5k0kA, 0.7879, 2.32, 0.321, 260, 246, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC2434
2502, 5i3rB, 0.7879, 2.99, 0.217, 302, 254, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH AN INDAZOLE INHIBITOR
2503, 4wnpD, 0.7879, 2.82, 0.256, 272, 258, STRUCTURE OF ULK1 BOUND TO A POTENT INHIBITOR
2504, 4eooC, 0.7879, 2.84, 0.266, 297, 256, THR 160 PHOSPHORYLATED CDK2 Q131E - HUMAN CYCLIN A3 COMPLEX WITH ATP
2505, 3blhA, 0.7879, 2.85, 0.210, 291, 257, CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1
2506, 2v5qB, 0.7879, 2.87, 0.249, 285, 257, CRYSTAL STRUCTURE OF WILD-TYPE PLK-1 KINASE DOMAIN IN COMPLEX WITH A SELECTIVE DARPIN
2507, 2ozoA, 0.7879, 2.67, 0.348, 545, 253, AUTOINHIBITED INTACT HUMAN ZAP-70
2508, 2c4gA, 0.7879, 2.91, 0.252, 301, 258, STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514
2509, 6c9dA, 0.7878, 2.80, 0.262, 425, 256, CRYSTAL STRUCTURE OF KA1-AUTOINHIBITED MARK1 KINASE 
2510, 5oumA, 0.7878, 2.80, 0.187, 326, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 21
2511, 5mrdA, 0.7878, 2.77, 0.246, 283, 256, HUMAN PDK1-PKCIOTA KINASE CHIMERA IN COMPLEX WITH ALLOSTERIC COMPOUND PS267 BOUND TO THE PIF-POCKET
2512, 4xufA, 0.7878, 2.57, 0.355, 270, 248, CRYSTAL STRUCTURE OF THE FLT3 KINASE DOMAIN BOUND TO THE INHIBITOR QUIZARTINIB (AC220)
2513, 4eheB, 0.7878, 2.79, 0.294, 276, 255, B-RAF KINASE DOMAIN IN COMPLEX WITH AN AMINOTHIENOPYRIMIDINE-BASED INHIBITOR
2514, 4dfzE, 0.7878, 2.61, 0.217, 347, 253, CRYSTAL STRUCTURE OF MYRISTOYLATED K7C CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE IN COMPLEX WITH SP20
2515, 4dfxE, 0.7878, 2.62, 0.217, 347, 253, CRYSTAL STRUCTURE OF MYRISTOYLATED K7C CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE IN COMPLEX WITH SP20 AND AMP-PNP
2516, 4bcnC, 0.7878, 2.82, 0.262, 295, 256, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
2517, 4anmA, 0.7878, 2.94, 0.186, 328, 258, COMPLEX OF CK2 WITH A CDC7 INHIBITOR
2518, 3pwyA, 0.7878, 2.60, 0.250, 281, 252, CRYSTAL STRUCTURE OF AN EXTENDER (SPD28345)-MODIFIED HUMAN PDK1 COMPLEX 2
2519, 3efjA, 0.7878, 2.36, 0.302, 276, 245, STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 7
2520, 1tkiB, 0.7878, 2.97, 0.165, 321, 260, AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN
2521, 1tkiA, 0.7878, 2.97, 0.165, 321, 260, AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN
2522, 5vhbA, 0.7877, 2.60, 0.225, 325, 253, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH THE PKI PEPTIDE AND AMINOBENZOTHIAZOLE BASED INHIBITOR
2523, 5n3gA, 0.7877, 2.63, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE (R)-14-OXAZEPAN-6-OL
2524, 5n1nA, 0.7877, 2.63, 0.225, 348, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-CHLORO-9-PROPAN-2-YLPURINE
2525, 5mo7B, 0.7877, 2.73, 0.192, 325, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2526, 5j87C, 0.7877, 2.41, 0.336, 261, 250, DISCOVERY OF N-(3-(5-((3-ACRYLAMIDO-4-(MORPHOLINE-4-CARBONYL)PHENYL) AMINO)-1-METHYL-6-OXO-16-DIHYDROPYRIDIN-3-YL)-2-METHYLPHENYL)-4- (TERT-BUTYL)BENZAMIDE (CHMFL-BTK-01) AS A HIGHLY SELECTIVE IRREVERSIBLE BTK KINASE INHIBITOR
2527, 5cu4A, 0.7877, 2.66, 0.186, 327, 253, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 10 BOUND
2528, 4jqeA, 0.7877, 2.91, 0.182, 369, 258, CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH AMPPN
2529, 4gs6A, 0.7877, 2.17, 0.282, 294, 245, IRREVERSIBLE INHIBITION OF TAK1 KINASE BY 5Z-7-OXOZEAENOL
2530, 3qa0A, 0.7877, 2.82, 0.187, 330, 257, CRYSTAL STRUCTURE OF THE APO-FORM OF HUMAN CK2 ALPHA AT PH 6.5
2531, 3juhA, 0.7877, 2.79, 0.192, 334, 255, CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PROTEIN KINASE CK2ALPHA WITH ALTERED COSUBSTRATE SPECIFICITY
2532, 3fl5A, 0.7877, 2.82, 0.191, 324, 257, PROTEIN KINASE CK2 IN COMPLEX WITH THE INHIBITOR QUINALIZARIN
2533, 3e8eL, 0.7877, 2.65, 0.224, 336, 254, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2534, 3agmA, 0.7877, 2.64, 0.224, 337, 254, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-670
2535, 2yakA, 0.7877, 2.63, 0.247, 277, 255, STRUCTURE OF DEATH-ASSOCIATED PROTEIN KINASE 1 (DAPK1) IN COMPLEX WITH A RUTHENIUM OCTASPORINE LIGAND (OSV)
2536, 2vo0A, 0.7877, 2.67, 0.220, 340, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  C-(4-(4- CHLOROPHENYL)-1-(7H-PYRROLO(23-D)PYRIMIDIN-4-YL)PIPERIDIN- 4-YL)METHYLAMINE
2537, 2uzeA, 0.7877, 2.72, 0.264, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2538, 1vywA, 0.7877, 2.90, 0.252, 302, 258, STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137
2539, 1jksA, 0.7877, 2.66, 0.244, 280, 254, 1.5A X-RAY STRUCTURE OF APO FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE
2540, 1eh4B, 0.7877, 3.28, 0.169, 293, 267, BINARY COMPLEX OF CASEIN KINASE-1 FROM S. POMBE WITH AN ATP COMPETITIVE INHIBITOR IC261
2541, 6cmjB, 0.7876, 2.96, 0.231, 284, 255, HUMAN CAMKK2 WITH GSK650393
2542, 5n3jA, 0.7876, 2.64, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-NITROBENZOIC ACID
2543, 5modA, 0.7876, 2.80, 0.184, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2544, 4wnpA, 0.7876, 2.81, 0.260, 273, 258, STRUCTURE OF ULK1 BOUND TO A POTENT INHIBITOR
2545, 3skcB, 0.7876, 2.76, 0.294, 276, 255, HUMAN B-RAF KINASE IN COMPLEX WITH AN AMIDE LINKED PYRAZOLOPYRIDINE INHIBITOR
2546, 3oezA, 0.7876, 2.35, 0.316, 261, 247, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH IMATINIB
2547, 3o17B, 0.7876, 2.80, 0.227, 357, 256, CRYSTAL STRUCTURE OF JNK1-ALPHA1 ISOFORM
2548, 3ha6A, 0.7876, 2.72, 0.243, 263, 255, CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH TPX2 AND COMPOUND 10
2549, 3gu7A, 0.7876, 2.69, 0.239, 280, 255, CRYSTAL STRUCTURE OF DAPKQ23V-ADP-MG2+
2550, 3ckxA, 0.7876, 2.61, 0.273, 276, 253, CRYSTAL STRUCTURE OF STERILE 20-LIKE KINASE 3 (MST3 STK24) IN COMPLEX WITH STAUROSPORINE
2551, 1q8wA, 0.7876, 2.64, 0.225, 334, 253, THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH RHO-KINASE INHIBITOR FASUDIL (HA-1077)
2552, 1om1A, 0.7876, 2.83, 0.195, 325, 257, CRYSTAL STRUCTURE OF MAIZE CK2 ALPHA IN COMPLEX WITH IQA
2553, 6c9dB, 0.7875, 2.81, 0.266, 422, 256, CRYSTAL STRUCTURE OF KA1-AUTOINHIBITED MARK1 KINASE 
2554, 5mo5A, 0.7875, 2.73, 0.188, 326, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2555, 5ct0A, 0.7875, 2.80, 0.187, 326, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH 3-(3-CHLORO-4-(PHENYL)BENZYLAMINO) PROPAN-1-OL BOUND
2556, 4qmuA, 0.7875, 2.73, 0.263, 286, 255, MST3 IN COMPLEX WITH JNJ-7706621 4-({5-AMINO-1-[(26-DIFLUOROPHENYL) CARBONYL]-1H-124-TRIAZOL-3-YL}AMINO)BENZENESULFONAMIDE
2557, 4kioD, 0.7875, 1.72, 0.336, 242, 238, KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH A COVALENTLY-BINDING INHIBITOR
2558, 4aw0A, 0.7875, 2.71, 0.239, 283, 255, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC COMPOUND PS182 BOUND TO THE PIF-POCKET
2559, 3nusA, 0.7875, 2.52, 0.248, 276, 250, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) WITH FRAGMENT8
2560, 3be9A, 0.7875, 2.94, 0.186, 327, 258, STRUCTURE-BASED DESIGN AND SYNTHESIS OF NOVEL MACROCYCLIC PYRAZOLO[15-A] [135]TRIAZINE COMPOUNDS AS POTENT INHIBITORS OF PROTEIN KINASE CK2 AND THEIR ANTICANCER ACTIVITIES
2561, 1z5mA, 0.7875, 2.47, 0.249, 275, 249, CRYSTAL STRUCTURE OF N1-[3-[[5-BROMO-2-[[3-[(1-PYRROLIDINYLCARBONYL) AMINO]PHENYL]AMINO]-4-PYRIMIDINYL]AMINO]PROPYL]-22- DIMETHYLPROPANEDIAMIDE COMPLEXED WITH HUMAN PDK1
2562, 6eiiB, 0.7874, 2.73, 0.188, 326, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 18
2563, 4dinA, 0.7874, 2.62, 0.217, 340, 254, NOVEL LOCALIZATION AND QUATERNARY STRUCTURE OF THE PKA RI BETA HOLOENZYME
2564, 3qcxA, 0.7874, 2.51, 0.248, 276, 250, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 6-{2- AMINO-6-[(3R)-3-METHYL-4-MORPHOLINYL]-4-PYRIMIDINYL}-1H-INDAZOL-3- AMINE
2565, 3d5uA, 0.7874, 2.72, 0.247, 288, 255, CRYSTAL STRUCTURE OF A WILDTYPE POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN.
2566, 3ambA, 0.7874, 2.66, 0.220, 340, 254, PROTEIN KINASE A SIXFOLD MUTANT MODEL OF AURORA B WITH INHIBITOR VX- 680
2567, 2uzeC, 0.7874, 2.73, 0.264, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2568, 2iw9C, 0.7874, 2.69, 0.265, 268, 253, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
2569, 2dwbA, 0.7874, 2.57, 0.258, 259, 252, AURORA-A KINASE COMPLEXED WITH AMPPNP
2570, 1h1rA, 0.7874, 2.77, 0.263, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086
2571, 5w5oG, 0.7873, 2.13, 0.266, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2572, 5n3bA, 0.7873, 2.61, 0.229, 342, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-(PYRIDIN-3-YL)ETHANAMINE
2573, 5n36A, 0.7873, 2.63, 0.225, 347, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3H-ISOINDOL-2-IUM-1-AMINE
2574, 5n33A, 0.7873, 2.64, 0.221, 347, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3-AMINO-5-(TRIFLUOROMETHYL)-1H-PYRIDIN-2- ONE
2575, 5n1mA, 0.7873, 2.64, 0.225, 347, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE (5-CHLORO-2-METHOXYPHENYL)METHANAMINE
2576, 5moeA, 0.7873, 2.73, 0.192, 325, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2577, 4pmsA, 0.7873, 2.45, 0.396, 283, 250, THE STRUCTURE OF TRKA KINASE BOUND TO THE INHIBITOR 4-NAPHTHALEN-1-YL- 1-[(5-PHENYL-124-OXADIAZOL-3-YL)METHYL]-1H-PYRROLO[32-C]PYRIDINE- 2-CARBOXYLIC ACID
2578, 4m15A, 0.7873, 2.52, 0.296, 263, 250, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 9 [4- (CARBAMOYLAMINO)-1-[7-(PROPAN-2-YLOXY)NAPHTHALEN-1-YL]-1H-PYRAZOLE-3- CARBOXAMIDE] AND ADP
2579, 3zo1A, 0.7873, 2.62, 0.225, 339, 253, THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE INHIBITORS
2580, 3v5jB, 0.7873, 1.74, 0.329, 241, 237, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 090
2581, 3juhB, 0.7873, 2.80, 0.192, 334, 255, CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PROTEIN KINASE CK2ALPHA WITH ALTERED COSUBSTRATE SPECIFICITY
2582, 2vo3A, 0.7873, 2.63, 0.221, 334, 253, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  C-(4-(4- CHLOROPHENYL)-1-(7H-PYRROLO(23-D)PYRIMIDIN-4-YL)PIPERIDIN- 4-YL)METHYLAMINE
2583, 2ptkA, 0.7873, 2.14, 0.313, 425, 243, CHICKEN SRC TYROSINE KINASE
2584, 5wneC, 0.7872, 2.81, 0.202, 384, 257, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
2585, 5to8A, 0.7872, 2.27, 0.354, 250, 246, SELECTIVITY SWITCH BETWEEN FAK AND PYK2: MACROCYCLIZATION OF FAK INHIBITORS IMPROVES PYK2 POTENCY
2586, 5swhB, 0.7872, 2.19, 0.314, 261, 245, C-SRC V281C KINASE DOMAIN IN COMPLEX WITH RAO-IV-151
2587, 5omyA, 0.7872, 2.89, 0.194, 332, 258, HIGH-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR 4P
2588, 5objA, 0.7872, 2.63, 0.257, 260, 253, AURORA A KINASE IN COMPLEX WITH 2-(3-FLUOROPHENYL)QUINOLINE-4- CARBOXYLIC ACID AND ATP
2589, 5kmoA, 0.7872, 2.44, 0.396, 291, 250, TRKA JM-KINASE WITH 1-(2-METHYL-4-PHENYL-PYRIMIDIN-5-YL)-3-(2- PYRIDYL)UREA
2590, 5cyiA, 0.7872, 2.76, 0.259, 298, 255, CDK2/CYCLIN A COVALENT COMPLEX WITH 6-(CYCLOHEXYLMETHOXY)-N-(4- (VINYLSULFONYL)PHENYL)-9H-PURIN-2-AMINE (NU6300)
2591, 5cu2A, 0.7872, 2.81, 0.191, 328, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH 2-HYDROXY-5-METHYLBENZOIC ACID AND (METHYL 4-((3-(3-CHLORO-4-(PHENYL)BENZYLAMINO)PROPYL)AMINO)-4- OXOBUTANOAT BOUND
2592, 4qmxA, 0.7872, 2.74, 0.263, 287, 255, MST3 IN COMPLEX WITH SARACATINIB
2593, 4qmtA, 0.7872, 2.72, 0.259, 284, 255, MST3 IN COMPLEX WITH HESPERADIN
2594, 4aw5A, 0.7872, 2.43, 0.333, 261, 249, COMPLEX OF THE EPHB4 KINASE DOMAIN WITH AN OXINDOLE INHIBITOR
2595, 3o2mA, 0.7872, 2.73, 0.224, 358, 255, CRYSTAL STRUCTURE OF JNK1-ALPHA1 ISOFORM COMPLEX WITH A BIARYL TETRAZOL (A-82118)
2596, 3hrcA, 0.7872, 2.72, 0.247, 279, 255, CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ATP
2597, 3blqA, 0.7872, 2.88, 0.210, 295, 257, CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH ATP
2598, 2vnwA, 0.7872, 2.62, 0.221, 334, 253, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6- YL)PIPERIDIN-4-YL)METHANAMINE
2599, 1jkkA, 0.7872, 2.65, 0.240, 277, 254, 2.4A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MG.
2600, 5uzjA, 0.7871, 3.06, 0.199, 387, 261, CRYSTAL STRUCTURE OF ROCK1 BOUND TO AN AMINOPYRIDINE INHIBITOR
2601, 5orjA, 0.7871, 2.73, 0.184, 325, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 3
2602, 5n1hA, 0.7871, 2.64, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE METHYL 4-(AMINOMETHYL)BENZOATE
2603, 5av1A, 0.7871, 2.61, 0.249, 275, 253, CRYSTAL STRUCTURE OF DAPK1 IN THE PRESENCE OF BROMIDE IONS.
2604, 4pf4A, 0.7871, 2.68, 0.243, 278, 255, 1.1A X-RAY STRUCTURE OF THE APO CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE 1 AA 1-277
2605, 4fr4F, 0.7871, 2.96, 0.232, 346, 259, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE 32A (YANK1)
2606, 4c33A, 0.7871, 2.64, 0.217, 335, 253, PKA-S6K1 CHIMERA APO
2607, 3utoB, 0.7871, 2.95, 0.196, 566, 260, TWITCHIN KINASE REGION FROM C.ELEGANS (FN31-NL-KIN-CRD-IG26)
2608, 3svvB, 0.7871, 1.99, 0.302, 257, 242, CRYSTAL STRUCTURE OF T338C C-SRC COVALENTLY BOUND TO VINYLSULFONAMIDE- PYRAZOLOPYRIMIDINE 9
2609, 3ehaA, 0.7871, 2.61, 0.245, 279, 253, CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH AMPPNP
2610, 3e8eE, 0.7871, 2.66, 0.224, 341, 254, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2611, 3d0eB, 0.7871, 2.71, 0.235, 322, 255, CRYSTAL STRUCTURE OF HUMAN AKT2 IN COMPLEX WITH GSK690693
2612, 3d0eA, 0.7871, 2.71, 0.235, 322, 255, CRYSTAL STRUCTURE OF HUMAN AKT2 IN COMPLEX WITH GSK690693
2613, 3bhtA, 0.7871, 2.81, 0.262, 297, 256, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 3
2614, 2zjwA, 0.7871, 2.69, 0.182, 332, 253, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH ELLAGIC ACID
2615, 6ft9B, 0.7870, 3.00, 0.203, 337, 256, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH INHIBITOR 16 
2616, 5xfjA, 0.7870, 2.20, 0.366, 266, 246, CRYSTAL STRUCTURE OF LY2874455 IN COMPLEX OF FGFR4 GATEKEEPER MUTATION (V550M) 
2617, 5w5oL, 0.7870, 2.13, 0.275, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2618, 5mmfA, 0.7870, 2.82, 0.191, 326, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 7 BOUND
2619, 5cu3A, 0.7870, 2.74, 0.188, 325, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 10 BOUND
2620, 4u44A, 0.7870, 2.66, 0.246, 286, 252, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 16)
2621, 4iazA, 0.7870, 2.62, 0.217, 334, 253, STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH BA2+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2622, 3v5qB, 0.7870, 2.29, 0.381, 265, 247, DISCOVERY OF A SELECTIVE TRK INHIBITOR WITH EFFICACY IN RODENT CANCER TUMOR MODELS
2623, 3bhyA, 0.7870, 2.54, 0.234, 268, 252, CRYSTAL STRUCTURE OF HUMAN DEATH ASSOCIATED PROTEIN KINASE 3 (DAPK3) IN COMPLEX WITH A BETA-CARBOLINE LIGAND
2624, 3at4A, 0.7870, 2.81, 0.187, 331, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH PYRADINE DERIVERTIVE
2625, 2wevA, 0.7870, 2.81, 0.258, 296, 256, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2626, 1uwhA, 0.7870, 2.55, 0.307, 264, 251, THE COMPLEX OF WILD TYPE B-RAF AND BAY439006
2627, 1f0qA, 0.7870, 2.89, 0.187, 329, 257, CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT OF PROTEIN KINASE CK2 IN COMPLEX WITH THE NUCLEOTIDE COMPETITIVE INHIBITOR EMODIN
2628, 6fykC, 0.7869, 2.95, 0.200, 349, 255, X-RAY STRUCTURE OF CLK2-KD(136-496)/INDAZOLE1 AT 2.39A 
2629, 5wnfC, 0.7869, 2.82, 0.198, 386, 257, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
2630, 5nk0A, 0.7869, 2.58, 0.345, 273, 249, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 1J
2631, 5n3eA, 0.7869, 2.63, 0.229, 348, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 6-DIMETHYLAMINOPYRIDINE-3-CARBOXYLIC ACID
2632, 5cu0A, 0.7869, 2.81, 0.187, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH 2-HYDROXY-5-METHYLBENZOIC ACID AND N-(3-(3-CHLORO-4-(PHENYL)BENZYLAMINO)PROPYL)ACETAMIDE BOUND
2633, 4r1yA, 0.7869, 2.40, 0.318, 265, 245, IDENTIFICATION AND OPTIMIZATION OF PYRIDAZINONES AS POTENT AND SELECTIVE C-MET KINASE INHIBITOR
2634, 4ib5C, 0.7869, 2.93, 0.186, 332, 258, STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH A CK2BETA-COMPETITIVE CYCLIC PEPTIDE
2635, 4eoiA, 0.7869, 2.64, 0.265, 294, 253, THR 160 PHOSPHORYLATED CDK2 K89D Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
2636, 4dg0E, 0.7869, 2.63, 0.217, 338, 253, CRYSTAL STRUCTURE OF MYRISTOYLATED WT CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE IN COMPLEX WITH SP20 AND AMP-PNP
2637, 3nuuA, 0.7869, 2.52, 0.248, 276, 250, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) WITH FRAGMENT11
2638, 3gqlC, 0.7869, 2.55, 0.401, 275, 252, CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
2639, 3dndA, 0.7869, 2.66, 0.224, 334, 254, CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
2640, 3bprB, 0.7869, 2.31, 0.327, 256, 245, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE- PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR C52
2641, 2zoqB, 0.7869, 3.06, 0.198, 351, 258, STRUCTURAL DISSECTION OF HUMAN MITOGEN-ACTIVATED KINASE ERK1
2642, 2iw6C, 0.7869, 2.80, 0.267, 295, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
2643, 2cchA, 0.7869, 2.81, 0.263, 296, 255, THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA- LINKED ATP ANALOGUE
2644, 1zwsC, 0.7869, 2.73, 0.237, 278, 257, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
2645, 5w5oE, 0.7868, 2.13, 0.266, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2646, 4twoA, 0.7868, 2.57, 0.365, 278, 252, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH COMPOUND 164
2647, 4gv1A, 0.7868, 2.72, 0.235, 329, 255, PKB ALPHA IN COMPLEX WITH AZD5363
2648, 3tnqB, 0.7868, 2.61, 0.217, 331, 253, STRUCTURE AND ALLOSTERY OF THE PKA RIIB TETRAMERIC HOLOENZYME
2649, 3kkvA, 0.7868, 2.62, 0.225, 335, 253, STRUCTURE OF PKA WITH A PROTEIN KINASE B-SELECTIVE INHIBITOR.
2650, 3e87A, 0.7868, 2.83, 0.234, 321, 256, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2651, 2y9qA, 0.7868, 2.83, 0.200, 349, 255, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE
2652, 2jdvA, 0.7868, 2.68, 0.220, 334, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH A-443654
2653, 2h96B, 0.7868, 2.73, 0.224, 357, 255, DISCOVERY OF POTENT HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PYRIDINE CARBOXAMIDE C-JUN NH2-TERMINAL KINASE INHIBITORS
2654, 2cciC, 0.7868, 2.81, 0.263, 296, 255, CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6
2655, 1u5rA, 0.7868, 2.78, 0.270, 308, 256, CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K
2656, 1fvvA, 0.7868, 2.76, 0.255, 298, 255, THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLE INHIBITOR
2657, 6ehkA, 0.7867, 2.67, 0.186, 327, 253, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH CAM4712 AND COMPOUND 37
2658, 5w5oH, 0.7867, 2.14, 0.266, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2659, 5nwzA, 0.7867, 2.39, 0.355, 271, 248, FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527
2660, 5n1kA, 0.7867, 2.63, 0.225, 341, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-AMINO-1-(4-FLUOROPHENYL)ETHANOL
2661, 5n1fA, 0.7867, 2.64, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-QUINOLIN-5-YLPYRIDINE-3-CARBOXAMIDE
2662, 5hvjA, 0.7867, 2.63, 0.286, 283, 252, CRYSTAL STRUCTURE OF LIMK1 D460N MUTANT IN COMPLEX WITH AMP-PNP
2663, 4jnwA, 0.7867, 3.00, 0.165, 320, 260, BACTERIALLY EXPRESSED TITIN KINASE
2664, 4fbxA, 0.7867, 2.89, 0.190, 333, 258, COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT CRYSTALLIZED IN THE PRESENCE OF A BISUBSTRATE INHIBITOR
2665, 4bcoA, 0.7867, 2.77, 0.263, 298, 255, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
2666, 3uzpA, 0.7867, 3.24, 0.182, 292, 264, CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P21 CRYSTAL FORM
2667, 3rwpA, 0.7867, 2.53, 0.248, 277, 250, DISCOVERY OF A NOVEL POTENT AND SELECTIVE INHIBITOR OF 3- PHOSPHOINOSITIDE DEPENDENT KINASE (PDK1)
2668, 3lm5A, 0.7867, 2.77, 0.213, 274, 253, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE 17B (STK17B) IN COMPLEX WITH QUERCETIN
2669, 3f5gA, 0.7867, 2.60, 0.245, 279, 253, CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH ADP AND MG2+
2670, 3e88B, 0.7867, 2.72, 0.239, 319, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2671, 3e88A, 0.7867, 2.72, 0.239, 319, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2672, 3e87B, 0.7867, 2.83, 0.234, 321, 256, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2673, 3be2A, 0.7867, 2.35, 0.359, 290, 248, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZAMIDE INHIBITOR
2674, 3at2A, 0.7867, 2.96, 0.186, 334, 258, CRYSTAL STRUCTURE OF CK2ALPHA
2675, 2x4fA, 0.7867, 2.69, 0.199, 289, 256, THE CRYSTAL STRUCTURE OF THE HUMAN MYOSIN LIGHT CHAIN KINASE LOC340156.
2676, 2wihA, 0.7867, 2.89, 0.252, 302, 258, STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125
2677, 2uw0A, 0.7867, 2.64, 0.221, 334, 253, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  6-(4-(4-(4- CHLORO-PHENYL)-PIPERIDIN-4-YL)-PHENYL)-9H-PURINE
2678, 6cmjA, 0.7866, 2.87, 0.244, 285, 254, HUMAN CAMKK2 WITH GSK650393
2679, 5w5oI, 0.7866, 2.15, 0.266, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2680, 5uorB, 0.7866, 2.52, 0.261, 262, 249, STRUCTURE-BASED DESIGN OF ASK1 INHIBITORS AS POTENTIAL FIRST-IN-CLASS AGENTS FOR HEART FAILURE
2681, 5n3dA, 0.7866, 2.63, 0.229, 346, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-(TRIFLUOROMETHYL)BENZENECARBOXIMIDAMIDE
2682, 5m4cA, 0.7866, 2.73, 0.185, 329, 254, COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A THIENO[23-D]PYRIMIDIN INHIBITOR CRYSTALLIZED UNDER LOW-SALT CONDITIONS
2683, 4wnpC, 0.7866, 2.79, 0.261, 271, 257, STRUCTURE OF ULK1 BOUND TO A POTENT INHIBITOR
2684, 4euuB, 0.7866, 3.05, 0.226, 307, 261, STRUCTURE OF BX-795 COMPLEXED WITH HUMAN TBK1 KINASE DOMAIN PHOSPHORYLATED ON SER172
2685, 4cfwC, 0.7866, 2.86, 0.262, 297, 256, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
2686, 3nr9A, 0.7866, 3.01, 0.203, 341, 256, STRUCTURE OF HUMAN CDC2-LIKE KINASE 2 (CLK2)
2687, 3kxhA, 0.7866, 2.96, 0.190, 326, 258, CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR (2-DYMETHYLAMMINO-4567-TETRABROMOBENZOIMIDAZOL-1YL- ACETIC ACID (K66)
2688, 3f66A, 0.7866, 2.87, 0.332, 288, 253, HUMAN C-MET KINASE IN COMPLEX WITH QUINOXALINE INHIBITOR
2689, 2pe1A, 0.7866, 2.47, 0.249, 275, 249, CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) {2-OXO-3-[1-(1H-PYRROL-2-YL)-ETH-(Z)-YLIDENE]-23-DIHYDRO-1H- INDOL-5-YL}-UREA {BX-517} COMPLEX
2690, 1okzA, 0.7866, 2.53, 0.248, 276, 250, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH UCN-01
2691, 5oktA, 0.7865, 3.21, 0.205, 285, 264, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH IWP-2 
2692, 5n1gA, 0.7865, 2.65, 0.229, 337, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-(2-AMINO-13-THIAZOL-4-YL)-1- OXASPIRO[4.5]DECAN-2-ONE
2693, 5clpB, 0.7865, 2.83, 0.191, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH 34-DICHLOROPHENETHYLAMINE BOUND
2694, 5av0A, 0.7865, 2.61, 0.245, 275, 253, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH 73 4 - TRIHYDROXYISOFLAVONE.
2695, 4ra5A, 0.7865, 2.74, 0.235, 332, 255, HUMAN PROTEIN KINASE C THETA IN COMPLEX WITH LIGAND COMPOUND 11A (6- [(13-DIMETHYL-AZETIDIN-3-YL)-METHYL-AMINO]-4(R)-METHYL-7-PHENYL-2 10-DIHYDRO-9-OXA-124A-TRIAZA-PHENANTHREN-3-ONE)
2696, 4qmsA, 0.7865, 2.76, 0.263, 283, 255, MST3 IN COMPLEX WITH DASATINIB
2697, 4k2rA, 0.7865, 2.48, 0.344, 551, 250, STRUCTURAL BASIS FOR ACTIVATION OF ZAP-70 BY PHOSPHORYLATION OF THE SH2-KINASE LINKER
2698, 3qgyA, 0.7865, 1.93, 0.328, 246, 241, CRYSTAL STRUCTURE OF ITK INHIBITOR COMPLEX
2699, 3fbvK, 0.7865, 2.84, 0.216, 422, 255, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
2700, 3cd8A, 0.7865, 2.74, 0.340, 278, 250, X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR.
2701, 1oiuC, 0.7865, 2.68, 0.270, 265, 252, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
2702, 5n3rA, 0.7864, 2.65, 0.229, 336, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-(CARBAMOYLAMINO)-4- METHYLSULFANYLBUTANOIC ACID
2703, 5n3aA, 0.7864, 2.64, 0.229, 349, 253, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-METHYL-5-(1-METHYLIMIDAZOL-2-YL)-13- THIAZOL-2-AMINE
2704, 5ctpB, 0.7864, 2.82, 0.187, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(3-CHLORO-4-(PHENYL) BENZYLAMINO)PROPYL)ACETAMIDE BOUND
2705, 5ar3B, 0.7864, 2.25, 0.276, 276, 246, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH AMP-PCP
2706, 3rawB, 0.7864, 3.05, 0.184, 349, 256, CRYSTAL STRUCTURE OF HUMAN CDC-LIKE KINASE 3 ISOFORM IN COMPLEX WITH LEUCETTINE L41
2707, 3qd3A, 0.7864, 2.55, 0.248, 278, 250, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 11- DIMETHYLETHYL {(3R6S)-1-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4- PYRIMIDINYL]-6-METHYL-3-PIPERIDINYL}CARBAMATE
2708, 3nuyA, 0.7864, 2.54, 0.248, 276, 250, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) WITH FRAGMENT17
2709, 3fbvD, 0.7864, 2.84, 0.216, 422, 255, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
2710, 3d5wA, 0.7864, 2.72, 0.235, 284, 255, CRYSTAL STRUCTURE OF A PHOSPHORYLATED POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH ADP.
2711, 1zwsD, 0.7864, 2.69, 0.238, 278, 256, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
2712, 1h1sA, 0.7864, 2.78, 0.267, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102
2713, 5v60A, 0.7863, 2.86, 0.199, 347, 256, PHOSPHO-ERK2 BOUND TO AMP-PCP
2714, 5ot6B, 0.7863, 2.75, 0.192, 326, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 19
2715, 5mpjA, 0.7863, 2.82, 0.191, 326, 256, 1-(2-CHLORO-[11 -BIPHENYL]-4-YL)-N-METHYLETHANAMINE
2716, 5ax9C, 0.7863, 2.53, 0.241, 282, 249, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2 AND NCK- INTERACTING PROTEIN KINASE IN COMPLEX WITH COMPUND 9
2717, 4ct2A, 0.7863, 2.65, 0.245, 277, 253, HUMAN PDK1-PKCZETA KINASE CHIMERA
2718, 3rpsA, 0.7863, 2.79, 0.184, 334, 255, STRUCTURE OF HUMAN CK2ALPHA IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 3-(4567-TETRABROMO-1H-BENZOTRIAZOL-1-YL)PROPAN-1-OL
2719, 3miyA, 0.7863, 1.51, 0.332, 239, 235, X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH SUNITINIB
2720, 3eh9A, 0.7863, 2.65, 0.240, 278, 254, CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH ADP
2721, 3dogA, 0.7863, 2.81, 0.263, 297, 255, STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR N-&-N1
2722, 2qobA, 0.7863, 2.65, 0.335, 279, 251, HUMAN EPHA3 KINASE DOMAIN BASE STRUCTURE
2723, 1urcC, 0.7863, 2.80, 0.259, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY
2724, 1q8uA, 0.7863, 2.66, 0.224, 341, 254, THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH RHO-KINASE INHIBITOR H-1152P
2725, 1bygA, 0.7863, 1.97, 0.376, 246, 242, KINASE DOMAIN OF HUMAN C-TERMINAL SRC KINASE (CSK) IN COMPLEX WITH INHIBITOR STAUROSPORINE
2726, 5uyjA, 0.7862, 2.87, 0.244, 281, 254, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B
2727, 5kmjA, 0.7862, 2.65, 0.397, 300, 252, TRKA JM-KINASE WITH {N}-(2-PYRIDYLMETHYL)-2-[2-(2-THIENYL)INDOL-1- YL]ACETAMIDE
2728, 5dt4A, 0.7862, 2.60, 0.258, 259, 252, AURORA A KINASE IN COMPLEX WITH AA35 AND ATP IN SPACE GROUP P6122
2729, 5drdA, 0.7862, 2.62, 0.258, 259, 252, AURORA A KINASE IN COMPLEX WITH ATP IN SPACE GROUP P6122
2730, 4mhaA, 0.7862, 2.29, 0.318, 256, 245, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC1817
2731, 4fr4A, 0.7862, 2.98, 0.232, 350, 259, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE 32A (YANK1)
2732, 3x2uA, 0.7862, 2.64, 0.217, 336, 253, MICHAELIS-LIKE INITIAL COMPLEX OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT.
2733, 3tv6A, 0.7862, 2.75, 0.298, 268, 255, HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A METHOXYPYRAZOLOPYRIDINYL BENZAMIDE INHIBITOR
2734, 3n9xB, 0.7862, 3.03, 0.189, 374, 259, CRYSTAL STRUCTURE OF MAP KINASE FROM PLASMODIUM BERGHEI PB000659.00.0
2735, 3iopA, 0.7862, 2.55, 0.248, 275, 250, PDK-1 IN COMPLEX WITH THE INHIBITOR COMPOUND-8I
2736, 3en5B, 0.7862, 2.24, 0.317, 261, 246, TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP494 A MULTITARGETED KINASE INHIBITOR
2737, 2pvlA, 0.7862, 2.94, 0.182, 327, 258, STRUCTURE-BASED DESIGN OF PYRAZOLO[15-A][135]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2738, 2oxyA, 0.7862, 2.84, 0.184, 327, 255, PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17 K22 AND K32
2739, 2jdsA, 0.7862, 2.63, 0.225, 334, 253, STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A- 443654
2740, 1zohA, 0.7862, 2.84, 0.191, 326, 257, CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- DERIVATIVES INHIBITORS
2741, 5oyfA, 0.7861, 2.81, 0.195, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 31
2742, 5n1vA, 0.7861, 2.82, 0.184, 331, 255, CRYSTAL STRUCTURE OF THE PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH PYRAZOLO-PYRIMIDINE MACROCYCLIC LIGAND
2743, 4jnwB, 0.7861, 3.01, 0.165, 321, 260, BACTERIALLY EXPRESSED TITIN KINASE
2744, 4ib5B, 0.7861, 2.86, 0.191, 329, 257, STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH A CK2BETA-COMPETITIVE CYCLIC PEPTIDE
2745, 4iayA, 0.7861, 2.63, 0.217, 333, 253, ROOM TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH SR2+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2746, 3orzB, 0.7861, 2.65, 0.250, 278, 252, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR 2A2
2747, 1h26C, 0.7861, 2.71, 0.265, 267, 253, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53
2748, 1h1qA, 0.7861, 2.78, 0.263, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094
2749, 5w5oC, 0.7860, 2.15, 0.270, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2750, 5w5oA, 0.7860, 2.15, 0.266, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2751, 5t1hA, 0.7860, 2.94, 0.194, 331, 258, CRYSTAL STRUCTURE OF CK2
2752, 5lqfA, 0.7860, 2.72, 0.259, 287, 251, CDK1/CYCLINB1/CKS2 IN COMPLEX WITH NU6102
2753, 5k0xA, 0.7860, 2.35, 0.318, 258, 245, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC2541
2754, 5ar2A, 0.7860, 2.19, 0.265, 277, 245, RIP2 KINASE CATALYTIC DOMAIN (1 - 310)
2755, 4mq2A, 0.7860, 2.71, 0.231, 343, 251, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
2756, 3wowA, 0.7860, 2.96, 0.182, 334, 258, CRYSTAL STRUCTURE OF HUMAN CK2A WITH AMPPNP
2757, 3sdjK, 0.7860, 2.77, 0.220, 422, 254, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
2758, 3orzD, 0.7860, 2.66, 0.250, 278, 252, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR 2A2
2759, 3f3uA, 0.7860, 2.32, 0.316, 261, 247, KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL37 (TYPE III)
2760, 3at3A, 0.7860, 2.82, 0.187, 332, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH PYRADINE DERIVATIVE
2761, 5oueA, 0.7859, 2.83, 0.191, 328, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 20
2762, 4q9zB, 0.7859, 2.74, 0.220, 308, 255, HUMAN PROTEIN KINASE C THETA IN COMPLEX WITH COMPOUND35 ((1R)-9- (AZETIDIN-3-YLAMINO)-18-DIMETHYL-35-DIHYDRO[124]TRIAZINO[34- C][14]BENZOXAZIN-2(1H)-ONE)
2763, 4bcpA, 0.7859, 2.79, 0.263, 298, 255, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
2764, 3zh8A, 0.7859, 2.83, 0.195, 318, 257, A NOVEL SMALL MOLECULE APKC INHIBITOR
2765, 3sdmG, 0.7859, 2.83, 0.216, 415, 255, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
2766, 3sdmD, 0.7859, 2.83, 0.216, 415, 255, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
2767, 3sdjD, 0.7859, 2.77, 0.220, 422, 254, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
2768, 3nieB, 0.7859, 3.01, 0.190, 367, 258, CRYSTAL STRUCTURE OF PF11_0147
2769, 3fbvN, 0.7859, 2.83, 0.216, 415, 255, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
2770, 3fbvM, 0.7859, 2.84, 0.216, 415, 255, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
2771, 3fbvH, 0.7859, 2.84, 0.216, 415, 255, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
2772, 3fbvG, 0.7859, 2.84, 0.216, 415, 255, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
2773, 6e4tA, 0.7858, 2.57, 0.257, 361, 253, STRUCTURE OF AMPK BOUND TO ACTIVATOR 
2774, 5w5oF, 0.7858, 2.16, 0.266, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2775, 5orhA, 0.7858, 2.76, 0.188, 324, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 2
2776, 5ia5A, 0.7858, 2.95, 0.340, 273, 256, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH GOLVATINIB (E7050)
2777, 5cvhA, 0.7858, 2.82, 0.184, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA
2778, 5av3A, 0.7858, 2.64, 0.244, 275, 254, CRYSTAL STRUCTURE OF DAPK1-KAEMPFEROL COMPLEX IN THE PRESENCE OF IODIDE IONS.
2779, 4zs0A, 0.7858, 2.54, 0.259, 257, 251, HUMAN AURORA A CATALYTIC DOMAIN BOUND TO SB-6-OH
2780, 4fr4D, 0.7858, 2.98, 0.232, 346, 259, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE 32A (YANK1)
2781, 4bcmA, 0.7858, 2.79, 0.266, 295, 256, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
2782, 3zh8C, 0.7858, 2.83, 0.195, 312, 257, A NOVEL SMALL MOLECULE APKC INHIBITOR
2783, 3sdmF, 0.7858, 2.83, 0.216, 415, 255, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
2784, 3sdmE, 0.7858, 2.83, 0.216, 415, 255, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
2785, 3sdmC, 0.7858, 2.83, 0.216, 415, 255, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
2786, 3sdmB, 0.7858, 2.83, 0.216, 415, 255, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
2787, 3sdmA, 0.7858, 2.83, 0.216, 415, 255, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
2788, 3fbvF, 0.7858, 2.84, 0.216, 415, 255, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
2789, 3fbvE, 0.7858, 2.84, 0.216, 415, 255, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
2790, 3fbvC, 0.7858, 2.84, 0.216, 415, 255, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
2791, 3fbvB, 0.7858, 2.83, 0.216, 415, 255, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
2792, 3fbvA, 0.7858, 2.84, 0.216, 415, 255, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
2793, 3f66B, 0.7858, 2.63, 0.333, 269, 249, HUMAN C-MET KINASE IN COMPLEX WITH QUINOXALINE INHIBITOR
2794, 3bprC, 0.7858, 2.33, 0.331, 259, 245, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE- PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR C52
2795, 2uzbA, 0.7858, 2.76, 0.268, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2796, 2iw8C, 0.7858, 2.68, 0.266, 265, 252, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V- H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR
2797, 2g9xA, 0.7858, 2.81, 0.263, 298, 255, STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR NU6271
2798, 1oi9A, 0.7858, 2.81, 0.263, 295, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
2799, 6cd6D, 0.7857, 2.79, 0.257, 267, 253, CRYSTAL STRUCTURE OF THE HUMAN CAMKK1A IN COMPLEX WITH GSK650394
2800, 5ouuB, 0.7857, 2.76, 0.192, 325, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 22
2801, 5lqeA, 0.7857, 2.79, 0.263, 295, 255, CDK2/CYCLIN A IN COMPLEX WITH COMPOUND 73
2802, 3fbvL, 0.7857, 2.84, 0.216, 415, 255, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
2803, 3dogC, 0.7857, 2.66, 0.266, 267, 252, STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR N-&-N1
2804, 2xckA, 0.7857, 2.62, 0.243, 275, 251, CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
2805, 1zwsB, 0.7857, 2.74, 0.233, 278, 257, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
2806, 5otyA, 0.7856, 2.82, 0.195, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH CAM4712
2807, 5j5sA, 0.7856, 2.16, 0.314, 258, 245, SRC KINASE IN COMPLEX WITH A SULFONAMIDE INHIBITOR
2808, 5auvA, 0.7856, 2.63, 0.245, 275, 253, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH APIGENIN.
2809, 4p5qA, 0.7856, 2.54, 0.359, 275, 251, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH QUINOXALINE DERIVATIVES
2810, 4cffA, 0.7856, 2.58, 0.249, 424, 253, STRUCTURE OF FULL LENGTH HUMAN AMPK IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR A THIENOPYRIDONE DERIVATIVE (A-769662)
2811, 4appA, 0.7856, 2.70, 0.188, 291, 255, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH (S)-N-(5-(3-BENZYL-1-METHYLPIPERAZINE-4- CARBONYL)-66-DIMETHYL-1456-TETRAHYDROPYRROLO(34-C) PYRAZOL-3-YL)-3-PHENOXYBENZAMIDE
2812, 3nr9B, 0.7856, 2.88, 0.201, 347, 254, STRUCTURE OF HUMAN CDC2-LIKE KINASE 2 (CLK2)
2813, 3ionA, 0.7856, 2.51, 0.249, 274, 249, PDK1 IN COMPLEX WITH COMPOUND 8H
2814, 3bprD, 0.7856, 2.34, 0.331, 259, 245, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE- PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR C52
2815, 2x0gA, 0.7856, 2.94, 0.220, 318, 259, X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX
2816, 2acxA, 0.7856, 3.00, 0.185, 495, 259, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 6 BOUND TO AMPPNP
2817, 6e4uA, 0.7855, 2.57, 0.257, 365, 253, STRUCTURE OF AMPK BOUND TO ACTIVATOR 
2818, 5w5oB, 0.7855, 2.16, 0.266, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
2819, 5t3qA, 0.7855, 2.44, 0.321, 278, 246, CRYSTAL STRUCTURE OF THE C-MET KINASE DOMAIN IN COMPLEX WITH A PYRAZOLONE INHIBITOR
2820, 5t18A, 0.7855, 2.36, 0.335, 261, 248, CRYSTAL STRUCTURE OF BRUTON AGAMMABULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-986142 AKA (2S)-6-FLUORO-5-[3-(8-FLUORO-1-METHYL-24-DIOXO- 1234-TETRAHYDROQUINAZOLIN-3-YL)-2-METHYLPHENYL]-2-(2- HYDROXYPROPAN-2-YL)-2349-TETRAHYDRO-1H-CARBAZOLE-8-CARBOXAMIDE
2821, 5o5mA, 0.7855, 2.66, 0.229, 336, 253, CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP120 AND RKP117 
2822, 4f0iA, 0.7855, 2.75, 0.398, 284, 251, CRYSTAL STRUCTURE OF APO TRKA
2823, 3a7iA, 0.7855, 2.77, 0.285, 286, 256, HUMAN MST3 KINASE IN COMPLEX WITH ADENINE
2824, 2c5vC, 0.7855, 2.78, 0.263, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2825, 1zwsH, 0.7855, 2.71, 0.238, 278, 256, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
2826, 1ol1C, 0.7855, 2.78, 0.263, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE-(P-F-PHE)-NH2
2827, 6e4wA, 0.7854, 2.57, 0.257, 361, 253, STRUCTURE OF AMPK BOUND TO ACTIVATOR 
2828, 6dkbA, 0.7854, 2.65, 0.397, 272, 252, CRYSTAL STRUCTURE OF TRK-A IN COMPLEX WITH THE PAN-TRK KINASE INHIBITOR; COMPOUND 10B. 
2829, 5otdA, 0.7854, 2.83, 0.195, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 25
2830, 4ypsA, 0.7854, 2.38, 0.390, 280, 246, (R)-2-PHENYLPYRROLIDINE SUBSTITUTE IMIDAZOPYRIDAZINES: A NEW CLASS OF POTENT AND SELECTIVE PAN-TRK INHIBITORS
2831, 3zh8B, 0.7854, 2.84, 0.195, 317, 257, A NOVEL SMALL MOLECULE APKC INHIBITOR
2832, 3tniA, 0.7854, 2.74, 0.205, 297, 254, STRUCTURE OF CDK9/CYCLIN T F241L
2833, 3of0A, 0.7854, 2.25, 0.313, 260, 246, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC TYROSINE KINASE DOMAIN
2834, 3e8dB, 0.7854, 2.73, 0.239, 317, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2835, 3cqwA, 0.7854, 2.75, 0.235, 318, 255, CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR
2836, 2pvmA, 0.7854, 2.95, 0.186, 327, 258, STRUCTURE-BASED DESIGN OF PYRAZOLO[15-A][135]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2837, 2iw6A, 0.7854, 2.73, 0.264, 292, 254, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
2838, 2clqA, 0.7854, 2.56, 0.260, 263, 250, STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 2 5
2839, 2c5vA, 0.7854, 2.78, 0.263, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2840, 6fykA, 0.7853, 2.98, 0.200, 349, 255, X-RAY STRUCTURE OF CLK2-KD(136-496)/INDAZOLE1 AT 2.39A 
2841, 5oslA, 0.7853, 2.68, 0.186, 328, 253, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 7
2842, 5oquA, 0.7853, 2.77, 0.188, 324, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 5
2843, 5m0uA, 0.7853, 2.53, 0.224, 346, 250, APOSTRUCTURE STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) FROM CHO CELLS WITH A PEPTIDIC INHIBITOR FRAGMENT 
2844, 5lmkC, 0.7853, 2.60, 0.271, 265, 251, STRUCTURE OF PHOPSHO-CDK2-CYCLIN A IN COMPLEX WITH AN ATP-COMPETITIVE INHIBITOR
2845, 5hkmA, 0.7853, 2.51, 0.249, 272, 249, DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS
2846, 4yzmA, 0.7853, 2.45, 0.286, 260, 248, HUMANIZED ROCO4 BOUND TO LRRK2-IN1
2847, 4m14A, 0.7853, 2.55, 0.296, 263, 250, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 9 [4- (CARBAMOYLAMINO)-1-[7-(PROPAN-2-YLOXY)NAPHTHALEN-1-YL]-1H-PYRAZOLE-3- CARBOXAMIDE]
2848, 4l52A, 0.7853, 2.23, 0.280, 295, 246, CRYSTAL STRUCTURE OF 1-(4-{4-[7-AMINO-2-(123-BENZOTHIADIAZOL-7-YL) FURO[23-C]PYRIDIN-4-YL]-1H-PYRAZOL-1-YL}PIPERIDIN-1-YL)ETHAN-1-ONE BOUND TO TAK1-TAB1
2849, 3wikA, 0.7853, 2.96, 0.182, 334, 258, CRYSTAL STRUCTURE OF THE CK2ALPHA/COMPOUND10 COMPLEX
2850, 3q9wA, 0.7853, 2.83, 0.187, 328, 256, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH EMODIN AT PH 8.5
2851, 3oezB, 0.7853, 2.30, 0.313, 261, 246, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH IMATINIB
2852, 3ocbB, 0.7853, 2.74, 0.235, 319, 255, AKT1 KINASE DOMAIN WITH PYRROLOPYRIMIDINE INHIBITOR
2853, 3e8dA, 0.7853, 2.73, 0.239, 315, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2854, 3ddqC, 0.7853, 2.69, 0.270, 266, 252, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR ROSCOVITINE
2855, 2uzbC, 0.7853, 2.71, 0.269, 292, 253, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2856, 2bkzA, 0.7853, 2.94, 0.252, 302, 258, STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611
2857, 6b2eA, 0.7852, 2.58, 0.249, 442, 253, STRUCTURE OF FULL LENGTH HUMAN AMPK (A2B2G1) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR SC4. 
2858, 5ufuA, 0.7852, 2.57, 0.257, 368, 253, STRUCTURE OF AMPK BOUND TO ACTIVATOR
2859, 5mpjB, 0.7852, 2.76, 0.192, 324, 255, 1-(2-CHLORO-[11 -BIPHENYL]-4-YL)-N-METHYLETHANAMINE
2860, 5j79B, 0.7852, 2.32, 0.268, 277, 246, THE IDENTIFICATION AND PHARMACOLOGICAL CHARACTERIZATION OF 6-(TERT- BUTYLSULFONYL)-N-(5-FLUORO-1H-INDAZOL-3-YL)QUINOLIN-4-AMINE (GSK583) A HIGHLY POTENT AND SELECTIVE INHIBITOR OF RIP2 KINASE COMPOUND 3 COMPLEX
2861, 4yvcA, 0.7852, 3.03, 0.200, 388, 260, ROCK 1 BOUND TO THIAZOLE INHIBITOR
2862, 4qfsA, 0.7852, 2.58, 0.257, 361, 253, STRUCTURE OF AMPK IN COMPLEX WITH BR2-A769662CORE ACTIVATOR AND STAUROSPORINE INHIBITOR
2863, 4qfrA, 0.7852, 2.58, 0.257, 361, 253, STRUCTURE OF AMPK IN COMPLEX WITH CL-A769662 ACTIVATOR AND STAUROSPORINE INHIBITOR
2864, 4azeC, 0.7852, 2.72, 0.223, 348, 251, HUMAN DYRK1A IN COMPLEX WITH LEUCETTINE L41
2865, 3wilA, 0.7852, 2.83, 0.184, 331, 256, CRYSTAL STRUCTURE OF THE CK2ALPHA/COMPOUND3 COMPLEX
2866, 3sdjC, 0.7852, 2.84, 0.216, 415, 255, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
2867, 3mb6A, 0.7852, 2.84, 0.191, 329, 256, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A DIFURANE DERIVATIVE INHIBITOR (CPA)
2868, 3ej1A, 0.7852, 2.73, 0.256, 295, 254, CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
2869, 1zoeA, 0.7852, 2.86, 0.191, 325, 257, CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- DERIVATIVES INHIBITORS
2870, 6cd6B, 0.7851, 2.79, 0.257, 266, 253, CRYSTAL STRUCTURE OF THE HUMAN CAMKK1A IN COMPLEX WITH GSK650394
2871, 5uq1C, 0.7851, 2.78, 0.256, 289, 254, CRYSTAL STRUCTURE OF HUMAN CDK2-SPY1 COMPLEX
2872, 5orjB, 0.7851, 2.77, 0.188, 324, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 3
2873, 5cu0B, 0.7851, 2.84, 0.191, 325, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH 2-HYDROXY-5-METHYLBENZOIC ACID AND N-(3-(3-CHLORO-4-(PHENYL)BENZYLAMINO)PROPYL)ACETAMIDE BOUND
2874, 4yzbA, 0.7851, 2.84, 0.253, 466, 257, CDPK1 FROM EIMERIA TENELLA IN COMPLEX WITH INHIBITOR UW1521
2875, 4twcA, 0.7851, 3.28, 0.200, 293, 265, 2-BENZAMIDO-N-(1H-BENZO[D]IMIDAZOL-2-YL)THIAZOLE-4- CARBOXAMIDE DERIVATIVES AS POTENT INHIBITORS OF CK1D/E
2876, 4qnaA, 0.7851, 2.79, 0.270, 284, 256, MST3 IN COMPLEX WITH 2-(46-DIAMINO-135-TRIAZIN-2-YL)PHENOL
2877, 4mbjB, 0.7851, 2.82, 0.294, 276, 255, HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH AN IMIDAZOPYRIDINE-BASED INHIBITOR
2878, 4i4eA, 0.7851, 2.37, 0.339, 254, 248, STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH HINGE BINDING PYRAZOLOBENZOTHIAZINE COMPOUND.
2879, 4euuA, 0.7851, 3.07, 0.226, 307, 261, STRUCTURE OF BX-795 COMPLEXED WITH HUMAN TBK1 KINASE DOMAIN PHOSPHORYLATED ON SER172
2880, 4cfeC, 0.7851, 2.58, 0.249, 403, 253, STRUCTURE OF FULL LENGTH HUMAN AMPK IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR A BENZIMIDAZOLE DERIVATIVE (991)
2881, 4azeB, 0.7851, 2.72, 0.223, 345, 251, HUMAN DYRK1A IN COMPLEX WITH LEUCETTINE L41
2882, 4azeA, 0.7851, 2.72, 0.223, 348, 251, HUMAN DYRK1A IN COMPLEX WITH LEUCETTINE L41
2883, 3sdjB, 0.7851, 2.84, 0.216, 415, 255, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
2884, 3sdjA, 0.7851, 2.84, 0.216, 415, 255, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
2885, 3f3uB, 0.7851, 2.26, 0.314, 259, 245, KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL37 (TYPE III)
2886, 2xzsA, 0.7851, 2.91, 0.242, 301, 260, DEATH ASSOCIATED PROTEIN KINASE 1 RESIDUES 1-312
2887, 2wpaA, 0.7851, 2.92, 0.252, 302, 258, OPTIMISATION OF 66-DIMETHYL PYRROLO 34-C PYRAZOLES: IDENTIFICATION OF PHA-793887 A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING
2888, 5t1hB, 0.7850, 2.96, 0.190, 331, 258, CRYSTAL STRUCTURE OF CK2
2889, 5otoA, 0.7850, 2.84, 0.195, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 30
2890, 5mohA, 0.7850, 2.80, 0.187, 326, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0583 BOUND.
2891, 5av2A, 0.7850, 2.68, 0.248, 275, 254, CRYSTAL STRUCTURE OF DAPK1-KAEMPFEROL COMPLEX IN THE PRESENCE OF BROMIDE IONS.
2892, 4krdA, 0.7850, 2.91, 0.238, 294, 256, CRYSTAL STRUCTURE OF PHO85-PCL10 COMPLEX
2893, 4eorC, 0.7850, 2.80, 0.264, 270, 254, THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR NU6102
2894, 3w8lB, 0.7850, 2.83, 0.187, 326, 256, CRYSTAL STRUCTURE OF HUMAN CK2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE
2895, 3qkmA, 0.7850, 2.73, 0.235, 329, 255, SPIROCYCLIC SULFONAMIDES AS AKT INHIBITORS
2896, 3f5pT, 0.7850, 2.98, 0.291, 295, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2897, 3e8eI, 0.7850, 2.69, 0.224, 345, 254, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2898, 2c5nA, 0.7850, 2.77, 0.263, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND  INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2899, 5v62A, 0.7849, 2.90, 0.199, 349, 256, PHOSPHO-ERK2 BOUND TO BIVALENT INHIBITOR SBP3
2900, 5sysA, 0.7849, 2.25, 0.306, 258, 245, C-SRC V281C BOUND TO N-[3-({6-[(1E)-2-CYANO-3-(METHYLAMINO)-3-OXOPROP- 1-EN-1-YL]-7-(2-METHOXYETHYL)-7H-PYRROLO[23-D]PYRIMIDIN-5- YL}ETHYNYL)-4-METHYLPHENYL]-3-(TRIFLUOROMETHYL)BENZAMIDE INHIBITOR
2901, 5orkA, 0.7849, 2.78, 0.188, 324, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 6
2902, 5nqcA, 0.7849, 2.82, 0.184, 331, 255, CK2ALPHA IN COMPLEX WITH NMR154
2903, 5n9nA, 0.7849, 2.82, 0.176, 329, 256, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE TIGHT-BINDING DIBENZOFURAN INHIBITOR TF85 (4A)
2904, 5n9lA, 0.7849, 2.84, 0.184, 329, 256, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE DIBENZOFURAN INHIBITOR TF (4B)
2905, 5n3fA, 0.7849, 2.57, 0.223, 318, 251, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-[3-(AMINOMETHYL)PHENYL]ACETAMIDE
2906, 5moeB, 0.7849, 2.71, 0.193, 323, 254, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2907, 5m56B, 0.7849, 2.96, 0.186, 328, 258, MONOCLINIC COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA ) WITH THE INHIBITOR 4 -CARBOXY-68-CHLORO- FLAVONOL (FLC21)
2908, 5auxA, 0.7849, 2.68, 0.244, 275, 254, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH KAEMPFEROL.
2909, 4tnbA, 0.7849, 2.99, 0.174, 529, 259, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 5 IN COMPLEX WITH SANGIVAMYCIN
2910, 4ra4A, 0.7849, 2.65, 0.197, 317, 254, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE C ALPHA IN COMPLEX WITH COMPOUND 28 ((R)-6-((3S4S)-13-DIMETHYL-PIPERIDIN-4-YL)-7-(2-FLUORO- PHENYL)-4-METHYL-210-DIHYDRO-9-OXA-124A-TRIAZA-PHENANTHREN-3-ONE)
2911, 3sdjH, 0.7849, 2.85, 0.216, 415, 255, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
2912, 3g6gA, 0.7849, 2.40, 0.310, 264, 248, EQUALLY POTENT INHIBITION OF C-SRC AND ABL BY COMPOUNDS THAT RECOGNIZE INACTIVE KINASE CONFORMATIONS
2913, 3efjB, 0.7849, 2.34, 0.320, 275, 244, STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 7
2914, 3ce3A, 0.7849, 2.99, 0.315, 293, 254, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A PYRROLOPYRIDINEPYRIDONE BASED INHIBITOR
2915, 6cd6A, 0.7848, 2.76, 0.262, 264, 252, CRYSTAL STRUCTURE OF THE HUMAN CAMKK1A IN COMPLEX WITH GSK650394
2916, 5nevA, 0.7848, 2.81, 0.263, 295, 255, CDK2/CYCLIN A IN COMPLEX WITH COMPOUND 73
2917, 5lmkA, 0.7848, 2.82, 0.267, 296, 255, STRUCTURE OF PHOPSHO-CDK2-CYCLIN A IN COMPLEX WITH AN ATP-COMPETITIVE INHIBITOR
2918, 4rllA, 0.7848, 2.85, 0.187, 329, 256, CRYSTAL STRUCTURE OF HUMAN CK2ALPHA IN COMPLEX WITH THE ATP- COMPETITIVE INHIBITOR 4-[(E)-(FLUOREN-9-YLIDENEHYDRAZINYLIDENE)- METHYL] BENZOATE
2919, 3sdjM, 0.7848, 2.85, 0.216, 415, 255, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
2920, 3sdjG, 0.7848, 2.85, 0.216, 415, 255, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
2921, 3sdjF, 0.7848, 2.85, 0.216, 415, 255, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
2922, 3sdjE, 0.7848, 2.85, 0.216, 415, 255, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
2923, 3bqcA, 0.7848, 2.84, 0.187, 328, 256, HIGH PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
2924, 2fysA, 0.7848, 2.91, 0.202, 348, 258, CRYSTAL STRUCTURE OF ERK2 COMPLEX WITH KIM PEPTIDE DERIVED FROM MKP3
2925, 2c5oC, 0.7848, 2.80, 0.259, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND  INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2926, 2c5oA, 0.7848, 2.80, 0.259, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND  INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2927, 5x17A, 0.7847, 3.24, 0.201, 290, 264, CRYSTAL STRUCTURE OF MURINE CK1D IN COMPLEX WITH ADP
2928, 5n9kA, 0.7847, 2.85, 0.184, 329, 256, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE TIGHT-BINDING DIBENZOFURAN INHIBITOR TF107 (5)
2929, 4qmnA, 0.7847, 2.80, 0.263, 283, 255, MST3 IN COMPLEX WITH BOSUTINIB
2930, 4l3pA, 0.7847, 2.20, 0.282, 295, 245, CRYSTAL STRUCTURE OF 2-(1-BENZOTHIOPHEN-7-YL)-4-[1-(PIPERIDIN-4-YL)- 1H-PYRAZOL-4-YL]FURO[23-C]PYRIDIN-7-AMINE BOUND TO TAK1-TAB1
2931, 4h1mA, 0.7847, 2.62, 0.347, 256, 251, CRYSTAL STRUCTURE OF PYK2 WITH THE INDOLE 10C
2932, 4bcmC, 0.7847, 2.81, 0.271, 294, 255, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
2933, 3sdjL, 0.7847, 2.85, 0.216, 415, 255, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
2934, 2wu7A, 0.7847, 3.05, 0.180, 348, 256, CRYSTAL STRUCTURE OF THE HUMAN CLK3 IN COMPLEX WITH V25
2935, 2pmoX, 0.7847, 2.87, 0.202, 340, 257, CRYSTAL STRUCTURE OF PFPK7 IN COMPLEX WITH HYMENIALDISINE
2936, 5otiA, 0.7846, 2.82, 0.187, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 27
2937, 5oquB, 0.7846, 2.78, 0.188, 324, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 5
2938, 5dosA, 0.7846, 2.62, 0.258, 259, 252, AURORA A KINASE IN COMPLEX WITH AA35 AND ATP IN SPACE GROUP P6122
2939, 5cx9B, 0.7846, 2.77, 0.192, 325, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH (METHYL 4-((3-(3-CHLORO-4-(PHENYL) BENZYLAMINO)PROPYL)AMINO)-4-OXOBUTANOATE BOUND
2940, 5cu2B, 0.7846, 2.77, 0.188, 325, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH 2-HYDROXY-5-METHYLBENZOIC ACID AND (METHYL 4-((3-(3-CHLORO-4-(PHENYL)BENZYLAMINO)PROPYL)AMINO)-4- OXOBUTANOAT BOUND
2941, 5auwA, 0.7846, 2.57, 0.246, 274, 252, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH QUERCETIN.
2942, 4yuqA, 0.7846, 2.70, 0.261, 462, 253, CDPK1 FROM EIMERIA TENELLA IN COMPLEX WITH INHIBITOR UW1354
2943, 4yu2C, 0.7846, 2.73, 0.223, 346, 251, CRYSTAL STRUCTURE OF DYRK1A WITH HARMINE-DERIVATIZED ANNH-75 INHIBITOR
2944, 4qnyA, 0.7846, 2.76, 0.213, 333, 254, CRYSTAL STRUCTURE OF MAPK FROM LEISHMANIA DONOVANI LDBPK_331470
2945, 4qmwA, 0.7846, 2.80, 0.255, 286, 255, MST3 IN COMPLEX WITH PP-121 1-CYCLOPENTYL-3-(1H-PYRROLO[23- B]PYRIDIN-5-YL)-1H-PYRAZOLO[34-D]PYRIMIDIN-4-AMINE
2946, 4crsA, 0.7846, 2.60, 0.251, 331, 251, HUMAN PROTEIN KINASE N2 (PKN2 PRKCL2) IN COMPLEX WITH ATPGAMMAS
2947, 4cfvA, 0.7846, 2.89, 0.257, 300, 257, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
2948, 3sdjN, 0.7846, 2.85, 0.216, 415, 255, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
2949, 3rpsB, 0.7846, 2.91, 0.187, 334, 256, STRUCTURE OF HUMAN CK2ALPHA IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 3-(4567-TETRABROMO-1H-BENZOTRIAZOL-1-YL)PROPAN-1-OL
2950, 3qklA, 0.7846, 2.75, 0.235, 317, 255, SPIROCHROMANE AKT INHIBITORS
2951, 3f5uA, 0.7846, 2.69, 0.240, 279, 254, CRYSTAL STRUCTURE OF THE DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH AMPPNP AND MG2+
2952, 5v5nA, 0.7845, 2.24, 0.285, 294, 246, CRYSTAL STRUCTURE OF TAKINIB BOUND TO TAK1
2953, 5oumB, 0.7845, 2.77, 0.192, 326, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 21
2954, 5ia4A, 0.7845, 2.72, 0.341, 269, 252, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH FORETINIB (XL880)
2955, 5auyA, 0.7845, 2.62, 0.245, 275, 253, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH MORIN.
2956, 4yljA, 0.7845, 2.74, 0.223, 346, 251, CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-IODO-SUBSTITUTED 11H- INDOLO[32-C]QUINOLINE-6-CARBOXYLIC ACID INHIBITOR 5J
2957, 4cffC, 0.7845, 2.59, 0.249, 422, 253, STRUCTURE OF FULL LENGTH HUMAN AMPK IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR A THIENOPYRIDONE DERIVATIVE (A-769662)
2958, 3ofmA, 0.7845, 2.85, 0.187, 325, 257, STRUCTURE OF A HUMAN CK2ALPHA PRIME THE PARALOG ISOFORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM HOMO SAPIENS
2959, 1oiyA, 0.7845, 2.73, 0.264, 293, 254, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
2960, 5mo6A, 0.7844, 2.77, 0.188, 325, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2961, 4cfnA, 0.7844, 2.81, 0.262, 296, 256, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6-CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
2962, 3mvhA, 0.7844, 2.72, 0.236, 311, 254, CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES
2963, 1yomA, 0.7844, 2.13, 0.311, 260, 244, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH PURVALANOL A
2964, 1mruB, 0.7844, 2.38, 0.219, 271, 247, INTRACELLULAR SER/THR PROTEIN KINASE DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKNB.
2965, 5swhA, 0.7843, 2.23, 0.314, 258, 245, C-SRC V281C KINASE DOMAIN IN COMPLEX WITH RAO-IV-151
2966, 5nevC, 0.7843, 2.82, 0.263, 296, 255, CDK2/CYCLIN A IN COMPLEX WITH COMPOUND 73
2967, 5mp8A, 0.7843, 2.78, 0.184, 325, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0432 BOUND
2968, 5hvuB, 0.7843, 2.92, 0.202, 394, 258, RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH A PYRIDINE THIAZOLE PIPERIDINE INHIBITOR
2969, 4nusA, 0.7843, 2.94, 0.230, 301, 257, RSK2 N-TERMINAL KINASE IN COMPLEX WITH LJH685
2970, 4h3qA, 0.7843, 2.88, 0.198, 352, 257, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE
2971, 3q9yA, 0.7843, 2.85, 0.187, 327, 256, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH QUINALIZARIN AT PH 8.5
2972, 2pe2A, 0.7843, 2.52, 0.249, 275, 249, CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 3-{5-[2-OXO-5-UREIDO-12-DIHYDRO-INDOL-(3Z)-YLIDENEMETHYL]-1H- PYRROL-3-YL}-N-(2-PIPERIDIN-1-YL-ETHYL)-BENZAMIDE COMPLEX
2973, 1uu9A, 0.7843, 2.58, 0.248, 276, 250, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-3
2974, 1jktA, 0.7843, 2.75, 0.239, 276, 255, TETRAGONAL CRYSTAL FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE
2975, 5otrA, 0.7842, 2.70, 0.190, 327, 253, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 14
2976, 5ia0A, 0.7842, 2.39, 0.339, 263, 248, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH ALISERTIB (MLN8237)
2977, 5cvhB, 0.7842, 2.77, 0.188, 324, 255, CRYSTAL STRUCTURE OF CK2ALPHA
2978, 5av4A, 0.7842, 2.59, 0.246, 274, 252, CRYSTAL STRUCTURE OF DAPK1-GENISTEIN COMPLEX IN THE PRESENCE OF BROMIDE IONS.
2979, 4hnfB, 0.7842, 3.18, 0.205, 290, 264, CRYSTAL STRUCTURE OF CK1D IN COMPLEX WITH PF4800567
2980, 4fr4C, 0.7842, 2.98, 0.232, 344, 259, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE 32A (YANK1)
2981, 4cfmA, 0.7842, 2.81, 0.263, 296, 255, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
2982, 2yn8B, 0.7842, 2.37, 0.328, 260, 247, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2983, 2e2bB, 0.7842, 2.14, 0.388, 262, 242, CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH INNO-406
2984, 2b9iA, 0.7842, 2.60, 0.232, 338, 250, CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM MSG5
2985, 3d7uB, 0.7841, 2.15, 0.307, 258, 244, STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
2986, 3cpbB, 0.7841, 1.82, 0.366, 263, 238, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BISAMIDE INHIBITOR
2987, 3axwA, 0.7841, 2.87, 0.183, 329, 257, CRYSTAL STRUCTURE OF HUMAN CK2ALPHA COMPLEXED WITH A POTENT INHIBITOR
2988, 3a7jA, 0.7841, 2.78, 0.251, 286, 255, HUMAN MST3 KINASE IN COMPLEX WITH MNADP
2989, 2pvkA, 0.7841, 2.98, 0.186, 327, 258, STRUCTURE-BASED DESIGN OF PYRAZOLO[15-A][135]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2990, 5mmrB, 0.7840, 2.78, 0.192, 325, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-((2-CHLORO-[11 -BIPHENYL]-4-YL) METHYL)BUTANE-14-DIAMINE BOUND
2991, 5dzcA, 0.7840, 2.93, 0.205, 816, 258, CRYSTAL STRUCTURE OF PVX_084705 IN COMPLEX WITH AMP-PNP
2992, 4ybjA, 0.7840, 2.11, 0.313, 255, 243, TYPE II DASATINIB ANALOG CRYSTALLIZED WITH C-SRC KINASE
2993, 4kbkB, 0.7840, 3.16, 0.183, 289, 263, CK1D IN COMPLEX WITH (3S)-3-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H- PYRAZOL-4-YL]PYRIDIN-2-YL}MORPHOLINE INHIBITOR
2994, 4gubA, 0.7840, 2.73, 0.176, 329, 255, CASEIN KINASE II BOUND TO INHIBITOR
2995, 3utoA, 0.7840, 2.99, 0.200, 559, 260, TWITCHIN KINASE REGION FROM C.ELEGANS (FN31-NL-KIN-CRD-IG26)
2996, 3ddqA, 0.7840, 2.83, 0.267, 296, 255, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR ROSCOVITINE
2997, 2c4gC, 0.7840, 2.94, 0.257, 300, 257, STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514
2998, 5motA, 0.7839, 2.82, 0.184, 328, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0627 BOUND
2999, 5lqeC, 0.7839, 2.82, 0.263, 296, 255, CDK2/CYCLIN A IN COMPLEX WITH COMPOUND 73
3000, 5cs6A, 0.7839, 2.86, 0.191, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 3 BOUND
3001, 4knbA, 0.7839, 2.76, 0.328, 273, 250, C-MET IN COMPLEX WITH OSI LIGAND
3002, 4kioA, 0.7839, 1.68, 0.331, 240, 236, KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH A COVALENTLY-BINDING INHIBITOR
3003, 3qcyA, 0.7839, 2.52, 0.249, 275, 249, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 4-[2- AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4-PYRIMIDINYL]-N-PHENYL-2- MORPHOLINECARBOXAMIDE
3004, 3o7lB, 0.7839, 2.65, 0.203, 326, 251, CRYSTAL STRUCTURE OF PHOSPHOLAMBAN (1-19):PKA C-SUBUNIT:AMP-PNP:MG2+ COMPLEX
3005, 3h30A, 0.7839, 2.83, 0.184, 333, 255, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 WITH 56-DICHLORO-1-BETA-D- RIBOFURANOSYLBENZIMIDAZOLE
3006, 3g6hB, 0.7839, 2.29, 0.321, 259, 246, SRC THR338ILE INHIBITED IN THE DFG-ASP-OUT CONFORMATION
3007, 2x1nC, 0.7839, 2.83, 0.263, 296, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3008, 2iw9A, 0.7839, 2.69, 0.257, 293, 253, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
3009, 1unlA, 0.7839, 2.86, 0.227, 292, 255, STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE ALOISINE AND INDIRUBIN.
3010, 1ckjB, 0.7839, 3.22, 0.186, 293, 264, CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317 COMPLEX WITH BOUND TUNGSTATE
3011, 6bqpA, 0.7838, 2.83, 0.245, 263, 253, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH CRENOLANIB
3012, 6bleA, 0.7838, 2.84, 0.245, 265, 253, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH CP673451
3013, 5vjaD, 0.7838, 2.64, 0.238, 261, 252, CRYSTAL STRUCTURE OF HUMAN ZIPPER-INTERACTING PROTEIN KINASE (ZIPK; ALIAS DAPK3) IN COMPLEX WITH A PYRAZOLO[3;4-D]PYRIMIDINONE LIGAND (HS38) 
3014, 5otdB, 0.7838, 2.78, 0.196, 324, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 25
3015, 5nhjA, 0.7838, 3.10, 0.205, 345, 259, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
3016, 5n1oA, 0.7838, 2.66, 0.226, 335, 252, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-CHLORO-4-(CHLOROMETHYL)-5- HYDROXYPHENYL)ETHAN-1-ONE
3017, 5mmfB, 0.7838, 2.78, 0.192, 325, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 7 BOUND
3018, 5ct0B, 0.7838, 2.78, 0.192, 326, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH 3-(3-CHLORO-4-(PHENYL)BENZYLAMINO) PROPAN-1-OL BOUND
3019, 4yu2B, 0.7838, 2.75, 0.223, 347, 251, CRYSTAL STRUCTURE OF DYRK1A WITH HARMINE-DERIVATIZED ANNH-75 INHIBITOR
3020, 4i6fA, 0.7838, 3.18, 0.201, 285, 259, SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
3021, 3v5lA, 0.7838, 1.66, 0.335, 240, 236, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 542
3022, 2wevC, 0.7838, 2.83, 0.263, 296, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3023, 2pvjA, 0.7838, 2.99, 0.186, 326, 258, STRUCTURE-BASED DESIGN OF PYRAZOLO[15-A][135]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
3024, 1urcA, 0.7838, 2.82, 0.259, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY
3025, 1k9aD, 0.7838, 2.67, 0.333, 433, 249, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
3026, 5oktB, 0.7837, 3.05, 0.185, 281, 260, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH IWP-2 
3027, 4eevA, 0.7837, 2.65, 0.328, 283, 250, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH LY2801653
3028, 3pe2A, 0.7837, 2.82, 0.187, 327, 256, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 IN COMPLEX WITH THE INHIBITOR CX-5011
3029, 3pe1A, 0.7837, 2.82, 0.187, 327, 256, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR CX-4945
3030, 2qokA, 0.7837, 2.65, 0.347, 281, 251, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y596F:Y602F:S768A TRIPLE MUTANT
3031, 4uy9A, 0.7836, 2.86, 0.335, 313, 254, STRUCTURE OF MLK1 KINASE DOMAIN WITH LEUCINE ZIPPER 1
3032, 4qmlA, 0.7836, 2.79, 0.270, 280, 256, MST3 IN COMPLEX WITH AMP-PNP
3033, 3lvpD, 0.7836, 2.47, 0.294, 282, 248, CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR
3034, 3e3bX, 0.7836, 2.76, 0.184, 334, 255, CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2ALPHA PRIME WITH A POTENT INDAZOLE-DERIVATIVE INHIBITOR
3035, 2vagA, 0.7836, 2.89, 0.202, 330, 253, CRYSTAL STRUCTURE OF DI-PHOSPHORYLATED HUMAN CLK1 IN COMPLEX WITH A NOVEL SUBSTITUTED INDOLE INHIBITOR
3036, 6bfnB, 0.7835, 2.82, 0.221, 294, 253, CRYSTAL STRUCTURE OF HUMAN IRAK1
3037, 6b1uC, 0.7835, 2.62, 0.249, 459, 253, STRUCTURE OF FULL-LENGTH HUMAN AMPK (A2B1G1) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR SC4 
3038, 5nwzB, 0.7835, 2.41, 0.347, 268, 248, FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527
3039, 5lxcB, 0.7835, 2.87, 0.217, 385, 253, CRYSTAL STRUCTURE OF DYRK2 IN COMPLEX WITH EHT 5372 (COMPOUND 1)
3040, 5d7aA, 0.7835, 2.66, 0.243, 289, 251, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TRAF2 AND NCK-INTERACTING PROTEIN KINASE WITH NCB-0846
3041, 5bpyB, 0.7835, 2.28, 0.354, 247, 246, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-824171 AKA 6-[(3R)-3-(4-TERT-BU TYLBENZAMIDO) PIPERIDIN-1-YL]-2-{[4-(MORPHOLINE-4-CARBONYL) PHENYL]AMINO}PYRIDINE- 3-CARBOXAMIDE
3042, 4yljC, 0.7835, 2.76, 0.231, 346, 251, CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-IODO-SUBSTITUTED 11H- INDOLO[32-C]QUINOLINE-6-CARBOXYLIC ACID INHIBITOR 5J
3043, 4o0tA, 0.7835, 2.85, 0.214, 292, 257, BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
3044, 4mq1A, 0.7835, 2.71, 0.232, 345, 250, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
3045, 3qkkA, 0.7835, 2.76, 0.235, 326, 255, SPIROCHROMANE AKT INHIBITORS
3046, 3o17A, 0.7835, 2.85, 0.227, 357, 256, CRYSTAL STRUCTURE OF JNK1-ALPHA1 ISOFORM
3047, 3c13A, 0.7835, 2.83, 0.176, 328, 256, LOW PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3048, 6fnlA, 0.7834, 2.48, 0.310, 262, 248, CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE 
3049, 5v61A, 0.7834, 2.90, 0.199, 348, 256, PHOSPHO-ERK2 BOUND TO BIVALENT INHIBITOR SBP2
3050, 5kq5A, 0.7834, 2.60, 0.257, 362, 253, AMPK BOUND TO ALLOSTERIC ACTIVATOR
3051, 4yu2D, 0.7834, 2.75, 0.223, 346, 251, CRYSTAL STRUCTURE OF DYRK1A WITH HARMINE-DERIVATIZED ANNH-75 INHIBITOR
3052, 3h30B, 0.7834, 2.83, 0.184, 333, 255, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 WITH 56-DICHLORO-1-BETA-D- RIBOFURANOSYLBENZIMIDAZOLE
3053, 5otzA, 0.7833, 2.71, 0.182, 327, 253, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 1
3054, 5oszA, 0.7833, 2.85, 0.195, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 23
3055, 5n1vB, 0.7833, 2.98, 0.182, 331, 258, CRYSTAL STRUCTURE OF THE PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH PYRAZOLO-PYRIMIDINE MACROCYCLIC LIGAND
3056, 5jkgA, 0.7833, 2.25, 0.370, 266, 246, THE CRYSTAL STRUCTURE OF FGFR4 KINASE DOMAIN IN COMPLEX WITH LY2874455
3057, 4tndA, 0.7833, 3.01, 0.178, 529, 259, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 5 IN COMPLEX WITH AMP-PNP
3058, 3uytB, 0.7833, 3.24, 0.195, 286, 262, CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P1 CRYSTAL FORM
3059, 3dpkA, 0.7833, 2.33, 0.348, 279, 244, CFMS TYROSINE KINASE IN COMPLEX WITH A PYRIDOPYRIMIDINONE INHIBITOR
3060, 2qurA, 0.7833, 2.72, 0.217, 338, 254, CRYSTAL STRUCTURE OF F327A/K285P MUTANT OF CAMP-DEPENDENT PROTEIN KINASE
3061, 2oxyB, 0.7833, 3.00, 0.190, 327, 258, PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17 K22 AND K32
3062, 1zwsG, 0.7833, 2.78, 0.233, 278, 257, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
3063, 1e9hC, 0.7833, 2.84, 0.267, 296, 255, THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND
3064, 6bfnA, 0.7832, 2.85, 0.221, 301, 253, CRYSTAL STRUCTURE OF HUMAN IRAK1
3065, 5uy6A, 0.7832, 2.88, 0.245, 282, 253, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B
3066, 5otoB, 0.7832, 2.79, 0.192, 324, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 30
3067, 5mo6B, 0.7832, 2.79, 0.192, 324, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
3068, 5b0xA, 0.7832, 2.90, 0.187, 329, 257, CRYSTAL STRUCTURE OF THE CK2A/BENZOIC ACID DERIVATIVE COMPLEX
3069, 4nksA, 0.7832, 2.42, 0.387, 265, 248, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 3
3070, 4eomA, 0.7832, 2.89, 0.266, 296, 256, THR 160 PHOSPHORYLATED CDK2 H84S Q85M Q131E - HUMAN CYCLIN A3 COMPLEX WITH ATP
3071, 4cfxA, 0.7832, 2.83, 0.263, 298, 255, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6-CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
3072, 3orzA, 0.7832, 2.66, 0.251, 276, 251, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR 2A2
3073, 3my5C, 0.7832, 2.76, 0.265, 266, 253, CDK2/CYCLINA IN COMPLEX WITH DRB
3074, 2whbC, 0.7832, 2.83, 0.259, 296, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3075, 2whbA, 0.7832, 2.90, 0.254, 296, 256, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3076, 5w5oP, 0.7831, 2.22, 0.270, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3077, 5ezvC, 0.7831, 2.63, 0.249, 440, 253, X-RAY CRYSTAL STRUCTURE OF AMP-ACTIVATED PROTEIN KINASE ALPHA-2/ALPHA- 1 RIM CHIMAERA (ALPHA-2(1-347)/ALPHA-1(349-401)/ALPHA-2(397-END) BETA-1 GAMMA-1) CO-CRYSTALLIZED WITH C2 (5-(5-HYDROXYL-ISOXAZOL-3- YL)-FURAN-2-PHOSPHONIC ACID)
3078, 4i5pA, 0.7831, 2.96, 0.203, 284, 256, SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
3079, 3orzC, 0.7831, 2.66, 0.251, 276, 251, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR 2A2
3080, 3o0gA, 0.7831, 2.87, 0.231, 289, 255, CRYSTAL STRUCTURE OF CDK5:P25 IN COMPLEX WITH AN ATP ANALOGUE
3081, 3bhvA, 0.7831, 2.87, 0.262, 297, 256, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR VARIOLIN B
3082, 2pl0A, 0.7831, 2.53, 0.364, 268, 247, LCK BOUND TO IMATINIB
3083, 2henB, 0.7831, 2.44, 0.328, 259, 247, CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP
3084, 2gmxB, 0.7831, 2.87, 0.227, 357, 256, SELECTIVE AMINOPYRIDINE-BASED C-JUN N-TERMINAL KINASE INHIBITORS WITH CELLULAR ACTIVITY
3085, 2c5xC, 0.7831, 2.82, 0.259, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
3086, 5xvuA, 0.7830, 2.72, 0.190, 321, 252, CRYSTAL STRUCTURE OF THE PROTEIN KINASE CK2 CATALYTIC DOMAIN FROM PLASMODIUM FALCIPARUM BOUND TO ATP
3087, 5oueB, 0.7830, 2.79, 0.192, 326, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 20
3088, 5mowA, 0.7830, 2.78, 0.184, 328, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0432 BOUND
3089, 4eorA, 0.7830, 2.72, 0.261, 293, 253, THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR NU6102
3090, 3qrjB, 0.7830, 2.62, 0.389, 265, 247, THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN T315I MUTANT IN COMPLEX WITH DCC-2036
3091, 3ms9A, 0.7830, 2.14, 0.388, 265, 242, ABL KINASE IN COMPLEX WITH IMATINIB AND A FRAGMENT (FRAG1) IN THE MYRISTATE POCKET
3092, 3f3vB, 0.7830, 2.33, 0.309, 262, 246, KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL45 (TYPE II)
3093, 1yomB, 0.7830, 2.21, 0.314, 261, 245, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH PURVALANOL A
3094, 5xvuB, 0.7829, 2.83, 0.186, 321, 253, CRYSTAL STRUCTURE OF THE PROTEIN KINASE CK2 CATALYTIC DOMAIN FROM PLASMODIUM FALCIPARUM BOUND TO ATP
3095, 4yljD, 0.7829, 2.75, 0.223, 347, 251, CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-IODO-SUBSTITUTED 11H- INDOLO[32-C]QUINOLINE-6-CARBOXYLIC ACID INHIBITOR 5J
3096, 4ra5B, 0.7829, 2.89, 0.219, 310, 256, HUMAN PROTEIN KINASE C THETA IN COMPLEX WITH LIGAND COMPOUND 11A (6- [(13-DIMETHYL-AZETIDIN-3-YL)-METHYL-AMINO]-4(R)-METHYL-7-PHENYL-2 10-DIHYDRO-9-OXA-124A-TRIAZA-PHENANTHREN-3-ONE)
3097, 4fr4E, 0.7829, 2.99, 0.232, 342, 259, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE 32A (YANK1)
3098, 4fr4B, 0.7829, 2.95, 0.233, 350, 258, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE 32A (YANK1)
3099, 4dhfA, 0.7829, 2.56, 0.255, 258, 251, STRUCTURE OF AURORA A MUTANT BOUND TO BIOGENIDEC CPD 15
3100, 4cfuA, 0.7829, 2.91, 0.265, 299, 257, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
3101, 3db6A, 0.7829, 2.78, 0.247, 287, 255, CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND 902
3102, 5cspA, 0.7828, 2.83, 0.184, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 5 BOUND
3103, 5auuA, 0.7828, 2.61, 0.242, 274, 252, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH LUTEOLIN.
3104, 4ix5B, 0.7828, 3.18, 0.130, 350, 261, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE IN COMPLEX WITH AMP-PNP
3105, 4dhfB, 0.7828, 2.56, 0.255, 258, 251, STRUCTURE OF AURORA A MUTANT BOUND TO BIOGENIDEC CPD 15
3106, 3r0tA, 0.7828, 2.84, 0.187, 327, 256, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR CX-5279
3107, 3eocA, 0.7828, 2.78, 0.256, 295, 254, CDK2/CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-AMINE
3108, 2v22C, 0.7828, 2.85, 0.263, 296, 255, REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
3109, 2r7bA, 0.7828, 2.54, 0.249, 274, 249, CRYSTAL STRUCTURE OF THE PHOSPHOINOSITIDE-DEPENDENT KINASE- 1 (PDK-1)CATALYTIC DOMAIN BOUND TO A DIBENZONAPHTHYRIDINE INHIBITOR
3110, 2pmlX, 0.7828, 2.90, 0.198, 340, 257, CRYSTAL STRUCTURE OF PFPK7 IN COMPLEX WITH AN ATP ANALOGUE
3111, 2bpmA, 0.7828, 2.96, 0.252, 302, 258, STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529
3112, 1zwsF, 0.7828, 2.79, 0.233, 278, 257, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
3113, 5u6iA, 0.7827, 3.08, 0.202, 339, 258, DISCOVERY OF MLI-2 AN ORALLY AVAILABLE AND SELECTIVE LRRK2 INHIBITOR THAT REDUCES BRAIN KINASE ACTIVITY
3114, 4qteA, 0.7827, 3.13, 0.205, 348, 259, STRUCTURE OF ERK2 IN COMPLEX WITH VTX-11E 4-{2-[(2-CHLORO-4- FLUOROPHENYL)AMINO]-5-METHYLPYRIMIDIN-4-YL}-N-[(1S)-1-(3- CHLOROPHENYL)-2-HYDROXYETHYL]-1H-PYRROLE-2-CARBOXAMIDE
3115, 4mbjA, 0.7827, 2.83, 0.298, 269, 255, HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH AN IMIDAZOPYRIDINE-BASED INHIBITOR
3116, 4lueA, 0.7827, 2.29, 0.374, 422, 243, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH 7-[TRANS-4-(4- METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE (RESULTING FROM DISPLACEMENT OF SKF86002)
3117, 4ludA, 0.7827, 2.28, 0.376, 421, 242, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH THE FLUORESCENT COMPOUND SKF86002
3118, 4i6hA, 0.7827, 3.12, 0.198, 285, 258, SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE ALPHA-SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
3119, 1jstC, 0.7827, 2.80, 0.268, 297, 254, PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A
3120, 1gy3C, 0.7827, 2.80, 0.264, 295, 254, PCDK2/CYCLIN A IN COMPLEX WITH MGADP NITRATE AND PEPTIDE SUBSTRATE
3121, 5ztnB, 0.7826, 2.90, 0.217, 395, 254, THE CRYSTAL STRUCTURE OF HUMAN DYRK2 IN COMPLEX WITH CURCUMIN 
3122, 5ztnA, 0.7826, 2.91, 0.209, 395, 254, THE CRYSTAL STRUCTURE OF HUMAN DYRK2 IN COMPLEX WITH CURCUMIN 
3123, 5kmkA, 0.7826, 2.65, 0.394, 304, 251, TRKA JM-KINASE WITH 2-FLUORO-{N}-[2-(4-FLUOROPHENYL)-6-METHYL-3- PYRIDYL]-4-(TRIFLUOROMETHYL)BENZAMIDE
3124, 4wo5A, 0.7826, 2.93, 0.301, 266, 256, CRYSTAL STRUCTURE OF A BRAF KINASE DOMAIN MONOMER
3125, 4iz5D, 0.7826, 2.91, 0.199, 347, 256, STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
3126, 4iz5C, 0.7826, 2.91, 0.199, 347, 256, STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
3127, 4i6bA, 0.7826, 3.14, 0.202, 285, 258, SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
3128, 2c5xA, 0.7826, 2.90, 0.250, 296, 256, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
3129, 6gt1C, 0.7825, 2.34, 0.247, 257, 247, NEK7 BOUND TO PURINE INHIBITOR 
3130, 5w4wC, 0.7825, 3.21, 0.190, 284, 263, IDENTIFICATION AND PROFILING OF A SELECTIVE AND BRAIN PENETRANT RADIOLIGAND FOR IN VIVO TARGET OCCUPANCY MEASUREMENT OF CASEIN KINASE 1 (CK1) INHIBITORS
3131, 5kmiA, 0.7825, 2.64, 0.394, 300, 251, TRKA JM-KINASE WITH 1-(9{H}-FLUOREN-9-YL)-3-(2-METHYL-4-PHENYL- PYRIMIDIN-5-YL)UREA
3132, 5cquA, 0.7825, 2.87, 0.187, 328, 256, MONOCLINIC COMPLEX STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A BENZOTRIAZOLE-BASED INHIBITOR GENERATED BY CLICK-CHEMISTRY
3133, 4zhxC, 0.7825, 2.63, 0.249, 452, 253, NOVEL BINDING SITE FOR ALLOSTERIC ACTIVATION OF AMPK
3134, 4wunB, 0.7825, 2.31, 0.397, 268, 247, STRUCTURE OF FGFR1 IN COMPLEX WITH AZD4547 (N-{3-[2-(35- DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R5S)-35- DIMETHYLPIPERAZIN-1-YL]BENZAMIDE) AT 1.65 ANGSTROM
3135, 4iz5B, 0.7825, 2.91, 0.199, 347, 256, STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
3136, 4iz5A, 0.7825, 2.92, 0.199, 347, 256, STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
3137, 3dbeA, 0.7825, 2.82, 0.236, 284, 254, CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND 557
3138, 1j91B, 0.7825, 3.06, 0.186, 327, 258, CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4567- TETRABROMOBENZOTRIAZOLE
3139, 1h28C, 0.7825, 2.86, 0.263, 296, 255, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107
3140, 5u94A, 0.7824, 2.39, 0.219, 263, 247, CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS PASTA KINASE PKNB IN COMPLEX WITH THE POTENTIAL THERAPUTIC KINASE INHIBITOR GSK690693.
3141, 5csvA, 0.7824, 2.83, 0.184, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 6 BOUND
3142, 3ow4A, 0.7824, 2.89, 0.234, 317, 256, DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS POTENT PAN AKT INHIBITORS
3143, 3mssA, 0.7824, 2.15, 0.388, 264, 242, ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN THE MYRISTATE SITE
3144, 3f5pI, 0.7824, 3.02, 0.291, 294, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3145, 3f5pA, 0.7824, 3.03, 0.291, 299, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3146, 2g01B, 0.7824, 2.87, 0.230, 356, 256, PYRAZOLOQUINOLONES AS NOVEL SELECTIVE JNK1 INHIBITORS
3147, 5modB, 0.7823, 2.80, 0.192, 324, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
3148, 5bvnA, 0.7823, 2.81, 0.323, 278, 254, FRAGMENT-BASED DISCOVERY OF POTENT AND SELECTIVE DDR1/2 INHIBITORS
3149, 5auzA, 0.7823, 2.61, 0.242, 274, 252, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH GENISTEIN.
3150, 4eojA, 0.7823, 2.85, 0.259, 295, 255, THR 160 PHOSPHORYLATED CDK2 H84S Q85M K89D - HUMAN CYCLIN A3 COMPLEX WITH ATP
3151, 3f3wA, 0.7823, 2.34, 0.313, 261, 246, DRUG RESISTANT CSRC KINASE DOMAIN IN COMPLEX WITH INHIBITOR RL45 (TYPE II)
3152, 2pmnX, 0.7823, 2.92, 0.202, 340, 257, CRYSTAL STRUCTURE OF PFPK7 IN COMPLEX WITH AN ATP-SITE INHIBITOR
3153, 1rjbA, 0.7823, 2.42, 0.359, 298, 245, CRYSTAL STRUCTURE OF FLT3
3154, 1ol2C, 0.7823, 2.84, 0.263, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F-PHE)-NH2
3155, 5l6oA, 0.7822, 2.52, 0.329, 267, 246, EPHB3 KINASE DOMAIN COVALENTLY BOUND TO AN IRREVERSIBLE INHIBITOR (COMPOUND 3)
3156, 5ezrA, 0.7822, 2.95, 0.202, 803, 258, CRYSTAL STRUCTURE OF PVX_084705 BOUND TO COMPOUND
3157, 4cfeA, 0.7822, 2.62, 0.249, 425, 253, STRUCTURE OF FULL LENGTH HUMAN AMPK IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR A BENZIMIDAZOLE DERIVATIVE (991)
3158, 3ocbA, 0.7822, 2.78, 0.235, 315, 255, AKT1 KINASE DOMAIN WITH PYRROLOPYRIMIDINE INHIBITOR
3159, 3f5pD, 0.7822, 3.04, 0.291, 297, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3160, 2jgzA, 0.7822, 2.77, 0.264, 288, 254, CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B
3161, 2henD, 0.7822, 2.40, 0.321, 259, 246, CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP
3162, 2c5nC, 0.7822, 2.85, 0.263, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND  INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
3163, 1j91A, 0.7822, 3.04, 0.186, 327, 258, CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4567- TETRABROMOBENZOTRIAZOLE
3164, 5owlA, 0.7821, 2.99, 0.191, 331, 257, LOW SALT STRUCTURE OF HUMAN PROTEIN KINASE CK2ALPHA IN COMPLEX WITH 3- AMINOPROPYL-4;5;6;7-TETRABROMOBENZIMIDAZOL 
3165, 5if1A, 0.7821, 2.83, 0.255, 298, 255, CRYSTAL STRUCTURE APO CDK2/CYCLIN A
3166, 4ybjB, 0.7821, 2.02, 0.315, 253, 241, TYPE II DASATINIB ANALOG CRYSTALLIZED WITH C-SRC KINASE
3167, 3tl8D, 0.7821, 2.69, 0.265, 306, 253, THE AVRPTOB-BAK1 COMPLEX REVEALS TWO STRUCTURALLY SIMILAR KINASEINTERACTING DOMAINS IN A SINGLE TYPE III EFFECTOR
3168, 3fbvJ, 0.7821, 2.79, 0.221, 413, 253, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3169, 3d7tA, 0.7821, 2.14, 0.362, 249, 243, STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
3170, 3a8xA, 0.7821, 2.83, 0.198, 334, 257, CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
3171, 2r7iD, 0.7821, 2.77, 0.185, 322, 254, CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3172, 1p5eC, 0.7821, 2.89, 0.263, 296, 255, THE STRUCTURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4567-TETRABROMOBENZOTRIAZOLE (TBS)
3173, 4dggB, 0.7820, 2.28, 0.320, 259, 244, C-SRC KINASE DOMAIN IN COMPLEX WITH RM-1-176
3174, 4c2vA, 0.7820, 2.74, 0.216, 270, 255, AURORA B KINASE IN COMPLEX WITH THE SPECIFIC INHIBITOR BARASERTIB
3175, 3qd4A, 0.7820, 2.51, 0.250, 276, 248, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 11- DIMETHYLETHYL{(3R5R)-1-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4- PYRIMIDINYL]-5-METHYL-3-PIPERIDINYL}CARBAMATE
3176, 3miyB, 0.7820, 1.65, 0.331, 240, 236, X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH SUNITINIB
3177, 3fwqB, 0.7820, 2.87, 0.184, 334, 255, INACTIVE CONFORMATION OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
3178, 3fbvI, 0.7820, 2.79, 0.221, 413, 253, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3179, 2x1nA, 0.7820, 2.88, 0.259, 296, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3180, 2acxB, 0.7820, 2.82, 0.187, 492, 256, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 6 BOUND TO AMPPNP
3181, 1w98A, 0.7820, 2.84, 0.263, 297, 255, THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E
3182, 6fnjA, 0.7819, 2.65, 0.328, 262, 250, CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE WITH AN ISOMER OF NVP-BHG712 
3183, 6fngA, 0.7819, 2.55, 0.341, 277, 249, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH AN ISOMER OF NVP-BHG712 
3184, 5orkB, 0.7819, 2.78, 0.189, 323, 254, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 6
3185, 5nhoA, 0.7819, 3.08, 0.202, 343, 258, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
3186, 5nhhA, 0.7819, 3.16, 0.205, 348, 259, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
3187, 5f9eB, 0.7819, 2.86, 0.207, 293, 256, STRUCTURE OF PROTEIN KINASE C THETA WITH COMPOUND 10: 22-DIMETHYL-7- (2-OXIDANYLIDENE-3~{H}-IMIDAZO[45-B]PYRIDIN-1-YL)-1-(PHENYLMETHYL)- 3~{H}-QUINAZOLIN-4-ONE
3188, 4ix6B, 0.7819, 3.19, 0.130, 350, 261, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE SOAKED WITH ATP
3189, 3sdjI, 0.7819, 2.72, 0.222, 413, 252, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3190, 2x4zA, 0.7819, 2.84, 0.180, 290, 256, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH PF-03758309
3191, 2vx3A, 0.7819, 2.76, 0.231, 346, 251, CRYSTAL STRUCTURE OF THE HUMAN DUAL SPECIFICITY TYROSINE- PHOSPHORYLATION-REGULATED KINASE 1A
3192, 2cciA, 0.7819, 2.94, 0.262, 296, 256, CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6
3193, 1wvyA, 0.7819, 2.65, 0.249, 273, 253, CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
3194, 5xvuC, 0.7818, 2.74, 0.190, 321, 252, CRYSTAL STRUCTURE OF THE PROTEIN KINASE CK2 CATALYTIC DOMAIN FROM PLASMODIUM FALCIPARUM BOUND TO ATP
3195, 4mq2D, 0.7818, 2.71, 0.232, 329, 250, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
3196, 3f5pM, 0.7818, 3.03, 0.291, 295, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3197, 3f5pB, 0.7818, 3.04, 0.291, 298, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3198, 2c6tC, 0.7818, 2.81, 0.264, 295, 254, CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
3199, 1gy3A, 0.7818, 2.82, 0.268, 295, 254, PCDK2/CYCLIN A IN COMPLEX WITH MGADP NITRATE AND PEPTIDE SUBSTRATE
3200, 5lpvA, 0.7817, 2.67, 0.248, 282, 250, CRYSTAL STRUCTURE OF THE BRI1 KINASE DOMAIN (865-1160) IN COMPLEX WITH AMPPNP AND MN FROM ARABIDOPSIS THALIANA
3201, 4qnyB, 0.7817, 2.97, 0.205, 339, 258, CRYSTAL STRUCTURE OF MAPK FROM LEISHMANIA DONOVANI LDBPK_331470
3202, 4pdoB, 0.7817, 2.01, 0.344, 261, 241, STRUCTURE OF EPHRIN TYPE-A RECEPTOR 2
3203, 4pdoA, 0.7817, 2.01, 0.344, 261, 241, STRUCTURE OF EPHRIN TYPE-A RECEPTOR 2
3204, 3sdjJ, 0.7817, 2.72, 0.222, 413, 252, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3205, 3mssC, 0.7817, 2.16, 0.388, 264, 242, ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN THE MYRISTATE SITE
3206, 3i5nA, 0.7817, 2.96, 0.331, 280, 251, CRYSTAL STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR 13
3207, 3f5pK, 0.7817, 2.99, 0.292, 293, 257, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3208, 3f3vA, 0.7817, 2.36, 0.313, 261, 246, KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL45 (TYPE II)
3209, 2wmbA, 0.7817, 2.86, 0.267, 296, 255, STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OF PEPTIDE LIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A
3210, 1h27C, 0.7817, 2.87, 0.263, 291, 255, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27
3211, 5nkiA, 0.7816, 2.40, 0.341, 268, 246, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 4B
3212, 5lxdB, 0.7816, 2.86, 0.221, 385, 253, CRYSTAL STRUCTURE OF DYRK2 IN COMPLEX WITH EHT 1610 (COMPOUND 2)
3213, 5lxdA, 0.7816, 2.81, 0.214, 385, 252, CRYSTAL STRUCTURE OF DYRK2 IN COMPLEX WITH EHT 1610 (COMPOUND 2)
3214, 5cshA, 0.7816, 2.81, 0.192, 324, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 4 BOUND
3215, 4ix4B, 0.7816, 3.25, 0.130, 350, 262, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE IN COMPLEX WITH ADP
3216, 3my5A, 0.7816, 2.92, 0.258, 296, 256, CDK2/CYCLINA IN COMPLEX WITH DRB
3217, 3f5pG, 0.7816, 3.05, 0.291, 299, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3218, 3f5pC, 0.7816, 3.04, 0.291, 301, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3219, 3el7A, 0.7816, 2.03, 0.311, 254, 241, CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDINE 3
3220, 3d14A, 0.7816, 2.58, 0.243, 262, 251, CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY LYS240->ARG MET302- >LEU) IN COMPLEX WITH 1-{5-[2-(THIENO[32-D]PYRIMIDIN-4-YLAMINO)- ETHYL]- THIAZOL-2-YL}-3-(3-TRIFLUOROMETHYL-PHENYL)-UREA
3221, 3cjfA, 0.7816, 2.46, 0.359, 276, 248, CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 345-TRIMETHOXY ANILINE CONTAINING PYRIMIDINE
3222, 1wvwA, 0.7816, 2.65, 0.248, 275, 254, CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
3223, 5te0A, 0.7815, 3.02, 0.198, 316, 253, CRYSTAL STRUCTURE OF ADAPTOR PROTEIN 2 ASSOCIATED KINASE (AAK1) IN COMPLEX WITH BIBF 1120
3224, 5mo5B, 0.7815, 2.81, 0.192, 325, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
3225, 5kmmA, 0.7815, 2.66, 0.394, 301, 251, TRKA JM-KINASE WITH 1-(2-METHYL-4-PHENYL-PYRIMIDIN-5-YL)-3-(1- NAPHTHYL)UREA
3226, 5isoA, 0.7815, 2.70, 0.248, 453, 254, STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR A BENZIMIDAZOLE DERIVATIVE (991)
3227, 4mq2C, 0.7815, 2.74, 0.232, 339, 250, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
3228, 4ix3B, 0.7815, 3.19, 0.130, 350, 261, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE
3229, 3pyyA, 0.7815, 2.42, 0.380, 265, 245, DISCOVERY AND CHARACTERIZATION OF A CELL-PERMEABLE SMALL-MOLECULE C- ABL KINASE ACTIVATOR THAT BINDS TO THE MYRISTOYL BINDING SITE
3230, 3ow4B, 0.7815, 2.80, 0.235, 317, 255, DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS POTENT PAN AKT INHIBITORS
3231, 2uueC, 0.7815, 2.87, 0.263, 296, 255, REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
3232, 2r7iB, 0.7815, 2.78, 0.185, 322, 254, CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3233, 2g01A, 0.7815, 3.01, 0.226, 355, 257, PYRAZOLOQUINOLONES AS NOVEL SELECTIVE JNK1 INHIBITORS
3234, 5autA, 0.7814, 2.60, 0.242, 274, 252, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH ANS.
3235, 4c57A, 0.7814, 3.14, 0.225, 310, 258, STRUCTURE OF GAK KINASE IN COMPLEX WITH A NANOBODY
3236, 3mssB, 0.7814, 2.20, 0.388, 264, 242, ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN THE MYRISTATE SITE
3237, 2no3B, 0.7814, 2.90, 0.227, 357, 256, NOVEL 4-ANILINOPYRIMIDINES AS POTENT JNK1 INHIBITORS
3238, 2h96A, 0.7814, 2.89, 0.223, 358, 256, DISCOVERY OF POTENT HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PYRIDINE CARBOXAMIDE C-JUN NH2-TERMINAL KINASE INHIBITORS
3239, 1zwsA, 0.7814, 2.81, 0.233, 278, 257, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
3240, 1pkdC, 0.7814, 2.88, 0.267, 296, 255, THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO- CDK2/CYCLIN A
3241, 4ianA, 0.7813, 2.87, 0.217, 321, 253, CRYSTAL STRUCTURE OF APO HUMAN PRPF4B KINASE DOMAIN
3242, 4ehgA, 0.7813, 2.52, 0.308, 262, 250, B-RAF KINASE DOMAIN IN COMPLEX WITH AN AMINOPYRIDIMINE-BASED INHIBITOR
3243, 3otuA, 0.7813, 2.68, 0.246, 276, 252, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR JS30
3244, 3f5pH, 0.7813, 3.06, 0.291, 299, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3245, 3efkB, 0.7813, 2.28, 0.322, 272, 242, STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 50
3246, 3dj7A, 0.7813, 2.60, 0.239, 257, 251, CRYSTAL STRUCTURE OF THE MOUSE AURORA-A CATALYTIC DOMAIN (ASN186->GLY LYS240->ARG MET302->LEU) IN COMPLEX WITH COMPOUND 130.
3247, 2nruA, 0.7813, 2.96, 0.274, 293, 252, CRYSTAL STRUCTURE OF IRAK-4
3248, 1h28A, 0.7813, 2.86, 0.267, 296, 255, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107
3249, 5x17B, 0.7812, 3.18, 0.187, 289, 262, CRYSTAL STRUCTURE OF MURINE CK1D IN COMPLEX WITH ADP
3250, 5f0aA, 0.7812, 2.98, 0.205, 811, 258, CRYSTAL STRUCTURE OF PVX_084705 WITH BOUND 1-TERT-BUTYL-3-(3- CHLOROPHENOXY)-1H-PYRAZOLO[34-D]PYRIMIDIN-4-AMINE INHIBITOR
3251, 3q53A, 0.7812, 2.82, 0.215, 291, 256, STRUCTURE OF PHOSPHORYLATED PAK1 KINASE DOMAIN IN COMPLEX WITH ATP
3252, 3f5pS, 0.7812, 3.04, 0.291, 295, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3253, 2welA, 0.7812, 2.98, 0.198, 304, 258, CRYSTAL STRUCTURE OF SU6656-BOUND CALCIUM/CALMODULIN- DEPENDENT PROTEIN KINASE II DELTA IN COMPLEX WITH CALMODULIN
3254, 1szmA, 0.7812, 2.69, 0.225, 317, 253, DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEIN KINASE A (PKA)
3255, 6ccyA, 0.7811, 2.83, 0.235, 325, 255, CRYSTAL STRUCTURE OF AKT1 IN COMPLEX WITH A SELECTIVE INHIBITOR 
3256, 6bkuA, 0.7811, 2.89, 0.241, 267, 253, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B BOUND TO GSK650394
3257, 5os8A, 0.7811, 2.88, 0.195, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 11
3258, 5mowB, 0.7811, 2.81, 0.188, 324, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0432 BOUND
3259, 5lihA, 0.7811, 2.73, 0.198, 324, 253, STRUCTURE OF A PEPTIDE-SUBSTRATE BOUND TO PKCIOTA CORE KINASE DOMAIN
3260, 4ysjB, 0.7811, 2.64, 0.263, 462, 251, CALCIUM-DEPENDENT PROTEIN KINASE FROM EIMERIA TENELLA IN COMPLEX WITH ADP
3261, 4oh4A, 0.7811, 2.70, 0.248, 299, 250, CRYSTAL STRUCTURE OF BRI1 IN COMPLEX WITH BKI1
3262, 3q04A, 0.7811, 2.88, 0.187, 328, 256, CRYSTAL STRUCTURE OF THE APO-FORM OF HUMAN CK2 ALPHA AT PH 8.5
3263, 3mssD, 0.7811, 2.21, 0.388, 264, 242, ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN THE MYRISTATE SITE
3264, 2gphA, 0.7811, 2.81, 0.200, 345, 255, DOCKING MOTIF INTERACTIONS IN THE MAP KINASE ERK2
3265, 1koaA, 0.7811, 3.09, 0.199, 447, 261, TWITCHIN KINASE FRAGMENT (C.ELEGANS) AUTOREGULATED PROTEIN KINASE AND IMMUNOGLOBULIN DOMAINS
3266, 4mq2B, 0.7810, 2.74, 0.228, 338, 250, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
3267, 4mq1B, 0.7810, 2.76, 0.232, 340, 250, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
3268, 4g3dD, 0.7810, 2.25, 0.212, 290, 245, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK)
3269, 4aojB, 0.7810, 2.15, 0.404, 258, 245, HUMAN TRKA IN COMPLEX WITH THE INHIBITOR AZ-23
3270, 3u4uA, 0.7810, 2.87, 0.187, 327, 256, CASEIN KINASE 2 IN COMPLEX WITH AZ-INHIBITOR
3271, 3fzsA, 0.7810, 2.56, 0.345, 254, 249, CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH BIRB796
3272, 3ccnA, 0.7810, 2.63, 0.340, 275, 247, X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR.
3273, 2gsfA, 0.7810, 2.62, 0.337, 281, 249, THE HUMAN EPHA3 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION
3274, 1yolB, 0.7810, 2.04, 0.311, 253, 241, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH CGP77675
3275, 1na7A, 0.7810, 2.92, 0.191, 326, 256, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2
3276, 5m4fA, 0.7809, 2.83, 0.185, 330, 254, COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH THE INHIBITOR 4 -CARBOXY-68-CHLORO-FLAVONOL (FLC21) CRYSTALLIZED UNDER LOW-SALT CONDITIONS
3277, 4wnpB, 0.7809, 2.91, 0.256, 272, 258, STRUCTURE OF ULK1 BOUND TO A POTENT INHIBITOR
3278, 4azfA, 0.7809, 2.93, 0.217, 404, 254, HUMAN DYRK2 IN COMPLEX WITH LEUCETTINE L41
3279, 2x6dA, 0.7809, 2.71, 0.258, 255, 252, AURORA-A BOUND TO AN INHIBITOR
3280, 2no3A, 0.7809, 2.90, 0.227, 357, 256, NOVEL 4-ANILINOPYRIMIDINES AS POTENT JNK1 INHIBITORS
3281, 1h26A, 0.7809, 2.94, 0.258, 296, 256, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53
3282, 5unpB, 0.7808, 3.03, 0.200, 347, 255, STRUCTURE OF CDC2-LIKE KINASE 2 (CLK2) IN COMPLEX WITH COMPOUND T-025 [N2-METHYL-N4-(PYRIMIDIN-2-YLMETHYL)-5-(QUINOLIN-6-YL)-7H-PYRROLO[2; 3-D]PYRIMIDINE-2;4-DIAMINE] 
3283, 5unpA, 0.7808, 3.03, 0.200, 347, 255, STRUCTURE OF CDC2-LIKE KINASE 2 (CLK2) IN COMPLEX WITH COMPOUND T-025 [N2-METHYL-N4-(PYRIMIDIN-2-YLMETHYL)-5-(QUINOLIN-6-YL)-7H-PYRROLO[2; 3-D]PYRIMIDINE-2;4-DIAMINE] 
3284, 5lxcA, 0.7808, 2.79, 0.215, 383, 251, CRYSTAL STRUCTURE OF DYRK2 IN COMPLEX WITH EHT 5372 (COMPOUND 1)
3285, 5izjA, 0.7808, 2.69, 0.225, 328, 253, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1411
3286, 5dylA, 0.7808, 2.93, 0.206, 802, 257, CRYSTAL STRUCTURE OF PVX_084705
3287, 4bcnA, 0.7808, 2.86, 0.267, 296, 255, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
3288, 3uysC, 0.7808, 3.24, 0.186, 286, 263, CRYSTAL STRUCTURE OF APO HUMAN CK1D
3289, 3ndmA, 0.7808, 2.82, 0.200, 383, 255, CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT ISOQUINOLONE DERIVATIVE
3290, 3f5pL, 0.7808, 3.00, 0.292, 293, 257, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3291, 2v22A, 0.7808, 2.92, 0.254, 296, 256, REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
3292, 6fnjB, 0.7807, 2.67, 0.328, 262, 250, CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE WITH AN ISOMER OF NVP-BHG712 
3293, 5lqfD, 0.7807, 2.87, 0.254, 285, 252, CDK1/CYCLINB1/CKS2 IN COMPLEX WITH NU6102
3294, 5dt0A, 0.7807, 2.72, 0.258, 259, 252, AURORA A KINASE IN COMPLEX WITH JNJ-7706621 IN SPACE GROUP P6122
3295, 4kwpA, 0.7807, 2.87, 0.180, 329, 256, CRYSTAL STRUCTURE OF HUMAN CK2-ALPHA IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR (K164) AT 1.25 A RESOLUTION
3296, 3c1xA, 0.7807, 2.71, 0.325, 290, 249, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A PYRROLOTRIAZINE BASED INHIBITOR
3297, 2pvrA, 0.7807, 2.87, 0.184, 328, 256, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 (C- TERMINAL DELETION MUTANT 1-335) IN COMPLEX WITH TWO SULFATE IONS
3298, 3vidA, 0.7806, 2.41, 0.364, 299, 247, CRYSTAL STRUCTURE OF HUMAN VEGFR2 KINASE DOMAIN WITH COMPOUND A.
3299, 3owkA, 0.7806, 2.80, 0.188, 330, 255, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A BENZOPYRIDOINDOLE DERIVATIVE INHIBITOR
3300, 3lijA, 0.7806, 2.82, 0.235, 465, 255, CRYSTAL STRUCTURE OF FULL LENGTH CPCDPK3 (CGD5_820) IN COMPLEX WITH CA2+ AND AMPPNP
3301, 3f3zA, 0.7806, 2.86, 0.183, 271, 257, CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM CALCIUM DEPENDENT PROTEIN KINASE CGD7_1840 IN PRESENCE OF INDIRUBIN E804
3302, 1csnA, 0.7806, 3.32, 0.169, 293, 266, BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP
3303, 5ctpA, 0.7805, 2.83, 0.192, 324, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(3-CHLORO-4-(PHENYL) BENZYLAMINO)PROPYL)ACETAMIDE BOUND
3304, 4yuqB, 0.7805, 2.59, 0.264, 462, 250, CDPK1 FROM EIMERIA TENELLA IN COMPLEX WITH INHIBITOR UW1354
3305, 3tz9A, 0.7805, 2.37, 0.313, 261, 246, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL130
3306, 3tz7A, 0.7805, 2.31, 0.310, 260, 245, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL103
3307, 3owlA, 0.7805, 2.83, 0.188, 330, 255, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A BENZOPYRIDOINDOLE DERIVATIVE INHIBITOR
3308, 3kvwA, 0.7805, 2.79, 0.219, 403, 251, CRYSTAL STRUCTURE OF DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 2 (DYRK2) IN COMPLEX WITH AN INDIRUBIN LIGAND
3309, 3k2lA, 0.7805, 2.97, 0.224, 402, 254, CRYSTAL STRUCTURE OF DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 2 (DYRK2)
3310, 2xzsB, 0.7805, 2.97, 0.224, 293, 259, DEATH ASSOCIATED PROTEIN KINASE 1 RESIDUES 1-312
3311, 2rfnA, 0.7805, 2.21, 0.315, 268, 241, X-RAY STRUCTURE OF C-MET WITH INHIBITOR.
3312, 2zoqA, 0.7804, 3.08, 0.202, 351, 257, STRUCTURAL DISSECTION OF HUMAN MITOGEN-ACTIVATED KINASE ERK1
3313, 1okwC, 0.7804, 2.88, 0.263, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN-(M-CL-PHE)-NH2
3314, 5movA, 0.7803, 2.81, 0.184, 325, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0633 BOUND
3315, 5j7bA, 0.7803, 2.35, 0.264, 277, 246, THE IDENTIFICATION AND PHARMACOLOGICAL CHARACTERIZATION OF 6-(TERT- BUTYLSULFONYL)-N-(5-FLUORO-1H-INDAZOL-3-YL)QUINOLIN-4-AMINE (GSK583) A HIGHLY POTENT AND SELECTIVE INHIBITOR OF RIP2 KINASE GSK583 COMPLEX
3316, 5bvoA, 0.7803, 2.72, 0.368, 276, 253, FRAGMENT-BASED DISCOVERY OF POTENT AND SELECTIVE DDR1/2 INHIBITORS
3317, 4qtbB, 0.7803, 2.98, 0.196, 348, 255, STRUCTURE OF HUMAN ERK1 IN COMPLEX WITH SCH772984 REVEALING A NOVEL INHIBITOR-INDUCED BINDING POCKET
3318, 4q9sA, 0.7803, 2.34, 0.336, 252, 247, CRYSTAL STRUCTURE OF HUMAN FOCAL ADHESION KINASE (FAK) BOUND TO COMPOUND1 (35-DIHYDRO[124]TRIAZINO[34-C][14]BENZOXAZIN-2(1H)- ONE)
3319, 4dawA, 0.7803, 2.83, 0.215, 293, 256, CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH THE RUTHENIUM PHTHALIMIDE COMPLEX
3320, 4bicA, 0.7803, 2.53, 0.263, 260, 247, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
3321, 3tz8A, 0.7803, 2.39, 0.313, 261, 246, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL104
3322, 2gmxA, 0.7803, 2.92, 0.227, 357, 256, SELECTIVE AMINOPYRIDINE-BASED C-JUN N-TERMINAL KINASE INHIBITORS WITH CELLULAR ACTIVITY
3323, 2bkzC, 0.7803, 2.93, 0.258, 298, 256, STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611
3324, 6gihA, 0.7802, 2.76, 0.190, 324, 253, CRYSTAL STRUCTURE OF CK2ALPHA WITH CAM187 BOUND 
3325, 5y86A, 0.7802, 2.93, 0.217, 391, 253, CRYSTAL STRUCTURE OF KINASE 
3326, 5v19B, 0.7802, 2.52, 0.259, 260, 247, STRUCTURE-BASED DRUG DESIGN OF NOVEL ASK1 INHIBITORS USING A FULLY INTEGRATED LEAD OPTIMIZATION STRATEGY
3327, 5ouuA, 0.7802, 2.78, 0.186, 324, 253, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 22
3328, 5j5sB, 0.7802, 2.15, 0.313, 258, 243, SRC KINASE IN COMPLEX WITH A SULFONAMIDE INHIBITOR
3329, 4kioB, 0.7802, 1.67, 0.332, 239, 235, KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH A COVALENTLY-BINDING INHIBITOR
3330, 2fumB, 0.7802, 2.38, 0.215, 262, 246, CATALYTIC DOMAIN OF PROTEIN KINASE PKNB FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MITOXANTRONE
3331, 2b9jA, 0.7802, 2.62, 0.233, 337, 249, CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM FAR1
3332, 4eooA, 0.7801, 2.80, 0.260, 294, 254, THR 160 PHOSPHORYLATED CDK2 Q131E - HUMAN CYCLIN A3 COMPLEX WITH ATP
3333, 3f5pF, 0.7801, 3.06, 0.291, 299, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3334, 2wmaA, 0.7801, 2.85, 0.267, 296, 255, STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OF PEPTIDE LIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A
3335, 2bujA, 0.7801, 3.17, 0.216, 291, 259, CRYSTAL STRUCTURE OF THE HUMAN SERINE-THREONINE KINASE 16 IN COMPLEX WITH STAUROSPORINE
3336, 2b9hA, 0.7801, 2.63, 0.233, 337, 249, CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM STE7
3337, 1mqbA, 0.7801, 2.60, 0.339, 263, 251, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE
3338, 6cpeA, 0.7800, 2.49, 0.261, 256, 249, STRUCTURE OF APO; DEPHOSPHORYLATED AURORA A (122-403) IN AN ACTIVE CONFORMATION 
3339, 4eoqA, 0.7800, 2.86, 0.267, 295, 255, THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH ATP
3340, 3n9xA, 0.7800, 3.01, 0.195, 374, 257, CRYSTAL STRUCTURE OF MAP KINASE FROM PLASMODIUM BERGHEI PB000659.00.0
3341, 5cvgA, 0.7799, 2.69, 0.183, 326, 251, CRYSTAL STRUCTURE OF CK2ALPHA WITH A NOVEL CLOSED CONFORMATION OF THE AD LOOP
3342, 4ysmB, 0.7799, 3.07, 0.224, 475, 259, CALCIUM-DEPENDENT PROTEIN KINASE FROM EIMERIA TENELLA
3343, 4u43A, 0.7799, 2.76, 0.243, 287, 251, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 6)
3344, 4cxaA, 0.7799, 2.96, 0.249, 329, 257, CRYSTAL STRUCTURE OF THE HUMAN CDK12-CYCLIN K COMPLEX BOUND TO AMPPNP
3345, 3v8tA, 0.7799, 1.63, 0.333, 238, 234, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 477
3346, 3mb7A, 0.7799, 2.83, 0.188, 330, 255, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A DIFURANE DERIVATIVE INHIBITOR (AMR)
3347, 5i8aA, 0.7798, 2.13, 0.398, 269, 241, TRKA WITH (6~{R})-3-METHYLSULFANYL-6-PHENYL-1-(1~{H}-PYRAZOL-3-YL)-6 7-DIHYDRO-5~{H}-THIENO[34-C]PYRIDIN-4-ONE
3348, 3tnwC, 0.7798, 2.75, 0.262, 291, 252, STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH CAN508
3349, 3qriA, 0.7798, 2.67, 0.391, 275, 248, THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DCC- 2036
3350, 2rfnB, 0.7798, 2.22, 0.315, 269, 241, X-RAY STRUCTURE OF C-MET WITH INHIBITOR.
3351, 2fumA, 0.7798, 2.46, 0.215, 263, 247, CATALYTIC DOMAIN OF PROTEIN KINASE PKNB FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MITOXANTRONE
3352, 4yljB, 0.7797, 2.81, 0.231, 347, 251, CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-IODO-SUBSTITUTED 11H- INDOLO[32-C]QUINOLINE-6-CARBOXYLIC ACID INHIBITOR 5J
3353, 4y83B, 0.7797, 2.57, 0.203, 302, 251, CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(2-AMINO-5- (QUINOLIN-3-YL)PYRIDIN-3-YL)-134-OXADIAZOLE-2(3H)-THIONE
3354, 4pp7B, 0.7797, 2.67, 0.299, 274, 251, HIGHLY POTENT AND SELECTIVE 3-N-METHYLQUINAZOLINE-4(3H)-ONE BASED INHIBITORS OF B-RAFV600E KINASE
3355, 3q5iA, 0.7797, 2.81, 0.245, 470, 253, CRYSTAL STRUCTURE OF PBANKA_031420
3356, 2wfyC, 0.7797, 2.89, 0.259, 296, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3357, 2uueA, 0.7797, 2.93, 0.254, 296, 256, REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
3358, 2i0eA, 0.7797, 2.71, 0.242, 326, 252, STRUCTURE OF CATALYTIC DOMAIN OF HUMAN PROTEIN KINASE C BETA II COMPLEXED WITH A BISINDOLYLMALEIMIDE INHIBITOR
3359, 5p9lA, 0.7796, 2.35, 0.333, 252, 246, BTK1 IN COMPLEX WITH CC 292
3360, 5fd2A, 0.7796, 2.74, 0.310, 264, 252, B-RAF WILD-TYPE KINASE DOMAIN IN COMPLEX WITH A PURINYLPYRIDINYLAMINO- BASED INHIBITOR
3361, 3ztxA, 0.7796, 2.76, 0.201, 269, 254, AURORA KINASE SELECTIVE INHIBITORS IDENTIFIED USING A TAXOL- INDUCED CHECKPOINT SENSITIVITY SCREEN.
3362, 3uytC, 0.7796, 3.30, 0.204, 286, 265, CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P1 CRYSTAL FORM
3363, 3lw0B, 0.7796, 2.74, 0.320, 292, 250, IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1
3364, 3f5pJ, 0.7796, 3.02, 0.292, 293, 257, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3365, 3f5pE, 0.7796, 3.08, 0.291, 299, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3366, 3f3tA, 0.7796, 2.41, 0.312, 261, 247, KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL38 (TYPE III)
3367, 5j7bB, 0.7795, 2.34, 0.264, 281, 246, THE IDENTIFICATION AND PHARMACOLOGICAL CHARACTERIZATION OF 6-(TERT- BUTYLSULFONYL)-N-(5-FLUORO-1H-INDAZOL-3-YL)QUINOLIN-4-AMINE (GSK583) A HIGHLY POTENT AND SELECTIVE INHIBITOR OF RIP2 KINASE GSK583 COMPLEX
3368, 5fqdF, 0.7795, 3.22, 0.194, 294, 263, STRUCTURAL BASIS OF LENALIDOMIDE INDUCED CK1A DEGRADATION BY THE CRL4CRBN UBIQUITIN LIGASE
3369, 5cu6A, 0.7795, 2.90, 0.187, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA
3370, 4yzbB, 0.7795, 3.00, 0.257, 464, 257, CDPK1 FROM EIMERIA TENELLA IN COMPLEX WITH INHIBITOR UW1521
3371, 4pmtA, 0.7795, 2.40, 0.389, 273, 244, THE STRUCTURE OF TRKA KINASE BOUND TO THE INHIBITOR N~4~-(4-MORPHOLIN- 4-YLPHENYL)-N~6~-(PYRIDIN-3-YLMETHYL)PYRIDO[32-D]PYRIMIDINE-46- DIAMINE
3372, 4obpA, 0.7795, 2.86, 0.241, 285, 253, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 29) 6-(2-FLUOROPYRIDIN-4- YL)PYRIDO[32-D]PYRIMIDIN-4-AMINE
3373, 4ianB, 0.7795, 2.90, 0.221, 319, 253, CRYSTAL STRUCTURE OF APO HUMAN PRPF4B KINASE DOMAIN
3374, 4e4xB, 0.7795, 2.79, 0.304, 274, 253, CRYSTAL STRUCTURE OF B-RAF KINASE DOMAIN IN COMPLEX WITH A DIHYDROPYRIDO[23-D]PYRIMIDINONE-BASED INHIBITOR
3375, 3qd0A, 0.7795, 2.53, 0.250, 274, 248, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH (2R5S)- 1-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4-PYRIMIDINYL]-6-METHYL-N- PHENYL-3-PIPERIDINECARBOXAMIDE
3376, 2xh5A, 0.7795, 2.84, 0.235, 316, 255, STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(23-D) PYRIMIDIN-4-YL)PIPERIDIN-4-AMINE BOUND TO PKB
3377, 1ol1A, 0.7795, 2.93, 0.258, 296, 256, CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE-(P-F-PHE)-NH2
3378, 5ke0A, 0.7794, 3.11, 0.202, 340, 258, DISCOVERY OF 1-1H-PYRAZOLO 43-C PYRIDINE-6-YL UREA INHIBITORS OF EXTRACELLULAR SIGNAL REGULATED KINASE ERK FOR THE TREATMENT OF CANCERS
3379, 5ax9A, 0.7794, 2.62, 0.242, 282, 248, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2 AND NCK- INTERACTING PROTEIN KINASE IN COMPLEX WITH COMPUND 9
3380, 4y73C, 0.7794, 2.61, 0.282, 290, 248, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN WITH INHIBITOR
3381, 4tw9A, 0.7794, 3.25, 0.202, 290, 262, DIFLUORO-DIOXOLO-BENZOIMIDAZOL-BENZAMIDES AS POTENT INHIBITORS OF CK1DELTA AND EPSILON WITH NANOMOLAR INHIBITORY ACTIVITY ON CANCER CELL PROLIFERATION
3382, 4pp7A, 0.7794, 2.76, 0.292, 267, 253, HIGHLY POTENT AND SELECTIVE 3-N-METHYLQUINAZOLINE-4(3H)-ONE BASED INHIBITORS OF B-RAFV600E KINASE
3383, 4grbA, 0.7794, 2.91, 0.187, 327, 256, CASEIN KINASE 2 (CK2) BOUND TO INHIBITOR
3384, 4csvA, 0.7794, 2.08, 0.387, 244, 240, TYROSINE KINASE AS - A COMMON ANCESTOR OF SRC AND ABL BOUND TO GLEEVEC
3385, 3lw0A, 0.7794, 2.74, 0.320, 292, 250, IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1
3386, 2qonA, 0.7794, 2.62, 0.337, 281, 249, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y596F:Y602F:Y742A TRIPLE MUTANT
3387, 2f2cB, 0.7794, 2.92, 0.237, 280, 253, X-RAY STRUCTURE OF HUMAN CDK6-VCYCLINWITH THE INHIBITOR AMINOPURVALANOL
3388, 5tehA, 0.7793, 2.30, 0.306, 261, 245, C-SRC V281C KINASE DOMAIN IN COMPLEX WITH RAO-IV-156
3389, 5oulA, 0.7793, 2.90, 0.187, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 9
3390, 5kx8C, 0.7793, 2.61, 0.282, 287, 248, IRAK4-INHIBITOR CO-STRUCTURE
3391, 3lw0C, 0.7793, 2.75, 0.320, 292, 250, IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1
3392, 2uzdC, 0.7793, 2.85, 0.268, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
3393, 1uwhB, 0.7793, 2.66, 0.299, 264, 251, THE COMPLEX OF WILD TYPE B-RAF AND BAY439006
3394, 1uu3A, 0.7793, 2.60, 0.249, 276, 249, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH LY333531
3395, 1fmkA, 0.7793, 2.52, 0.310, 437, 248, CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC
3396, 6b2qB, 0.7792, 2.65, 0.252, 266, 250, DUAL INHIBITION OF THE ESSENTIAL PROTEIN KINASES A AND B IN MYCOBACTERIUM TUBERCULOSIS
3397, 5uq2A, 0.7792, 2.89, 0.255, 296, 255, CRYSTAL STRUCTURE OF HUMAN CDK2-SPY1 COMPLEX
3398, 5mp8B, 0.7792, 2.77, 0.190, 323, 253, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0432 BOUND
3399, 5m4uA, 0.7792, 2.95, 0.187, 332, 256, ORTHORHOMBIC COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA ) WITH THE INHIBITOR 4 -CARBOXY-68-CHLORO- FLAVONOL (FLC21)
3400, 4ysmA, 0.7792, 3.08, 0.224, 475, 259, CALCIUM-DEPENDENT PROTEIN KINASE FROM EIMERIA TENELLA
3401, 4gk2A, 0.7792, 2.39, 0.362, 265, 246, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 66
3402, 4cfwA, 0.7792, 2.90, 0.262, 299, 256, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
3403, 4c57B, 0.7792, 3.18, 0.221, 308, 258, STRUCTURE OF GAK KINASE IN COMPLEX WITH A NANOBODY
3404, 3lw0D, 0.7792, 2.75, 0.320, 292, 250, IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1
3405, 2vx3C, 0.7792, 2.76, 0.232, 338, 250, CRYSTAL STRUCTURE OF THE HUMAN DUAL SPECIFICITY TYROSINE- PHOSPHORYLATION-REGULATED KINASE 1A
3406, 2eu9A, 0.7792, 3.06, 0.180, 345, 255, CRYSTAL STRUCTURE OF CLK3
3407, 3f5pR, 0.7791, 3.07, 0.291, 294, 258, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
3408, 4ztmA, 0.7790, 2.60, 0.283, 287, 247, IRAK4-INHIBITOR CO-STRUCTURE
3409, 1yolA, 0.7790, 2.06, 0.307, 256, 241, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH CGP77675
3410, 1h25C, 0.7790, 2.81, 0.265, 278, 253, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN
3411, 5otqA, 0.7789, 2.94, 0.187, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 33
3412, 4zk5A, 0.7789, 2.86, 0.241, 286, 253, MAP4K4 IN COMPLEX WITH INHIBITOR GNE-495
3413, 4g9cB, 0.7789, 2.68, 0.299, 264, 251, HUMAN B-RAF KINASE DOMAIN BOUND TO A TYPE II PYRAZOLOPYRIDINE INHIBITOR
3414, 4o0rA, 0.7788, 2.90, 0.215, 293, 256, BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
3415, 4bcpC, 0.7788, 2.81, 0.266, 267, 252, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
3416, 1pjkA, 0.7788, 2.86, 0.188, 331, 255, CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
3417, 5sysB, 0.7787, 2.27, 0.303, 258, 244, C-SRC V281C BOUND TO N-[3-({6-[(1E)-2-CYANO-3-(METHYLAMINO)-3-OXOPROP- 1-EN-1-YL]-7-(2-METHOXYETHYL)-7H-PYRROLO[23-D]PYRIMIDIN-5- YL}ETHYNYL)-4-METHYLPHENYL]-3-(TRIFLUOROMETHYL)BENZAMIDE INHIBITOR
3418, 4ix5A, 0.7787, 3.20, 0.127, 346, 260, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE IN COMPLEX WITH AMP-PNP
3419, 1fvvC, 0.7787, 2.91, 0.263, 298, 255, THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLE INHIBITOR
3420, 4cfmC, 0.7786, 2.71, 0.267, 266, 251, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
3421, 1kobB, 0.7786, 3.06, 0.204, 352, 260, TWITCHIN KINASE FRAGMENT (APLYSIA) AUTOREGULATED PROTEIN KINASE DOMAIN
3422, 6fyrA, 0.7785, 3.08, 0.180, 355, 255, X-RAY STRUCTURE OF CLK3-KD(GP-[275-632]; NON-PHOS.)/CPD-2 AT 1.42A 
3423, 5nk8A, 0.7785, 2.38, 0.340, 266, 244, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2F
3424, 4ijpA, 0.7785, 2.92, 0.221, 330, 253, CRYSTAL STRUCTURE OF HUMAN PRPF4B KINASE DOMAIN IN COMPLEX WITH 4-{5- [(2-CHLORO-PYRIDIN-4-YLMETHYL)-CARBAMOYL]-THIOPHEN-2-YL}- BENZO[B]THIOPHENE-2-CARBOXYLIC ACID AMINE
3425, 4fv7A, 0.7785, 3.16, 0.194, 342, 258, CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E94
3426, 3owjA, 0.7785, 2.83, 0.184, 328, 255, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A PYRIDOCARBAZOLE DERIVATIVE INHIBITOR
3427, 6fu5B, 0.7784, 2.38, 0.256, 286, 246, STRUCTURE OF THE KINASE DOMAIN OF HUMAN RIPK2 IN COMPLEX WITH THE INHIBITOR CSLP18 
3428, 5xqxA, 0.7784, 2.88, 0.206, 340, 253, HUMAN CDK8-CYCC IN COMPLEX WITH COMPOUND 4: N-METHYL-4-(4-PYRIDYL)-1H- PYRROLE-2-CARBOXAMIDE
3429, 5w4wB, 0.7784, 3.25, 0.186, 291, 263, IDENTIFICATION AND PROFILING OF A SELECTIVE AND BRAIN PENETRANT RADIOLIGAND FOR IN VIVO TARGET OCCUPANCY MEASUREMENT OF CASEIN KINASE 1 (CK1) INHIBITORS
3430, 5nhlA, 0.7784, 3.02, 0.200, 345, 255, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
3431, 5l8lA, 0.7784, 2.81, 0.224, 263, 255, AURORA-A KINASE DOMAIN IN COMPLEX WITH VNAR-D01 (CRYSTAL FORM 1)
3432, 5dpvA, 0.7784, 2.57, 0.260, 257, 250, AURORA A KINASE IN COMPLEX WITH AA35 AND JNJ-7706621 IN SPACE GROUP P6122
3433, 4fzdB, 0.7784, 2.81, 0.270, 275, 252, CRYSTAL STRUCTURE OF MST4-MO25 COMPLEX WITH WSF MOTIF
3434, 3tl8G, 0.7784, 2.74, 0.261, 301, 253, THE AVRPTOB-BAK1 COMPLEX REVEALS TWO STRUCTURALLY SIMILAR KINASEINTERACTING DOMAINS IN A SINGLE TYPE III EFFECTOR
3435, 2wxvC, 0.7784, 2.97, 0.258, 299, 256, STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(43-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR
3436, 2csnA, 0.7784, 3.34, 0.169, 293, 266, BINARY COMPLEX OF CASEIN KINASE-1 WITH CKI7
3437, 1p5eA, 0.7784, 3.00, 0.258, 296, 256, THE STRUCTURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4567-TETRABROMOBENZOTRIAZOLE (TBS)
3438, 1jktB, 0.7784, 2.81, 0.247, 276, 255, TETRAGONAL CRYSTAL FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE
3439, 5nudA, 0.7783, 2.42, 0.360, 267, 247, FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527
3440, 4au8B, 0.7783, 2.51, 0.239, 277, 247, CRYSTAL STRUCTURE OF COMPOUND 4A IN COMPLEX WITH CDK5 SHOWING AN UNUSUAL BINDING MODE TO THE HINGE REGION VIA A WATER MOLECULE
3441, 2yn8A, 0.7783, 2.30, 0.332, 253, 244, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
3442, 2og8A, 0.7783, 2.24, 0.364, 246, 242, CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 36 BOUND TO LCK
3443, 1uv5A, 0.7783, 3.18, 0.222, 348, 257, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3 -OXIME
3444, 5dr9A, 0.7782, 2.67, 0.260, 257, 250, AURORA A KINASE IN COMPLEX WITH AA29 AND JNJ-7706621 IN SPACE GROUP P6122
3445, 4ix4A, 0.7782, 3.21, 0.127, 346, 260, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE IN COMPLEX WITH ADP
3446, 3nszA, 0.7782, 2.91, 0.191, 327, 256, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH AMPPN
3447, 3dkfA, 0.7782, 2.89, 0.331, 294, 251, STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR SGX-523
3448, 3d15A, 0.7782, 2.60, 0.244, 256, 250, CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY LYS240->ARG MET302- >LEU) IN COMPLEX WITH 1-(3-CHLORO-PHENYL)-3-{5-[2-(THIENO[32- D]PYRIMIDIN-4-YLAMINO)- ETHYL]-THIAZOL-2-YL}-UREA [SNS-314]
3449, 5mxxA, 0.7781, 3.22, 0.182, 361, 258, CRYSTAL STRUCTURE OF HUMAN SR PROTEIN KINASE 1 (SRPK1) IN COMPLEX WITH COMPOUND 1
3450, 5fetA, 0.7781, 2.92, 0.203, 802, 256, CRYSTAL STRUCTURE OF PVX_084705 IN PRESENCE OF COMPOUND 2
3451, 5d7aB, 0.7781, 2.78, 0.243, 286, 251, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TRAF2 AND NCK-INTERACTING PROTEIN KINASE WITH NCB-0846
3452, 4eheA, 0.7781, 2.80, 0.296, 266, 253, B-RAF KINASE DOMAIN IN COMPLEX WITH AN AMINOTHIENOPYRIMIDINE-BASED INHIBITOR
3453, 6g97A, 0.7780, 3.16, 0.205, 344, 258, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
3454, 6fu5A, 0.7780, 2.45, 0.264, 282, 246, STRUCTURE OF THE KINASE DOMAIN OF HUMAN RIPK2 IN COMPLEX WITH THE INHIBITOR CSLP18 
3455, 5lvpC, 0.7780, 2.65, 0.256, 275, 250, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN HM-PEPTIDE BOUND TO THE PIF-POCKET
3456, 4ix6A, 0.7780, 3.21, 0.127, 346, 260, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE SOAKED WITH ATP
3457, 2wu6A, 0.7780, 3.13, 0.176, 350, 256, CRYSTAL STRUCTURE OF THE HUMAN CLK3 IN COMPLEX WITH DKI
3458, 2wipA, 0.7780, 2.82, 0.249, 297, 253, STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1- METHYL-45-DIHYDRO-1H-PYRAZOLO[43-H] QUINAZOLINE-3- CARBOXYLIC ACID
3459, 5w4wA, 0.7779, 3.23, 0.187, 291, 262, IDENTIFICATION AND PROFILING OF A SELECTIVE AND BRAIN PENETRANT RADIOLIGAND FOR IN VIVO TARGET OCCUPANCY MEASUREMENT OF CASEIN KINASE 1 (CK1) INHIBITORS
3460, 4ijpB, 0.7779, 2.92, 0.221, 333, 253, CRYSTAL STRUCTURE OF HUMAN PRPF4B KINASE DOMAIN IN COMPLEX WITH 4-{5- [(2-CHLORO-PYRIDIN-4-YLMETHYL)-CARBAMOYL]-THIOPHEN-2-YL}- BENZO[B]THIOPHENE-2-CARBOXYLIC ACID AMINE
3461, 1okvC, 0.7779, 2.90, 0.263, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2
3462, 4nu1A, 0.7778, 3.14, 0.222, 356, 257, CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED N-TERMINAL AUTO-INHIBITORY PS9 PEPTIDE
3463, 4ix3A, 0.7778, 3.22, 0.131, 346, 260, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE
3464, 3d2iA, 0.7778, 2.61, 0.244, 255, 250, CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY LYS240- >ARG MET302->LEU) IN COMPLEX WITH 1-{5-[2-(1-METHYL-1H- PYRAZOLO[43-D]PYRIMIDIN-7-YLAMINO)-ETHYL]-THIAZOL-2-YL}-3- (3-TRIFLUOROMETHYL-PHENYL)-UREA
3465, 2p2hA, 0.7778, 2.48, 0.367, 292, 248, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDINYL-TRIAZINE INHIBITOR
3466, 6cpfA, 0.7777, 2.57, 0.257, 259, 249, STRUCTURE OF DEPHOSPHORYLATED AURORA A (122-403) BOUND TO AMPPCP IN AN ACTIVE CONFORMATION 
3467, 4qo9B, 0.7777, 2.81, 0.248, 285, 254, MST3 IN COMPLEX WITH DANUSERTIB
3468, 4pqnA, 0.7777, 1.89, 0.336, 240, 238, ITK KINASE DOMAIN WITH COMPOUND GNE-9822
3469, 4ifcB, 0.7777, 2.89, 0.218, 329, 252, CRYSTAL STRUCTURE OF ADP-BOUND HUMAN PRPF4B KINASE DOMAIN
3470, 3f3wB, 0.7777, 2.42, 0.317, 260, 246, DRUG RESISTANT CSRC KINASE DOMAIN IN COMPLEX WITH INHIBITOR RL45 (TYPE II)
3471, 2wtkC, 0.7777, 2.82, 0.213, 285, 253, STRUCTURE OF THE HETEROTRIMERIC LKB1-STRADALPHA-MO25ALPHA COMPLEX
3472, 2wfyA, 0.7777, 2.92, 0.259, 295, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3473, 1mp8A, 0.7777, 2.38, 0.321, 252, 246, CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE (FAK)
3474, 6cz3A, 0.7776, 2.59, 0.331, 262, 248, STRUCTURE OF THE PTK6 KINASE DOMAIN BOUND TO A TYPE I INHIBITOR (3- FLUORO-4-{[6-METHYL-3-(1H-PYRAZOL-4-YL)IMIDAZO[1;2-A]PYRAZIN-8- YL]AMINO}PHENYL)(MORPHOLIN-4-YL)METHANONE 
3475, 5if1C, 0.7776, 2.91, 0.263, 296, 255, CRYSTAL STRUCTURE APO CDK2/CYCLIN A
3476, 3e8nA, 0.7776, 3.19, 0.239, 291, 259, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) COMPLEXED WITH A POTENT INHIBITOR RDEA119 AND MGATP
3477, 2qi8A, 0.7776, 2.17, 0.322, 255, 242, CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN
3478, 1kobA, 0.7776, 3.05, 0.200, 352, 260, TWITCHIN KINASE FRAGMENT (APLYSIA) AUTOREGULATED PROTEIN KINASE DOMAIN
3479, 6ft7B, 0.7775, 3.17, 0.180, 356, 256, CRYSTAL STRUCTURE OF CLK3 IN COMPLEX WITH COMPOUND 8A 
3480, 5nhpA, 0.7775, 3.21, 0.205, 338, 259, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
3481, 5lpzA, 0.7775, 2.72, 0.249, 283, 249, CRYSTAL STRUCTURE OF THE BRI1 KINASE DOMAIN (865-1196) IN COMPLEX WITH ADP FROM ARABIDOPSIS THALIANA
3482, 4jr7A, 0.7775, 2.84, 0.178, 367, 253, CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH GMPPNP
3483, 4ifcA, 0.7775, 2.93, 0.221, 327, 253, CRYSTAL STRUCTURE OF ADP-BOUND HUMAN PRPF4B KINASE DOMAIN
3484, 2bfyA, 0.7775, 2.81, 0.201, 270, 254, COMPLEX OF AURORA-B WITH INCENP AND HESPERADIN.
3485, 1h24C, 0.7775, 3.02, 0.262, 293, 256, CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F
3486, 5uafA, 0.7774, 2.67, 0.346, 291, 246, MET TYROSINE KINASE INHIBITION ENHANCES THE ANTITUMOR EFFICACY OF AN HGF ANTIBODY
3487, 5uadA, 0.7774, 2.67, 0.346, 291, 246, MET TYROSINE KINASE INHIBITION ENHANCES THE ANTITUMOR EFFICACY OF AN HGF ANTIBODY
3488, 4ysjA, 0.7774, 2.54, 0.262, 459, 248, CALCIUM-DEPENDENT PROTEIN KINASE FROM EIMERIA TENELLA IN COMPLEX WITH ADP
3489, 4bicB, 0.7774, 2.47, 0.272, 259, 246, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
3490, 2vx3D, 0.7774, 2.77, 0.232, 342, 250, CRYSTAL STRUCTURE OF THE HUMAN DUAL SPECIFICITY TYROSINE- PHOSPHORYLATION-REGULATED KINASE 1A
3491, 2erkA, 0.7774, 2.74, 0.190, 351, 252, PHOSPHORYLATED MAP KINASE ERK2
3492, 1pkdA, 0.7774, 2.90, 0.267, 296, 255, THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO- CDK2/CYCLIN A
3493, 5up3A, 0.7773, 2.44, 0.265, 258, 245, STRUCTURE-BASED DESIGN OF ASK1 INHIBITORS AS POTENTIAL FIRST-IN-CLASS AGENTS FOR HEART FAILURE
3494, 5fqdC, 0.7773, 3.25, 0.194, 294, 263, STRUCTURAL BASIS OF LENALIDOMIDE INDUCED CK1A DEGRADATION BY THE CRL4CRBN UBIQUITIN LIGASE
3495, 5dr6A, 0.7773, 2.67, 0.260, 257, 250, AURORA A KINASE IN COMPLEX WITH AA30 AND JNJ-7706621 IN SPACE GROUP P6122
3496, 4twcB, 0.7773, 3.20, 0.188, 292, 261, 2-BENZAMIDO-N-(1H-BENZO[D]IMIDAZOL-2-YL)THIAZOLE-4- CARBOXAMIDE DERIVATIVES AS POTENT INHIBITORS OF CK1D/E
3497, 4b8mA, 0.7773, 2.80, 0.201, 270, 254, AURORA B KINASE IN COMPLEX WITH VX-680
3498, 3w8lA, 0.7773, 2.89, 0.181, 326, 254, CRYSTAL STRUCTURE OF HUMAN CK2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE
3499, 3ag9B, 0.7773, 2.80, 0.224, 317, 254, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1012
3500, 2vrxA, 0.7773, 2.80, 0.197, 268, 254, STRUCTURE OF AURORA B KINASE IN COMPLEX WITH ZM447439
3501, 6brcA, 0.7772, 2.90, 0.242, 265, 252, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH AP26113-ANALOG (ALK-IN-1)
3502, 4ztlD, 0.7772, 2.63, 0.283, 285, 247, IRAK4-INHIBITOR CO-STRUCTURE
3503, 4rfmA, 0.7772, 2.41, 0.306, 249, 245, ITK KINASE DOMAIN IN COMPLEX WITH COMPOUND 1 N-{1-[(11-DIOXO-1-THIAN- 2-YL)(PHENYL)METHYL]-1H- PYRAZOL-4-YL}-55-DIFLUORO-5A-METHYL-1H4H 4AH5H5AH6H-CYCLOPROPA[F]INDAZOLE-3-CARBOXAMIDE
3504, 4mq1D, 0.7772, 2.75, 0.233, 336, 249, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
3505, 3iecC, 0.7772, 2.68, 0.263, 311, 251, HELICOBACTER PYLORI CAGA INHIBITS PAR1/MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
3506, 3brbB, 0.7772, 2.66, 0.327, 271, 248, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE- PROTEIN KINASE MER IN COMPLEX WITH ADP
3507, 1finA, 0.7772, 2.93, 0.263, 298, 255, CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX
3508, 4bidB, 0.7771, 2.44, 0.269, 258, 245, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
3509, 4anbA, 0.7771, 2.94, 0.243, 282, 255, CRYSTAL STRUCTURES OF HUMAN MEK1 WITH CARBOXAMIDE-BASED ALLOSTERIC INHIBITOR XL518 (GDC-0973) OR RELATED ANALOGS.
3510, 4agwA, 0.7771, 2.25, 0.307, 258, 244, DISCOVERY OF A SMALL MOLECULE TYPE II INHIBITOR OF WILD- TYPE AND GATEKEEPER MUTANTS OF BCR-ABL PDGFRALPHA KIT AND SRC KINASES
3511, 3iecD, 0.7771, 2.67, 0.263, 311, 251, HELICOBACTER PYLORI CAGA INHIBITS PAR1/MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
3512, 2f57B, 0.7771, 2.81, 0.184, 299, 255, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 5
3513, 6dkwA, 0.7770, 2.49, 0.403, 284, 248, CRYSTAL STRUCTURE OF TRK-A IN COMPLEX WITH THE PAN-TRK KINASE INHIBITOR; COMPOUND 3. 
3514, 5mo4A, 0.7770, 2.26, 0.370, 429, 243, ABL1 KINASE (T334I_D382N) IN COMPLEX WITH ASCIMINIB AND NILOTINIB
3515, 4au8A, 0.7770, 2.57, 0.231, 276, 247, CRYSTAL STRUCTURE OF COMPOUND 4A IN COMPLEX WITH CDK5 SHOWING AN UNUSUAL BINDING MODE TO THE HINGE REGION VIA A WATER MOLECULE
3516, 3tz9B, 0.7770, 2.31, 0.303, 259, 244, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL130
3517, 3eidA, 0.7770, 2.76, 0.258, 292, 252, CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3518, 2yexA, 0.7770, 3.20, 0.234, 269, 256, SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE 1 INHIBITORS
3519, 2xyuA, 0.7770, 2.54, 0.343, 260, 248, CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH VUF 12058
3520, 1zwsE, 0.7770, 2.86, 0.233, 278, 257, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
3521, 5mqvC, 0.7769, 3.20, 0.187, 288, 262, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH 4-(2 5-DIMETHOXYPHENYL)-N-(4-(5-(4-FLUORPHENYL)-2-(METHYLTHIO)-1H- IMIDAZOL-4-YL)-PYRIDIN-2-YL)-1-METHYL-1H-PYRROLE-2-CARBOXAMIDE
3522, 4nttB, 0.7769, 2.81, 0.209, 339, 254, STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE BOUND TO ADP AND ONE MAGNESIUM ION
3523, 3eocC, 0.7769, 2.88, 0.260, 293, 254, CDK2/CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-AMINE
3524, 2vwvA, 0.7769, 2.45, 0.333, 255, 246, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
3525, 2bfxA, 0.7769, 2.81, 0.197, 269, 254, MECHANISM OF AURORA-B ACTIVATION BY INCENP AND INHIBITION BY HESPERADIN.
3526, 5otlA, 0.7768, 2.71, 0.191, 320, 251, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 29
3527, 4u7zA, 0.7768, 3.35, 0.238, 291, 261, MITOGEN-ACTIVATED PROTEIN KINASE KINASE (MEK1) BOUND TO G805
3528, 4eqcA, 0.7768, 2.90, 0.219, 296, 256, CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN IN COMPLEX WITH FRAX597 INHIBITOR
3529, 4bhnB, 0.7768, 2.39, 0.275, 257, 244, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
3530, 3brbA, 0.7768, 2.55, 0.325, 260, 246, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE- PROTEIN KINASE MER IN COMPLEX WITH ADP
3531, 5op2A, 0.7767, 3.00, 0.238, 263, 252, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH ARYLBENZAMIDE LRRK2 INHIBITOR
3532, 5lvpD, 0.7767, 2.67, 0.248, 276, 250, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN HM-PEPTIDE BOUND TO THE PIF-POCKET
3533, 5c03B, 0.7767, 2.29, 0.249, 260, 245, CRYSTAL STRUCTURE OF KINASE
3534, 4ztnD, 0.7767, 2.62, 0.283, 285, 247, IRAK4-INHIBITOR CO-STRUCTURE
3535, 4qp8B, 0.7767, 2.74, 0.198, 337, 252, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 2-(1H-PYRAZOL-4-YL)-7- (PYRIDIN-3-YL)-5H-PYRROLO[23-B]PYRAZINE
3536, 3v5qA, 0.7767, 2.24, 0.383, 263, 243, DISCOVERY OF A SELECTIVE TRK INHIBITOR WITH EFFICACY IN RODENT CANCER TUMOR MODELS
3537, 2vx3B, 0.7767, 2.81, 0.232, 340, 250, CRYSTAL STRUCTURE OF THE HUMAN DUAL SPECIFICITY TYROSINE- PHOSPHORYLATION-REGULATED KINASE 1A
3538, 1k9aC, 0.7767, 2.70, 0.336, 438, 247, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
3539, 5ng3A, 0.7766, 2.73, 0.265, 283, 253, STRUCTURE OF INACTIVE KINASE RIP2K(K47R)
3540, 4wa9A, 0.7766, 2.15, 0.361, 246, 241, THE CRYSTAL STRUCTURE OF HUMAN ABL1 WILD TYPE KINASE DOMAIN IN COMPLEX WITH AXITINIB
3541, 4mq1C, 0.7766, 2.78, 0.229, 328, 249, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
3542, 4fk3B, 0.7766, 2.45, 0.304, 257, 247, B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX3203
3543, 2wpaC, 0.7766, 2.99, 0.258, 299, 256, OPTIMISATION OF 66-DIMETHYL PYRROLO 34-C PYRAZOLES: IDENTIFICATION OF PHA-793887 A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING
3544, 1mruA, 0.7766, 2.48, 0.219, 269, 247, INTRACELLULAR SER/THR PROTEIN KINASE DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKNB.
3545, 6fc8A, 0.7765, 3.07, 0.232, 269, 254, CHK1 KINASE IN COMPLEX WITH COMPOUND 13
3546, 5vczA, 0.7765, 2.80, 0.219, 294, 251, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH BOSUTINIB ISOMER
3547, 5kx7B, 0.7765, 2.62, 0.283, 286, 247, IRAK4-INHIBITOR CO-STRUCTURE
3548, 4tyeA, 0.7765, 2.91, 0.357, 292, 255, STRUCTURAL ANALYSIS OF THE HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE
3549, 3iecB, 0.7765, 2.78, 0.257, 313, 253, HELICOBACTER PYLORI CAGA INHIBITS PAR1/MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
3550, 3etaB, 0.7765, 2.75, 0.312, 292, 250, KINASE DOMAIN OF INSULIN RECEPTOR COMPLEXED WITH A PYRROLO PYRIDINE INHIBITOR
3551, 2np8A, 0.7765, 2.57, 0.268, 256, 250, STRUCTURAL BASIS FOR THE INHIBITION OF AURORA A KINASE BY A NOVEL CLASS OF HIGH AFFINITY DISUBSTITUTED PYRIMIDINE INHIBITORS
3552, 1vr2A, 0.7765, 2.53, 0.371, 275, 248, HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN
3553, 1ol2A, 0.7765, 2.92, 0.259, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F-PHE)-NH2
3554, 5opbA, 0.7764, 2.93, 0.239, 262, 251, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH INDAZOLE LRRK2 INHIBITOR
3555, 4xs2A, 0.7764, 2.72, 0.283, 283, 247, IRAK4-INHIBITOR CO-STRUCTURE
3556, 1h25A, 0.7764, 3.00, 0.258, 293, 256, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN
3557, 6fckA, 0.7763, 3.21, 0.234, 269, 256, CHK1 KINASE IN COMPLEX WITH COMPOUND 13
3558, 5gjdA, 0.7763, 2.41, 0.283, 292, 247, CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH LIGAND 2
3559, 5cshB, 0.7763, 2.78, 0.187, 323, 252, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 4 BOUND
3560, 4yo6A, 0.7763, 2.64, 0.283, 286, 247, IRAK4-INHIBITOR CO-STRUCTURE
3561, 3cs9B, 0.7763, 2.07, 0.383, 247, 240, HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB
3562, 2wmaC, 0.7763, 2.71, 0.275, 265, 251, STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OF PEPTIDE LIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A
3563, 2nruB, 0.7763, 3.06, 0.274, 294, 252, CRYSTAL STRUCTURE OF IRAK-4
3564, 2b9fA, 0.7763, 2.67, 0.229, 337, 249, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FUS3
3565, 5l8kA, 0.7762, 2.96, 0.212, 266, 255, AURORA-A KINASE DOMAIN IN COMPLEX WITH VNAR-D01 (CRYSTAL FORM 2)
3566, 3krlA, 0.7762, 2.61, 0.340, 281, 247, CFMS TYROSINE KINASE IN COMPLEX WITH 5-CYANO-FURAN-2-CARBOXYLIC ACID [4-(4-METHYL-PIPERAZIN-1-YL)-2-PIPERIDIN-1-YL-PHENYL]-AMIDE
3567, 3a7gB, 0.7762, 2.89, 0.271, 290, 255, HUMAN MST3 KINASE
3568, 1vywC, 0.7762, 3.00, 0.258, 299, 256, STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137
3569, 4uy9B, 0.7761, 2.91, 0.332, 315, 253, STRUCTURE OF MLK1 KINASE DOMAIN WITH LEUCINE ZIPPER 1
3570, 4u6rA, 0.7761, 3.07, 0.206, 403, 257, CRYSTAL STRUCTURE OF HUMAN IRE1 CYTOPLASMIC DOMAINS IN COMPLEX WITH A SULFONAMIDE INHIBITOR.
3571, 3anqB, 0.7761, 2.84, 0.219, 343, 251, HUMAN DYRK1A/INHIBITOR COMPLEX
3572, 3a7gA, 0.7761, 2.88, 0.263, 289, 255, HUMAN MST3 KINASE
3573, 4g9cA, 0.7760, 2.47, 0.298, 265, 248, HUMAN B-RAF KINASE DOMAIN BOUND TO A TYPE II PYRAZOLOPYRIDINE INHIBITOR
3574, 3zuvA, 0.7760, 2.77, 0.190, 357, 252, CRYSTAL STRUCTURE OF A DESIGNED SELECTED ANKYRIN REPEAT PROTEIN IN COMPLEX WITH THE PHOSPHORYLATED MAP KINASE ERK2
3575, 3bhhD, 0.7760, 2.83, 0.202, 286, 253, CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 1 (CAMK2B)
3576, 3anrB, 0.7760, 2.84, 0.227, 342, 251, HUMAN DYRK1A/HARMINE COMPLEX
3577, 2r7iA, 0.7760, 2.77, 0.183, 322, 252, CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3578, 5hhwA, 0.7759, 2.73, 0.311, 306, 251, CRYSTAL STRUCTURE OF INSULIN RECEPTOR KINASE DOMAIN IN COMPLEX WITH CIS-(R)-7-(3-(AZETIDIN-1-YLMETHYL)CYCLOBUTYL)-5-(3-((TETRAHYDRO-2H- PYRAN-2-YL)METHOXY)PHENYL)-7H-PYRROLO[23-D]PYRIMIDIN-4-AMINE.
3579, 5ar4B, 0.7759, 2.39, 0.264, 279, 246, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH SB-203580
3580, 4an2A, 0.7759, 2.95, 0.243, 282, 255, CRYSTAL STRUCTURES OF HUMAN MEK1 WITH CARBOXAMIDE-BASED ALLOSTERIC INHIBITOR XL518 (GDC-0973) OR RELATED ANALOGS.
3581, 2oibD, 0.7759, 2.74, 0.281, 288, 249, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM
3582, 5hgiA, 0.7758, 2.93, 0.201, 395, 254, CRYSTAL STRUCTURE OF APO HUMAN IRE1 ALPHA
3583, 4bibB, 0.7758, 2.46, 0.273, 258, 245, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
3584, 3ej1C, 0.7758, 2.89, 0.260, 294, 254, CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3585, 2yerA, 0.7758, 3.07, 0.240, 268, 254, SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE 1 INHIBITORS
3586, 2wqbA, 0.7758, 2.63, 0.325, 289, 249, STRUCTURE OF THE TIE2 KINASE DOMAIN IN COMPLEX WITH A THIAZOLOPYRIMIDINE INHIBITOR
3587, 2vgoB, 0.7758, 2.77, 0.198, 277, 253, CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH REVERSINE INHIBITOR
3588, 5vcyA, 0.7757, 2.98, 0.218, 296, 252, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH BOSUTINIB
3589, 4e4xA, 0.7757, 2.85, 0.300, 267, 253, CRYSTAL STRUCTURE OF B-RAF KINASE DOMAIN IN COMPLEX WITH A DIHYDROPYRIDO[23-D]PYRIMIDINONE-BASED INHIBITOR
3590, 3tv4A, 0.7757, 2.72, 0.295, 264, 251, HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH AN BROMOPYRIDINE BENZAMIDE INHIBITOR
3591, 3pp1A, 0.7757, 3.24, 0.243, 291, 259, CRYSTAL STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK 1) IN COMPLEX WITH LIGAND AND MGATP
3592, 3fwqA, 0.7757, 2.98, 0.184, 334, 255, INACTIVE CONFORMATION OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
3593, 6ft7A, 0.7756, 3.14, 0.176, 356, 255, CRYSTAL STRUCTURE OF CLK3 IN COMPLEX WITH COMPOUND 8A 
3594, 5vd3A, 0.7756, 2.88, 0.207, 293, 251, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN (DE-PHOSPHORYLATED) IN COMPLEX WITH SARACATINIB
3595, 4ztnA, 0.7756, 2.66, 0.283, 286, 247, IRAK4-INHIBITOR CO-STRUCTURE
3596, 4ub7A, 0.7756, 3.19, 0.190, 334, 258, HIGH-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH 4 - CARBOXY-68-BROMO-FLAVONOL (FLC26) SHOWING AN EXTREME DISTORTION OF THE ATP-BINDING LOOP COMBINED WITH A PI-HALOGEN BOND
3597, 4cfvC, 0.7756, 2.72, 0.264, 264, 250, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
3598, 1jwhA, 0.7756, 3.12, 0.190, 336, 258, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 HOLOENZYME
3599, 1h27A, 0.7756, 2.93, 0.263, 296, 255, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27
3600, 6fyiA, 0.7755, 3.11, 0.192, 336, 255, X-RAY STRUCTURE OF CLK2-KD(130-496)/TG003 AT 2.6A 
3601, 5ntjA, 0.7755, 2.84, 0.229, 346, 253, CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUND RKP032 
3602, 4k9yA, 0.7755, 3.26, 0.304, 271, 257, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 1-[4-(6-AMINO- PURIN-9-YL)-PHENYL]-3-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-UREA
3603, 3tcpA, 0.7755, 2.35, 0.313, 256, 243, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC569
3604, 6b3eA, 0.7754, 3.51, 0.243, 309, 263, CRYSTAL STRUCTURE OF HUMAN CDK12/CYCLINK IN COMPLEX WITH AN INHIBITOR
3605, 5t1tC, 0.7754, 2.69, 0.282, 286, 248, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
3606, 5lvpB, 0.7754, 2.68, 0.256, 276, 250, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN HM-PEPTIDE BOUND TO THE PIF-POCKET
3607, 5kbqA, 0.7754, 2.91, 0.215, 289, 256, PAK1 IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
3608, 5efqA, 0.7754, 3.08, 0.248, 321, 258, CRYSTAL STRUCTURE OF HUMAN CDK13/CYCLIN K IN COMPLEX WITH ADP-ALUMINUM FLUORIDE
3609, 3pfqA, 0.7754, 2.77, 0.242, 520, 252, CRYSTAL STRUCTURE AND ALLOSTERIC ACTIVATION OF PROTEIN KINASE C BETA II
3610, 2wo6B, 0.7754, 2.80, 0.232, 339, 250, HUMAN DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A IN COMPLEX WITH A CONSENSUS SUBSTRATE PEPTIDE
3611, 2vgoA, 0.7754, 2.85, 0.189, 268, 254, CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH REVERSINE INHIBITOR
3612, 2clqB, 0.7754, 2.49, 0.268, 259, 246, STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 2 5
3613, 1yhwA, 0.7754, 2.96, 0.207, 293, 256, CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH ONE POINT MUTATIONS (K299R)
3614, 5vd0A, 0.7753, 2.86, 0.207, 293, 251, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH MK1775
3615, 5dfpA, 0.7753, 2.97, 0.222, 292, 257, CRYSTAL STRUCTURE OF PAK1 IN COMPLEX WITH AN INHIBITOR COMPOUND FRAX1036
3616, 4iirA, 0.7753, 2.90, 0.215, 325, 251, CRYSTAL STRUCTURE OF AMPPNP-BOUND HUMAN PRPF4B KINASE DOMAIN
3617, 3orxE, 0.7753, 2.70, 0.248, 274, 250, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
3618, 3dlsD, 0.7753, 2.88, 0.223, 284, 251, CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
3619, 3anqC, 0.7753, 2.86, 0.219, 340, 251, HUMAN DYRK1A/INHIBITOR COMPLEX
3620, 6b8jA, 0.7752, 3.27, 0.224, 344, 259, CO-STRUCTURE OF HUMAN GLYCOGEN SYNTHASE KINASE BETA WITH A SELECTIVE (5-IMIDAZOL-2-YL-4-PHENYLPYRIMIDIN-2-YL)[2-(2-PYRIDYLAMINO) ETHYL]AMINE INHIBITOR
3621, 5nhvA, 0.7752, 3.26, 0.197, 345, 259, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
3622, 4y83A, 0.7752, 2.57, 0.213, 299, 249, CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(2-AMINO-5- (QUINOLIN-3-YL)PYRIDIN-3-YL)-134-OXADIAZOLE-2(3H)-THIONE
3623, 4qtbA, 0.7752, 3.23, 0.201, 351, 259, STRUCTURE OF HUMAN ERK1 IN COMPLEX WITH SCH772984 REVEALING A NOVEL INHIBITOR-INDUCED BINDING POCKET
3624, 3skcA, 0.7752, 2.52, 0.290, 260, 248, HUMAN B-RAF KINASE IN COMPLEX WITH AN AMIDE LINKED PYRAZOLOPYRIDINE INHIBITOR
3625, 3pixA, 0.7752, 2.79, 0.307, 268, 251, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-ISOPROPYL-7- (4-METHYL-PIPERAZIN-1-YL)-4-(5-METHYL-2H-PYRAZOL-3-YLAMINO)-2H- PHTHALAZIN-1-ONE
3626, 3anrC, 0.7752, 2.86, 0.219, 337, 251, HUMAN DYRK1A/HARMINE COMPLEX
3627, 1zrzA, 0.7752, 2.92, 0.192, 310, 255, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ATYPICAL PROTEIN KINASE C-IOTA
3628, 1o6yA, 0.7752, 2.35, 0.217, 260, 244, CATALYTIC DOMAIN OF PKNB KINASE FROM MYCOBACTERIUM TUBERCULOSIS
3629, 5efqC, 0.7751, 3.10, 0.248, 325, 258, CRYSTAL STRUCTURE OF HUMAN CDK13/CYCLIN K IN COMPLEX WITH ADP-ALUMINUM FLUORIDE
3630, 5d11B, 0.7751, 2.15, 0.324, 255, 241, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL235
3631, 4yo6D, 0.7751, 2.68, 0.283, 285, 247, IRAK4-INHIBITOR CO-STRUCTURE
3632, 4rzvA, 0.7751, 2.62, 0.305, 261, 249, CRYSTAL STRUCTURE OF THE BRAF (R509H) KINASE DOMAIN MONOMER BOUND TO VEMURAFENIB
3633, 3zuvC, 0.7751, 2.78, 0.190, 357, 252, CRYSTAL STRUCTURE OF A DESIGNED SELECTED ANKYRIN REPEAT PROTEIN IN COMPLEX WITH THE PHOSPHORYLATED MAP KINASE ERK2
3634, 2wo6A, 0.7751, 2.85, 0.231, 344, 251, HUMAN DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A IN COMPLEX WITH A CONSENSUS SUBSTRATE PEPTIDE
3635, 6fylA, 0.7750, 3.10, 0.192, 340, 255, X-RAY STRUCTURE OF CLK2-KD(136-496)/CX-4945 AT 1.95A 
3636, 5t1sA, 0.7750, 2.61, 0.285, 280, 246, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
3637, 5hvjB, 0.7750, 2.73, 0.296, 284, 250, CRYSTAL STRUCTURE OF LIMK1 D460N MUTANT IN COMPLEX WITH AMP-PNP
3638, 4yp8C, 0.7750, 2.65, 0.282, 287, 248, IRAK4-INHIBITOR CO-STRUCTURE
3639, 2y6oA, 0.7750, 2.54, 0.347, 263, 248, CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH DASATINIB.
3640, 1ckiA, 0.7750, 3.01, 0.202, 292, 257, RECOMBINANT CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317
3641, 6cz2A, 0.7749, 2.64, 0.331, 261, 248, STRUCTURE OF THE PTK6 KINASE DOMAIN 
3642, 5w5oN, 0.7749, 2.19, 0.266, 272, 241, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3643, 5aagA, 0.7749, 2.60, 0.262, 253, 248, AURORA A KINASE BOUND TO AN IMIDAZOPYRIDINE INHIBITOR (14B)
3644, 3a7hA, 0.7749, 2.84, 0.260, 289, 254, HUMAN MST3 KINASE IN COMPLEX WITH ATP
3645, 2nruC, 0.7749, 3.01, 0.275, 293, 251, CRYSTAL STRUCTURE OF IRAK-4
3646, 4izaA, 0.7748, 2.98, 0.200, 346, 255, STRUCTURE OF DUALLY PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN
3647, 4f9aC, 0.7748, 3.26, 0.202, 317, 258, HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND NUCLEOTIDE
3648, 3tl8A, 0.7748, 2.75, 0.258, 300, 252, THE AVRPTOB-BAK1 COMPLEX REVEALS TWO STRUCTURALLY SIMILAR KINASEINTERACTING DOMAINS IN A SINGLE TYPE III EFFECTOR
3649, 3mblA, 0.7748, 3.34, 0.238, 290, 260, CRYSTAL STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK 1) IN COMPLEX WITH LIGAND AND MGADP
3650, 1okwA, 0.7748, 2.97, 0.259, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN-(M-CL-PHE)-NH2
3651, 3tz7B, 0.7747, 2.42, 0.310, 260, 245, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL103
3652, 1yhvA, 0.7747, 2.97, 0.207, 293, 256, CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH TWO POINT MUTATIONS (K299R T423E)
3653, 1jpaB, 0.7747, 2.35, 0.348, 269, 244, CRYSTAL STRUCTURE OF UNPHOSPHORYLATED EPHB2 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION
3654, 5h8gA, 0.7746, 2.86, 0.177, 324, 254, CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 7B
3655, 4ztlC, 0.7746, 2.95, 0.273, 282, 249, IRAK4-INHIBITOR CO-STRUCTURE
3656, 5hieC, 0.7745, 2.25, 0.313, 253, 243, BRAF KINASE DOMAIN B3AC LOOP DELETION MUTANT IN COMPLEX WITH DABRAFENIB
3657, 5cenA, 0.7745, 2.47, 0.344, 281, 247, CRYSTAL STRUCTURE OF DLK (KINASE DOMAIN)
3658, 4kikB, 0.7745, 2.89, 0.252, 648, 254, HUMAN IKB KINASE BETA
3659, 4ic7A, 0.7745, 3.20, 0.215, 355, 260, CRYSTAL STRUCTURE OF THE ERK5 KINASE DOMAIN IN COMPLEX WITH AN MKK5 BINDING FRAGMENT
3660, 3tnwA, 0.7745, 2.88, 0.264, 295, 254, STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH CAN508
3661, 2cjmC, 0.7745, 2.86, 0.269, 294, 253, MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE
3662, 1jpaA, 0.7745, 2.45, 0.341, 273, 246, CRYSTAL STRUCTURE OF UNPHOSPHORYLATED EPHB2 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION
3663, 5uiqC, 0.7744, 2.72, 0.279, 280, 247, CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 9
3664, 5jsmA, 0.7744, 2.68, 0.301, 265, 249, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-3-VEM
3665, 4ksqA, 0.7744, 2.49, 0.305, 258, 246, CRYSTAL STRUCTURE OF HUMAN B-RAF BOUND TO A DFG-OUT INHIBITOR 5B
3666, 3f69B, 0.7744, 2.92, 0.214, 282, 257, CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS PKNB MUTANT KINASE DOMAIN IN COMPLEX WITH KT5720
3667, 3eqgA, 0.7744, 3.21, 0.239, 314, 259, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A TERNARY COMPLEX WITH PD ADP AND MG2P
3668, 5d7aC, 0.7743, 2.76, 0.248, 286, 250, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TRAF2 AND NCK-INTERACTING PROTEIN KINASE WITH NCB-0846
3669, 4nstA, 0.7743, 3.06, 0.245, 322, 257, CRYSTAL STRUCTURE OF HUMAN CDK12/CYCLIN K IN COMPLEX WITH ADP-ALUMINUM FLUORIDE
3670, 3a7hB, 0.7743, 2.92, 0.271, 290, 255, HUMAN MST3 KINASE IN COMPLEX WITH ATP
3671, 2vwwA, 0.7743, 2.43, 0.327, 253, 245, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
3672, 6groA, 0.7742, 3.39, 0.162, 293, 265, HUMAN CSNK1G3 BOUND TO SB-223133 
3673, 5k3yB, 0.7742, 2.91, 0.185, 277, 254, CRYSTAL STRUCTURE OF AURORAB/INCENP IN COMPLEX WITH BI 811283
3674, 3q52A, 0.7742, 2.96, 0.219, 292, 256, STRUCTURE OF PHOSPHORYLATED PAK1 KINASE DOMAIN
3675, 3orxG, 0.7742, 2.67, 0.249, 274, 249, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
3676, 3c7qA, 0.7742, 2.52, 0.360, 286, 247, STRUCTURE OF VEGFR2 KINASE DOMAIN IN COMPLEX WITH BIBF1120
3677, 2nryB, 0.7742, 3.00, 0.277, 286, 249, CRYSTAL STRUCTURE OF IRAK-4
3678, 2nruD, 0.7742, 3.06, 0.274, 293, 252, CRYSTAL STRUCTURE OF IRAK-4
3679, 6bqqA, 0.7741, 2.92, 0.246, 271, 252, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH BI2526
3680, 6b3eC, 0.7741, 3.52, 0.243, 307, 263, CRYSTAL STRUCTURE OF HUMAN CDK12/CYCLINK IN COMPLEX WITH AN INHIBITOR
3681, 5ya5A, 0.7741, 2.68, 0.317, 273, 246, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH NOVEL INHIBITOR 
3682, 3ornA, 0.7741, 3.19, 0.236, 280, 259, MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN COMPLEX WITH CH4987655 AND MGAMP-PNP
3683, 5cvfA, 0.7740, 2.90, 0.189, 325, 254, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 5 BOUND
3684, 5c01B, 0.7740, 2.27, 0.258, 260, 244, CRYSTAL STRUCTURE OF KINASE
3685, 3f5xC, 0.7740, 2.96, 0.263, 298, 255, CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE
3686, 2og8B, 0.7740, 2.40, 0.366, 249, 243, CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 36 BOUND TO LCK
3687, 6cz4A, 0.7739, 2.64, 0.308, 257, 247, STRUCTURE OF THE PTK6 KINASE DOMAIN BOUND TO A TYPE II INHIBITOR 2- {[(3R;4S)-3-FLUORO-1-{[4-(TRIFLUOROMETHOXY)PHENYL]ACETYL}PIPERIDIN-4- YL]OXY}-5-(1-METHYL-1H-IMIDAZOL-4-YL)PYRIDINE-3-CARBOXAMIDE 
3688, 5deyA, 0.7739, 3.02, 0.214, 295, 257, CRYSTAL STRUCTURE OF PAK1 IN COMPLEX WITH AN INHIBITOR COMPOUND G-5555
3689, 5ceiA, 0.7739, 3.34, 0.205, 345, 259, CRYSTAL STRUCTURE OF CDK8:CYCLIN C COMPLEX WITH COMPOUND 22
3690, 4mwiA, 0.7739, 2.34, 0.224, 266, 245, CRYSTAL STRUCTURE OF THE HUMAN MLKL PSEUDOKINASE DOMAIN
3691, 3vugA, 0.7739, 2.85, 0.217, 356, 253, CRYSTAL STRUCTURE OF A CYSTEINE-DEFICIENT MUTANT M2 IN MAP KINASE JNK1
3692, 3dlsA, 0.7739, 2.89, 0.223, 285, 251, CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
3693, 1q8zB, 0.7739, 3.25, 0.192, 364, 260, THE APOENZYME STRUCTURE OF THE YEAST SR PROTEIN KINASE SKY1P
3694, 5vd1A, 0.7738, 2.79, 0.217, 295, 249, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH PHA- 848125
3695, 5lpbA, 0.7738, 2.71, 0.250, 280, 248, CRYSTAL STRUCTURE OF THE BRI1 KINASE DOMAIN (865-1160) IN COMPLEX WITH ADP FROM ARABIDOPSIS THALIANA
3696, 5hieB, 0.7738, 2.70, 0.297, 259, 249, BRAF KINASE DOMAIN B3AC LOOP DELETION MUTANT IN COMPLEX WITH DABRAFENIB
3697, 5hd4A, 0.7738, 3.08, 0.200, 347, 255, DISSECTING THERAPEUTIC RESISTANCE TO ERK INHIBITION RAT WILD TYPE SCH772984 IN COMPLEX WITH (3R)-1-(2-OXO-2-{4-[4-(PYRIMIDIN-2-YL) PHENYL]PIPERAZIN-1-YL}ETHYL)-N-[3-(PYRIDIN-4-YL)-2H-INDAZOL-5- YL]PYRROLIDINE-3-CARBOXAMIDE
3698, 4agwB, 0.7738, 2.34, 0.307, 257, 244, DISCOVERY OF A SMALL MOLECULE TYPE II INHIBITOR OF WILD- TYPE AND GATEKEEPER MUTANTS OF BCR-ABL PDGFRALPHA KIT AND SRC KINASES
3699, 5myvB, 0.7737, 3.31, 0.182, 349, 258, CRYSTAL STRUCTURE OF SRPK2 IN COMPLEX WITH COMPOUND 1
3700, 3anrA, 0.7737, 2.87, 0.227, 342, 251, HUMAN DYRK1A/HARMINE COMPLEX
3701, 2wihC, 0.7737, 3.02, 0.262, 299, 256, STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125
3702, 1p4fA, 0.7737, 2.55, 0.242, 269, 248, DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH BOUND INHIBITOR FRAGMENT
3703, 1e9hA, 0.7737, 2.98, 0.259, 295, 255, THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND
3704, 5dykA, 0.7736, 2.99, 0.195, 809, 256, CRYSTAL STRUCTURE OF PF3D7_1436600
3705, 4qp7A, 0.7736, 2.78, 0.198, 337, 252, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 2-(1H-PYRAZOL-4-YL)-5H- PYRROLO[23-B]PYRAZINE
3706, 3iecA, 0.7736, 2.78, 0.255, 311, 251, HELICOBACTER PYLORI CAGA INHIBITS PAR1/MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
3707, 2r7iC, 0.7736, 2.76, 0.187, 321, 251, CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3708, 5ih6A, 0.7735, 3.26, 0.185, 286, 259, HUMAN CASEIN KINASE 1 ISOFORM DELTA (KINASE DOMAIN) IN COMPLEX WITH EPIBLASTIN A DERIVATIVE
3709, 5c03A, 0.7735, 2.30, 0.250, 260, 244, CRYSTAL STRUCTURE OF KINASE
3710, 4qp9A, 0.7735, 2.73, 0.200, 335, 250, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 7-(1-PROPYL-1H-PYRAZOL-4- YL)-2-(PYRIDIN-4-YL)-5H-PYRROLO[23-B]PYRAZINE
3711, 4b8mB, 0.7735, 2.89, 0.197, 279, 254, AURORA B KINASE IN COMPLEX WITH VX-680
3712, 1pyxA, 0.7735, 3.26, 0.222, 343, 257, GSK-3 BETA COMPLEXED WITH AMP-PNP
3713, 6gdqA, 0.7734, 3.07, 0.201, 339, 254, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
3714, 5clpA, 0.7734, 2.81, 0.191, 322, 251, CRYSTAL STRUCTURE OF CK2ALPHA WITH 34-DICHLOROPHENETHYLAMINE BOUND
3715, 4y73A, 0.7734, 2.62, 0.285, 289, 246, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN WITH INHIBITOR
3716, 4nstC, 0.7734, 3.08, 0.249, 317, 257, CRYSTAL STRUCTURE OF HUMAN CDK12/CYCLIN K IN COMPLEX WITH ADP-ALUMINUM FLUORIDE
3717, 4kspA, 0.7734, 2.42, 0.302, 257, 245, CRYSTAL STRUCTURE OF HUMAN B-RAF BOUND TO A DFG-OUT INHIBITOR TAK-632
3718, 4iirB, 0.7734, 2.86, 0.216, 327, 250, CRYSTAL STRUCTURE OF AMPPNP-BOUND HUMAN PRPF4B KINASE DOMAIN
3719, 4c2wA, 0.7734, 2.87, 0.197, 268, 254, CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH AMP-PNP
3720, 4c2vB, 0.7734, 2.89, 0.197, 280, 254, AURORA B KINASE IN COMPLEX WITH THE SPECIFIC INHIBITOR BARASERTIB
3721, 3lltA, 0.7734, 2.85, 0.240, 341, 250, CRYSTAL STRUCTURE OF PF14_0431 KINASE DOMAIN.
3722, 3anqA, 0.7734, 2.87, 0.219, 342, 251, HUMAN DYRK1A/INHIBITOR COMPLEX
3723, 2nryA, 0.7734, 2.99, 0.277, 286, 249, CRYSTAL STRUCTURE OF IRAK-4
3724, 2jd5A, 0.7734, 2.95, 0.198, 353, 252, SKY1P BOUND TO NPL3P-DERIVED SUBSTRATE PEPTIDE
3725, 1z9xC, 0.7734, 3.03, 0.219, 303, 260, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 3 MONOMERS IN THE ASYMMETRIC UNIT
3726, 4yo6C, 0.7733, 2.63, 0.283, 286, 247, IRAK4-INHIBITOR CO-STRUCTURE
3727, 4ixpA, 0.7733, 3.10, 0.234, 334, 256, CRYSTAL STRUCTURE OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (MELK)
3728, 4byiA, 0.7733, 2.53, 0.259, 254, 247, AURORA A KINASE BOUND TO A HIGHLY SELECTIVE IMIDAZOPYRIDINE INHIBITOR
3729, 2bfyB, 0.7733, 2.87, 0.185, 278, 254, COMPLEX OF AURORA-B WITH INCENP AND HESPERADIN.
3730, 5kx8A, 0.7732, 2.64, 0.285, 285, 246, IRAK4-INHIBITOR CO-STRUCTURE
3731, 5aadA, 0.7732, 2.43, 0.268, 252, 246, AURORA A KINASE BOUND TO AN IMIDAZOPYRIDINE INHIBITOR (7A)
3732, 3qrjA, 0.7732, 2.28, 0.396, 258, 240, THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN T315I MUTANT IN COMPLEX WITH DCC-2036
3733, 3orxH, 0.7732, 2.69, 0.249, 274, 249, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
3734, 3orxF, 0.7732, 2.69, 0.249, 274, 249, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
3735, 4f9bA, 0.7731, 3.15, 0.202, 318, 257, HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND PHA767491
3736, 4bieA, 0.7731, 2.49, 0.266, 257, 244, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
3737, 3qc4A, 0.7731, 2.87, 0.246, 276, 252, PDK1 IN COMPLEX WITH DFG-OUT INHIBITOR XXX
3738, 5kziA, 0.7730, 2.66, 0.194, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH AN IMIDAZOPYRIDAZINE INHIBITOR.
3739, 4z7hA, 0.7730, 2.84, 0.200, 385, 250, CRYSTAL STRUCTURE OF HUMAN IRE1 CYTOPLASMIC KINASE-RNASE REGION - COMPLEX WITH IMIDAZOPYRIDINE COMPOUND 3
3740, 4p5zA, 0.7730, 2.50, 0.346, 267, 246, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH QUINOXALINE DERIVATIVES
3741, 3r22A, 0.7730, 2.63, 0.254, 255, 248, DESIGN SYNTHESIS AND BIOLOGICAL EVALUATION OF PYRAZOLOPYRIDINE- SULFONAMIDES AS POTENT MULTIPLE-MITOTIC KINASE (MMK) INHIBITORS (PART I)
3742, 2i40C, 0.7730, 3.02, 0.259, 296, 255, CDK2/CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE INHIBITOR
3743, 5vamB, 0.7729, 2.59, 0.294, 260, 248, BRAF IN COMPLEX WITH RAF709
3744, 5k3yA, 0.7729, 2.83, 0.178, 267, 253, CRYSTAL STRUCTURE OF AURORAB/INCENP IN COMPLEX WITH BI 811283
3745, 5ih5A, 0.7729, 3.30, 0.200, 286, 260, HUMAN CASEIN KINASE 1 ISOFORM DELTA (KINASE DOMAIN) IN COMPLEX WITH EPIBLASTIN A
3746, 5hieA, 0.7729, 2.57, 0.300, 258, 247, BRAF KINASE DOMAIN B3AC LOOP DELETION MUTANT IN COMPLEX WITH DABRAFENIB
3747, 5gjfA, 0.7729, 2.52, 0.285, 298, 246, CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH LIGAND 3
3748, 4tn6A, 0.7729, 3.26, 0.183, 292, 262, CK1D IN COMPLEX WITH INHIBITOR
3749, 4o0wA, 0.7729, 2.63, 0.254, 259, 248, CRYSTAL STRUCTURES OF HUMAN KINASE AURORA A
3750, 4btjB, 0.7729, 3.20, 0.158, 293, 259, TTBK1 IN COMPLEX WITH ATP
3751, 3d7uD, 0.7729, 2.15, 0.311, 248, 241, STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
3752, 5m4iA, 0.7728, 3.15, 0.178, 331, 258, COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH THE INHIBITOR 4 -CARBOXY-68-CHLORO-FLAVONOL (FLC21) CRYSTALLIZED UNDER HIGH-SALT CONDITIONS
3753, 3vuhA, 0.7728, 2.86, 0.217, 355, 253, CRYSTAL STRUCTURE OF A CYSTEINE-DEFICIENT MUTANT M3 IN MAP KINASE JNK1
3754, 3sv0A, 0.7728, 3.43, 0.177, 294, 265, CRYSTAL STRUCTURE OF CASEIN KINASE-1 LIKE PROTEIN IN PLANT
3755, 2xngA, 0.7728, 2.56, 0.263, 253, 247, STRUCTURE OF AURORA-A BOUND TO A SELECTIVE IMIDAZOPYRAZINE INHIBITOR
3756, 2i40A, 0.7728, 2.79, 0.259, 291, 251, CDK2/CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE INHIBITOR
3757, 2i0eB, 0.7728, 2.79, 0.246, 300, 252, STRUCTURE OF CATALYTIC DOMAIN OF HUMAN PROTEIN KINASE C BETA II COMPLEXED WITH A BISINDOLYLMALEIMIDE INHIBITOR
3758, 1uwjA, 0.7728, 2.66, 0.301, 264, 249, THE COMPLEX OF MUTANT V599E B-RAF AND BAY439006
3759, 5d11A, 0.7727, 2.16, 0.320, 254, 241, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL235
3760, 5a54B, 0.7727, 2.85, 0.224, 339, 250, DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENT
3761, 5uitB, 0.7726, 2.60, 0.286, 283, 245, CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 14
3762, 5hd7A, 0.7726, 3.28, 0.201, 347, 259, DISSECTING THERAPEUTIC RESISTANCE TO ERK INHIBITION RAT MUTANT SCH772984 IN COMPLEX WITH (3R)-1-(2-OXO-2-{4-[4-(PYRIMIDIN-2-YL) PHENYL]PIPERAZIN-1-YL}ETHYL)-N-[3-(PYRIDIN-4-YL)-2H-INDAZOL-5- YL]PYRROLIDINE-3-CARBOXAMIDE
3763, 4qo9A, 0.7726, 2.91, 0.263, 280, 255, MST3 IN COMPLEX WITH DANUSERTIB
3764, 4f99A, 0.7726, 3.19, 0.202, 312, 257, HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND NUCLEOTIDE
3765, 4bhnA, 0.7726, 2.49, 0.272, 256, 243, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
3766, 3vvhC, 0.7726, 3.15, 0.240, 283, 258, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN COMPLEX WITH AN INHIBITOR AND MGATP
3767, 2vwuA, 0.7726, 2.46, 0.327, 253, 245, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
3768, 4ty1A, 0.7725, 2.66, 0.194, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH AN AMINOOXADIAZOLE-INDOLE INHIBITOR.
3769, 4mh7B, 0.7725, 2.34, 0.318, 255, 242, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC1896
3770, 4lmnA, 0.7725, 3.26, 0.239, 292, 259, CRYSTAL STRUCTURE OF MEK1 KINASE BOUND TO GDC0973
3771, 4bckC, 0.7725, 3.06, 0.263, 293, 255, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
3772, 3og7B, 0.7725, 2.42, 0.305, 254, 246, B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX4032
3773, 6gwrA, 0.7724, 3.24, 0.348, 300, 256, STRUCTURE OF THE KINASE DOMAIN OF HUMAN DDR1 IN COMPLEX WITH A POTENT AND SELECTIVE INHIBITOR OF DDR1 AND DDR2 
3774, 5oq8A, 0.7724, 2.97, 0.244, 261, 250, STRUCTURE OF CHK1 12-PT. MUTANT COMPLEX WITH ARYLBENZAMIDE LRRK2 INHIBITOR
3775, 5ng3D, 0.7724, 2.77, 0.266, 278, 252, STRUCTURE OF INACTIVE KINASE RIP2K(K47R)
3776, 5m44A, 0.7724, 2.80, 0.187, 329, 252, COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A THIENO[23-D]PYRIMIDIN INHIBITOR CRYSTALLIZED UNDER HIGH-SALT CONDITIONS
3777, 4bckA, 0.7724, 3.12, 0.257, 298, 257, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
3778, 3etaA, 0.7724, 2.70, 0.317, 293, 249, KINASE DOMAIN OF INSULIN RECEPTOR COMPLEXED WITH A PYRROLO PYRIDINE INHIBITOR
3779, 3tl8H, 0.7723, 2.81, 0.262, 303, 252, THE AVRPTOB-BAK1 COMPLEX REVEALS TWO STRUCTURALLY SIMILAR KINASEINTERACTING DOMAINS IN A SINGLE TYPE III EFFECTOR
3780, 4f7sA, 0.7722, 3.31, 0.205, 339, 258, CRYSTAL STRUCTURE OF HUMAN CDK8/CYCC IN THE DMG-IN CONFORMATION
3781, 3vudA, 0.7722, 2.86, 0.217, 355, 253, CRYSTAL STRUCTURE OF A CYSTEINE-DEFICIENT MUTANT M1 IN MAP KINASE JNK1
3782, 6f3dB, 0.7721, 2.55, 0.287, 283, 244, IRAK4 IN COMPLEX WITH INHIBITOR 
3783, 5aafA, 0.7721, 2.52, 0.263, 254, 247, AURORA A KINASE BOUND TO AN IMIDAZOPYRIDINE INHIBITOR (14A)
3784, 4iebA, 0.7721, 3.20, 0.225, 472, 258, CRYSTAL STRUCTURE OF A GLY128MET MUTANT OF THE TOXOPLASMA CDPK TGME49_101440
3785, 4arkA, 0.7721, 3.30, 0.239, 291, 259, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MAP KINASE KINASE 1 (MEK1) IN COMPLEX WITH  A SMALL MOLECULE INHIBITOR AND ADP
3786, 3pj2A, 0.7721, 2.10, 0.336, 248, 241, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-[4-(2- DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-6-(4-FLUORO-PHENOXY)-8-METHYL-8H- PYRIDO[23-D]PYRIMIDIN-7-ONE
3787, 1q99B, 0.7721, 3.27, 0.192, 364, 260, CRYSTAL STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINSAE SKY1P COMPLEXED WITH THE NON-HYDROLYZABLE ATP ANALOGUE AMP-PNP
3788, 5buiA, 0.7720, 2.82, 0.203, 338, 251, ERK2 COMPLEXED WITH 2-PYRIDIYL TETRAHYDROAZAINDAZOLE
3789, 5a4lB, 0.7720, 2.85, 0.224, 339, 250, DYRK1A IN COMPLEX WITH FLUORO BENZOTHIAZOLE FRAGMENT
3790, 4ztmC, 0.7720, 2.66, 0.285, 282, 246, IRAK4-INHIBITOR CO-STRUCTURE
3791, 4an3A, 0.7720, 2.93, 0.244, 280, 254, CRYSTAL STRUCTURES OF HUMAN MEK1 WITH CARBOXAMIDE-BASED ALLOSTERIC INHIBITOR XL518 (GDC-0973) OR RELATED ANALOGS.
3792, 3os3A, 0.7720, 2.99, 0.244, 272, 254, MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN COMPLEX WITH CH4858061 AND MGATP
3793, 1yxtA, 0.7720, 2.58, 0.190, 274, 247, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMPPNP
3794, 1okvA, 0.7720, 3.03, 0.258, 295, 256, CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2
3795, 5w4wD, 0.7719, 3.22, 0.185, 287, 260, IDENTIFICATION AND PROFILING OF A SELECTIVE AND BRAIN PENETRANT RADIOLIGAND FOR IN VIVO TARGET OCCUPANCY MEASUREMENT OF CASEIN KINASE 1 (CK1) INHIBITORS
3796, 5vamA, 0.7719, 2.78, 0.290, 269, 252, BRAF IN COMPLEX WITH RAF709
3797, 5kx8D, 0.7719, 2.93, 0.279, 283, 247, IRAK4-INHIBITOR CO-STRUCTURE
3798, 5eykB, 0.7719, 2.89, 0.185, 275, 254, CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH BI 847325
3799, 4itjB, 0.7719, 2.81, 0.286, 276, 248, CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-4
3800, 6b2qC, 0.7718, 2.63, 0.255, 264, 247, DUAL INHIBITION OF THE ESSENTIAL PROTEIN KINASES A AND B IN MYCOBACTERIUM TUBERCULOSIS
3801, 4btmB, 0.7718, 3.20, 0.162, 293, 259, TTBK1 IN COMPLEX WITH INHIBITOR
3802, 2w1gA, 0.7718, 2.66, 0.262, 254, 248, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
3803, 2vgpB, 0.7718, 2.92, 0.197, 277, 254, CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH A AMINOTHIAZOLE INHIBITOR
3804, 5t1tD, 0.7717, 2.61, 0.286, 283, 245, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
3805, 5hlnB, 0.7717, 3.26, 0.228, 346, 259, X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH CHIR99021
3806, 4c2wB, 0.7717, 2.92, 0.197, 277, 254, CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH AMP-PNP
3807, 3qrkA, 0.7717, 2.73, 0.390, 270, 246, THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DP- 987
3808, 3qriB, 0.7717, 2.49, 0.399, 262, 243, THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DCC- 2036
3809, 2o5kA, 0.7716, 3.26, 0.222, 350, 257, CRYSTAL STRUCTURE OF GSK3BETA IN COMPLEX WITH A BENZOIMIDAZOL INHIBITOR
3810, 5ih4A, 0.7715, 3.28, 0.185, 286, 259, HUMAN CASEIN KINASE 1 ISOFORM DELTA APO (KINASE DOMAIN)
3811, 4bieB, 0.7715, 2.47, 0.275, 257, 244, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
3812, 3octA, 0.7715, 2.04, 0.325, 244, 240, CRYSTAL STRUCTURE OF BRUTON S TYROSINE KINASE MUTANT V555R IN COMPLEX WITH DASATINIB
3813, 3ii5A, 0.7715, 2.70, 0.301, 262, 249, THE COMPLEX OF WILD-TYPE B-RAF WITH PYRAZOLO PYRIMIDINE INHIBITOR
3814, 3f5xA, 0.7715, 2.95, 0.260, 297, 254, CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE
3815, 1h24A, 0.7715, 2.97, 0.259, 293, 255, CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F
3816, 1cmkE, 0.7715, 2.87, 0.206, 348, 253, CRYSTAL STRUCTURES OF THE MYRISTYLATED CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE REVEAL OPEN AND CLOSED CONFORMATIONS
3817, 5lpyA, 0.7714, 2.65, 0.247, 282, 247, CRYSTAL STRUCTURE OF THE BRI1 KINASE DOMAIN (865-1160) IN COMPLEX WITH ATP FROM ARABIDOPSIS THALIANA
3818, 4yp8A, 0.7714, 2.64, 0.285, 284, 246, IRAK4-INHIBITOR CO-STRUCTURE
3819, 4crlA, 0.7714, 3.07, 0.204, 339, 255, CRYSTAL STRUCTURE OF HUMAN CDK8-CYCLIN C IN COMPLEX WITH CORTISTATIN A
3820, 3zonA, 0.7714, 2.27, 0.251, 261, 243, HUMAN TYK2 PSEUDOKINASE DOMAIN BOUND TO A KINASE INHIBITOR
3821, 3v3vA, 0.7714, 2.85, 0.222, 351, 252, STRUCTURAL AND FUNCTIONAL ANALYSIS OF QUERCETAGETIN A NATURAL JNK1 INHIBITOR
3822, 3qd2B, 0.7714, 2.72, 0.222, 271, 248, CRSYTAL STRUCTURE OF MOUSE PERK KINASE DOMAIN
3823, 3eqhA, 0.7714, 3.12, 0.241, 314, 257, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A TERNARY COMPLEX WITH U0126 ADP AND MG2P
3824, 3dlsF, 0.7714, 2.79, 0.226, 281, 248, CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
3825, 3cs9D, 0.7714, 2.63, 0.388, 263, 245, HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB
3826, 2qoqA, 0.7714, 2.58, 0.336, 284, 247, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BASE AMP-PNP BOUND STRUCTURE
3827, 5g15A, 0.7713, 3.07, 0.215, 265, 256, STRUCTURE AURORA A (122-403) BOUND TO ACTIVATING MONOBODY MB1 AND AMPPCP
3828, 5d12B, 0.7713, 2.15, 0.321, 253, 240, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL40
3829, 3tubA, 0.7713, 2.49, 0.341, 253, 246, CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH 1-(5-(67- DIMETHOXYQUINOLIN-4-YLOXY)PYRIDIN-2-YL)-3-((1R2S)-2- PHENYLCYCLOPROPYL)UREA
3830, 3sayA, 0.7713, 3.24, 0.223, 347, 256, CRYSTAL STRUCTURE OF HUMAN GLYCOGEN SYNTHASE KINASE 3 BETA (GSK3B) IN COMPLEX WITH INHIBITOR 142
3831, 3piyA, 0.7713, 2.55, 0.347, 262, 245, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH R406
3832, 2wtwA, 0.7713, 2.64, 0.241, 256, 249, AURORA-A INHIBITOR STRUCTURE (2ND CRYSTAL FORM)
3833, 1j1bB, 0.7713, 3.28, 0.218, 364, 257, BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH AMPPNP
3834, 4knbB, 0.7712, 2.67, 0.332, 256, 244, C-MET IN COMPLEX WITH OSI LIGAND
3835, 4fc0A, 0.7712, 2.42, 0.302, 254, 245, CRYSTAL STRUCTURE OF HUMAN KINASE DOMAIN OF B-RAF WITH A DFG-OUT INHIBITOR
3836, 4f9bC, 0.7712, 3.13, 0.203, 316, 256, HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND PHA767491
3837, 3zlsA, 0.7712, 3.17, 0.241, 315, 257, CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 6
3838, 3vw6A, 0.7712, 2.45, 0.273, 255, 242, CRYSTAL STRUCTURE OF HUMAN APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) WITH IMIDAZOPYRIDINE INHIBITOR
3839, 3nczB, 0.7712, 2.85, 0.198, 379, 252, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT 2H-ISOQUINOLIN-1-ONE INHIBITOR
3840, 1s9iA, 0.7712, 3.39, 0.236, 303, 259, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 (MEK2)IN A COMPLEX WITH LIGAND AND MGATP
3841, 5ur1B, 0.7711, 2.53, 0.391, 265, 248, FGFR1 KINASE DOMAIN COMPLEX WITH SN37333 IN REVERSIBLE BINDING MODE
3842, 5icpA, 0.7711, 3.29, 0.202, 343, 258, CDK8-CYCC IN COMPLEX WITH [(S)-2-(4-CHLORO-PHENYL)-PYRROLIDIN-1-YL]- (5-METHYL-IMIDAZO[51-B][134]THIADIAZOL-2-YL)-METHANONE
3843, 4qp3B, 0.7711, 3.17, 0.198, 331, 257, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-2-((9H-PURIN-6-YL) AMINO)-3-PHENYLPROPAN-1-OL
3844, 4an9A, 0.7711, 3.06, 0.238, 281, 256, CRYSTAL STRUCTURES OF HUMAN MEK1 WITH CARBOXAMIDE-BASED ALLOSTERIC INHIBITOR XL518 (GDC-0973) OR RELATED ANALOGS.
3845, 3vuiA, 0.7711, 2.90, 0.217, 355, 253, CRYSTAL STRUCTURE OF A CYSTEINE-DEFICIENT MUTANT M2 IN MAP KINASE JNK1
3846, 1r0pA, 0.7711, 3.05, 0.323, 301, 251, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH THE MICROBIAL ALKALOID K-252A
3847, 1h4lA, 0.7711, 2.59, 0.228, 278, 246, STRUCTURE AND REGULATION OF THE CDK5-P25(NCK5A) COMPLEX
3848, 5li9A, 0.7710, 2.71, 0.187, 329, 252, STRUCTURE OF A NUCLEOTIDE-BOUND FORM OF PKCIOTA CORE KINASE DOMAIN
3849, 5cwzA, 0.7710, 2.86, 0.240, 284, 250, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2 AND NCK- INTERACTING PROTEIN KINASE
3850, 5a4eB, 0.7710, 2.89, 0.220, 322, 250, DYRK1A IN COMPLEX WITH METHOXY BENZOTHIAZOLE FRAGMENT
3851, 2y6mA, 0.7710, 2.57, 0.344, 262, 247, CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN
3852, 2qq7A, 0.7710, 2.02, 0.325, 251, 237, CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN WITH IRREVERSIBLE INHIBITOR
3853, 2chlA, 0.7710, 3.34, 0.163, 298, 263, STRUCTURE OF CASEIN KINASE 1 GAMMA 3
3854, 6b2qA, 0.7709, 2.56, 0.256, 261, 246, DUAL INHIBITION OF THE ESSENTIAL PROTEIN KINASES A AND B IN MYCOBACTERIUM TUBERCULOSIS
3855, 5w5qA, 0.7709, 3.11, 0.239, 291, 255, MAP4K4 IN COMPLEX WITH INHIBITOR COMPOUND 12 (N3-METHYL-10-(3-METHYL- 3-(5-METHYLOXAZOL-2-YL)BUT-1-YN-1-YL)-6;7-DIHYDRO-5H-5;7- METHANOBENZO[C]IMIDAZO[1;2-A]AZEPINE-2;3-DICARBOXAMIDE) 
3856, 4xhgA, 0.7709, 3.42, 0.144, 357, 264, STRUCTURE OF C. GLABRATA HRR25 BOUND TO ADP (FORMATE CONDITION)
3857, 4f9aA, 0.7709, 3.11, 0.203, 315, 256, HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND NUCLEOTIDE
3858, 1y6bA, 0.7709, 2.29, 0.362, 266, 243, CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR
3859, 1unhA, 0.7709, 2.51, 0.221, 276, 244, STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE ALOISINE AND INDIRUBIN.
3860, 1q8yA, 0.7709, 3.13, 0.202, 351, 253, THE STRUCTURE OF THE YEAST SR PROTEIN KINASE SKY1P WITH BOUND ADP
3861, 5mqvA, 0.7708, 3.16, 0.189, 286, 259, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH 4-(2 5-DIMETHOXYPHENYL)-N-(4-(5-(4-FLUORPHENYL)-2-(METHYLTHIO)-1H- IMIDAZOL-4-YL)-PYRIDIN-2-YL)-1-METHYL-1H-PYRROLE-2-CARBOXAMIDE
3862, 4c0tA, 0.7708, 3.21, 0.208, 290, 259, CANDIDA ALBICANS PKH KINASE DOMAIN
3863, 5ct7A, 0.7707, 2.56, 0.305, 257, 246, BRAF IN COMPLEX WITH RAF265
3864, 4qp4A, 0.7707, 2.83, 0.194, 337, 252, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-CYCLOHEXYL-9H-PURIN-6- AMINE
3865, 3dzqA, 0.7707, 2.71, 0.332, 268, 247, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH INHIBITOR AWL-II- 38.3
3866, 3a8xB, 0.7707, 2.85, 0.193, 329, 254, CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
3867, 2bpmC, 0.7707, 3.08, 0.262, 299, 256, STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529
3868, 1q41A, 0.7707, 3.31, 0.222, 339, 257, GSK-3 BETA COMPLEXED WITH INDIRUBIN-3 -MONOXIME
3869, 5vcxA, 0.7706, 2.90, 0.204, 287, 250, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN (UNTREATED) IN COMPLEX WITH SARACATINIB
3870, 5myvC, 0.7706, 3.34, 0.182, 348, 258, CRYSTAL STRUCTURE OF SRPK2 IN COMPLEX WITH COMPOUND 1
3871, 4mtaA, 0.7706, 2.58, 0.198, 273, 247, CRYSTAL STRUCTURE OF PIM-1 KINASE DOMAIN IN COMPLEX WITH 2-METHYL-5- PHENYLFURAN-3-CARBOXYLIC ACID
3872, 5jsmC, 0.7705, 2.62, 0.301, 262, 246, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-3-VEM
3873, 5ar4A, 0.7705, 2.23, 0.273, 274, 242, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH SB-203580
3874, 4ztmD, 0.7705, 2.72, 0.286, 282, 245, IRAK4-INHIBITOR CO-STRUCTURE
3875, 3r21A, 0.7705, 2.69, 0.262, 254, 248, DESIGN SYNTHESIS AND BIOLOGICAL EVALUATION OF PYRAZOLOPYRIDINE- SULFONAMIDES AS POTENT MULTIPLE-MITOTIC KINASE (MMK) INHIBITORS (PART I)
3876, 3of0B, 0.7705, 2.07, 0.315, 251, 238, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC TYROSINE KINASE DOMAIN
3877, 3dlsE, 0.7705, 2.89, 0.225, 282, 249, CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
3878, 1unhB, 0.7705, 2.52, 0.221, 276, 244, STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE ALOISINE AND INDIRUBIN.
3879, 5vcwA, 0.7704, 2.89, 0.208, 285, 250, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH PELITINIB
3880, 5hlwA, 0.7704, 3.10, 0.325, 284, 252, CRYSTAL STRUCTURE OF C-MET MUTANT Y1230H IN COMPLEX WITH COMPOUND 14
3881, 4ehgB, 0.7704, 2.62, 0.298, 260, 248, B-RAF KINASE DOMAIN IN COMPLEX WITH AN AMINOPYRIDIMINE-BASED INHIBITOR
3882, 2hz0B, 0.7704, 1.76, 0.397, 243, 232, ABL KINASE DOMAIN IN COMPLEX WITH NVP-AEG082
3883, 1ctpE, 0.7704, 2.79, 0.206, 332, 252, STRUCTURE OF THE MAMMALIAN CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE AND AN INHIBITOR PEPTIDE DISPLAYS AN OPEN CONFORMATION
3884, 4ztnC, 0.7703, 2.79, 0.279, 284, 247, IRAK4-INHIBITOR CO-STRUCTURE
3885, 4qp1B, 0.7703, 2.99, 0.193, 343, 254, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-CYCLOHEXYL-9H-PURIN-6- AMINE
3886, 4h3pA, 0.7703, 2.89, 0.206, 342, 253, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE
3887, 4c8bB, 0.7703, 2.54, 0.261, 281, 245, STRUCTURE OF THE KINASE DOMAIN OF HUMAN RIPK2 IN COMPLEX WITH PONATINIB
3888, 3fxzA, 0.7703, 3.03, 0.215, 292, 256, CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH RUTHENIUM COMPLEX LAMBDA-FL172
3889, 1ungA, 0.7703, 2.86, 0.223, 288, 251, STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE ALOISINE AND INDIRUBIN.
3890, 5lihB, 0.7702, 2.63, 0.211, 318, 247, STRUCTURE OF A PEPTIDE-SUBSTRATE BOUND TO PKCIOTA CORE KINASE DOMAIN
3891, 4alvA, 0.7702, 2.69, 0.190, 274, 248, BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1
3892, 3dv3A, 0.7702, 3.29, 0.240, 288, 258, MEK1 WITH PF-04622664 BOUND
3893, 5t1sD, 0.7701, 2.54, 0.284, 281, 243, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
3894, 5lvpA, 0.7701, 2.64, 0.249, 275, 249, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN HM-PEPTIDE BOUND TO THE PIF-POCKET
3895, 4u80A, 0.7701, 3.35, 0.239, 286, 259, MEK 1 KINASE BOUND TO G799
3896, 5y9mX, 0.7700, 2.88, 0.187, 319, 252, CRYSTAL STRUCTURE OF CK2A2 FORM 3 
3897, 5a4eA, 0.7700, 2.90, 0.228, 341, 250, DYRK1A IN COMPLEX WITH METHOXY BENZOTHIAZOLE FRAGMENT
3898, 4yc3A, 0.7700, 3.12, 0.254, 295, 256, CDK1/CYCLINB1/CKS2 APO
3899, 4ux9D, 0.7700, 2.92, 0.219, 344, 251, CRYSTAL STRUCTURE OF JNK1 BOUND TO A MKK7 DOCKING MOTIF
3900, 4nm5A, 0.7700, 3.29, 0.218, 361, 257, CRYSTAL STRUCTURE OF GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED WNT RECEPTOR LRP6 C-MOTIF
3901, 4nm3A, 0.7700, 3.25, 0.222, 357, 257, CRYSTAL STRUCTURE OF GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED N- TERMINAL AUTO-INHIBITORY PS9 PEPTIDE
3902, 2wipC, 0.7700, 2.88, 0.255, 292, 251, STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1- METHYL-45-DIHYDRO-1H-PYRAZOLO[43-H] QUINAZOLINE-3- CARBOXYLIC ACID
3903, 5t1sC, 0.7699, 2.68, 0.289, 284, 246, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
3904, 5hesA, 0.7699, 2.65, 0.321, 287, 246, HUMAN LEUCINE ZIPPER- AND STERILE ALPHA MOTIF-CONTAINING KINASE (ZAK MLT HCCS-4 MRK AZK MLTK) IN COMPLEX WITH VEMURAFENIB
3905, 5diaA, 0.7699, 2.68, 0.194, 273, 248, PIM1 IN COMPLEX WITH CPD36 ((1S3S)-N1-(6-(5-(PYRIDIN-3-YL)-1H- PYRAZOLO[34-C]PYRIDIN-3-YL)PYRIDIN-2-YL)CYCLOHEXANE-13-DIAMINE)
3906, 5dhjA, 0.7699, 2.68, 0.194, 273, 248, PIM1 IN COMPLEX WITH CPD4 (3-METHYL-5-(PYRIDIN-3-YL)-1H-PYRAZOLO[34- C]PYRIDINE)
3907, 4wo5B, 0.7699, 2.47, 0.302, 257, 245, CRYSTAL STRUCTURE OF A BRAF KINASE DOMAIN MONOMER
3908, 3vvhB, 0.7699, 3.23, 0.240, 290, 258, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN COMPLEX WITH AN INHIBITOR AND MGATP
3909, 3vukA, 0.7699, 2.91, 0.217, 355, 253, CRYSTAL STRUCTURE OF A CYSTEINE-DEFICIENT MUTANT M5 IN MAP KINASE JNK1
3910, 1h4lB, 0.7699, 2.61, 0.228, 278, 246, STRUCTURE AND REGULATION OF THE CDK5-P25(NCK5A) COMPLEX
3911, 4wrsA, 0.7698, 2.69, 0.194, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH AN AZASPIRO PYRAZINYL-INDAZOLE INHIBITOR.
3912, 4qq5A, 0.7698, 2.66, 0.357, 275, 249, CRYSTAL STRUCTURE OF FGF RECEPTOR (FGFR) 4 KINASE HARBORING THE V550L GATE-KEEPER MUTATION IN COMPLEX WITH FIIN-2 AN IRREVERSIBLE TYROSINE KINASE INHIBITOR CAPABLE OF OVERCOMING FGFR KINASE GATE-KEEPER MUTATIONS
3913, 4k0yA, 0.7698, 2.69, 0.194, 274, 248, STRUCTURE OF PIM-1 KINASE BOUND TO N-(4-FLUOROPHENYL)-7-HYDROXY-5- (PIPERIDIN-4-YL)PYRAZOLO[15-A]PYRIMIDINE-3-CARBOXAMIDE
3914, 4jbpA, 0.7698, 2.61, 0.263, 255, 247, NOVEL AURORA KINASE INHIBITORS REVEAL MECHANISMS OF HURP IN NUCLEATION OF CENTROSOMAL AND KINETOCHORE MICROTUBULES
3915, 4bcqC, 0.7698, 2.96, 0.269, 292, 253, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
3916, 3zu7A, 0.7698, 3.07, 0.188, 344, 255, CRYSTAL STRUCTURE OF A DESIGNED SELECTED ANKYRIN REPEAT PROTEIN IN COMPLEX WITH THE MAP KINASE ERK2
3917, 5kgdA, 0.7697, 2.69, 0.194, 273, 248, CRYSTAL STRUCTURE OF PIM1 WITH INHIBITOR: 2-PYRIDIN-3-YL-1~{H}- BENZIMIDAZOLE
3918, 5h3qA, 0.7697, 2.73, 0.375, 302, 248, CRYSTAL STRUCTURE OF TRKA KINASE WITH LIGAND
3919, 5cwzB, 0.7697, 2.81, 0.241, 284, 249, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2 AND NCK- INTERACTING PROTEIN KINASE
3920, 5ax9B, 0.7697, 2.70, 0.244, 274, 246, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2 AND NCK- INTERACTING PROTEIN KINASE IN COMPLEX WITH COMPUND 9
3921, 5ar7B, 0.7697, 2.44, 0.269, 278, 245, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH BIARYL UREA
3922, 4wt6A, 0.7697, 2.69, 0.194, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A THIADIAZOLAMINE-INDOLE INHIBITOR.
3923, 3qtiA, 0.7697, 2.91, 0.331, 292, 248, C-MET KINASE IN COMPLEX WITH NVP-BVU972
3924, 3eqbA, 0.7697, 3.29, 0.244, 289, 258, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
3925, 1pyxB, 0.7697, 3.34, 0.222, 338, 257, GSK-3 BETA COMPLEXED WITH AMP-PNP
3926, 5mqvF, 0.7696, 3.18, 0.189, 286, 259, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH 4-(2 5-DIMETHOXYPHENYL)-N-(4-(5-(4-FLUORPHENYL)-2-(METHYLTHIO)-1H- IMIDAZOL-4-YL)-PYRIDIN-2-YL)-1-METHYL-1H-PYRROLE-2-CARBOXAMIDE
3927, 5c01A, 0.7696, 2.30, 0.259, 258, 243, CRYSTAL STRUCTURE OF KINASE
3928, 4n70A, 0.7696, 2.70, 0.190, 274, 248, PIM1 COMPLEXED WITH A PYRIDYLCARBOXAMIDE
3929, 4kbkC, 0.7696, 3.27, 0.181, 280, 260, CK1D IN COMPLEX WITH (3S)-3-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H- PYRAZOL-4-YL]PYRIDIN-2-YL}MORPHOLINE INHIBITOR
3930, 4at4A, 0.7696, 2.97, 0.369, 292, 252, CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH EX429
3931, 3zduA, 0.7696, 2.89, 0.250, 297, 248, CRYSTAL STRUCTURE OF THE HUMAN CDKL3 KINASE DOMAIN
3932, 2ofvB, 0.7696, 1.72, 0.371, 244, 232, CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 1 BOUND TO LCK
3933, 1q5kB, 0.7696, 3.31, 0.222, 344, 257, CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 IN COMPLEXED WITH INHIBITOR
3934, 1q5kA, 0.7696, 3.33, 0.222, 345, 257, CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 IN COMPLEXED WITH INHIBITOR
3935, 5uabA, 0.7695, 2.63, 0.346, 288, 243, MET TYROSINE KINASE INHIBITION ENHANCES THE ANTITUMOR EFFICACY OF AN HGF ANTIBODY
3936, 5izjB, 0.7695, 2.86, 0.225, 325, 253, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1411
3937, 5a4qB, 0.7695, 2.88, 0.224, 335, 250, DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENT
3938, 4wovA, 0.7695, 2.28, 0.255, 258, 243, CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH BMS-066 AKA 2-METHOXY-N-({6-[3-METHYL-7-(METHYLAMINO)- 35810-TETRAAZATRICYCLO[7.3.0.0 6]DODECA-1(9)2(6)4711-PENTAEN- 11-YL]PYRIDIN-2-YL}METHY L)ACETAMIDE
3939, 4prjA, 0.7695, 2.46, 0.258, 251, 244, AURORA A KINASE DOMAIN WITH COMPOUND 2 (N-[1-(3-CYANOBENZYL)-1H- PYRAZOL-4-YL]-6-(1H-PYRAZOL-4-YL)-1H-INDAZOLE-3-CARBOXAMIDE)
3940, 4hgsA, 0.7695, 3.53, 0.155, 302, 265, CRYSTAL STRUCTURE OF CK1GS WITH COMPOUND 13
3941, 4aszA, 0.7695, 2.99, 0.367, 289, 251, CRYSTAL STRUCTURE OF APO TRKB KINASE DOMAIN
3942, 3l1sA, 0.7695, 3.32, 0.222, 336, 257, 3-ARYL-4-(ARYLHYDRAZONO)-1H-PYRAZOL-5-ONES: HIGHLY LIGAND EFFICIENT AND POTENT INHIBITORS OF GSK3
3943, 3kk8A, 0.7695, 3.18, 0.189, 283, 259, CAMKII SUBSTRATE COMPLEX A
3944, 3c4yB, 0.7695, 2.93, 0.217, 466, 254, CRYSTAL STRUCTURE OF APO FORM OF G PROTEIN COUPLED RECEPTOR KINASE 1 AT 7.51A
3945, 6g93A, 0.7694, 3.23, 0.202, 343, 257, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
3946, 6es0B, 0.7694, 2.74, 0.274, 287, 248, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN RIPK2 IN COMPLEX WITH THE ACTIVATION LOOP TARGETING INHIBITOR CS-R35
3947, 6bskA, 0.7694, 2.59, 0.194, 273, 247, HUMAN PIM1 KINASE IN COMPLEX WITH COMPOUND 12B
3948, 4nm7A, 0.7694, 3.28, 0.222, 355, 257, CRYSTAL STRUCTURE OF GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED WNT RECEPTOR LRP6 E-MOTIF
3949, 6fniA, 0.7693, 2.67, 0.329, 261, 246, CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE WITH NVP-BHG712 
3950, 4xj0B, 0.7693, 3.04, 0.197, 338, 254, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR 14K
3951, 4dtkA, 0.7693, 2.70, 0.190, 273, 248, NOVEL AND SELECTIVE PAN-PIM KINASE INHIBITOR
3952, 3amyA, 0.7693, 2.73, 0.173, 318, 248, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH APIGENIN
3953, 2jd5B, 0.7693, 3.31, 0.196, 360, 260, SKY1P BOUND TO NPL3P-DERIVED SUBSTRATE PEPTIDE
3954, 5nguA, 0.7692, 2.99, 0.198, 339, 253, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
3955, 5mqvD, 0.7692, 3.12, 0.190, 287, 258, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH 4-(2 5-DIMETHOXYPHENYL)-N-(4-(5-(4-FLUORPHENYL)-2-(METHYLTHIO)-1H- IMIDAZOL-4-YL)-PYRIDIN-2-YL)-1-METHYL-1H-PYRROLE-2-CARBOXAMIDE
3956, 5dgzA, 0.7692, 2.70, 0.194, 273, 248, DISCOVERY OF 35-SUBSTITUTED 6-AZAINDAZOLES AS POTENT PAN-PIM INHIBITORS
3957, 5a3xC, 0.7692, 2.82, 0.220, 333, 250, DYRK1A IN COMPLEX WITH HYDROXY BENZOTHIAZOLE FRAGMENT
3958, 4c8bA, 0.7692, 2.33, 0.260, 279, 242, STRUCTURE OF THE KINASE DOMAIN OF HUMAN RIPK2 IN COMPLEX WITH PONATINIB
3959, 5l6pA, 0.7691, 2.83, 0.329, 274, 249, EPHB3 KINASE DOMAIN COVALENTLY BOUND TO AN IRREVERSIBLE INHIBITOR (COMPOUND 6)
3960, 4kbaC, 0.7691, 3.19, 0.187, 277, 257, CK1D IN COMPLEX WITH 9-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]- 2345-TETRAHYDROPYRIDO[23-F][14]OXAZEPINE INHIBITOR
3961, 4kb8C, 0.7691, 3.13, 0.187, 277, 256, CK1D IN COMPLEX WITH 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4- YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE LIGAND
3962, 4g16A, 0.7691, 3.53, 0.155, 302, 265, CRYSTAL STRUCTURE OF CK1G3 WITH 2-[(4-{[3-(TRIFLUOROMETHYL)PYRIDIN2- YL]OXY}PHENYL)AMINO]-1H-BENZIMIDAZOLE-6-CARBONITRILE
3963, 3r00A, 0.7691, 2.60, 0.190, 274, 247, THE DISCOVERY OF NOVEL BENZOFURAN-2-CARBOXYLIC ACIDS AS POTENT PIM-1 INHIBITORS
3964, 2o64A, 0.7691, 2.60, 0.194, 274, 247, CRYSTAL STRUCTURE OF PIM1 WITH QUERCETAGETIN
3965, 1q99A, 0.7691, 3.04, 0.194, 354, 253, CRYSTAL STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINSAE SKY1P COMPLEXED WITH THE NON-HYDROLYZABLE ATP ANALOGUE AMP-PNP
3966, 1q97A, 0.7691, 3.16, 0.202, 351, 253, THE STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINASE SKY1P WITH BOUND ATP
3967, 6g9aA, 0.7690, 3.31, 0.205, 341, 258, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
3968, 5idpA, 0.7690, 3.38, 0.201, 342, 259, CDK8-CYCC IN COMPLEX WITH (3-AMINO-1H-INDAZOL-5-YL)-[(S)-2-(4-FLUORO- PHENYL)-PIPERIDIN-1-YL]-METHANONE
3969, 5eolA, 0.7690, 2.71, 0.194, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A MACROCYCLIC QUINOXALINE-PYRROLODIHYDROPIPERIDINONE INHIBITOR
3970, 5ebzJ, 0.7690, 3.27, 0.249, 655, 261, CRYSTAL STRUCTURE OF HUMAN IKK1
3971, 4qqcA, 0.7690, 2.52, 0.360, 273, 247, CRYSTAL STRUCTURE OF FGF RECEPTOR (FGFR) 4 KINASE DOMAIN IN COMPLEX WITH FIIN-2 AN IRREVERSIBLE TYROSINE KINASE INHIBITOR CAPABLE OF OVERCOMING FGFR KINASE GATE-KEEPER MUTATIONS
3972, 4nttA, 0.7690, 2.77, 0.198, 339, 252, STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE BOUND TO ADP AND ONE MAGNESIUM ION
3973, 4kbcA, 0.7690, 3.26, 0.177, 288, 260, CK1D IN COMPLEX WITH {4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDIN-2- YL}METHANOL INHIBITOR
3974, 2x7fB, 0.7690, 2.87, 0.248, 288, 250, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2- AND NCK-INTERACTING KINASE WITH WEE1CHK1 INHIBITOR
3975, 2w1fA, 0.7690, 2.65, 0.263, 253, 247, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
3976, 2henA, 0.7690, 2.64, 0.321, 259, 246, CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP
3977, 1j1cB, 0.7690, 3.30, 0.218, 364, 257, BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH ADP
3978, 5v80A, 0.7689, 2.70, 0.194, 273, 248, PIM1 KINASE IN COMPLEX WITH CPD1 (1-METHYL-4-(3-(6-(PIPERAZIN-1-YL) PYRIDIN-2-YL)-1H-PYRAZOLO[3;4-C]PYRIDIN-5-YL)PIPERAZIN-2-ONE) 
3979, 5oy4B, 0.7689, 3.41, 0.224, 353, 259, GSK3BETA COMPLEX WITH N-(6-(34-DIHYDROXYPHENYL)-1H-PYRAZOLO[34- B]PYRIDIN-3-YL)ACETAMIDE
3980, 3eqcA, 0.7689, 3.25, 0.240, 312, 258, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A TERNARY COMPLEX WITH COMPOUND 1 ATP-GS AND MG2P
3981, 3c4eD, 0.7689, 2.71, 0.190, 273, 248, PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7- AZAINDOLE
3982, 2vgpA, 0.7689, 2.83, 0.187, 265, 251, CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH A AMINOTHIAZOLE INHIBITOR
3983, 2aypA, 0.7689, 2.91, 0.236, 268, 250, CRYSTAL STRUCTURE OF CHK1 WITH AN INDOL INHIBITOR
3984, 5hnbA, 0.7688, 3.29, 0.202, 342, 257, CDK8-CYCC IN COMPLEX WITH [6-HYDROXY-3-(3-METHYL-BENZYL)-1H-INDAZOL-5- YL]-((S)-3-HYDROXY-PYRROLIDIN-1-YL)-METHANONE
3985, 4gcjA, 0.7688, 2.87, 0.260, 304, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-3-89
3986, 4g17A, 0.7688, 3.53, 0.155, 302, 265, CRYSTAL STRUCTURE OF CK1G3 WITH 2-[(4-TERT-BUTYLPHENYL)AMINO]-1H- BENZIMIDAZOLE-6-CARBONITRILE
3987, 5uq0B, 0.7687, 2.28, 0.405, 256, 242, FGFR1 KINASE DOMAIN COMPLEX WITH FRAGMENT 22-DIMETHYL-23- DIHYDROBENZOFURAN-7-CARBOXAMIDE
3988, 5kggA, 0.7687, 2.61, 0.194, 273, 247, CRYSTAL STRUCTURE OF PIM1 WITH INHIBITOR: 2-(5-CHLORANYL-1~{H}-INDOL- 3-YL)ETHANAMINE
3989, 5ipjA, 0.7687, 2.71, 0.198, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A QUINAZOLINONE-PYRROLOPYRROLONE INHIBITOR.
3990, 4kbaB, 0.7687, 3.24, 0.186, 285, 258, CK1D IN COMPLEX WITH 9-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]- 2345-TETRAHYDROPYRIDO[23-F][14]OXAZEPINE INHIBITOR
3991, 3vc4A, 0.7687, 2.71, 0.190, 274, 248, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
3992, 3mygA, 0.7687, 2.48, 0.261, 252, 245, AURORA A KINASE COMPLEXED WITH SCH 1473759
3993, 3eqfA, 0.7687, 3.16, 0.242, 314, 256, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A BINARY COMPLEX WITH K252A AND MG2P
3994, 1q97B, 0.7687, 3.30, 0.188, 361, 260, THE STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINASE SKY1P WITH BOUND ATP
3995, 5v82A, 0.7686, 2.66, 0.190, 273, 247, PIM1 KINASE IN COMPLEX WITH CPD17 (1-(6-(44-DIFLUOROPIPERIDIN-3-YL) PYRIDIN-2-YL)-6-(6-METHYLPYRAZIN-2-YL)-1H-PYRAZOLO[43-C]PYRIDINE)
3996, 5ng3B, 0.7686, 2.74, 0.268, 275, 250, STRUCTURE OF INACTIVE KINASE RIP2K(K47R)
3997, 5kgiA, 0.7686, 2.71, 0.194, 273, 248, CRYSTAL STRUCTURE OF PIM1 WITH INHIBITOR 2-[34-BIS(CHLORANYL) PHENOXY]ETHANAMINE
3998, 5a3xB, 0.7686, 2.93, 0.219, 340, 251, DYRK1A IN COMPLEX WITH HYDROXY BENZOTHIAZOLE FRAGMENT
3999, 4qp2B, 0.7686, 3.04, 0.197, 329, 254, CRYSTAL STRUCTURE OF ERKS IN COMPLEX WITH 5-CHLOROBENZO[D]OXAZOL-2- AMINE
4000, 4ic7D, 0.7686, 3.26, 0.189, 353, 259, CRYSTAL STRUCTURE OF THE ERK5 KINASE DOMAIN IN COMPLEX WITH AN MKK5 BINDING FRAGMENT
4001, 1yxxA, 0.7686, 2.59, 0.190, 274, 247, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH (3E)-3-[(4- HYDROXYPHENYL)IMINO]-1H-INDOL-2(3H)-ONE
4002, 5lpwA, 0.7685, 2.81, 0.251, 280, 247, CRYSTAL STRUCTURE OF THE APO-BRI1 KINASE DOMAIN (865-1160)
4003, 4btjA, 0.7685, 3.22, 0.155, 292, 258, TTBK1 IN COMPLEX WITH ATP
4004, 3f2aA, 0.7685, 2.73, 0.194, 276, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 IN COMPLEX WITH DAPPA
4005, 2xj2A, 0.7685, 2.67, 0.190, 273, 247, PROTEIN KINASE PIM-1 IN COMPLEX WITH SMALL MOLECULE INHIBITOR
4006, 1uwjB, 0.7685, 2.91, 0.299, 263, 251, THE COMPLEX OF MUTANT V599E B-RAF AND BAY439006
4007, 1q41B, 0.7685, 3.35, 0.222, 343, 257, GSK-3 BETA COMPLEXED WITH INDIRUBIN-3 -MONOXIME
4008, 5a54C, 0.7684, 2.77, 0.226, 332, 248, DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENT
4009, 5a4qC, 0.7684, 2.76, 0.222, 332, 248, DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENT
4010, 4zy4A, 0.7684, 2.95, 0.213, 288, 253, CRYSTAL STRUCTURE OF P21 ACTIVATED KINASE 1 IN COMPLEX WITH AN INHIBITOR COMPOUND 4
4011, 4rz7A, 0.7684, 2.95, 0.177, 801, 254, CRYSTAL STRUCTURE OF PVX_084705 WITH BOUND PCI32765
4012, 3zlxA, 0.7684, 3.31, 0.240, 312, 258, CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 18
4013, 3d5xA, 0.7684, 2.72, 0.245, 279, 249, CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH WORTMANNIN.
4014, 2bfxB, 0.7684, 2.75, 0.200, 275, 250, MECHANISM OF AURORA-B ACTIVATION BY INCENP AND INHIBITION BY HESPERADIN.
4015, 1ywnA, 0.7684, 2.51, 0.367, 279, 245, VEGFR2 IN COMPLEX WITH A NOVEL 4-AMINO-FURO[23-D]PYRIMIDINE
4016, 6gwrB, 0.7683, 3.11, 0.368, 285, 253, STRUCTURE OF THE KINASE DOMAIN OF HUMAN DDR1 IN COMPLEX WITH A POTENT AND SELECTIVE INHIBITOR OF DDR1 AND DDR2 
4017, 4wsyA, 0.7683, 2.60, 0.198, 273, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A THIAZOLAMINE-INDAZOLE INHIBITOR.
4018, 4qyyA, 0.7683, 3.30, 0.198, 337, 258, DISCOVERY OF NOVEL DUAL MECHANISM ERK INHIBITORS BY AFFINITY SELECTION SCREENING OF AN INACTIVE KINASE STATE
4019, 2xj0A, 0.7683, 2.70, 0.194, 274, 248, PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-4 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
4020, 1q8zA, 0.7683, 3.15, 0.197, 354, 254, THE APOENZYME STRUCTURE OF THE YEAST SR PROTEIN KINASE SKY1P
4021, 5mqvB, 0.7682, 3.26, 0.188, 287, 260, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH 4-(2 5-DIMETHOXYPHENYL)-N-(4-(5-(4-FLUORPHENYL)-2-(METHYLTHIO)-1H- IMIDAZOL-4-YL)-PYRIDIN-2-YL)-1-METHYL-1H-PYRROLE-2-CARBOXAMIDE
4022, 5bx0A, 0.7682, 3.28, 0.240, 315, 258, AN AUTOMATED MICROSCALE THERMOPHORESIS SCREENING APPROACH FOR FRAGMENT-BASED LEAD DISCOVERY
4023, 4rmzA, 0.7682, 3.03, 0.277, 284, 249, CRYSTAL STRUCTURE OF IRAK-4
4024, 4m69A, 0.7682, 2.56, 0.261, 284, 245, CRYSTAL STRUCTURE OF THE MOUSE RIP3-MLKL COMPLEX
4025, 3zrkB, 0.7682, 3.25, 0.223, 348, 256, IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS
4026, 3uytA, 0.7682, 3.25, 0.203, 287, 261, CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P1 CRYSTAL FORM
4027, 3qupA, 0.7682, 1.91, 0.323, 241, 235, INHIBITOR BOUND STRUCTURE OF THE KINASE DOMAIN OF THE MURINE RECEPTOR TYROSINE KINASE TYRO3 (SKY)
4028, 3bhhC, 0.7682, 2.94, 0.202, 285, 253, CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 1 (CAMK2B)
4029, 2henC, 0.7682, 2.65, 0.321, 259, 246, CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP
4030, 1finC, 0.7682, 3.08, 0.259, 298, 255, CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX
4031, 1ckiB, 0.7682, 3.31, 0.200, 286, 260, RECOMBINANT CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317
4032, 6cthA, 0.7681, 2.77, 0.271, 295, 247, CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN 1G (PR-1G) KINASE DOMAIN FROM CACAO 
4033, 6brcB, 0.7681, 2.89, 0.245, 260, 249, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH AP26113-ANALOG (ALK-IN-1)
4034, 5kgeA, 0.7681, 2.71, 0.194, 273, 248, CRYSTAL STRUCTURE OF PIM1 WITH INHIBITOR: 5-(34-DICHLOROPHENYL)- 1~{H}-PYRAZOL-3-AMINE
4035, 4xj0A, 0.7681, 3.17, 0.200, 345, 255, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR 14K
4036, 4k18A, 0.7681, 2.75, 0.193, 277, 249, STRUCTURE OF PIM-1 KINASE BOUND TO 5-(4-CYANOBENZYL)-N-(4- FLUOROPHENYL)-7-HYDROXYPYRAZOLO[15-A]PYRIMIDINE-3-CARBOXAMIDE
4037, 4g9rA, 0.7681, 2.64, 0.304, 262, 247, B-RAF V600E KINASE DOMAIN BOUND TO A TYPE II DIHYDROQUINAZOLINE INHIBITOR
4038, 4aluA, 0.7681, 2.61, 0.190, 274, 247, BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1
4039, 3kk9A, 0.7681, 3.01, 0.196, 275, 255, CAMKII SUBSTRATE COMPLEX B
4040, 3begA, 0.7681, 3.40, 0.190, 348, 258, CRYSTAL STRUCTURE OF SR PROTEIN KINASE 1 COMPLEXED TO ITS SUBSTRATE ASF/SF2
4041, 2xruA, 0.7681, 2.62, 0.271, 253, 247, AURORA-A T288E COMPLEXED WITH PHA-828300
4042, 1howA, 0.7681, 3.06, 0.194, 346, 253, THE X-RAY CRYSTAL STRUCTURE OF SKY1P AN SR PROTEIN KINASE IN YEAST
4043, 5ar8B, 0.7680, 2.42, 0.263, 274, 243, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH BIPHENYLSULFONAMIDE
4044, 5aaeA, 0.7680, 2.59, 0.260, 252, 246, AURORA A KINASE BOUND TO AN IMIDAZOPYRIDINE INHIBITOR (14D)
4045, 5a4qA, 0.7680, 2.91, 0.224, 341, 250, DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENT
4046, 4y83C, 0.7679, 2.58, 0.206, 293, 247, CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(2-AMINO-5- (QUINOLIN-3-YL)PYRIDIN-3-YL)-134-OXADIAZOLE-2(3H)-THIONE
4047, 4u81A, 0.7679, 3.31, 0.240, 289, 258, MEK1 KINASE BOUND TO SMALL MOLECULE INHIBITOR G659
4048, 3v04A, 0.7679, 3.29, 0.236, 289, 259, DISCOVERY OF NOVEL ALLOSTERIC MEK INHIBITORS POSSESSING CLASSICAL AND NON-CLASSICAL BIDENTATE SER212 INTERACTIONS.
4049, 2vrxB, 0.7679, 2.76, 0.204, 274, 250, STRUCTURE OF AURORA B KINASE IN COMPLEX WITH ZM447439
4050, 5vcwB, 0.7678, 2.93, 0.202, 285, 252, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH PELITINIB
4051, 4xv9A, 0.7678, 2.55, 0.296, 261, 247, B-RAF KINASE DOMAIN IN COMPLEX WITH PLX5568
4052, 4ptgB, 0.7678, 3.36, 0.218, 332, 257, STRUCTURE OF A CARBOXAMINE COMPOUND (26) (2-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}-4-METHOXYPYRIMIDINE-5-CARBOXAMIDE) TO GSK3B
4053, 4ibmA, 0.7678, 2.86, 0.315, 301, 251, CRYSTAL STRUCTURE OF INSULIN RECEPTOR KINASE DOMAIN IN COMPLEX WITH AN INHIBITOR IRFIN-1
4054, 4dglC, 0.7678, 3.13, 0.176, 334, 255, CRYSTAL STRUCTURE OF THE CK2 TETRAMERIC HOLOENZYME
4055, 3ulzA, 0.7678, 2.95, 0.271, 291, 247, CRYSTAL STRUCTURE OF APO BAK1
4056, 3dlsC, 0.7678, 3.06, 0.224, 281, 250, CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
4057, 2xj1A, 0.7678, 2.68, 0.194, 273, 247, PROTEIN KINASE PIM-1 IN COMPLEX WITH SMALL MOLECULE INIBITOR
4058, 2oicD, 0.7678, 2.60, 0.276, 284, 243, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN COMPLEXED WITH STAUROSPORINE
4059, 5obrA, 0.7677, 2.63, 0.259, 255, 247, AURORA A KINASE IN COMPLEX WITH 2-(3-CHLORO-5-FLUOROPHENYL)QUINOLINE- 4-CARBOXYLIC ACID AND JNJ-7706621
4060, 5f94B, 0.7677, 3.37, 0.218, 349, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH COMPOUND 15: 2- [(CYCLOPROPYLCARBONYL)AMINO]-N-(4-METHOXYPYRIDIN-3-YL)PYRIDINE-4- CARBOXAMIDE
4061, 4oh4B, 0.7677, 2.67, 0.253, 289, 245, CRYSTAL STRUCTURE OF BRI1 IN COMPLEX WITH BKI1
4062, 4hglA, 0.7677, 3.54, 0.155, 302, 265, CRYSTAL STRUCTURE OF CK1G3 WITH COMPOUND 1
4063, 4alwA, 0.7677, 2.58, 0.195, 273, 246, BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1
4064, 3sayB, 0.7677, 3.29, 0.223, 347, 256, CRYSTAL STRUCTURE OF HUMAN GLYCOGEN SYNTHASE KINASE 3 BETA (GSK3B) IN COMPLEX WITH INHIBITOR 142
4065, 3k5uA, 0.7677, 2.63, 0.259, 260, 247, IDENTIFICATION SAR STUDIES AND X-RAY COCRYSTAL ANALYSIS OF A NOVEL FURANO-PYRIMIDINE AURORA KINASE A INHIBITOR
4066, 3i4bA, 0.7677, 3.33, 0.218, 359, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH A PYRIMIDYLPYRROLE INHIBITOR
4067, 3fy0A, 0.7677, 3.08, 0.215, 292, 256, CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH RUTHENIUM COMPLEX DW1
4068, 3eqiA, 0.7677, 3.23, 0.241, 315, 257, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A BINARY COMPLEX WITH ADP AND MG2P
4069, 2p55A, 0.7677, 3.38, 0.235, 289, 260, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
4070, 5jsmB, 0.7676, 2.82, 0.297, 263, 249, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-3-VEM
4071, 5ebzD, 0.7676, 3.26, 0.250, 655, 260, CRYSTAL STRUCTURE OF HUMAN IKK1
4072, 5ct7B, 0.7676, 2.35, 0.300, 254, 243, BRAF IN COMPLEX WITH RAF265
4073, 5a54A, 0.7676, 2.92, 0.228, 341, 250, DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENT
4074, 4o91A, 0.7676, 2.44, 0.282, 293, 245, CRYSTAL STRUCTURE OF TYPE II INHIBITOR NG25 BOUND TO TAK1-TAB1
4075, 4mygB, 0.7676, 2.91, 0.214, 335, 252, MAPK13 ACTIVE FORM
4076, 4jx7A, 0.7676, 2.61, 0.190, 274, 247, CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH INHIBITOR 2-[(TRANS- 4-AMINOCYCLOHEXYL)AMINO]-4-{[3-(TRIFLUOROMETHYL) PHENYL]AMINO}PYRIDO[43-D]PYRIMIDIN-5(6H)-ONE
4077, 4f9cA, 0.7676, 3.26, 0.208, 306, 255, HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND XL413
4078, 3teiA, 0.7676, 2.66, 0.198, 339, 248, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE
4079, 3eqdA, 0.7676, 3.28, 0.236, 315, 258, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A BINARY COMPLEX WITH ATP-GS AND MG2P
4080, 2ojgA, 0.7676, 3.23, 0.199, 337, 256, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH NN-DIMETHYL-4-(4- PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
4081, 1yxuD, 0.7676, 2.73, 0.194, 273, 248, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP
4082, 1j1bA, 0.7676, 3.35, 0.222, 354, 257, BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH AMPPNP
4083, 5a4tB, 0.7675, 2.91, 0.228, 339, 250, DYRK1A IN COMPLEX WITH NITRILE BENZOTHIAZOLE FRAGMENT
4084, 4btmA, 0.7675, 3.23, 0.155, 292, 258, TTBK1 IN COMPLEX WITH INHIBITOR
4085, 3hx4A, 0.7675, 2.98, 0.234, 467, 252, CRYSTAL STRUCTURE OF CDPK1 OF TOXOPLASMA GONDII TGME49_101440 IN PRESENCE OF CALCIUM
4086, 2qo7A, 0.7675, 2.59, 0.354, 278, 246, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION DEPHOSPHORYLATED AMP-PNP BOUND
4087, 6gt1D, 0.7674, 2.52, 0.241, 260, 245, NEK7 BOUND TO PURINE INHIBITOR 
4088, 5m5aA, 0.7674, 2.40, 0.252, 315, 242, CRYSTAL STRUCTURE OF MELK IN COMPLEX WITH AN INHIBITOR
4089, 5hlnA, 0.7674, 3.33, 0.224, 346, 259, X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH CHIR99021
4090, 5a4lC, 0.7674, 2.87, 0.221, 332, 249, DYRK1A IN COMPLEX WITH FLUORO BENZOTHIAZOLE FRAGMENT
4091, 4y73B, 0.7674, 2.63, 0.287, 289, 244, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN WITH INHIBITOR
4092, 4tw9B, 0.7674, 3.26, 0.189, 289, 259, DIFLUORO-DIOXOLO-BENZOIMIDAZOL-BENZAMIDES AS POTENT INHIBITORS OF CK1DELTA AND EPSILON WITH NANOMOLAR INHIBITORY ACTIVITY ON CANCER CELL PROLIFERATION
4093, 4mneE, 0.7674, 3.41, 0.238, 286, 260, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
4094, 3i4bB, 0.7674, 3.33, 0.222, 347, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH A PYRIMIDYLPYRROLE INHIBITOR
4095, 3fdnA, 0.7674, 2.67, 0.258, 261, 248, STRUCTURE-BASED DRUG DESIGN OF NOVEL AURORA KINASE A INHIBITORS: STRUCTURE BASIS FOR POTENCY AND SPECIFICITY
4096, 5telA, 0.7673, 2.61, 0.198, 273, 247, PIM-1 KINASE IN COMPLEX WITH A 7-AZAINDOLE
4097, 5e1sA, 0.7673, 2.46, 0.306, 284, 245, THE CRYSTAL STRUCTURE OF INSR TYROSINE KINASE IN COMPLEX WITH THE INHIBITOR BI 885578
4098, 4o0uA, 0.7673, 2.69, 0.237, 259, 249, CRYSTAL STRUCTURES OF HUMAN KINASE AURORA A
4099, 3m1sA, 0.7673, 3.33, 0.222, 348, 257, STRUCTURE OF RUTHENIUM HALF-SANDWICH COMPLEX BOUND TO GLYCOGEN SYNTHASE KINASE 3
4100, 3c4yA, 0.7673, 3.15, 0.220, 478, 259, CRYSTAL STRUCTURE OF APO FORM OF G PROTEIN COUPLED RECEPTOR KINASE 1 AT 7.51A
4101, 2qi8B, 0.7673, 2.00, 0.314, 249, 236, CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN
4102, 2f9gA, 0.7673, 2.55, 0.234, 332, 244, CRYSTAL STRUCTURE OF FUS3 PHOSPHORYLATED ON TYR182
4103, 1i44A, 0.7673, 2.51, 0.317, 282, 246, CRYSTALLOGRAPHIC STUDIES OF AN ACTIVATION LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE
4104, 5u6cB, 0.7672, 2.28, 0.324, 257, 238, CRYSTAL STRUCTURE OF THE MER KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC INHIBITOR
4105, 5oktC, 0.7672, 3.25, 0.182, 285, 258, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH IWP-2 
4106, 5jrsB, 0.7672, 2.17, 0.347, 240, 239, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -34-DIHYDROQUINAZOLIN-3-YL) PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE
4107, 5dewA, 0.7672, 3.15, 0.214, 295, 257, CRYSTAL STRUCTURE OF PAK1 IN COMPLEX WITH AN INHIBITOR COMPOUND 5
4108, 4ztlA, 0.7672, 2.74, 0.287, 280, 244, IRAK4-INHIBITOR CO-STRUCTURE
4109, 4xhkB, 0.7672, 2.73, 0.194, 269, 248, PIM1 KINASE IN COMPLEX WITH COMPOUND 1S
4110, 4kb8B, 0.7672, 3.29, 0.185, 285, 259, CK1D IN COMPLEX WITH 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4- YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE LIGAND
4111, 4dbnA, 0.7672, 2.51, 0.307, 257, 244, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN B-RAF WITH A [1 3]THIAZOLO[54-B]PYRIDINE DERIVATIVE
4112, 3r01A, 0.7672, 2.61, 0.190, 274, 247, THE DISCOVERY OF NOVEL BENZOFURAN-2-CARBOXYLIC ACIDS AS POTENT PIM-1 INHIBITORS
4113, 5hbjA, 0.7671, 3.14, 0.204, 342, 255, CDK8-CYCC IN COMPLEX WITH 8-[2-AMINO-3-CHLORO-5-(1-METHYL-1H-INDAZOL- 5-YL)-PYRIDIN-4-YL]-28-DIAZA-SPIRO[4.5]DECAN-1-ONE
4114, 5hbeA, 0.7671, 3.35, 0.202, 344, 258, CDK8-CYCC IN COMPLEX WITH 8-[3-CHLORO-5-(1-METHYL-22-DIOXO-2 3- DIHYDRO-1H-2L6-BENZO[C]ISOTHIAZOL-5-YL)-PYRIDIN- 4-YL]-1-OXA-38- DIAZA-SPIRO[4.5]DECAN-2-ONE
4115, 5a4lA, 0.7671, 2.92, 0.228, 341, 250, DYRK1A IN COMPLEX WITH FLUORO BENZOTHIAZOLE FRAGMENT
4116, 4qp6B, 0.7671, 3.20, 0.187, 334, 256, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 5H-PYRROLO[23-B]PYRAZINE
4117, 3zlwA, 0.7671, 3.25, 0.237, 312, 257, CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 3
4118, 3vbqA, 0.7671, 2.65, 0.191, 271, 246, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
4119, 3l1sB, 0.7671, 3.36, 0.222, 330, 257, 3-ARYL-4-(ARYLHYDRAZONO)-1H-PYRAZOL-5-ONES: HIGHLY LIGAND EFFICIENT AND POTENT INHIBITORS OF GSK3
4120, 3krwA, 0.7671, 3.16, 0.205, 618, 259, HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (SOAK)
4121, 5dwrA, 0.7670, 2.69, 0.190, 273, 247, IDENTIFICATION OF N-(4-((1R3S5S)-3-AMINO-5-METHYLCYCLOHEXYL)PYRIDIN- 3-YL)-6-(26-DIFLUOROPHENYL)-5-FLUOROPICOLINAMIDE (PIM447) A POTENT AND SELECTIVE PROVIRAL INSERTION SITE OF MOLONEY MURINE LEUKEMIA (PIM) 12 AND 3 KINASE INHIBITOR IN CLINICAL TRIALS FOR HEMATOLOGICAL MALIGNANCIES
4122, 3zrmB, 0.7670, 3.29, 0.223, 347, 256, IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK- 3BETA INHIBITORS
4123, 3uqfB, 0.7670, 2.16, 0.315, 253, 238, C-SRC KINASE DOMAIN IN COMPLEX WITH BKI RM-1-89
4124, 3jyaA, 0.7670, 2.63, 0.194, 274, 247, DISCOVERY OF 3H-BENZO[45]THIENO[32-D]PYRIMIDIN-4-ONES AS POTENT HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
4125, 2oi4X, 0.7670, 2.66, 0.194, 275, 248, CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH FLUORINATED RUTHENIUM PYRIDOCARBAZOLE
4126, 1xqzA, 0.7670, 2.77, 0.193, 277, 249, CRYSTAL STRUCTURE OF HPIM-1 KINASE AT 2.1 A RESOLUTION
4127, 5mqvE, 0.7669, 3.23, 0.189, 287, 259, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH 4-(2 5-DIMETHOXYPHENYL)-N-(4-(5-(4-FLUORPHENYL)-2-(METHYLTHIO)-1H- IMIDAZOL-4-YL)-PYRIDIN-2-YL)-1-METHYL-1H-PYRROLE-2-CARBOXAMIDE
4128, 4mblA, 0.7669, 2.62, 0.198, 274, 247, DISCOVERY OF PYRAZOLO[15A]PYRIMIDINE-BASED PIM1 INHIBITORS
4129, 3eb0A, 0.7669, 2.97, 0.247, 311, 251, CRYSTAL STRUCTURE OF CGD4_240 FROM CRYPTOSPORIDIUM PARVUM IN COMPLEX WITH INDIRUBIN E804
4130, 1gngB, 0.7669, 3.39, 0.224, 355, 259, GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE
4131, 4ntsB, 0.7668, 2.83, 0.198, 341, 252, APO STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE
4132, 4d4rB, 0.7668, 3.17, 0.307, 270, 254, FOCAL ADHESION KINASE CATALYTIC DOMAIN
4133, 3zrlB, 0.7668, 3.30, 0.223, 347, 256, IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS
4134, 3uimA, 0.7668, 2.96, 0.271, 291, 247, STRUCTURAL BASIS FOR THE IMPACT OF PHOSPHORYLATION ON PLANT RECEPTOR- LIKE KINASE BAK1 ACTIVATION
4135, 3nizA, 0.7668, 3.11, 0.261, 288, 253, CRYPTOSPORIDIUM PARVUM CYCLIN-DEPENDENT KINASE CGD5_2510 WITH ADP BOUND.
4136, 1s9jA, 0.7668, 3.40, 0.235, 289, 260, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
4137, 5y9mA, 0.7667, 2.87, 0.183, 320, 252, CRYSTAL STRUCTURE OF CK2A2 FORM 3 
4138, 5uitA, 0.7667, 2.66, 0.287, 284, 244, CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 14
4139, 5iisA, 0.7667, 2.63, 0.194, 273, 247, DESIGN SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIP OF POTENT PAN- PIM KINASE INHIBITORS DERIVED FROM THE PYRIDYL-AMIDE SCAFFOLD
4140, 4yp8D, 0.7667, 3.00, 0.277, 285, 249, IRAK4-INHIBITOR CO-STRUCTURE
4141, 4qpaA, 0.7667, 3.17, 0.199, 331, 256, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 7-(1-BENZYL-1H-PYRAZOL-4- YL)-2-(PYRIDIN-4-YL)-5H-PYRROLO[23-B]PYRAZINE
4142, 4n6zA, 0.7667, 2.59, 0.191, 272, 246, PIM1 COMPLEXED WITH A PYRIDYLCARBOXAMIDE
4143, 3qlfA, 0.7667, 2.00, 0.314, 249, 236, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH PYRAZOLOPYRIMIDINE 5
4144, 2zv2A, 0.7667, 2.72, 0.249, 256, 245, CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2 BETA CAMKK2 KINASE DOMAIN IN COMPLEX WITH STO-609
4145, 2objA, 0.7667, 2.70, 0.194, 272, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH INHIBITOR
4146, 2iztA, 0.7667, 3.37, 0.153, 296, 262, STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
4147, 5cs6B, 0.7666, 2.68, 0.194, 316, 247, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 3 BOUND
4148, 4pteB, 0.7666, 3.36, 0.222, 347, 257, STRUCTURE OF A CARVOXAMIDE COMPOUND (15) (N-[4-(ISOQUINOLIN-7-YL) PYRIDIN-2-YL]CYCLOPROPANECARBOXAMIDE) TO GSK3B
4149, 3tucA, 0.7666, 2.64, 0.341, 257, 246, CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH 1-BENZYL-N-(5-(67- DIMETHOXYQUINOLIN-4-YLOXY)PYRIDIN-2-YL)-2-OXO-12-DIHYDROPYRIDINE-3- CARBOXAMIDE
4150, 3o71A, 0.7666, 3.17, 0.191, 340, 257, CRYSTAL STRUCTURE OF ERK2/DCC PEPTIDE COMPLEX
4151, 2ofvA, 0.7666, 1.97, 0.372, 244, 234, CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 1 BOUND TO LCK
4152, 1yxvA, 0.7666, 2.62, 0.198, 274, 247, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH 34-DIHYDROXY-1- METHYLQUINOLIN-2(1H)-ONE
4153, 4y73D, 0.7665, 2.99, 0.278, 288, 248, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN WITH INHIBITOR
4154, 4lueB, 0.7665, 2.29, 0.382, 417, 238, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH 7-[TRANS-4-(4- METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE (RESULTING FROM DISPLACEMENT OF SKF86002)
4155, 4l44A, 0.7665, 3.03, 0.255, 321, 251, CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389A (FORM II)
4156, 5jznA, 0.7664, 2.79, 0.212, 268, 250, CRYSTAL STRUCTURE OF DCLK1-KD IN COMPLEX WITH NVP-TAE684
4157, 5hbhA, 0.7664, 3.00, 0.202, 336, 252, CDK8-CYCC IN COMPLEX WITH 5-{5-CHLORO-4-[1-(2-METHOXY-ETHYL)-18- DIAZA-SPIRO[4.5]DEC-8-YL]-PYRIDIN-3-YL}-1-METHYL-13-DIHYDRO- BENZO[C]ISOTHIAZOLE 22-DIOXIDE
4158, 5f94A, 0.7664, 3.36, 0.222, 346, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH COMPOUND 15: 2- [(CYCLOPROPYLCARBONYL)AMINO]-N-(4-METHOXYPYRIDIN-3-YL)PYRIDINE-4- CARBOXAMIDE
4159, 4gt4B, 0.7664, 2.67, 0.343, 273, 248, STRUCTURE OF UNLIGANDED INACTIVE ROR2 KINASE DOMAIN
4160, 3krxA, 0.7664, 3.18, 0.189, 618, 259, HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (CO-CRYSTAL)
4161, 3dcvA, 0.7664, 2.76, 0.194, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM1 KINASE COMPLEXED WITH 4-(4- HYDROXY-3-METHYL-PHENYL)-6-PHENYLPYRIMIDIN-2(1H)-ONE
4162, 2o3pA, 0.7664, 2.62, 0.194, 274, 247, CRYSTAL STRUCTURE OF PIM1 WITH QUERCETIN
4163, 2bzhB, 0.7664, 2.67, 0.198, 275, 248, CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1
4164, 5ebzE, 0.7663, 3.26, 0.250, 655, 260, CRYSTAL STRUCTURE OF HUMAN IKK1
4165, 5a3xD, 0.7663, 2.82, 0.221, 331, 249, DYRK1A IN COMPLEX WITH HYDROXY BENZOTHIAZOLE FRAGMENT
4166, 4z7hB, 0.7663, 2.83, 0.211, 388, 247, CRYSTAL STRUCTURE OF HUMAN IRE1 CYTOPLASMIC KINASE-RNASE REGION - COMPLEX WITH IMIDAZOPYRIDINE COMPOUND 3
4167, 3qf9A, 0.7663, 2.68, 0.190, 274, 248, CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A FURAN- THIAZOLIDINEDIONE LIGAND
4168, 3ctjA, 0.7663, 2.74, 0.328, 289, 247, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A AMINOPYRIDINE BASED INHIBITOR
4169, 2xizA, 0.7663, 2.70, 0.194, 273, 247, PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-3 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
4170, 5uiuA, 0.7662, 2.97, 0.279, 286, 247, CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 30
4171, 5a4tC, 0.7662, 2.89, 0.221, 332, 249, DYRK1A IN COMPLEX WITH NITRILE BENZOTHIAZOLE FRAGMENT
4172, 4nt4A, 0.7662, 3.32, 0.157, 300, 261, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF GILGAMESH ISOFORM I FROM DROSOPHILA MELANOGASTER
4173, 4nctD, 0.7662, 2.91, 0.220, 331, 250, HUMAN DYRK1A IN COMPLEX WITH PKC412
4174, 3o7lD, 0.7662, 2.85, 0.202, 333, 252, CRYSTAL STRUCTURE OF PHOSPHOLAMBAN (1-19):PKA C-SUBUNIT:AMP-PNP:MG2+ COMPLEX
4175, 2bujB, 0.7662, 3.24, 0.216, 286, 259, CRYSTAL STRUCTURE OF THE HUMAN SERINE-THREONINE KINASE 16 IN COMPLEX WITH STAUROSPORINE
4176, 1j3hB, 0.7662, 2.88, 0.198, 327, 252, CRYSTAL STRUCTURE OF APOENZYME CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT
4177, 5tvtA, 0.7661, 2.59, 0.249, 321, 245, STRUCTURE OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE
4178, 4n6yA, 0.7661, 2.74, 0.194, 273, 248, PIM1 COMPLEXED WITH A PHENYLCARBOXAMIDE
4179, 4jbqA, 0.7661, 2.64, 0.263, 257, 247, NOVEL AURORA KINASE INHIBITORS REVEAL MECHANISMS OF HURP IN NUCLEATION OF CENTROSOMAL AND KINETOCHORE MICROTUBULES
4180, 3naxA, 0.7661, 3.00, 0.237, 278, 253, PDK1 IN COMPLEX WITH INHIBITOR MP7
4181, 3cqeA, 0.7661, 2.64, 0.224, 258, 246, WEE1 KINASE COMPLEX WITH INHIBITOR PD074291
4182, 3anqD, 0.7661, 2.89, 0.221, 334, 249, HUMAN DYRK1A/INHIBITOR COMPLEX
4183, 1jowB, 0.7661, 2.66, 0.241, 277, 245, CRYSTAL STRUCTURE OF A COMPLEX OF HUMAN CDK6 AND A VIRAL CYCLIN
4184, 1cm8B, 0.7661, 2.81, 0.213, 327, 249, PHOSPHORYLATED MAP KINASE P38-GAMMA
4185, 1cm8A, 0.7661, 2.82, 0.213, 327, 249, PHOSPHORYLATED MAP KINASE P38-GAMMA
4186, 5t1tA, 0.7660, 2.64, 0.287, 283, 244, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
4187, 5ebzC, 0.7660, 3.27, 0.254, 655, 260, CRYSTAL STRUCTURE OF HUMAN IKK1
4188, 4xh6A, 0.7660, 2.63, 0.194, 273, 247, CRYSTAL STRUCTURE OF PROTO-ONCOGENE KINASE PIM1 BOUND TO HISPIDULIN
4189, 4ptgA, 0.7660, 3.35, 0.222, 333, 257, STRUCTURE OF A CARBOXAMINE COMPOUND (26) (2-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}-4-METHOXYPYRIMIDINE-5-CARBOXAMIDE) TO GSK3B
4190, 4k1bA, 0.7660, 2.74, 0.194, 273, 248, STRUCTURE OF PIM-1 KINASE BOUND TO N-(5-(2-FLUOROPHENYL)-1H-PYRROLO[2 3-B]PYRIDIN-3-YL)-5-((((3R4R)-3-FLUOROPIPERIDIN-4-YL)METHYL)AMINO) PYRAZOLO[15-A]PYRIMIDINE-3-CARBOXAMIDE
4191, 3zdiA, 0.7660, 3.33, 0.223, 348, 256, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE AND INHIBITOR 7D
4192, 3p08A, 0.7660, 2.68, 0.316, 252, 244, CRYSTAL STRUCTURE OF THE HUMAN BTK KINASE DOMAIN
4193, 2qo2A, 0.7660, 2.74, 0.350, 282, 246, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION DEPHOSPHORYLATED APO STRUCTURE
4194, 2a1aB, 0.7660, 2.67, 0.248, 269, 246, PKR KINASE DOMAIN-EIF2ALPHA COMPLEX
4195, 3v01A, 0.7659, 3.36, 0.236, 289, 259, DISCOVERY OF NOVEL ALLOSTERIC MEK INHIBITORS POSSESSING CLASSICAL AND NON-CLASSICAL BIDENTATE SER212 INTERACTIONS.
4196, 2izuA, 0.7659, 3.36, 0.157, 297, 261, STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
4197, 1zysA, 0.7659, 3.29, 0.232, 271, 254, CO-CRYSTAL STRUCTURE OF CHECKPOINT KINASE CHK1 WITH A PYRROLO-PYRIDINE INHIBITOR
4198, 5tc0B, 0.7658, 2.25, 0.315, 250, 238, STRUCTURE-BASED OPTIMIZATION OF 1H-IMIDAZOLE-2-CARBOXAMIDES AS AXL KINASE INHIBITORS UTILIZING A MER MUTANT SURROGATE
4199, 5he0A, 0.7658, 3.21, 0.193, 621, 259, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG215022
4200, 4tn6B, 0.7658, 3.34, 0.185, 285, 259, CK1D IN COMPLEX WITH INHIBITOR
4201, 4p4cA, 0.7658, 2.62, 0.354, 266, 246, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH QUINOXALINE DERIVATIVES
4202, 2e9oA, 0.7658, 3.27, 0.236, 269, 254, STRUCTURE OF H-CHK1 COMPLEXED WITH AA582939
4203, 2cguA, 0.7658, 3.18, 0.238, 263, 252, IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
4204, 5j95A, 0.7657, 2.96, 0.240, 284, 250, MAP4K4 IN COMPLEX WITH INHIBITOR
4205, 5k76B, 0.7656, 2.60, 0.288, 281, 243, IRAK4 IN COMPLEX WITH COMPOUND 28
4206, 5jsmD, 0.7656, 2.69, 0.297, 259, 246, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-3-VEM
4207, 4bidA, 0.7656, 2.48, 0.274, 254, 241, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4208, 3m11A, 0.7656, 2.59, 0.264, 256, 246, CRYSTAL STRUCTURE OF AURORA A KINASE COMPLEXED WITH INHIBITOR
4209, 3bgpA, 0.7656, 2.72, 0.194, 272, 247, HUMAN PIM-1 COMPLEXED WITH A BENZOISOXAZOLE INHIBITOR VX1
4210, 1yxuC, 0.7656, 2.69, 0.194, 272, 247, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP
4211, 5uiuB, 0.7655, 2.97, 0.279, 287, 247, CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 30
4212, 5kgkA, 0.7655, 2.73, 0.194, 273, 248, CRYSTAL STRUCTURE OF PIM1 WITH INHIBITOR: 3-(4-METHOXYPHENYL)-1~{H}- PYRAZOL-5-AMINE
4213, 5k0xB, 0.7655, 2.11, 0.328, 254, 235, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC2541
4214, 5jzjA, 0.7655, 2.79, 0.237, 271, 249, CRYSTAL STRUCTURE OF DCLK1-KD IN COMPLEX WITH AMPPN
4215, 5ebzG, 0.7655, 3.26, 0.246, 655, 260, CRYSTAL STRUCTURE OF HUMAN IKK1
4216, 4jx3A, 0.7655, 2.73, 0.194, 274, 248, CRYSTAL STRUCTURE OF PIM1 KINASE
4217, 4j7bA, 0.7655, 2.82, 0.249, 284, 249, CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1
4218, 2izsA, 0.7655, 3.58, 0.151, 298, 265, STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
4219, 1x8bA, 0.7655, 2.61, 0.224, 259, 245, STRUCTURE OF HUMAN WEE1A KINASE: KINASE DOMAIN COMPLEXED WITH INHIBITOR PD0407824
4220, 1jstA, 0.7655, 3.03, 0.264, 297, 254, PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A
4221, 5oy4A, 0.7654, 3.35, 0.223, 349, 256, GSK3BETA COMPLEX WITH N-(6-(34-DIHYDROXYPHENYL)-1H-PYRAZOLO[34- B]PYRIDIN-3-YL)ACETAMIDE
4222, 4qp1A, 0.7654, 3.13, 0.189, 342, 254, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-CYCLOHEXYL-9H-PURIN-6- AMINE
4223, 4neuB, 0.7654, 2.22, 0.307, 268, 241, X-RAY STRUCTURE OF RECEPTOR INTERACTING PROTEIN 1 (RIP1)KINASE DOMAIN WITH A 1-AMINOISOQUINOLINE INHIBITOR
4224, 3r02A, 0.7654, 2.56, 0.192, 271, 245, THE DISCOVERY OF NOVEL BENZOFURAN-2-CARBOXYLIC ACIDS AS POTENT PIM-1 INHIBITORS
4225, 3jxwA, 0.7654, 2.65, 0.202, 274, 247, DISCOVERY OF 3H-BENZO[45]THIENO[32-D]PYRIMIDIN-4-ONES AS POTENT HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
4226, 2xiyA, 0.7654, 2.60, 0.195, 273, 246, PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-2 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
4227, 2j2iB, 0.7654, 2.73, 0.194, 273, 248, CRYSTAL STRUCTURE OF THE HUMAB PIM1 IN COMPLEX WITH LY333531
4228, 1q4lA, 0.7654, 3.39, 0.222, 342, 257, GSK-3 BETA COMPLEXED WITH INHIBITOR I-5
4229, 5hieD, 0.7653, 2.40, 0.296, 253, 243, BRAF KINASE DOMAIN B3AC LOOP DELETION MUTANT IN COMPLEX WITH DABRAFENIB
4230, 5ebzL, 0.7653, 3.23, 0.246, 655, 260, CRYSTAL STRUCTURE OF HUMAN IKK1
4231, 5c1qB, 0.7653, 2.73, 0.194, 273, 248, SERINE/THREONINE-PROTEIN KINASE PIM-1
4232, 5a3xA, 0.7653, 2.99, 0.227, 342, 251, DYRK1A IN COMPLEX WITH HYDROXY BENZOTHIAZOLE FRAGMENT
4233, 4nctA, 0.7653, 2.95, 0.220, 341, 250, HUMAN DYRK1A IN COMPLEX WITH PKC412
4234, 3jpvA, 0.7653, 2.64, 0.194, 273, 247, CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A PYRROLO[23- A]CARBAZOLE LIGAND
4235, 2cjmA, 0.7653, 3.00, 0.262, 285, 252, MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE
4236, 1wzyA, 0.7653, 3.08, 0.201, 350, 254, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A PYRAZOLOPYRIDAZINE DERIVATIVE
4237, 5n4vA, 0.7652, 2.64, 0.190, 273, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE 2-CYCLOPROPYL-45- DIMETHYLTHIENO[54-D]PYRIMIDINE-6-CARBOXYLIC ACID
4238, 5i5zA, 0.7652, 3.36, 0.202, 345, 257, CDK8-CYCC IN COMPLEX WITH 8-(1-METHYL-22-DIOXO-23-DIHYDRO-1H-2L6- BENZO[C]ISOTHIAZOL-5-YL)-[16]NAPHTHYRIDINE-2-CARBOXYLIC ACID METHYLAMIDE
4239, 5ebzK, 0.7652, 3.31, 0.250, 655, 260, CRYSTAL STRUCTURE OF HUMAN IKK1
4240, 4xs2C, 0.7652, 3.01, 0.274, 281, 248, IRAK4-INHIBITOR CO-STRUCTURE
4241, 4bibA, 0.7652, 2.50, 0.270, 254, 241, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4242, 3zrkA, 0.7652, 3.46, 0.224, 345, 259, IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS
4243, 4zy5A, 0.7651, 2.89, 0.215, 283, 251, CRYSTAL STRUCTURE OF P21-ACTIVATED KINASE 1 IN COMPLEX WITH AN INHIBITOR COMPOUND 17
4244, 4xs2D, 0.7651, 2.68, 0.276, 277, 243, IRAK4-INHIBITOR CO-STRUCTURE
4245, 4wovB, 0.7651, 2.29, 0.257, 256, 241, CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH BMS-066 AKA 2-METHOXY-N-({6-[3-METHYL-7-(METHYLAMINO)- 35810-TETRAAZATRICYCLO[7.3.0.0 6]DODECA-1(9)2(6)4711-PENTAEN- 11-YL]PYRIDIN-2-YL}METHY L)ACETAMIDE
4246, 4cxaC, 0.7651, 3.15, 0.253, 330, 257, CRYSTAL STRUCTURE OF THE HUMAN CDK12-CYCLIN K COMPLEX BOUND TO AMPPNP
4247, 4bzoA, 0.7651, 2.71, 0.190, 272, 247, CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH A PYRROLO- PYRAZINONE INHIBITOR
4248, 4bznA, 0.7651, 2.61, 0.195, 272, 246, CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH A PYRROLO(12-A) PYRAZINONE INHIBITOR
4249, 3ztxB, 0.7651, 2.76, 0.205, 272, 249, AURORA KINASE SELECTIVE INHIBITORS IDENTIFIED USING A TAXOL- INDUCED CHECKPOINT SENSITIVITY SCREEN.
4250, 3cxwA, 0.7651, 2.65, 0.194, 272, 247, CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A BETA CARBOLINE LIGAND I
4251, 2hwoA, 0.7651, 2.02, 0.305, 251, 236, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH COVALENT INHIBITOR
4252, 5k7gD, 0.7650, 2.98, 0.280, 283, 246, IRAK4 IN COMPLEX WITH AZ3862
4253, 5acbC, 0.7650, 3.18, 0.245, 324, 257, CRYSTAL STRUCTURE OF THE HUMAN CDK12-CYCLINK COMPLEX
4254, 4qpaB, 0.7650, 3.00, 0.190, 345, 252, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 7-(1-BENZYL-1H-PYRAZOL-4- YL)-2-(PYRIDIN-4-YL)-5H-PYRROLO[23-B]PYRAZINE
4255, 4ptcA, 0.7650, 3.38, 0.218, 342, 257, STRUCTURE OF A CARBOXAMIDE COMPOUND (3) (2-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}-4-OXO-4H-1LAMBDA~4~3-THIAZOLE-5-CARBOXAMIDE) TO GSK3B
4256, 4hgtA, 0.7650, 3.27, 0.198, 283, 258, CRYSTAL STRUCTURE OF CK1D WITH COMPOUND 13
4257, 3zlyA, 0.7650, 3.33, 0.237, 310, 257, CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 8
4258, 3m1sB, 0.7650, 3.37, 0.222, 349, 257, STRUCTURE OF RUTHENIUM HALF-SANDWICH COMPLEX BOUND TO GLYCOGEN SYNTHASE KINASE 3
4259, 2x7fC, 0.7650, 2.83, 0.250, 285, 248, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2- AND NCK-INTERACTING KINASE WITH WEE1CHK1 INHIBITOR
4260, 2e9vA, 0.7650, 3.28, 0.245, 268, 253, STRUCTURE OF H-CHK1 COMPLEXED WITH A859017
4261, 5kcxA, 0.7649, 2.61, 0.195, 272, 246, PIM-1 KINASE IN COMPLEX WITH A SELECTIVE N-SUBSTITUTED 7-AZAINDOLE INHIBITOR
4262, 3dkoA, 0.7649, 2.74, 0.328, 275, 247, COMPLEX BETWEEN THE KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7) AND INHIBITOR ALW-II-49-7
4263, 2ojiA, 0.7649, 3.22, 0.200, 344, 255, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-BENZYL-4-(4-(3- CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
4264, 1zltA, 0.7649, 3.22, 0.234, 272, 252, CRYSTAL STRUCTURE OF CHK1 COMPLEXED WITH A HYMENALDISINE ANALOG
4265, 5ebzH, 0.7648, 3.25, 0.246, 655, 260, CRYSTAL STRUCTURE OF HUMAN IKK1
4266, 5ebzA, 0.7648, 3.25, 0.246, 655, 260, CRYSTAL STRUCTURE OF HUMAN IKK1
4267, 4r6vA, 0.7648, 2.62, 0.346, 273, 246, CRYSTAL STRUCTURE OF FGF RECEPTOR (FGFR) 4 KINASE HARBORING THE V550L GATE-KEEPER MUTATION IN COMPLEX WITH FIIN-3 AN IRREVERSIBLE TYROSINE KINASE INHIBITOR CAPABLE OF OVERCOMING FGFR KINASE GATE-KEEPER MUTATIONS
4268, 4mbiA, 0.7648, 2.65, 0.194, 274, 247, DISCOVERY OF PYRAZOLO[15A]PYRIMIDINE-BASED PIM1 INHIBITORS
4269, 3cy2A, 0.7648, 2.66, 0.190, 271, 247, CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A BETA CARBOLINE LIGAND II
4270, 2y4iC, 0.7648, 3.34, 0.234, 313, 256, KSR2-MEK1 HETERODIMER
4271, 2cgxA, 0.7648, 3.20, 0.242, 265, 252, IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
4272, 6g9hA, 0.7647, 3.26, 0.204, 343, 255, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4273, 5mahA, 0.7647, 2.47, 0.251, 316, 243, CRYSTAL STRUCTURE OF MELK IN COMPLEX WITH AN INHIBITOR
4274, 5he1A, 0.7647, 3.21, 0.193, 618, 259, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224062
4275, 3w55A, 0.7647, 2.75, 0.198, 335, 248, THE STRUCTURE OF ERK2 IN COMPLEX WITH FR148083
4276, 3du8A, 0.7647, 3.38, 0.222, 336, 257, CRYSTAL STRUCTURE OF GSK-3 BETA IN COMPLEX WITH NMS-869553A
4277, 3bgqA, 0.7647, 2.61, 0.191, 272, 246, HUMAN PIM-1 KINASE IN COMPLEX WITH AN TRIAZOLO PYRIDAZINE INHIBITOR VX2
4278, 2cgvA, 0.7647, 3.20, 0.238, 264, 252, IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
4279, 5uoxB, 0.7646, 2.47, 0.278, 252, 241, STRUCTURE-BASED DESIGN OF ASK1 INHIBITORS AS POTENTIAL FIRST-IN-CLASS AGENTS FOR HEART FAILURE
4280, 5nhfA, 0.7646, 3.06, 0.202, 339, 253, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
4281, 5n4xA, 0.7646, 2.65, 0.194, 272, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE 45-DIBROMOTHIOPHENE-2- CARBOHYDRAZIDE
4282, 5jznB, 0.7646, 2.88, 0.236, 266, 250, CRYSTAL STRUCTURE OF DCLK1-KD IN COMPLEX WITH NVP-TAE684
4283, 5a4eD, 0.7646, 2.94, 0.220, 331, 250, DYRK1A IN COMPLEX WITH METHOXY BENZOTHIAZOLE FRAGMENT
4284, 4s33A, 0.7646, 3.09, 0.205, 347, 254, ERK2 R65S MUTANT COMPLEXED WITH AMP-PNP
4285, 4pnkA, 0.7646, 3.04, 0.187, 625, 257, G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH GSK180736A
4286, 4fv2A, 0.7646, 3.06, 0.206, 344, 253, CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK5
4287, 3hkoA, 0.7646, 3.31, 0.194, 319, 258, CRYSTAL STRUCTURE OF A CDPK KINASE DOMAIN FROM CRYPTOSPORIDIUM PARVUM CGD7_40
4288, 3du8B, 0.7646, 3.38, 0.222, 339, 257, CRYSTAL STRUCTURE OF GSK-3 BETA IN COMPLEX WITH NMS-869553A
4289, 3bgzA, 0.7646, 2.73, 0.194, 267, 247, HUMAN PIM-1 KINASE IN COMPLEX WITH DIPHENYL INDOLE INHIBITOR VX3
4290, 2pk9A, 0.7646, 3.05, 0.250, 287, 252, STRUCTURE OF THE PHO85-PHO80 CDK-CYCLIN COMPLEX OF THE PHOSPHATE-RESPONSIVE SIGNAL TRANSDUCTION PATHWAY
4291, 1yxuB, 0.7646, 2.65, 0.194, 273, 247, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP
4292, 1p4oA, 0.7646, 2.92, 0.320, 308, 250, STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION.
4293, 6es0A, 0.7645, 2.84, 0.274, 288, 248, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN RIPK2 IN COMPLEX WITH THE ACTIVATION LOOP TARGETING INHIBITOR CS-R35
4294, 4ptcB, 0.7645, 3.38, 0.222, 347, 257, STRUCTURE OF A CARBOXAMIDE COMPOUND (3) (2-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}-4-OXO-4H-1LAMBDA~4~3-THIAZOLE-5-CARBOXAMIDE) TO GSK3B
4295, 4nm0A, 0.7645, 3.39, 0.222, 356, 257, CRYSTAL STRUCTURE OF PEPTIDE INHIBITOR-FREE GSK-3/AXIN COMPLEX
4296, 4j7bD, 0.7645, 2.75, 0.239, 281, 247, CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1
4297, 4hokM, 0.7645, 3.48, 0.189, 291, 265, CRYSTAL STRUCTURE OF APO CK1E
4298, 4gw8A, 0.7645, 2.65, 0.194, 273, 247, HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND LEUCETTINE L41
4299, 4fv3A, 0.7645, 3.17, 0.201, 346, 254, CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK6
4300, 2e9uA, 0.7645, 3.20, 0.234, 269, 252, STRUCTURE OF H-CHK1 COMPLEXED WITH A780125
4301, 5vd4A, 0.7644, 2.86, 0.204, 261, 250, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV- 016 A MK1775 ANALOUGUE
4302, 4ux9A, 0.7644, 2.84, 0.224, 343, 250, CRYSTAL STRUCTURE OF JNK1 BOUND TO A MKK7 DOCKING MOTIF
4303, 3zm4A, 0.7644, 3.33, 0.242, 309, 256, CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 1
4304, 3wigA, 0.7644, 3.26, 0.230, 278, 257, HUMAN MEK1 KINASE IN COMPLEX WITH CH5126766 AND MGAMP-PNP
4305, 3vw6B, 0.7644, 2.40, 0.279, 253, 240, CRYSTAL STRUCTURE OF HUMAN APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) WITH IMIDAZOPYRIDINE INHIBITOR
4306, 1p4oB, 0.7644, 2.93, 0.320, 314, 250, STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION.
4307, 1j1cA, 0.7644, 3.39, 0.222, 354, 257, BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH ADP
4308, 5vd7A, 0.7643, 2.80, 0.217, 261, 249, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV- 098 A MK1775 ANALOGUE
4309, 5toeA, 0.7643, 2.62, 0.199, 272, 246, PIM-1 KINASE IN COMPLEX WITH A 7-AZAINDOLE
4310, 4rmzB, 0.7643, 3.02, 0.279, 282, 247, CRYSTAL STRUCTURE OF IRAK-4
4311, 3pizA, 0.7643, 2.07, 0.353, 245, 238, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH (5-AMINO-1-O- TOLYL-1H-PYRAZOL-4-YL)-[3-(1-METHANESULFONYL-PIPERIDIN-4-YL)-PHENYL]- METHANONE
4312, 3c4cA, 0.7643, 2.64, 0.291, 258, 247, B-RAF KINASE IN COMPLEX WITH PLX4720
4313, 5yf9X, 0.7642, 2.93, 0.187, 319, 251, CRYSTAL STRUCTURE OF CK2A2 FORM-2 
4314, 5turA, 0.7642, 2.61, 0.199, 270, 246, PIM-1 KINASE IN COMPLEX WITH A 7-AZAINDOLE
4315, 5n4rA, 0.7642, 2.66, 0.194, 273, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 2-(AZEPAN-1-YL)-1-(1H-INDOL-3-YL) PROPAN-1-ONE
4316, 5fdpA, 0.7642, 3.26, 0.323, 285, 254, STRUCTURE OF DDR1 RECEPTOR TYROSINE KINASE IN COMPLEX WITH D2099 INHIBITOR AT 2.25 ANGSTROMS RESOLUTION.
4317, 5ebzI, 0.7642, 3.31, 0.250, 655, 260, CRYSTAL STRUCTURE OF HUMAN IKK1
4318, 4fv1A, 0.7642, 3.06, 0.206, 342, 253, CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK4
4319, 3zrlA, 0.7642, 3.37, 0.223, 345, 256, IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS
4320, 2in6A, 0.7642, 2.65, 0.224, 256, 245, WEE1 KINASE COMPLEX WITH INHIBITOR PD311839
4321, 4ficA, 0.7641, 1.98, 0.306, 251, 235, KINASE DOMAIN OF CSRC IN COMPLEX WITH A HINGE REGION-BINDING FRAGMENT
4322, 3uysD, 0.7641, 3.24, 0.171, 284, 257, CRYSTAL STRUCTURE OF APO HUMAN CK1D
4323, 3q3bA, 0.7641, 3.40, 0.222, 344, 257, 6-AMINO-4-(PYRIMIDIN-4-YL)PYRIDONES: NOVEL GLYCOGEN SYNTHASE KINASE-3 INHIBITORS
4324, 3eidC, 0.7641, 2.91, 0.255, 290, 251, CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
4325, 2x7gA, 0.7641, 3.43, 0.178, 344, 258, STRUCTURE OF HUMAN SERINE-ARGININE-RICH PROTEIN-SPECIFIC KINASE 2 (SRPK2) BOUND TO PURVALANOL B
4326, 2ojjA, 0.7641, 3.08, 0.205, 344, 254, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-N-(1-(3- CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3- CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
4327, 4l46A, 0.7640, 3.10, 0.255, 317, 251, CRYSTAL STRUCTURES OF HUMAN P70S6K1-WT
4328, 4a7cA, 0.7640, 2.80, 0.194, 273, 248, CRYSTAL STRUCTURE OF PIM1 KINASE WITH ETP46546
4329, 3slsB, 0.7640, 3.07, 0.249, 294, 253, CRYSTAL STRUCTURE OF HUMAN MEK-1 KINASE IN COMPLEX WITH UCB1353770 AND AMPPNP
4330, 2z2wA, 0.7640, 2.75, 0.223, 260, 247, HUMAND WEE1 KINASE COMPLEXED WITH INHIBITOR PF0335770
4331, 2ydiA, 0.7640, 3.35, 0.235, 279, 255, DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS
4332, 2qodA, 0.7640, 2.72, 0.343, 274, 245, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y602F MUTANT
4333, 2oibB, 0.7640, 2.67, 0.280, 278, 243, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM
4334, 2e9vB, 0.7640, 3.27, 0.233, 268, 253, STRUCTURE OF H-CHK1 COMPLEXED WITH A859017
4335, 6g9mA, 0.7639, 3.28, 0.196, 341, 255, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4336, 5yf9B, 0.7639, 2.90, 0.175, 319, 251, CRYSTAL STRUCTURE OF CK2A2 FORM-2 
4337, 5o0yA, 0.7639, 3.29, 0.240, 288, 258, TLK2 KINASE DOMAIN FROM HUMAN 
4338, 5fdxA, 0.7639, 3.19, 0.364, 280, 253, STRUCTURE OF DDR1 RECEPTOR TYROSINE KINASE IN COMPLEX WITH D2164 INHIBITOR AT 2.65 ANGSTROMS RESOLUTION.
4339, 5aikA, 0.7639, 2.99, 0.219, 344, 251, HUMAN DYRK1A IN COMPLEX WITH LDN-211898
4340, 1tvoA, 0.7639, 3.29, 0.213, 350, 258, THE STRUCTURE OF ERK2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
4341, 5vd8A, 0.7638, 2.83, 0.204, 260, 250, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV- 099 A MK1775 ANALOGUE
4342, 5oq7A, 0.7638, 2.98, 0.250, 259, 248, STRUCTURE OF CHK1 8-PT. MUTANT COMPLEX WITH ARYLBENZAMIDE LRRK2 INHIBITOR
4343, 5ng3C, 0.7638, 2.77, 0.270, 272, 248, STRUCTURE OF INACTIVE KINASE RIP2K(K47R)
4344, 5k5nA, 0.7638, 3.21, 0.232, 331, 254, CRYSTAL STRUCTURE OF GSK-3BETA COMPLEXED WITH PF-04802367 A HIGHLY SELECTIVE BRAIN-PENETRANT KINASE INHIBITOR
4345, 5jrqA, 0.7638, 2.73, 0.310, 258, 248, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-6-VEM
4346, 5aikB, 0.7638, 2.99, 0.219, 342, 251, HUMAN DYRK1A IN COMPLEX WITH LDN-211898
4347, 4hnfA, 0.7638, 3.50, 0.179, 289, 263, CRYSTAL STRUCTURE OF CK1D IN COMPLEX WITH PF4800567
4348, 3qtiB, 0.7638, 2.74, 0.335, 280, 245, C-MET KINASE IN COMPLEX WITH NVP-BVU972
4349, 2bzjA, 0.7638, 2.65, 0.194, 273, 247, CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU3
4350, 1q4lB, 0.7638, 3.43, 0.222, 337, 257, GSK-3 BETA COMPLEXED WITH INHIBITOR I-5
4351, 6gn1B, 0.7637, 3.33, 0.223, 339, 256, CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3B) IN COMPLEX WITH PIK-75 
4352, 5vd5A, 0.7637, 2.84, 0.200, 260, 250, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV- 050 A MK1775 ANALOUGUE
4353, 5a4tD, 0.7637, 2.92, 0.221, 332, 249, DYRK1A IN COMPLEX WITH NITRILE BENZOTHIAZOLE FRAGMENT
4354, 4rpvA, 0.7637, 2.75, 0.194, 273, 248, CO-CRYSTAL STRUCTURE OF PIM1 WITH COMPOUND 3
4355, 4ae6A, 0.7637, 2.94, 0.206, 319, 253, STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM OF PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT CALPHA 2
4356, 4acgA, 0.7637, 3.40, 0.222, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4357, 3vbvA, 0.7637, 2.58, 0.196, 268, 245, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
4358, 2x8dA, 0.7637, 3.35, 0.239, 279, 255, DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
4359, 1q3wB, 0.7637, 3.41, 0.222, 341, 257, GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE
4360, 5w84A, 0.7636, 2.71, 0.280, 279, 243, CRYSTAL STRUCTURE OF IRAK-4 WITH A 46-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 4)
4361, 5ebzF, 0.7636, 3.29, 0.242, 655, 260, CRYSTAL STRUCTURE OF HUMAN IKK1
4362, 4rc4A, 0.7636, 2.62, 0.199, 272, 246, CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE DERIVATIVES
4363, 3c4cB, 0.7636, 2.46, 0.302, 257, 245, B-RAF KINASE IN COMPLEX WITH PLX4720
4364, 2ywpA, 0.7636, 3.24, 0.233, 269, 253, CRYSTAL STRUCTURE OF CHK1 WITH A UREA INHIBITOR
4365, 2yiyA, 0.7636, 2.41, 0.279, 293, 244, CRYSTAL STRUCTURE OF COMPOUND 8 BOUND TO TAK1-TAB
4366, 5uuuA, 0.7635, 3.20, 0.185, 414, 259, DESIGN SYNTHESIS AND EVALUATION OF THE FIRST SELECTIVE AND POTENT G- PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) INHIBITOR FOR THE POTENTIAL TREATMENT OF HEART FAILURE
4367, 5lcjA, 0.7635, 2.98, 0.194, 345, 252, IN-GEL ACTIVITY-BASED PROTEIN PROFILING OF A CLICKABLE COVALENT ERK 1/2 INHIBITOR
4368, 5he2A, 0.7635, 3.21, 0.185, 628, 259, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224406
4369, 5f95B, 0.7635, 3.42, 0.222, 338, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH COMPOUND 18: 2- [(CYCLOPROPYLCARBONYL)AMINO]-N-(4-PHENYLPYRIDIN-3-YL)PYRIDINE-4- CARBOXAMIDE
4370, 5f95A, 0.7635, 3.39, 0.222, 345, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH COMPOUND 18: 2- [(CYCLOPROPYLCARBONYL)AMINO]-N-(4-PHENYLPYRIDIN-3-YL)PYRIDINE-4- CARBOXAMIDE
4371, 4nctB, 0.7635, 2.98, 0.220, 333, 250, HUMAN DYRK1A IN COMPLEX WITH PKC412
4372, 2izrA, 0.7635, 3.51, 0.152, 298, 263, STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
4373, 1yi3A, 0.7635, 2.69, 0.195, 267, 246, CRYSTAL STRUCTURE OF PIM-1 BOUND TO LY294002
4374, 6g91A, 0.7634, 3.21, 0.193, 344, 254, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4375, 5ndtA, 0.7634, 2.66, 0.194, 273, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE (E)-3-(2-(THIOPHEN-2-YL)VINYL)-3; 4-DIHYDROQUINOXALIN-2(1H)-ONE 
4376, 5a4tA, 0.7634, 2.97, 0.228, 341, 250, DYRK1A IN COMPLEX WITH NITRILE BENZOTHIAZOLE FRAGMENT
4377, 5a4qD, 0.7634, 2.92, 0.221, 334, 249, DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENT
4378, 4l3lA, 0.7634, 3.17, 0.254, 291, 252, CRYSTAL STRUCTURES OF HUMAN P70S6K1 KINASE DOMAIN (ZINC ANOMALOUS)
4379, 3vbtA, 0.7634, 2.59, 0.196, 267, 245, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
4380, 3a8wB, 0.7634, 2.72, 0.184, 327, 250, CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
4381, 5x18A, 0.7633, 3.56, 0.155, 294, 265, CRYSTAL STRUCTURE OF CASEIN KINASE I HOMOLOG 1
4382, 5vc4A, 0.7633, 2.83, 0.200, 261, 250, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH BOSUTINIB-ISOMER
4383, 4rc2A, 0.7633, 2.62, 0.195, 272, 246, CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE DERIVATIVES
4384, 4mk0A, 0.7633, 3.18, 0.182, 631, 258, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH A A RATIONALLY DESIGNED PAROXETINE DERIVATIVE
4385, 2qoiA, 0.7633, 2.68, 0.343, 274, 245, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y596F:Y602F DOUBLE MUTANT
4386, 5v5yA, 0.7632, 2.77, 0.206, 259, 248, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH MK1775
4387, 5k7gC, 0.7632, 2.98, 0.280, 283, 246, IRAK4 IN COMPLEX WITH AZ3862
4388, 2qooA, 0.7632, 2.73, 0.339, 273, 245, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y596F:Y602F:Y742F TRIPLE MUTANT
4389, 2c3kA, 0.7632, 3.19, 0.243, 262, 251, IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
4390, 1yxuA, 0.7632, 2.67, 0.194, 273, 247, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP
4391, 6b16A, 0.7631, 3.03, 0.213, 285, 253, P21-ACTIVATED KINASE 1 IN COMPLEX WITH A 4-AZAINDOLE INHIBITOR
4392, 5di1A, 0.7631, 2.99, 0.240, 285, 250, MAP4K4 IN COMPLEX WITH AN INHIBITOR
4393, 4pteA, 0.7631, 3.29, 0.224, 341, 255, STRUCTURE OF A CARVOXAMIDE COMPOUND (15) (N-[4-(ISOQUINOLIN-7-YL) PYRIDIN-2-YL]CYCLOPROPANECARBOXAMIDE) TO GSK3B
4394, 4mygA, 0.7631, 2.99, 0.210, 335, 252, MAPK13 ACTIVE FORM
4395, 4as0A, 0.7631, 2.66, 0.194, 273, 247, CYCLOMETALATED PHTHALIMIDES AS PROTEIN KINASE INHIBITORS
4396, 3zrmA, 0.7631, 3.50, 0.224, 344, 259, IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK- 3BETA INHIBITORS
4397, 5vt1A, 0.7630, 3.04, 0.246, 265, 252, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B BOUND TO A BENZAMIDE INHIBITOR
4398, 5o13A, 0.7630, 2.55, 0.197, 270, 244, CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH SMALL-MOLECULE INHIBITOR
4399, 5n4yA, 0.7630, 2.67, 0.194, 273, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 25-DIHYDRO-1H-ISOTHIOCHROMENO[3 4-D]PYRAZOL-3-ONE
4400, 5k75C, 0.7630, 2.66, 0.287, 282, 244, IRAK4 IN COMPLEX WITH COMPOUND 1
4401, 5gjgA, 0.7630, 2.40, 0.292, 289, 243, CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH LIGAND 4
4402, 4yllA, 0.7630, 2.93, 0.220, 340, 250, CRYSTAL STRUCTURE OF DYRK1AA IN COMPLEX WITH 10-BROMO-SUBSTITUTED 11H- INDOLO[32-C]QUINOLONE-6-CARBOXYLIC ACID INHIBITOR 5T
4403, 4i5mA, 0.7630, 2.78, 0.220, 273, 246, SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
4404, 3dlsB, 0.7630, 3.04, 0.226, 280, 248, CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
4405, 3c4eB, 0.7630, 2.66, 0.194, 273, 247, PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7- AZAINDOLE
4406, 3anrD, 0.7630, 2.92, 0.229, 340, 249, HUMAN DYRK1A/HARMINE COMPLEX
4407, 2w1eA, 0.7630, 2.66, 0.248, 252, 246, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
4408, 2fysB, 0.7630, 2.80, 0.193, 338, 249, CRYSTAL STRUCTURE OF ERK2 COMPLEX WITH KIM PEPTIDE DERIVED FROM MKP3
4409, 5n4uA, 0.7629, 2.62, 0.195, 272, 246, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE 5-(2-AMINO-13-THIAZOL-4- YL)-13-DIHYDROBENZIMIDAZOL-2-ONE
4410, 5itaB, 0.7629, 2.24, 0.292, 252, 240, CRYSTAL STRUCTURE OF BRAF KINASE DOMAIN BOUND TO AZ-VEM
4411, 4xhlA, 0.7629, 3.21, 0.160, 330, 257, STRUCTURE OF S. CEREVISIAE HRR25 1-394 (K38R MUTANT)
4412, 4iq6A, 0.7629, 3.43, 0.222, 324, 257, GSK-3BETA WITH INHIBITOR 6-CHLORO-N-CYCLOHEXYL-4-(1H-PYRROLO[23- B]PYRIDIN-3-YL)PYRIDIN-2-AMINE
4413, 3q96A, 0.7629, 2.60, 0.306, 253, 245, B-RAF KINASE DOMAIN IN COMPLEX WITH A TETRAHYDRONAPHTHALENE INHIBITOR
4414, 3c4eC, 0.7629, 2.73, 0.194, 272, 247, PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7- AZAINDOLE
4415, 2jldA, 0.7629, 3.41, 0.222, 349, 257, EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE KINASE 3
4416, 5op7A, 0.7628, 3.04, 0.245, 261, 249, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH PYRROLOPYRIMIDINE LRRK2 INHIBITOR
4417, 5a4lD, 0.7628, 2.93, 0.221, 334, 249, DYRK1A IN COMPLEX WITH FLUORO BENZOTHIAZOLE FRAGMENT
4418, 3h0zA, 0.7628, 2.45, 0.267, 248, 243, AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE
4419, 3bwfA, 0.7628, 2.67, 0.198, 273, 247, CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AN OSMIUM COMPOUND
4420, 2xixA, 0.7628, 2.70, 0.195, 272, 246, PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-1 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
4421, 1q3wA, 0.7628, 3.41, 0.222, 344, 257, GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE
4422, 1p14A, 0.7628, 2.43, 0.313, 287, 243, CRYSTAL STRUCTURE OF A CATALYTIC-LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE
4423, 6g8xA, 0.7627, 3.34, 0.195, 338, 257, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4424, 5vd9A, 0.7627, 2.84, 0.204, 261, 250, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV- 097 A MK1775 ANALOGUE
4425, 4nctC, 0.7627, 2.93, 0.221, 339, 249, HUMAN DYRK1A IN COMPLEX WITH PKC412
4426, 4ll5A, 0.7627, 2.61, 0.195, 268, 246, CRYSTAL STRUCTURE OF PIM-1 IN COMPLEX WITH THE FLUORESCENT COMPOUND SKF86002
4427, 3rk5A, 0.7627, 2.90, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-72
4428, 3r04A, 0.7627, 2.59, 0.196, 271, 245, THE DISCOVERY OF NOVEL BENZOFURAN-2-CARBOXYLIC ACIDS AS POTENT PIM-1 INHIBITORS
4429, 3qtwA, 0.7627, 2.95, 0.263, 294, 251, CDK2 IN COMPLEX WITH INHIBITOR RC-2-13
4430, 3pvuA, 0.7627, 3.20, 0.186, 609, 258, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND A SELECTIVE KINASE INHIBITOR (CMPD101)
4431, 2c47D, 0.7627, 3.36, 0.154, 290, 259, STRUCTURE OF CASEIN KINASE 1 GAMMA 2
4432, 5texA, 0.7626, 2.69, 0.190, 274, 247, PIM-1 KINASE IN COMPLEX WITH A 7-AZAINDOLE
4433, 5k75B, 0.7626, 2.54, 0.289, 274, 242, IRAK4 IN COMPLEX WITH COMPOUND 1
4434, 4un0C, 0.7626, 3.24, 0.245, 308, 257, CRYSTAL STRUCTURE OF THE HUMAN CDK12-CYCLINK COMPLEX
4435, 3f88B, 0.7626, 3.25, 0.224, 340, 255, GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR COMPLEX
4436, 3f7zB, 0.7626, 3.46, 0.224, 339, 259, X-RAY CO-CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3BETA IN COMPLEX WITH AN INHIBITOR
4437, 3cr0A, 0.7626, 2.72, 0.224, 257, 246, WEE1 KINASE COMPLEX WITH INHIBITOR PD259_809
4438, 2jldB, 0.7626, 3.41, 0.222, 349, 257, EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE KINASE 3
4439, 2gdoA, 0.7626, 3.28, 0.242, 269, 252, 4-(AMINOALKYLAMINO)-3-BENZIMIDAZOLE-QUINOLINONES AS POTENT CHK1 INHIBITORS
4440, 5n50A, 0.7625, 2.67, 0.194, 273, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 2-(4-CHLOROPHENYL) SULFANYLACETOHYDRAZIDE
4441, 5ebzB, 0.7625, 3.28, 0.246, 655, 260, CRYSTAL STRUCTURE OF HUMAN IKK1
4442, 4ylkA, 0.7625, 2.98, 0.231, 341, 251, CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-CHLORO-SUBSTITUTED 11H- INDOLO[32-C]QUINOLONE-6-CARBOXYLIC ACID INHIBITOR 5S
4443, 4xv1B, 0.7625, 2.30, 0.299, 249, 241, B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX7904
4444, 2oibC, 0.7625, 2.74, 0.280, 278, 243, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM
4445, 1xr1A, 0.7625, 2.91, 0.193, 277, 249, CRYSTAL STRUCTURE OF HPIM-1 KINASE IN COMPLEX WITH AMP-PNP AT 2.1 A RESOLUTION
4446, 6ccfB, 0.7624, 3.04, 0.262, 262, 252, CRYSTAL STRUCTURE OF THE HUMAN CAMKK1A IN COMPLEX WITH HESPERADIN
4447, 5k4iA, 0.7624, 2.71, 0.199, 336, 246, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH COMPOUND 22
4448, 5a54D, 0.7624, 2.93, 0.221, 334, 249, DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENT
4449, 4lggB, 0.7624, 2.07, 0.314, 245, 236, STRUCTURE OF 3MB-PP1 BOUND TO ANALOG-SENSITIVE SRC KINASE
4450, 4i41A, 0.7624, 2.64, 0.195, 272, 246, CRYSTAL STRUCTURE OF HUMAN SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE
4451, 3vvhA, 0.7624, 3.25, 0.237, 287, 257, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN COMPLEX WITH AN INHIBITOR AND MGATP
4452, 1o9uA, 0.7624, 3.37, 0.223, 349, 256, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE
4453, 6ccfA, 0.7623, 2.96, 0.264, 260, 250, CRYSTAL STRUCTURE OF THE HUMAN CAMKK1A IN COMPLEX WITH HESPERADIN
4454, 6bqlA, 0.7623, 3.07, 0.246, 278, 252, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH TAE-226
4455, 5aikC, 0.7623, 3.03, 0.227, 342, 251, HUMAN DYRK1A IN COMPLEX WITH LDN-211898
4456, 4u40A, 0.7623, 3.12, 0.240, 295, 254, MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4 (MAP4K4) BOUND TO AMPPNP
4457, 4hyhA, 0.7623, 3.14, 0.244, 263, 250, X-RAY CRYSTAL STRUCTURE OF COMPOUND 39 BOUND TO HUMAN CHK1 KINASE DOMAIN
4458, 6c3eB, 0.7622, 2.90, 0.278, 259, 245, CRYSTAL STRUCTURE OF RIP1 KINASE BOUND TO INHIBITOR
4459, 4ez7A, 0.7622, 3.16, 0.257, 302, 253, CDK2 IN COMPLEX WITH STAUROSPORINE AND 2 MOLECULES OF 8-ANILINO-1- NAPHTHALENE SULFONIC ACID
4460, 3py1A, 0.7622, 3.21, 0.250, 302, 252, CDK2 TERNARY COMPLEX WITH SU9516 AND ANS
4461, 3gb2A, 0.7622, 3.49, 0.224, 340, 259, GSK3BETA INHIBITOR COMPLEX
4462, 2qofA, 0.7622, 2.70, 0.343, 280, 245, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y596F MUTANT
4463, 6gn1A, 0.7621, 3.36, 0.223, 339, 256, CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3B) IN COMPLEX WITH PIK-75 
4464, 4kaoA, 0.7621, 2.70, 0.318, 252, 245, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 1-(5-TERT- BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-(4-PYRIDIN-3- YL-PHENYL)-UREA
4465, 3bi6A, 0.7621, 2.75, 0.223, 258, 247, WEE1 KINASE COMPLEX WITH INHIBITOR PD352396
4466, 1yxsA, 0.7621, 2.79, 0.194, 274, 248, CRYSTAL STRUCTURE OF KINASE PIM1 WITH P123M MUTATION
4467, 5n5lA, 0.7620, 2.65, 0.195, 271, 246, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND [2-OXO-2-(1H-PYRROL-2-YL)ETHYL] 5-BROMO-1H- INDOLE-3-CARBOXYLATE
4468, 5n4zA, 0.7620, 2.63, 0.195, 272, 246, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE (E)-4-(4-HYDROXYPHENYL)BUT-3-EN-2- ONE
4469, 5aikD, 0.7620, 2.98, 0.220, 342, 250, HUMAN DYRK1A IN COMPLEX WITH LDN-211898
4470, 3my0X, 0.7620, 2.50, 0.273, 257, 242, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
4471, 3cy3A, 0.7620, 2.65, 0.195, 270, 246, CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND THE JNK INHIBITOR V
4472, 5t31B, 0.7619, 3.50, 0.232, 333, 259, EXPLOITING AN ASP-GLU SWITCH IN GLYCOGEN SYNTHASE KINASE 3 TO DESIGN PARALOG SELECTIVE INHIBITORS FOR USE IN ACUTE MYELOID LEUKEMIA
4473, 5t1sB, 0.7619, 2.72, 0.277, 282, 242, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
4474, 4mneA, 0.7619, 3.42, 0.239, 286, 259, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
4475, 4jvgD, 0.7619, 2.75, 0.306, 262, 248, B-RAF KINASE IN COMPLEX WITH BIRB796
4476, 4apcB, 0.7619, 2.90, 0.221, 296, 249, CRYSTAL STRUCTURE OF HUMAN NIMA-RELATED KINASE 1 (NEK1)
4477, 4achA, 0.7619, 3.44, 0.222, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4478, 3vbxA, 0.7619, 2.61, 0.196, 268, 245, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
4479, 3nlbA, 0.7619, 3.23, 0.248, 261, 250, NOVEL KINASE PROFILE HIGHLIGHTS THE TEMPORAL BASIS OF CONTEXT DEPENDENT CHECKPOINT PATHWAYS TO CELL DEATH
4480, 6cqhB, 0.7618, 3.58, 0.165, 316, 266, CRYSTAL STRUCTURE OF THE HUMAN VACCINIA-RELATED KINASE BOUND TO A N- PROPYNYL-N-ETHYL-DIHYDROPTERIDINE INHIBITOR
4481, 4xrlA, 0.7618, 3.22, 0.193, 337, 254, CRYSTAL STRUCTURE AT ROOM TEMPERATURE OF ERK2 IN COMPLEX WITH AN INHIBITOR
4482, 4fuxA, 0.7618, 3.23, 0.193, 342, 254, CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E75
4483, 4afjB, 0.7618, 3.16, 0.226, 346, 252, 5-ARYL-4-CARBOXAMIDE-13-OXAZOLES: POTENT AND SELECTIVE GSK-3 INHIBITORS
4484, 1yhsA, 0.7618, 2.60, 0.196, 267, 245, CRYSTAL STRUCTURE OF PIM-1 BOUND TO STAUROSPORINE
4485, 5t31A, 0.7617, 3.50, 0.232, 334, 259, EXPLOITING AN ASP-GLU SWITCH IN GLYCOGEN SYNTHASE KINASE 3 TO DESIGN PARALOG SELECTIVE INHIBITORS FOR USE IN ACUTE MYELOID LEUKEMIA
4486, 5airB, 0.7617, 3.40, 0.218, 361, 257, STRUCTURAL ANALYSIS OF MOUSE GSK3BETA FUSED WITH LRP6 PEPTIDE.
4487, 4xp2A, 0.7617, 3.28, 0.184, 337, 256, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR
4488, 3jy0A, 0.7617, 2.88, 0.194, 275, 248, DISCOVERY OF 3H-BENZO[45]THIENO[32-D]PYRIMIDIN-4-ONES AS POTENT HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
4489, 3c4eA, 0.7617, 2.68, 0.194, 273, 247, PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7- AZAINDOLE
4490, 2e9nA, 0.7617, 3.27, 0.233, 269, 253, STRUCTURE OF H-CHK1 COMPLEXED WITH A767085
4491, 6g92A, 0.7616, 3.23, 0.193, 343, 254, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4492, 4erkA, 0.7616, 3.41, 0.198, 350, 258, THE COMPLEX STRUCTURE OF THE MAP KINASE ERK2/OLOMOUCINE
4493, 3p1aA, 0.7616, 2.84, 0.215, 281, 247, STRUCTURE OF HUMAN MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE- SPECIFIC CDC2-INHIBITORY KINASE MYT1 (PKMYT1)
4494, 2f57A, 0.7616, 3.06, 0.185, 297, 254, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 5
4495, 1q8yB, 0.7616, 3.31, 0.187, 357, 257, THE STRUCTURE OF THE YEAST SR PROTEIN KINASE SKY1P WITH BOUND ADP
4496, 6aydA, 0.7615, 2.74, 0.194, 272, 247, PIM1 COMPLEXED WITH N-(6-(4-HYDROXYPHENYL)-1H-INDAZOL-3-YL) CYCLOPROPANECARBOXAMIDE
4497, 5x5oA, 0.7615, 2.96, 0.316, 291, 247, CRYSTAL STRUCTURE OF ZAK IN COMPLEX WITH COMPOUND D2829
4498, 5flfE, 0.7615, 2.56, 0.399, 258, 243, DISEASE LINKED MUTATION IN FGFR
4499, 4zp5A, 0.7615, 3.00, 0.240, 284, 250, MAP4K4 IN COMPLEX WITH INHIBITOR
4500, 4s32A, 0.7615, 3.49, 0.200, 346, 260, CRYSTAL STRUCTURE OF ERK2 AMP-PNP COMPLEX
4501, 4c3rA, 0.7615, 2.62, 0.244, 252, 246, STRUCTURE OF DEPHOSPHORYLATED AURORA A (122-403) BOUND TO AMPPCP
4502, 3f88A, 0.7615, 3.49, 0.224, 340, 259, GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR COMPLEX
4503, 2x7fA, 0.7615, 2.80, 0.256, 276, 246, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2- AND NCK-INTERACTING KINASE WITH WEE1CHK1 INHIBITOR
4504, 5uiqB, 0.7614, 2.57, 0.282, 272, 241, CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 9
4505, 5nzzG, 0.7614, 2.70, 0.215, 342, 246, CRYSTAL STRUCTURE OF PHOSPHORYLATED P38AMAPK IN COMPLEX WITH TAB1 
4506, 5n4nA, 0.7614, 2.67, 0.194, 273, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 34-DIMETHYL-5-(1H-124-TRIAZOL- 3-YL)THIOPHENE-2-CARBONITRILE
4507, 4xh0A, 0.7614, 3.43, 0.165, 350, 260, STRUCTURE OF C. GLABRATA HRR25 BOUND TO ADP (SO4 CONDITION)
4508, 4j71A, 0.7614, 3.49, 0.224, 347, 259, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 1R
4509, 3vbyA, 0.7614, 2.61, 0.196, 267, 245, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
4510, 3unjA, 0.7614, 2.90, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR YL1-038-31
4511, 3qc4B, 0.7614, 2.80, 0.243, 278, 247, PDK1 IN COMPLEX WITH DFG-OUT INHIBITOR XXX
4512, 6c2yA, 0.7613, 3.19, 0.195, 617, 257, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG257142 
4513, 4umpD, 0.7613, 2.89, 0.236, 321, 250, STRUCTURE OF MELK IN COMPLEX WITH INHIBITORS
4514, 4g6lA, 0.7613, 3.19, 0.206, 336, 253, CRYSTAL STRUCTURE OF HUMAN CDK8/CYCC IN THE DMG-IN CONFORMATION
4515, 3zfyA, 0.7613, 2.78, 0.328, 260, 244, CRYSTAL STRUCTURE OF EPHB3
4516, 3eb0C, 0.7613, 2.94, 0.246, 310, 248, CRYSTAL STRUCTURE OF CGD4_240 FROM CRYPTOSPORIDIUM PARVUM IN COMPLEX WITH INDIRUBIN E804
4517, 2w1dA, 0.7613, 2.62, 0.249, 251, 245, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
4518, 2nryD, 0.7613, 2.99, 0.273, 282, 245, CRYSTAL STRUCTURE OF IRAK-4
4519, 2bilB, 0.7613, 2.68, 0.194, 274, 247, THE HUMAN PROTEIN KINASE PIM1 IN COMPLEX WITH ITS CONSENSUS PEPTIDE PIMTIDE
4520, 1ywvA, 0.7613, 2.79, 0.194, 274, 248, CRYSTAL STRUCTURES OF PROTO-ONCOGENE KINASE PIM1: A TARGET OF ABERRANT SOMATIC HYPERMUTATIONS IN DIFFUSE LARGE CELL LYMPHOMA
4521, 1h8fB, 0.7613, 3.44, 0.222, 350, 257, GLYCOGEN SYNTHASE KINASE 3 BETA.
4522, 5vi9A, 0.7612, 2.78, 0.210, 306, 248, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH THE PKI PEPTIDE AND AMINOBENZOTHIAZOLE BASED INHIBITORS
4523, 5uvcA, 0.7612, 3.24, 0.193, 457, 259, DESIGN SYNTHESIS AND EVALUATION OF THE FIRST SELECTIVE AND POTENT G- PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) INHIBITOR FOR THE POTENTIAL TREATMENT OF HEART FAILURE
4524, 5eykA, 0.7612, 2.93, 0.188, 263, 250, CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH BI 847325
4525, 4zzoA, 0.7612, 3.30, 0.191, 339, 256, HUMAN ERK2 IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR
4526, 4gt4A, 0.7612, 2.65, 0.333, 274, 246, STRUCTURE OF UNLIGANDED INACTIVE ROR2 KINASE DOMAIN
4527, 3pvwA, 0.7612, 3.25, 0.193, 613, 259, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND A SELECTIVE KINASE INHIBITOR (CMPD103A)
4528, 3oriB, 0.7612, 2.53, 0.217, 267, 244, MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN L33D MUTANT (CRYSTAL FORM 1)
4529, 3a8wA, 0.7612, 2.91, 0.194, 326, 252, CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
4530, 2o63A, 0.7612, 2.80, 0.194, 274, 248, CRYSTAL STRUCTURE OF PIM1 WITH MYRICETIN
4531, 5l4qB, 0.7611, 2.73, 0.207, 287, 242, CRYSTAL STRUCTURE OF ADAPTOR PROTEIN 2 ASSOCIATED KINASE 1 (AAK1) IN COMPLEX WITH LKB1 (AAK1 DUAL INHIBITOR)
4532, 4bcqA, 0.7611, 3.08, 0.257, 292, 253, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
4533, 3cs9C, 0.7611, 2.17, 0.403, 243, 236, HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB
4534, 1i09B, 0.7611, 3.44, 0.222, 341, 257, STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B)
4535, 1h8fA, 0.7611, 3.44, 0.222, 352, 257, GLYCOGEN SYNTHASE KINASE 3 BETA.
4536, 5uorA, 0.7610, 2.31, 0.273, 249, 238, STRUCTURE-BASED DESIGN OF ASK1 INHIBITORS AS POTENTIAL FIRST-IN-CLASS AGENTS FOR HEART FAILURE
4537, 4j1rD, 0.7610, 3.51, 0.228, 345, 259, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 15R
4538, 4j1rB, 0.7610, 3.50, 0.224, 346, 259, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 15R
4539, 4achB, 0.7610, 3.45, 0.222, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4540, 3slsA, 0.7610, 3.03, 0.246, 292, 252, CRYSTAL STRUCTURE OF HUMAN MEK-1 KINASE IN COMPLEX WITH UCB1353770 AND AMPPNP
4541, 3pupB, 0.7610, 3.45, 0.222, 347, 257, STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA (GSK3B) IN COMPLEX WITH A RUTHENIUM OCTASPORINE LIGAND (OS1)
4542, 3f7zA, 0.7610, 3.39, 0.223, 339, 256, X-RAY CO-CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3BETA IN COMPLEX WITH AN INHIBITOR
4543, 6dcgA, 0.7609, 3.21, 0.185, 326, 254, DISCOVERY OF MK-8353: AN ORALLY BIOAVAILABLE DUAL MECHANISM ERK INHIBITOR FOR ONCOLOGY 
4544, 5oq5A, 0.7609, 3.21, 0.246, 265, 252, STRUCTURE OF CHK1 8-PT. MUTANT COMPLEX WITH AMINOPYRIMIDO- BENZODIAZEPINONE LRRK2 INHIBITOR
4545, 5itaA, 0.7609, 2.37, 0.307, 250, 241, CRYSTAL STRUCTURE OF BRAF KINASE DOMAIN BOUND TO AZ-VEM
4546, 5idnA, 0.7609, 2.93, 0.209, 336, 249, CDK8-CYCC IN COMPLEX WITH [(S)-2-(4-CHLORO-PHENYL)-PYRROLIDIN-1-YL]- (3-METHYL-1H-PYRAZOLO[34-B]PYRIDIN-5-YL)-METHANONE
4547, 4lmuA, 0.7609, 2.57, 0.197, 265, 244, CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH THE INHIBITOR QUERCETIN (RESULTING FROM DISPLACEMENT OF SKF86002)
4548, 4j1rA, 0.7609, 3.51, 0.228, 343, 259, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 15R
4549, 3i60A, 0.7609, 2.61, 0.193, 335, 243, CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-4-(2-(2-CHLOROPHENYLAMINO)-5- METHYLPYRIMIDIN-4-YL)-N-(2-HYDROXY-1-PHENYLETHYL)-1H-PYRROLE-2- CARBOXAMIDE
4550, 2p0cA, 0.7609, 2.29, 0.338, 249, 237, CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER
4551, 2i6lA, 0.7609, 2.66, 0.217, 292, 244, CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 6 (MAPK6)
4552, 5opuA, 0.7608, 2.99, 0.239, 261, 247, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH PYRROLOPYRIDINE LRRK2 INHIBITOR
4553, 4acgB, 0.7608, 3.43, 0.222, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4554, 3we8A, 0.7608, 2.70, 0.194, 273, 247, PIM-1 KINASE IN COMPLEX WITH RUTHENIUM-BASED INHIBITOR
4555, 3qu0A, 0.7608, 2.95, 0.268, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-38
4556, 3p08B, 0.7608, 2.75, 0.320, 258, 244, CRYSTAL STRUCTURE OF THE HUMAN BTK KINASE DOMAIN
4557, 3lokA, 0.7608, 1.98, 0.321, 248, 234, DRUG RESISTANT CSRC KINASE DOMAIN IN COMPLEX WITH COVALENT INHIBITOR PD168393
4558, 2xmyA, 0.7608, 2.99, 0.259, 295, 251, DISCOVERY AND CHARACTERISATION OF 2-ANILINO-4-(THIAZOL-5-YL) PYRIMIDINE TRANSCRIPTIONAL CDK INHIBITORS AS ANTICANCER AGENTS
4559, 2bziB, 0.7608, 2.65, 0.199, 272, 246, CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU2
4560, 6f3gB, 0.7607, 2.56, 0.290, 277, 241, IRAK4 IN COMPLEX WITH INHIBITOR 
4561, 5vc6A, 0.7607, 2.82, 0.201, 259, 249, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH PHA- 848125
4562, 4xp3A, 0.7607, 3.21, 0.196, 339, 255, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR
4563, 4medA, 0.7607, 2.76, 0.194, 272, 247, CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH THIORIDAZINE DERIVATIVES
4564, 4j1rC, 0.7607, 3.51, 0.228, 344, 259, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 15R
4565, 4b7tA, 0.7607, 3.44, 0.222, 350, 257, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE AND LEUCETTINE L4
4566, 3qzfA, 0.7607, 2.93, 0.268, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR JWS-6-52
4567, 3pupA, 0.7607, 3.45, 0.222, 346, 257, STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA (GSK3B) IN COMPLEX WITH A RUTHENIUM OCTASPORINE LIGAND (OS1)
4568, 2xnbA, 0.7607, 3.04, 0.267, 296, 251, DISCOVERY AND CHARACTERISATION OF 2-ANILINO-4-(THIAZOL-5-YL) PYRIMIDINE TRANSCRIPTIONAL CDK INHIBITORS AS ANTICANCER AGENTS
4569, 1y6aA, 0.7607, 2.20, 0.357, 261, 238, CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR
4570, 1xwsA, 0.7607, 2.78, 0.194, 273, 248, CRYSTAL STRUCTURE OF THE HUMAN PIM1 KINASE DOMAIN
4571, 5k5nB, 0.7606, 3.26, 0.232, 334, 254, CRYSTAL STRUCTURE OF GSK-3BETA COMPLEXED WITH PF-04802367 A HIGHLY SELECTIVE BRAIN-PENETRANT KINASE INHIBITOR
4572, 4ztnB, 0.7606, 2.59, 0.278, 282, 241, IRAK4-INHIBITOR CO-STRUCTURE
4573, 4lm5A, 0.7606, 2.58, 0.197, 264, 244, CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH 2-{4-[(3-AMINOPROPYL) AMINO]QUINAZOLIN-2-YL}PHENOL (RESULTING FROM DISPLACEMENT OF SKF86002)
4574, 4jvgA, 0.7606, 2.77, 0.302, 262, 248, B-RAF KINASE IN COMPLEX WITH BIRB796
4575, 4iq6B, 0.7606, 3.45, 0.222, 332, 257, GSK-3BETA WITH INHIBITOR 6-CHLORO-N-CYCLOHEXYL-4-(1H-PYRROLO[23- B]PYRIDIN-3-YL)PYRIDIN-2-AMINE
4576, 3uokB, 0.7606, 2.79, 0.268, 265, 246, AURORA A IN COMPLEX WITH YL5-81-1
4577, 3uokA, 0.7606, 2.79, 0.268, 265, 246, AURORA A IN COMPLEX WITH YL5-81-1
4578, 1i09A, 0.7606, 3.41, 0.218, 338, 257, STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B)
4579, 6g9dA, 0.7605, 3.38, 0.195, 345, 257, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4580, 5nzzE, 0.7605, 2.87, 0.213, 343, 249, CRYSTAL STRUCTURE OF PHOSPHORYLATED P38AMAPK IN COMPLEX WITH TAB1 
4581, 5byyA, 0.7605, 3.02, 0.223, 338, 251, ERK5 IN COMPLEX WITH SMALL MOLECULE
4582, 4twnA, 0.7605, 3.04, 0.356, 276, 250, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH BIRB796
4583, 4afjA, 0.7605, 3.36, 0.227, 342, 256, 5-ARYL-4-CARBOXAMIDE-13-OXAZOLES: POTENT AND SELECTIVE GSK-3 INHIBITORS
4584, 3r9dA, 0.7605, 2.96, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-135
4585, 3qqkA, 0.7605, 2.96, 0.268, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L4
4586, 5vcvA, 0.7604, 2.92, 0.213, 287, 249, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH DASATINIB
4587, 4rvtA, 0.7604, 2.94, 0.238, 281, 248, MAP4K4 IN COMPLEX WITH A PYRIDIN-2(1H)-ONE DERIVATIVE
4588, 3q3bB, 0.7604, 3.46, 0.222, 341, 257, 6-AMINO-4-(PYRIMIDIN-4-YL)PYRIDONES: NOVEL GLYCOGEN SYNTHASE KINASE-3 INHIBITORS
4589, 3ekkA, 0.7604, 2.51, 0.311, 285, 244, INSULIN RECEPTOR KINASE COMPLEXED WITH AN INHIBITOR
4590, 2ydkA, 0.7604, 3.17, 0.239, 263, 251, DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS
4591, 6gdmA, 0.7603, 3.08, 0.198, 341, 252, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4592, 5airA, 0.7603, 3.44, 0.222, 353, 257, STRUCTURAL ANALYSIS OF MOUSE GSK3BETA FUSED WITH LRP6 PEPTIDE.
4593, 4xneA, 0.7603, 3.19, 0.182, 344, 253, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR
4594, 4m67A, 0.7603, 2.41, 0.223, 264, 242, CRYSTAL STRUCTURE OF THE HUMAN MLKL KINASE-LIKE DOMAIN
4595, 3rpvA, 0.7603, 2.95, 0.268, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-88
4596, 2qg5A, 0.7603, 3.21, 0.193, 284, 254, CRYPTOSPORIDIUM PARVUM CALCIUM DEPENDENT PROTEIN KINASE CGD7_1840
4597, 5w7tA, 0.7602, 2.95, 0.276, 276, 250, STRUCTURE OF PHOSPHORYLATED WNK1 
4598, 4acdB, 0.7602, 3.45, 0.222, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4599, 3tcpB, 0.7602, 2.03, 0.328, 250, 232, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC569
4600, 3qtuA, 0.7602, 2.96, 0.268, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-132
4601, 3qruA, 0.7602, 2.98, 0.267, 295, 251, CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-12
4602, 6f3gA, 0.7601, 2.56, 0.283, 274, 240, IRAK4 IN COMPLEX WITH INHIBITOR 
4603, 5n5mA, 0.7601, 2.67, 0.195, 272, 246, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND (R)-3-(2-((ISOQUINOLIN-5-YLMETHYL)(METHYL) CARBAMOYL)PHENYL)PYRROLIDIN-1-IUM
4604, 4rc3A, 0.7601, 2.73, 0.199, 271, 246, CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE DERIVATIVES
4605, 4bf2A, 0.7601, 2.48, 0.271, 253, 240, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4606, 4aguA, 0.7601, 2.61, 0.239, 277, 243, CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN
4607, 3rk7A, 0.7601, 2.94, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-71
4608, 3my0K, 0.7601, 2.57, 0.277, 261, 242, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
4609, 3erkA, 0.7601, 3.33, 0.200, 350, 255, THE COMPLEX STRUCTURE OF THE MAP KINASE ERK2/SB220025
4610, 5vuaB, 0.7600, 2.70, 0.192, 270, 245, PIM1 KINASE IN COMPLEX WITH A BENZOFURANONE INHIBITOR
4611, 5uisB, 0.7600, 2.60, 0.286, 274, 241, CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 12
4612, 4qp8A, 0.7600, 2.71, 0.195, 335, 246, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 2-(1H-PYRAZOL-4-YL)-7- (PYRIDIN-3-YL)-5H-PYRROLO[23-B]PYRAZINE
4613, 4h3pD, 0.7600, 2.72, 0.203, 338, 246, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE
4614, 3uo6A, 0.7600, 2.81, 0.268, 264, 246, AURORA A IN COMPLEX WITH YL5-083
4615, 3oriA, 0.7600, 2.54, 0.217, 267, 244, MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN L33D MUTANT (CRYSTAL FORM 1)
4616, 2hxlA, 0.7600, 3.24, 0.239, 272, 251, CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1
4617, 6c3eA, 0.7599, 2.86, 0.266, 258, 244, CRYSTAL STRUCTURE OF RIP1 KINASE BOUND TO INHIBITOR
4618, 4zznA, 0.7599, 3.12, 0.198, 338, 253, HUMAN ERK2 IN COMPLEX WITH AN INHIBITOR
4619, 4wuaA, 0.7599, 3.52, 0.190, 344, 258, CRYSTAL STRUCTURE OF HUMAN SRPK1 COMPLEXED TO AN INHIBITOR SRPIN340
4620, 4ae9A, 0.7599, 2.97, 0.206, 321, 252, STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM OF PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT C ALPHA 2
4621, 4acdA, 0.7599, 3.46, 0.222, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4622, 3uo6B, 0.7599, 2.81, 0.268, 264, 246, AURORA A IN COMPLEX WITH YL5-083
4623, 1m7nB, 0.7599, 2.99, 0.320, 299, 250, CRYSTAL STRUCTURE OF UNACTIVATED APO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE DOMAIN
4624, 5ar7A, 0.7598, 2.71, 0.268, 278, 246, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH BIARYL UREA
4625, 4nfnA, 0.7598, 3.36, 0.162, 293, 259, HUMAN TAU TUBULIN KINASE 1 (TTBK1) COMPLEXED WITH 3-({5-[(4-AMINO-4- METHYLPIPERIDIN-1-YL)METHYL]PYRROLO[21-F][124]TRIAZIN-4-YL}AMINO)- 5-BROMOPHENOL
4626, 4lv8A, 0.7598, 3.39, 0.172, 360, 262, MURINE IRGA6 BOUND TO TOXOPLASMA ROP5C A PSEUDOKINASE GDI
4627, 4kbkA, 0.7598, 3.15, 0.185, 283, 254, CK1D IN COMPLEX WITH (3S)-3-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H- PYRAZOL-4-YL]PYRIDIN-2-YL}MORPHOLINE INHIBITOR
4628, 4ditA, 0.7598, 3.25, 0.226, 328, 252, CRYSTAL STRUCTURE OF GSK3BETA IN COMPLEX WITH A IMIDAZOPYRIDINE INHIBITOR
4629, 1v0oA, 0.7598, 2.89, 0.252, 276, 246, STRUCTURE OF P. FALCIPARUM PFPK5-INDIRUBIN-5-SULPHONATE LIGAND COMPLEX
4630, 5umoA, 0.7597, 3.33, 0.196, 347, 255, STRUCTURE OF EXTRACELLULAR SIGNAL-REGULATED KINASE
4631, 5lckA, 0.7597, 3.04, 0.187, 345, 251, A CLICKABLE COVALENT ERK 1/2 INHIBITOR
4632, 3ti1A, 0.7597, 2.97, 0.260, 294, 250, CDK2 IN COMPLEX WITH SUNITINIB
4633, 5ukmA, 0.7596, 3.26, 0.167, 621, 258, BOVINE GRK2 IN COMPLEX WITH HUMAN GBETAGAMMA SUBUNITS AND CCG258208 (14AS)
4634, 5nzzF, 0.7596, 2.85, 0.214, 341, 248, CRYSTAL STRUCTURE OF PHOSPHORYLATED P38AMAPK IN COMPLEX WITH TAB1 
4635, 5mafA, 0.7596, 2.53, 0.252, 315, 242, CRYSTAL STRUCTURE OF MELK IN COMPLEX WITH AN INHIBITOR
4636, 5kpkA, 0.7596, 3.42, 0.223, 346, 256, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH BRD0209
4637, 5hidB, 0.7596, 2.85, 0.301, 269, 249, BRAF KINASE DOMAIN B3AC LOOP DELETION MUTANT IN COMPLEX WITH AZ628
4638, 4jvgB, 0.7596, 2.76, 0.308, 259, 247, B-RAF KINASE IN COMPLEX WITH BIRB796
4639, 4h58C, 0.7596, 2.76, 0.300, 272, 247, BRAF IN COMPLEX WITH COMPOUND 3
4640, 4enxA, 0.7596, 2.55, 0.193, 266, 243, CRYSTAL STRUCTURE OF PIM-1 KINASE IN COMPLEX WITH INHIBITOR (2E5Z)-2- (2-CHLOROPHENYLIMINO)-5-(4-HYDROXY-3-NITROBENZYLIDENE)THIAZOLIDIN-4- ONE
4641, 3mvjB, 0.7596, 3.10, 0.185, 320, 254, HUMAN CYCLIC AMP-DEPENDENT PROTEIN KINASE PKA INHIBITOR COMPLEX
4642, 1golA, 0.7596, 3.23, 0.197, 357, 254, COORDINATES OF RAT MAP KINASE ERK2 WITH AN ARGININE MUTATION AT POSITION 52
4643, 6bu6A, 0.7595, 3.43, 0.148, 322, 264, CRYSTAL STRUCTURE OF THE HUMAN VACCINIA-RELATED KINASE BOUND TO A BIS- DIFLUOROPHENOL-AMINOPYRIDINE INHIBITOR
4644, 5hlpA, 0.7595, 3.54, 0.228, 337, 259, X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH BRD3937
4645, 3v5wA, 0.7595, 3.24, 0.182, 623, 258, HUMAN G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH SOLUBLE GBETAGAMMA SUBUNITS AND PAROXETINE
4646, 3unzB, 0.7595, 2.78, 0.268, 263, 246, AURORA A IN COMPLEX WITH RPM1679
4647, 3unzA, 0.7595, 2.78, 0.268, 263, 246, AURORA A IN COMPLEX WITH RPM1679
4648, 3sd0B, 0.7595, 3.46, 0.222, 349, 257, IDENTIFICATION OF A GLYCOGEN SYNTHASE KINASE-3B INHIBITOR THAT ATTENUATES HYPERACTIVITY IN CLOCK MUTANT MICE
4649, 3qtxA, 0.7595, 2.94, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-35
4650, 3cikA, 0.7595, 3.24, 0.182, 619, 258, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS
4651, 6g9nA, 0.7594, 3.41, 0.195, 344, 257, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4652, 6fdyU, 0.7594, 3.09, 0.229, 261, 253, UNC-51-LIKE KINASE 3 (ULK3) IN COMPLEX WITH BOSUTINIB 
4653, 6b2pA, 0.7594, 2.39, 0.217, 255, 240, DUAL INHIBITION OF THE ESSENTIAL PROTEIN KINASES A AND B IN MYCOBACTERIUM TUBERCULOSIS
4654, 5w85B, 0.7594, 2.60, 0.278, 279, 241, CRYSTAL STRUCTURE OF IRAK-4 WITH A 46-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 9)
4655, 5l4qA, 0.7594, 2.76, 0.211, 293, 242, CRYSTAL STRUCTURE OF ADAPTOR PROTEIN 2 ASSOCIATED KINASE 1 (AAK1) IN COMPLEX WITH LKB1 (AAK1 DUAL INHIBITOR)
4656, 5kpkB, 0.7594, 3.44, 0.223, 344, 256, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH BRD0209
4657, 5ko1A, 0.7594, 2.47, 0.226, 265, 243, PSEUDOKINASE DOMAIN OF MLKL BOUND TO COMPOUND 4.
4658, 4ztrA, 0.7594, 2.49, 0.259, 249, 243, HUMAN AURORA A CATALYTIC DOMAIN BOUND TO FK1141
4659, 2xneA, 0.7594, 2.52, 0.263, 246, 243, STRUCTURE OF AURORA-A BOUND TO AN IMIDAZOPYRAZINE INHIBITOR
4660, 5j9lA, 0.7593, 2.24, 0.277, 286, 238, CRYSTAL STRUCTURE OF CPT1691 BOUND TO TAK1-TAB1
4661, 4l3jA, 0.7593, 3.12, 0.251, 291, 251, CRYSTAL STRUCTURES OF HUMAN P70S6K1 KINASE DOMAIN
4662, 4jjrA, 0.7593, 3.02, 0.190, 284, 252, A P21 CRYSTAL FORM OF MAMMALIAN CASEIN KINASE 1 DELTA
4663, 4b9dB, 0.7593, 2.95, 0.225, 295, 249, CRYSTAL STRUCTURE OF HUMAN NIMA-RELATED KINASE 1 (NEK1) WITH INHIBITOR.
4664, 3uojB, 0.7593, 2.79, 0.264, 263, 246, AURORA A IN COMPLEX WITH RPM1715
4665, 3rp9A, 0.7593, 2.99, 0.204, 350, 250, CRYSTAL STRUCTURE OF THE APO MAPK FROM TOXOPLASMA GONDII 25.M01780 OR TGME49_007820
4666, 2bcjA, 0.7593, 3.16, 0.187, 624, 257, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH GALPHA-Q AND GBETAGAMMA SUBUNITS
4667, 4iz7A, 0.7592, 3.14, 0.197, 344, 254, STRUCTURE OF NON-PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN
4668, 4g6nA, 0.7592, 3.25, 0.193, 341, 254, CRYSTAL STRUCTURE OF THE ERK2
4669, 3uojA, 0.7592, 2.79, 0.264, 263, 246, AURORA A IN COMPLEX WITH RPM1715
4670, 3uohB, 0.7592, 2.81, 0.268, 264, 246, AURORA A IN COMPLEX WITH RPM1722
4671, 3uohA, 0.7592, 2.81, 0.268, 264, 246, AURORA A IN COMPLEX WITH RPM1722
4672, 3rk9A, 0.7592, 2.98, 0.268, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-74
4673, 1ym7D, 0.7592, 3.14, 0.183, 599, 257, G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
4674, 4s34A, 0.7591, 3.46, 0.197, 343, 259, ERK2 (I84A) IN COMPLEX WITH AMP-PNP
4675, 4s2zA, 0.7591, 3.34, 0.196, 346, 255, ERK2 INTRINSICALLY ACTIVE MUTANT R65S
4676, 3qtzA, 0.7591, 2.94, 0.264, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-36
4677, 3py0A, 0.7591, 2.91, 0.256, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR SU9516
4678, 3pxzA, 0.7591, 3.19, 0.255, 302, 251, CDK2 TERNARY COMPLEX WITH JWS648 AND ANS
4679, 3dkgA, 0.7591, 2.90, 0.322, 281, 245, STRUCTURE OF MUTANT(Y1248L) MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR SGX-523
4680, 1ym7C, 0.7591, 3.14, 0.183, 607, 257, G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
4681, 4zzmA, 0.7590, 3.38, 0.202, 344, 257, HUMAN ERK2 IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR
4682, 4g9rB, 0.7590, 2.87, 0.302, 261, 248, B-RAF V600E KINASE DOMAIN BOUND TO A TYPE II DIHYDROQUINAZOLINE INHIBITOR
4683, 4accB, 0.7590, 3.47, 0.222, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4684, 3o23A, 0.7590, 2.96, 0.325, 293, 249, HUMAN UNPHOSPHORYLATED IGF1-R KINASE DOMAIN IN COMPLEX WITH AN HYDANTOIN INHIBITOR
4685, 2fumD, 0.7590, 2.59, 0.219, 258, 242, CATALYTIC DOMAIN OF PROTEIN KINASE PKNB FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MITOXANTRONE
4686, 1ym7A, 0.7590, 3.14, 0.183, 608, 257, G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
4687, 1yi4A, 0.7590, 2.64, 0.196, 267, 245, STRUCTURE OF PIM-1 BOUND TO ADENOSINE
4688, 5ukfA, 0.7589, 3.51, 0.143, 322, 265, CRYSTAL STRUCTURE OF THE HUMAN VACCINIA-RELATED KINASE 1 BOUND TO AN OXINDOLE INHIBITOR
4689, 5jzjB, 0.7589, 2.82, 0.239, 261, 247, CRYSTAL STRUCTURE OF DCLK1-KD IN COMPLEX WITH AMPPN
4690, 5bnjA, 0.7589, 3.28, 0.204, 343, 255, CDK8/CYCC IN COMPLEX WITH 8-{3-CHLORO-5-[4-(1-METHYL-1H-PYRAZOL-4-YL)- PHENYL]-PYRIDIN- 4-YL}-28-DIAZA-SPIRO[4.5]DECAN-1-ONE
4691, 4lghB, 0.7589, 2.07, 0.319, 247, 235, CRYSTAL STRUCTURE OF 1NM-PP1 BOUND TO ANALOG-SENSITIVE SRC KINASE
4692, 4g6oA, 0.7589, 3.18, 0.198, 339, 252, CRYSTAL STRUCTURE OF THE ERK2
4693, 4accA, 0.7589, 3.47, 0.222, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4694, 3lj1A, 0.7589, 2.56, 0.228, 404, 241, IRE1 COMPLEXED WITH CDK1/2 INHIBITOR III
4695, 3ii5B, 0.7589, 2.70, 0.305, 257, 246, THE COMPLEX OF WILD-TYPE B-RAF WITH PYRAZOLO PYRIMIDINE INHIBITOR
4696, 3c9wA, 0.7589, 2.80, 0.198, 336, 247, CRYSTAL STRUCTURE OF ERK-2 WITH HYPOTHEMYCIN COVALENTLY BOUND
4697, 2ghgA, 0.7589, 3.37, 0.240, 269, 254, H-CHK1 COMPLEXED WITH A431994
4698, 1ym7B, 0.7589, 3.15, 0.183, 608, 257, G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
4699, 6ge0A, 0.7588, 3.35, 0.195, 343, 256, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4700, 6cpwA, 0.7588, 3.18, 0.182, 328, 253, DISCOVERY OF 3(S)-THIOMETHYL PYRROLIDINE ERK INHIBITORS FOR ONCOLOGY 
4701, 5vc5A, 0.7588, 2.90, 0.200, 261, 250, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH PD- 166285
4702, 5jh6A, 0.7588, 2.25, 0.268, 288, 239, CRYSTAL STRUCTURE OF TL10-92 BOUND TO TAK1-TAB1
4703, 4j71B, 0.7588, 3.54, 0.224, 347, 259, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 1R
4704, 4iaaA, 0.7588, 2.77, 0.194, 272, 247, CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH THIORIDAZINE
4705, 3oz6B, 0.7588, 2.81, 0.267, 341, 247, CRYSTAL STRUCTURE OF MAPK FROM CRYPTOSPORIDIUM PARVUM CGD2_1960
4706, 5k0kB, 0.7587, 2.01, 0.329, 248, 231, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC2434
4707, 4yfiC, 0.7587, 2.65, 0.272, 269, 239, TNNI3K COMPLEXED WITH INHIBITOR 1
4708, 4gt3A, 0.7587, 3.14, 0.206, 347, 253, ATP-BOUND FORM OF THE ERK2 KINASE
4709, 3rniA, 0.7587, 2.95, 0.256, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-3-86
4710, 3rjcA, 0.7587, 2.97, 0.264, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L4-12
4711, 3dy7A, 0.7587, 3.10, 0.247, 260, 251, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
4712, 5w85A, 0.7586, 2.69, 0.286, 278, 241, CRYSTAL STRUCTURE OF IRAK-4 WITH A 46-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 9)
4713, 5he3A, 0.7586, 3.26, 0.185, 623, 259, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224411
4714, 5fdxB, 0.7586, 3.16, 0.329, 274, 249, STRUCTURE OF DDR1 RECEPTOR TYROSINE KINASE IN COMPLEX WITH D2164 INHIBITOR AT 2.65 ANGSTROMS RESOLUTION.
4715, 3ql8A, 0.7586, 2.94, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR JWS-6-260
4716, 3pscA, 0.7586, 3.24, 0.178, 614, 258, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS
4717, 2o65A, 0.7586, 2.73, 0.194, 274, 247, CRYSTAL STRUCTURE OF PIM1 WITH PENTAHYDROXYFLAVONE
4718, 1pxnA, 0.7586, 2.96, 0.272, 294, 250, HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-[4-(4-METHYL-2-METHYLAMINO-THIAZOL-5-YL)- PYRIMIDIN-2-YLAMINO]-PHENOL
4719, 1erkA, 0.7586, 3.36, 0.196, 357, 255, STRUCTURE OF SIGNAL-REGULATED KINASE
4720, 5vubB, 0.7585, 2.68, 0.189, 269, 244, PIM1 KINASE IN COMPLEX WITH A BENZOFURANONE INHIBITOR
4721, 5vdaA, 0.7585, 2.85, 0.205, 259, 249, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV- 101 A MK1775 ANALOGUE
4722, 3qqgA, 0.7585, 2.91, 0.256, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L2-5
4723, 2f49A, 0.7585, 2.87, 0.237, 335, 249, CRYSTAL STRUCTURE OF FUS3 IN COMPLEX WITH A STE5 PEPTIDE
4724, 6f3eB, 0.7584, 3.03, 0.280, 282, 246, IRAK4 IN COMPLEX WITH INHIBITOR 
4725, 6eqiC, 0.7584, 3.23, 0.211, 392, 256, STRUCTURE OF PINK1 BOUND TO UBIQUITIN
4726, 4hniA, 0.7584, 3.28, 0.183, 284, 257, CRYSTAL STRUCTURE OF CK1E IN COMPLEX WITH PF4800567
4727, 1m7nA, 0.7584, 2.94, 0.321, 299, 249, CRYSTAL STRUCTURE OF UNACTIVATED APO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE DOMAIN
4728, 5wngB, 0.7583, 2.80, 0.215, 365, 247, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
4729, 5uq1A, 0.7583, 3.07, 0.243, 288, 251, CRYSTAL STRUCTURE OF HUMAN CDK2-SPY1 COMPLEX
4730, 4joaA, 0.7583, 2.33, 0.314, 250, 236, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 7-AZAINDOLE BASED INHIBITOR
4731, 4aguB, 0.7583, 2.65, 0.239, 276, 243, CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN
4732, 3unkA, 0.7583, 3.02, 0.263, 295, 251, CDK2 IN COMPLEX WITH INHIBITOR YL5-083
4733, 3qqjA, 0.7583, 2.95, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L2
4734, 2j4zA, 0.7583, 2.81, 0.247, 263, 247, STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-680626
4735, 2hxqA, 0.7583, 3.31, 0.242, 272, 252, CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2
4736, 2exmA, 0.7583, 3.08, 0.266, 298, 252, HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE
4737, 1s9iB, 0.7583, 3.25, 0.241, 291, 253, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 (MEK2)IN A COMPLEX WITH LIGAND AND MGATP
4738, 1pxpA, 0.7583, 2.97, 0.260, 294, 250, HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(24-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]- N N -DIMETHYL-BENZENE-14-DIAMINE
4739, 6b8uA, 0.7582, 2.68, 0.306, 253, 245, CRYSTALS STRUCTURE OF B-RAF KINASE DOMAIN IN COMPLEX WITH AN IMIDAZOPYRIDINYL BENZAMIDE INHIBITOR
4740, 4zy6A, 0.7582, 3.07, 0.214, 284, 252, CRYSTAL STRUCTURE OF P21-ACTIVATED KINASE 1 IN COMPLEX WITH AN INHIBITOR COMPOUND 29
4741, 4m66A, 0.7582, 2.19, 0.272, 268, 235, CRYSTAL STRUCTURE OF THE MOUSE RIP3 KINASE DOMAIN
4742, 4ksqB, 0.7582, 2.53, 0.305, 255, 243, CRYSTAL STRUCTURE OF HUMAN B-RAF BOUND TO A DFG-OUT INHIBITOR 5B
4743, 4ez3A, 0.7582, 2.87, 0.262, 294, 248, CDK2 IN COMPLEX WITH NSC 134199
4744, 4aguC, 0.7582, 2.64, 0.239, 278, 243, CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN
4745, 3lj1B, 0.7582, 2.57, 0.232, 404, 241, IRE1 COMPLEXED WITH CDK1/2 INHIBITOR III
4746, 5oq7B, 0.7581, 2.94, 0.253, 256, 245, STRUCTURE OF CHK1 8-PT. MUTANT COMPLEX WITH ARYLBENZAMIDE LRRK2 INHIBITOR
4747, 2a0cX, 0.7581, 3.00, 0.268, 294, 250, HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II A NOVEL 269- TRISUBSTITUTED PURINE CYCLIN-DEPENDENT KINASE INHIBITOR
4748, 1wakA, 0.7581, 3.54, 0.182, 353, 258, X-RAY STRUCTURE OF SRPK1
4749, 5k75D, 0.7580, 2.65, 0.285, 280, 242, IRAK4 IN COMPLEX WITH COMPOUND 1
4750, 4kd1A, 0.7580, 3.06, 0.266, 298, 252, CDK2 IN COMPLEX WITH DINACICLIB
4751, 4bgqA, 0.7580, 2.69, 0.229, 276, 245, CRYSTAL STRUCTURE OF THE HUMAN CDKL5 KINASE DOMAIN
4752, 3j4rE, 0.7580, 3.11, 0.201, 325, 254, PSEUDO-ATOMIC MODEL OF THE AKAP18-PKA COMPLEX IN A LINEAR CONFORMATION DERIVED FROM ELECTRON MICROSCOPY
4753, 3j4rD, 0.7580, 3.11, 0.201, 325, 254, PSEUDO-ATOMIC MODEL OF THE AKAP18-PKA COMPLEX IN A LINEAR CONFORMATION DERIVED FROM ELECTRON MICROSCOPY
4754, 3j4qE, 0.7580, 3.11, 0.201, 325, 254, PSEUDO-ATOMIC MODEL OF THE AKAP18-PKA COMPLEX IN A BENT CONFORMATION DERIVED FROM ELECTRON MICROSCOPY
4755, 3j4qD, 0.7580, 3.11, 0.201, 325, 254, PSEUDO-ATOMIC MODEL OF THE AKAP18-PKA COMPLEX IN A BENT CONFORMATION DERIVED FROM ELECTRON MICROSCOPY
4756, 1gngA, 0.7580, 3.54, 0.224, 348, 259, GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE
4757, 5v24A, 0.7579, 2.39, 0.282, 249, 238, STRUCTURE-BASED DRUG DESIGN OF NOVEL ASK1 INHIBITORS USING A FULLY INTEGRATED LEAD OPTIMIZATION STRATEGY
4758, 5j8iA, 0.7579, 2.34, 0.279, 288, 240, CRYSTAL STRUCTURE OF TL11-113 BOUND TO TAK1-TAB1
4759, 5es1A, 0.7579, 2.49, 0.293, 304, 242, CRYSTAL STRUCTURE OF MICROTUBULE AFFINITY-REGULATING KINASE 4 CATALYTIC DOMAIN IN COMPLEX WITH A PYRAZOLOPYRIMIDINE INHIBITOR
4760, 4l43A, 0.7579, 3.02, 0.258, 316, 248, CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389A (FORM I)
4761, 3lj2B, 0.7579, 2.57, 0.228, 404, 241, IRE1 COMPLEXED WITH JAK INHIBITOR I
4762, 3a99A, 0.7579, 2.82, 0.194, 273, 247, STRUCTURE OF PIM-1 KINASE CRYSTALLIZED IN THE PRESENCE OF P27KIP1 CARBOXY-TERMINAL PEPTIDE
4763, 2nryC, 0.7579, 2.86, 0.272, 280, 243, CRYSTAL STRUCTURE OF IRAK-4
4764, 5kplA, 0.7578, 3.47, 0.219, 339, 256, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH BRD0705
4765, 5czoA, 0.7578, 3.26, 0.174, 365, 258, STRUCTURE OF S. CEREVISIAE HRR25:MAM1 COMPLEX FORM 2
4766, 5byzA, 0.7578, 3.35, 0.227, 348, 255, ERK5 IN COMPLEX WITH SMALL MOLECULE
4767, 4ztsA, 0.7578, 2.52, 0.259, 249, 243, HUMAN AURORA A CATALYTIC DOMAIN BOUND TO FK1142
4768, 4nfmA, 0.7578, 3.39, 0.158, 293, 259, HUMAN TAU TUBULIN KINASE 1 (TTBK1)
4769, 4l45A, 0.7578, 3.05, 0.262, 317, 248, CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389E
4770, 3lj2A, 0.7578, 2.57, 0.237, 404, 241, IRE1 COMPLEXED WITH JAK INHIBITOR I
4771, 1v0oB, 0.7578, 2.81, 0.258, 274, 244, STRUCTURE OF P. FALCIPARUM PFPK5-INDIRUBIN-5-SULPHONATE LIGAND COMPLEX
4772, 5hlpB, 0.7577, 3.56, 0.228, 335, 259, X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH BRD3937
4773, 4ux9C, 0.7577, 2.84, 0.226, 333, 248, CRYSTAL STRUCTURE OF JNK1 BOUND TO A MKK7 DOCKING MOTIF
4774, 4jvgC, 0.7577, 2.76, 0.305, 258, 246, B-RAF KINASE IN COMPLEX WITH BIRB796
4775, 4ithB, 0.7577, 2.89, 0.265, 270, 245, CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-1 ANALOG
4776, 3pxyA, 0.7577, 2.95, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR JWS648
4777, 3c9wB, 0.7577, 2.84, 0.198, 336, 247, CRYSTAL STRUCTURE OF ERK-2 WITH HYPOTHEMYCIN COVALENTLY BOUND
4778, 4xhhA, 0.7576, 3.44, 0.147, 358, 259, STRUCTURE OF C. GLABRATA HRR25 APO STATE
4779, 3uolB, 0.7576, 2.82, 0.268, 263, 246, AURORA A IN COMPLEX WITH SO2-162
4780, 3uolA, 0.7576, 2.82, 0.268, 263, 246, AURORA A IN COMPLEX WITH SO2-162
4781, 3uixA, 0.7576, 2.57, 0.193, 266, 243, CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
4782, 3r63A, 0.7576, 3.37, 0.195, 347, 257, STRUCTURE OF ERK2 (SPE) MUTANT (S246E)
4783, 2a19B, 0.7576, 2.88, 0.248, 263, 246, PKR KINASE DOMAIN- EIF2ALPHA- AMP-PNP COMPLEX.
4784, 6bruA, 0.7575, 3.46, 0.148, 322, 264, CRYSTAL STRUCTURE OF THE HUMAN VACCINIA-RELATED KINASE BOUND TO A (S)- 2-PHENYLAMINOPTERIDINONE INHIBITOR
4785, 5vdkA, 0.7575, 2.88, 0.214, 260, 248, CRYSTAL STRUCTURE OF HUMAN WEE2 KINASE DOMAIN IN COMPLEX WITH MK1775
4786, 5hzeA, 0.7575, 3.15, 0.245, 305, 253, MEK1 ADOPTS DFG-OUT CONFORMATION WHEN BOUND TO AN ANALOG OF E6201.
4787, 6f3iB, 0.7574, 2.61, 0.290, 279, 241, IRAK4 IN COMPLEX WITH INHIBITOR 
4788, 5vucB, 0.7574, 2.59, 0.189, 269, 243, PIM1 KINASE IN COMPLEX WITH A BENZOFURANONE INHIBITOR
4789, 5kplB, 0.7574, 3.46, 0.223, 339, 256, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH BRD0705
4790, 4rblA, 0.7574, 2.75, 0.195, 271, 246, CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE DERIVATIVES
4791, 4hokE, 0.7574, 3.49, 0.192, 291, 261, CRYSTAL STRUCTURE OF APO CK1E
4792, 2cgwA, 0.7574, 3.25, 0.243, 262, 251, IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
4793, 5vd2A, 0.7573, 2.80, 0.206, 258, 248, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH PF- 03814735
4794, 3qzgA, 0.7573, 2.97, 0.256, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR JWS-6-76
4795, 3qywA, 0.7573, 3.37, 0.210, 340, 257, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR
4796, 2z7lA, 0.7573, 3.29, 0.192, 329, 255, UNPHOSPHORYLATED MITOGEN ACTIVATED PROTEIN KINASE ERK2 IN COMPLEX WITH (4-{[5-CARBAMOYL-4-(3-METHYLANILINO)PYRIMIDIN 2-YL]AMINO}PHENYL)ACETIC ACID
4797, 1j3hA, 0.7573, 2.93, 0.199, 329, 251, CRYSTAL STRUCTURE OF APOENZYME CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT
4798, 4s31A, 0.7572, 3.47, 0.190, 347, 258, CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE 1 WTERK2 AT 1.45A
4799, 3we4A, 0.7572, 3.13, 0.260, 286, 250, CRYSTAL STRUCTURE OF S6K1 KINASE DOMAIN IN COMPLEX WITH A PYRIMIDINE DERIVATIVE PF-4708671 2-{[4-(5-ETHYLPYRIMIDIN-4-YL)PIPERAZIN-1- YL]METHYL}-5-(TRIFLUOROMETHYL)-1H-BENZIMIDAZOLE
4800, 6b2qD, 0.7571, 2.72, 0.262, 259, 244, DUAL INHIBITION OF THE ESSENTIAL PROTEIN KINASES A AND B IN MYCOBACTERIUM TUBERCULOSIS
4801, 4qp3A, 0.7571, 2.94, 0.185, 339, 248, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-2-((9H-PURIN-6-YL) AMINO)-3-PHENYLPROPAN-1-OL
4802, 4hokU, 0.7571, 3.50, 0.192, 289, 261, CRYSTAL STRUCTURE OF APO CK1E
4803, 3pj1A, 0.7571, 2.09, 0.352, 241, 236, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 3-(26-DICHLORO- PHENYL)-7-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-1-METHYL-34- DIHYDRO-1H-PYRIMIDO[45-D]PYRIMIDIN-2-ONE
4804, 5uklA, 0.7570, 3.26, 0.163, 630, 258, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG222886 (14BD)
4805, 4lg4C, 0.7570, 2.95, 0.256, 288, 250, STRUCTURAL BASIS FOR AUTOACTIVATION OF HUMAN MST2 KINASE AND ITS REGULATION BY RASSF5
4806, 5valB, 0.7569, 2.60, 0.303, 254, 244, BRAF IN COMPLEX WITH N-(3-(TERT-BUTYL)PHENYL)-4-METHYL-3-(6- MORPHOLINOPYRIMIDIN-4-YL)BENZAMIDE
4807, 5n4oA, 0.7569, 2.66, 0.192, 271, 245, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE (E)-3-(P-TOLYL)ACRYLIC ACID
4808, 5my8A, 0.7569, 3.57, 0.186, 355, 258, CRYSTAL STRUCTURE OF SRPK1 IN COMPLEX WITH SPHINX31
4809, 4qp7B, 0.7569, 2.76, 0.195, 335, 246, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 2-(1H-PYRAZOL-4-YL)-5H- PYRROLO[23-B]PYRAZINE
4810, 3pj3A, 0.7569, 1.92, 0.343, 240, 233, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-METHYL-5-[(E)- (3-PHENYL-ACRYLOYL)AMINO]-N-(2-PHENYL-3H-IMIDAZO[45-B]PYRIDIN-6-YL)- BENZAMIDE
4811, 2bikB, 0.7569, 2.69, 0.195, 272, 246, HUMAN PIM1 PHOSPHORYLATED ON SER261
4812, 2b54A, 0.7569, 3.06, 0.255, 298, 251, HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2)COMPLEXED WITH DIN- 232305
4813, 5xv7A, 0.7568, 3.57, 0.178, 350, 258, SRPK1 IN COMPLEX WITH ALECTINIB
4814, 4qygB, 0.7568, 3.28, 0.244, 264, 250, CHK1 KINASE DOMAIN IN COMPLEX WITH DIAZACARBAZOLE COMPOUND 14
4815, 4hokI, 0.7568, 3.47, 0.192, 291, 261, CRYSTAL STRUCTURE OF APO CK1E
4816, 4fv6A, 0.7568, 2.71, 0.201, 332, 244, CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E57
4817, 4enyA, 0.7568, 2.55, 0.198, 261, 242, CRYSTAL STRUCTURE OF PIM-1 KINASE IN COMPLEX WITH (2E5Z)-2-(2- CHLOROPHENYLIMINO)-5-(4-HYDROXY-3-METHOXYBENZYLIDENE)THIAZOLIDIN-4- ONE
4818, 4cqgA, 0.7568, 2.56, 0.252, 313, 242, THE CRYSTAL STRUCTURE OF MPK38 IN COMPLEX WITH OTSSP167 AN ORALLY-ADMINISTRATIVE MELK SELECTIVE INHIBITOR
4819, 4bl1A, 0.7568, 2.49, 0.250, 312, 240, CRYSTAL STRUCTURE OF UNPHOSPHORYLATED MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (MELK) IN COMPLEX WITH AMP-PNP
4820, 3qxpA, 0.7568, 3.03, 0.261, 294, 249, CDK2 IN COMPLEX WITH INHIBITOR RC-3-89
4821, 1ia8A, 0.7568, 3.33, 0.242, 272, 252, THE 1.7 A CRYSTAL STRUCTURE OF HUMAN CELL CYCLE CHECKPOINT KINASE CHK1
4822, 5v19A, 0.7567, 2.30, 0.283, 250, 237, STRUCTURE-BASED DRUG DESIGN OF NOVEL ASK1 INHIBITORS USING A FULLY INTEGRATED LEAD OPTIMIZATION STRATEGY
4823, 5k00A, 0.7567, 2.55, 0.240, 311, 242, MELK IN COMPLEX WITH NVS-MELK5
4824, 4mneD, 0.7567, 3.38, 0.242, 285, 256, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
4825, 3tiyA, 0.7567, 2.97, 0.269, 293, 249, CDK2 IN COMPLEX WITH NSC 35676
4826, 3r8lA, 0.7567, 2.99, 0.268, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L3-4
4827, 2oicB, 0.7567, 2.67, 0.276, 276, 239, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN COMPLEXED WITH STAUROSPORINE
4828, 6bwkA, 0.7566, 2.44, 0.226, 263, 243, CRYSTAL STRUCTURE OF THE HUMAN MLKL PSEUDOKINASE DOMAIN T357E/S358E MUTANT 
4829, 4yfiA, 0.7566, 2.60, 0.261, 268, 238, TNNI3K COMPLEXED WITH INHIBITOR 1
4830, 4s30A, 0.7566, 3.45, 0.199, 342, 256, ERK2 INTRINSICALLY ACTIVE MUTANT (I84A)
4831, 6bu6D, 0.7565, 3.56, 0.152, 318, 264, CRYSTAL STRUCTURE OF THE HUMAN VACCINIA-RELATED KINASE BOUND TO A BIS- DIFLUOROPHENOL-AMINOPYRIDINE INHIBITOR
4832, 5uirB, 0.7565, 2.63, 0.282, 273, 241, CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 11
4833, 5d9kB, 0.7565, 2.90, 0.214, 280, 248, RSK2 N-TERMINAL KINASE IN COMPLEX WITH BI-D1870
4834, 5ci6B, 0.7565, 2.72, 0.213, 350, 244, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA MPK6
4835, 3r9hA, 0.7565, 3.01, 0.256, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-142
4836, 3qtqA, 0.7565, 3.01, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-1-137
4837, 5vc3A, 0.7564, 2.86, 0.205, 260, 249, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH BOSUTINIB
4838, 5uirA, 0.7564, 2.70, 0.290, 270, 241, CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 11
4839, 5op5A, 0.7564, 3.05, 0.239, 259, 247, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH PYRROLOPYRIMIDINE LRRK2 INHIBITOR
4840, 4l42A, 0.7564, 3.17, 0.259, 299, 251, CRYSTAL STRUCTURES OF HUMAN P70S6K1-PIF
4841, 3umwA, 0.7564, 2.60, 0.189, 264, 243, CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH INHIBITOR (Z)-2-[(1H- INDAZOL-3-YL)METHYLENE]-6-METHOXY-7-(PIPERAZIN-1-YLMETHYL)BENZOFURAN- 3(2H)-ONE
4842, 3pxfA, 0.7564, 3.35, 0.260, 302, 254, CDK2 IN COMPLEX WITH TWO MOLECULES OF 8-ANILINO-1-NAPHTHALENE SULFONATE
4843, 5kkrC, 0.7563, 3.20, 0.237, 309, 253, KSR2:MEK1 COMPLEX BOUND TO THE SMALL MOLECULE APS-2-79
4844, 4tthB, 0.7563, 2.74, 0.239, 256, 243, CRYSTAL STRUCTURE OF A CDK6/VCYCLIN COMPLEX WITH INHIBITOR BOUND
4845, 4nzwB, 0.7563, 2.51, 0.250, 266, 240, CRYSTAL STRUCTURE OF STK25-MO25 COMPLEX
4846, 4bf2B, 0.7563, 2.46, 0.280, 252, 239, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4847, 3tizA, 0.7563, 2.96, 0.269, 293, 249, CDK2 IN COMPLEX WITH NSC 111848
4848, 5w7tB, 0.7562, 3.13, 0.270, 276, 252, STRUCTURE OF PHOSPHORYLATED WNK1 
4849, 4mh7A, 0.7562, 2.06, 0.333, 248, 231, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC1896
4850, 4hokW, 0.7562, 3.49, 0.192, 289, 260, CRYSTAL STRUCTURE OF APO CK1E
4851, 4dbnB, 0.7562, 2.59, 0.305, 263, 243, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN B-RAF WITH A [1 3]THIAZOLO[54-B]PYRIDINE DERIVATIVE
4852, 4btkA, 0.7562, 3.30, 0.152, 287, 256, TTBK1 IN COMPLEX WITH INHIBITOR
4853, 3qqhA, 0.7562, 2.94, 0.264, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L2-2
4854, 3h0yA, 0.7562, 2.66, 0.262, 250, 244, AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE
4855, 2qvsE, 0.7562, 3.08, 0.202, 323, 253, CRYSTAL STRUCTURE OF TYPE IIA HOLOENZYME OF CAMP-DEPENDENT PROTEIN KINASE
4856, 2c47B, 0.7562, 3.39, 0.159, 289, 258, STRUCTURE OF CASEIN KINASE 1 GAMMA 2
4857, 4n4sA, 0.7561, 3.11, 0.190, 342, 252, A DOUBLE MUTANT RAT ERK2 IN COMPLEX WITH A PYRAZOLO[34-D]PYRIMIDINE INHIBITOR
4858, 4hyiA, 0.7561, 3.27, 0.239, 269, 251, X-RAY CRYSTAL STRUCTURE OF COMPOUND 40 BOUND TO HUMAN CHK1 KINASE DOMAIN
4859, 3vapA, 0.7561, 2.68, 0.266, 249, 244, SYNTHESIS AND SAR STUDIES OF IMIDAZO-[12-A]-PYRAZINE AURORA KINASE INHIBITORS WITH IMPROVED OFF TARGET KINASE SELECTIVITY
4860, 2x8eA, 0.7561, 3.08, 0.246, 259, 248, DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
4861, 2oibA, 0.7561, 2.78, 0.273, 280, 242, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM
4862, 2brnA, 0.7561, 3.30, 0.226, 268, 252, STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
4863, 4ztmB, 0.7560, 2.73, 0.279, 280, 240, IRAK4-INHIBITOR CO-STRUCTURE
4864, 4itjA, 0.7560, 2.76, 0.269, 261, 242, CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-4
4865, 3ormA, 0.7560, 2.62, 0.217, 266, 244, MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN D76A MUTANT
4866, 2x8iA, 0.7560, 3.13, 0.238, 261, 248, DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
4867, 2br1A, 0.7560, 3.33, 0.238, 272, 252, STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
4868, 1fotA, 0.7560, 3.03, 0.206, 299, 252, STRUCTURE OF THE UNLIGANDED CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT FROM SACCHAROMYCES CEREVISIAE
4869, 5imeA, 0.7559, 2.69, 0.221, 280, 244, CRYSTAL STRUCTURE OF P21-ACTIVATED KINASE 1 (PAK1) IN COMPLEX WITH COMPOUND 9
4870, 4iz7C, 0.7559, 2.85, 0.202, 340, 248, STRUCTURE OF NON-PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN
4871, 2qolA, 0.7559, 2.72, 0.331, 271, 242, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y596:Y602:S768G TRIPLE MUTANT
4872, 6g9kA, 0.7558, 3.40, 0.187, 343, 256, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4873, 4umpB, 0.7558, 2.95, 0.248, 324, 250, STRUCTURE OF MELK IN COMPLEX WITH INHIBITORS
4874, 4lgdB, 0.7558, 3.08, 0.241, 350, 253, STRUCTURAL BASIS FOR AUTOACTIVATION OF HUMAN MST2 KINASE AND ITS REGULATION BY RASSF5
4875, 3rm7A, 0.7558, 2.99, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-91
4876, 3idpA, 0.7558, 2.79, 0.305, 255, 246, B-RAF V600E KINASE DOMAIN IN COMPLEX WITH AN AMINOISOQUINOLINE INHIBITOR
4877, 3d2kA, 0.7558, 2.48, 0.254, 245, 240, CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY LYS240- >ARG MET302->LEU) IN COMPLEX WITH [7-(2-{2-[3-(3-CHLORO- PHENYL)-UREIDO]-THIAZOL-5-YL}-ETHYLAMINO)-PYRAZOLO[43- D]PYRIMIDIN-1-YL]-ACETIC ACID
4878, 2clxA, 0.7558, 2.97, 0.261, 293, 249, 4-ARYLAZO-35-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY CRYSTAL STRUCTURE IN COMPLEX WITH CDK2 SELECTIVITY AND CELLULAR EFFECTS
4879, 4qyhB, 0.7557, 3.24, 0.245, 264, 249, CHK1 KINASE DOMAIN IN COMPLEX WITH DIAZACARBAZOLE GNE-783
4880, 3sd0A, 0.7557, 3.52, 0.222, 350, 257, IDENTIFICATION OF A GLYCOGEN SYNTHASE KINASE-3B INHIBITOR THAT ATTENUATES HYPERACTIVITY IN CLOCK MUTANT MICE
4881, 1r0eB, 0.7557, 3.49, 0.222, 344, 257, GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3-INDOLYL-4- ARYLMALEIMIDE INHIBITOR
4882, 3qxoA, 0.7556, 2.97, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-84
4883, 2x6eA, 0.7556, 2.54, 0.264, 249, 242, AURORA-A BOUND TO AN INHIBITOR
4884, 2ow3B, 0.7556, 3.50, 0.223, 351, 256, GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH BIS- (INDOLE)MALEIMIDE PYRIDINOPHANE INHIBITOR
4885, 1pf8A, 0.7556, 2.87, 0.263, 298, 247, CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH A NUCLEOSIDE INHIBITOR
4886, 5oneA, 0.7555, 2.87, 0.269, 257, 245, CRYSTAL STRUCTURE OF AURORA-A IN COMPLEX WITH FMF-03-145-1 (COMPOUND 2)
4887, 5o11A, 0.7555, 2.57, 0.194, 268, 242, CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH SMALL-MOLECULE INHIBITOR
4888, 4kspB, 0.7555, 2.57, 0.306, 256, 242, CRYSTAL STRUCTURE OF HUMAN B-RAF BOUND TO A DFG-OUT INHIBITOR TAK-632
4889, 3zhpC, 0.7555, 3.00, 0.248, 272, 250, HUMAN MST3 (STK24) IN COMPLEX WITH MO25BETA
4890, 3qyzA, 0.7555, 3.51, 0.216, 339, 259, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR
4891, 5jt2B, 0.7554, 2.69, 0.322, 251, 242, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-BISAMIDE
4892, 4umqA, 0.7554, 2.61, 0.243, 314, 243, STRUCTURE OF MELK IN COMPLEX WITH INHIBITORS
4893, 3t9iA, 0.7554, 2.81, 0.187, 273, 246, PIM1 COMPLEXED WITH A NOVEL 36-DISUBSTITUTED INDOLE AT 2.6 ANG RESOLUTION
4894, 2broA, 0.7554, 3.43, 0.225, 272, 253, STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
4895, 4ux9B, 0.7553, 2.80, 0.220, 327, 246, CRYSTAL STRUCTURE OF JNK1 BOUND TO A MKK7 DOCKING MOTIF
4896, 3uzpB, 0.7553, 3.31, 0.195, 284, 256, CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P21 CRYSTAL FORM
4897, 3s0oA, 0.7553, 3.03, 0.256, 293, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-1-138
4898, 5oktD, 0.7552, 3.31, 0.191, 282, 256, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH IWP-2 
4899, 5k72A, 0.7552, 2.56, 0.280, 277, 239, IRAK4 IN COMPLEX WITH COMPOUND 21
4900, 4r5yB, 0.7552, 2.83, 0.305, 254, 246, THE COMPLEX STRUCTURE OF BRAF V600E KINASE DOMAIN WITH A NOVEL BRAF INHIBITOR
4901, 4qygA, 0.7552, 3.13, 0.239, 264, 247, CHK1 KINASE DOMAIN IN COMPLEX WITH DIAZACARBAZOLE COMPOUND 14
4902, 4itiB, 0.7552, 2.72, 0.266, 270, 241, CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-3 ANALOG
4903, 4bfmA, 0.7552, 2.59, 0.252, 313, 242, THE CRYSTAL STRUCTURE OF MOUSE PK38
4904, 1ykrA, 0.7552, 3.10, 0.263, 298, 251, CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINE INHIBITOR
4905, 4fkuA, 0.7551, 3.01, 0.261, 293, 249, CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH OXINDOLE INHIBITOR
4906, 2qlqB, 0.7551, 2.08, 0.321, 248, 234, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN WITH COVALENT INHIBITOR RL3
4907, 1r0eA, 0.7551, 3.50, 0.222, 344, 257, GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3-INDOLYL-4- ARYLMALEIMIDE INHIBITOR
4908, 5ukkA, 0.7550, 3.31, 0.189, 613, 259, HUMAN GRK2 IN COMPLEX WITH HUMAN G-BETA-GAMMA SUBUNITS AND CCG211998 (14AK)
4909, 4hniB, 0.7550, 3.19, 0.189, 284, 254, CRYSTAL STRUCTURE OF CK1E IN COMPLEX WITH PF4800567
4910, 3op5A, 0.7550, 3.52, 0.144, 320, 264, HUMAN VACCINIA-RELATED KINASE 1
4911, 3c51B, 0.7550, 2.69, 0.242, 461, 244, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ADP AND MAGNESIUM CHLORIDE AT 3.55A
4912, 6f3dA, 0.7549, 2.57, 0.280, 277, 239, IRAK4 IN COMPLEX WITH INHIBITOR 
4913, 5o21A, 0.7549, 3.01, 0.272, 272, 250, CRYSTAL STRUCTURE OF WNK3 KINASE DOMAIN IN A MONOPHOSPHORYLATED STATE WITH CHLORIDE BOUND IN THE ACTIVE SITE
4914, 5hesB, 0.7549, 2.55, 0.322, 278, 239, HUMAN LEUCINE ZIPPER- AND STERILE ALPHA MOTIF-CONTAINING KINASE (ZAK MLT HCCS-4 MRK AZK MLTK) IN COMPLEX WITH VEMURAFENIB
4915, 4xrjA, 0.7549, 3.36, 0.189, 344, 254, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR
4916, 4xozA, 0.7549, 3.36, 0.189, 341, 254, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR
4917, 4qp4B, 0.7549, 2.78, 0.195, 335, 246, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-CYCLOHEXYL-9H-PURIN-6- AMINE
4918, 4fv8A, 0.7549, 2.73, 0.201, 333, 244, CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E63
4919, 3r28A, 0.7549, 2.95, 0.256, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-140
4920, 1omwA, 0.7549, 3.28, 0.178, 614, 258, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN G PROTEIN-COUPLED RECEPTOR KINASE 2 AND HETEROTRIMERIC G PROTEIN BETA 1 AND GAMMA 2 SUBUNITS
4921, 5wg5A, 0.7548, 3.18, 0.184, 617, 255, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224061
4922, 5ootA, 0.7548, 3.13, 0.242, 260, 248, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH AMINOPYRIMIDO- BENZODIAZEPINONE LRRK2 INHIBITOR
4923, 4umrA, 0.7548, 2.64, 0.243, 313, 243, STRUCTURE OF MELK IN COMPLEX WITH INHIBITORS
4924, 3qwkA, 0.7548, 3.03, 0.268, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-150
4925, 4qtaA, 0.7547, 2.76, 0.209, 335, 244, STRUCTURE OF HUMAN ERK2 IN COMPLEX WITH SCH772984 REVEALING A NOVEL INHIBITOR-INDUCED BINDING POCKET
4926, 4itiA, 0.7547, 2.96, 0.265, 272, 245, CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-3 ANALOG
4927, 3v6rA, 0.7547, 2.86, 0.206, 349, 248, DISCOVERY OF POTENT AND SELECTIVE COVALENT INHIBITORS OF JNK
4928, 2ow3A, 0.7547, 3.57, 0.229, 346, 258, GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH BIS- (INDOLE)MALEIMIDE PYRIDINOPHANE INHIBITOR
4929, 2fa2A, 0.7547, 2.93, 0.233, 333, 249, CRYSTAL STRUCTURE OF FUS3 WITHOUT A PEPTIDE FROM STE5
4930, 6cnxA, 0.7546, 3.52, 0.144, 322, 264, CRYSTAL STRUCTURE OF THE HUMAN VACCINIA-RELATED KINASE 1 (VRK1) BOUND TO AN N-PROPYNYL-N-ISOPENTYL-DIHYDROPTERIDIN INHIBITOR
4931, 5kpmB, 0.7546, 3.46, 0.223, 345, 256, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH BRD3731
4932, 4xp0A, 0.7546, 3.39, 0.192, 336, 255, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR
4933, 3repA, 0.7546, 3.02, 0.255, 268, 251, CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (MNATP)
4934, 3f69A, 0.7546, 2.77, 0.215, 270, 247, CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS PKNB MUTANT KINASE DOMAIN IN COMPLEX WITH KT5720
4935, 1jqhA, 0.7546, 3.15, 0.296, 291, 253, IGF-1 RECEPTOR KINASE DOMAIN
4936, 6dkwB, 0.7545, 2.77, 0.374, 269, 246, CRYSTAL STRUCTURE OF TRK-A IN COMPLEX WITH THE PAN-TRK KINASE INHIBITOR; COMPOUND 3. 
4937, 5kpmA, 0.7545, 3.59, 0.224, 344, 259, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH BRD3731
4938, 4fk3A, 0.7545, 2.49, 0.303, 251, 241, B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX3203
4939, 3r8zA, 0.7545, 3.07, 0.268, 290, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-1-136
4940, 3r1qA, 0.7545, 2.95, 0.256, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-102
4941, 2qlqA, 0.7545, 1.93, 0.312, 245, 231, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN WITH COVALENT INHIBITOR RL3
4942, 6g9jA, 0.7544, 3.38, 0.188, 347, 255, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4943, 5k72D, 0.7544, 2.63, 0.287, 276, 240, IRAK4 IN COMPLEX WITH COMPOUND 21
4944, 4qp6A, 0.7544, 2.98, 0.185, 339, 248, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 5H-PYRROLO[23-B]PYRAZINE
4945, 4kbkD, 0.7544, 3.28, 0.173, 281, 254, CK1D IN COMPLEX WITH (3S)-3-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H- PYRAZOL-4-YL]PYRIDIN-2-YL}MORPHOLINE INHIBITOR
4946, 3kmwA, 0.7544, 3.03, 0.255, 268, 251, CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (MGATP)
4947, 2io6A, 0.7544, 2.61, 0.216, 252, 241, WEE1 KINASE COMPLEXED WITH INHIBITOR PD330961
4948, 2c47A, 0.7544, 3.37, 0.156, 288, 257, STRUCTURE OF CASEIN KINASE 1 GAMMA 2
4949, 1jqhC, 0.7544, 3.11, 0.302, 291, 252, IGF-1 RECEPTOR KINASE DOMAIN
4950, 5myvA, 0.7543, 3.51, 0.183, 352, 257, CRYSTAL STRUCTURE OF SRPK2 IN COMPLEX WITH COMPOUND 1
4951, 4ntsA, 0.7543, 2.98, 0.199, 341, 251, APO STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE
4952, 3qqfA, 0.7543, 3.00, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L1
4953, 2qg5D, 0.7543, 3.22, 0.194, 283, 252, CRYPTOSPORIDIUM PARVUM CALCIUM DEPENDENT PROTEIN KINASE CGD7_1840
4954, 2c3jA, 0.7543, 3.05, 0.240, 257, 246, IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
4955, 1hckA, 0.7543, 3.05, 0.268, 294, 250, HUMAN CYCLIN-DEPENDENT KINASE 2
4956, 5oopA, 0.7542, 3.21, 0.240, 261, 250, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH AMP-PNP
4957, 4lgdD, 0.7542, 3.07, 0.253, 338, 253, STRUCTURAL BASIS FOR AUTOACTIVATION OF HUMAN MST2 KINASE AND ITS REGULATION BY RASSF5
4958, 4kb8D, 0.7542, 3.20, 0.182, 278, 253, CK1D IN COMPLEX WITH 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4- YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE LIGAND
4959, 4erwA, 0.7542, 3.02, 0.257, 292, 249, CDK2 IN COMPLEX WITH STAUROSPORINE
4960, 3rzfA, 0.7542, 3.15, 0.257, 541, 253, CRYSTAL STRUCTURE OF INHIBITOR OF KAPPAB KINASE BETA (I4122)
4961, 3q4zA, 0.7542, 2.79, 0.207, 282, 246, STRUCTURE OF UNPHOSPHORYLATED PAK1 KINASE DOMAIN
4962, 3pxqA, 0.7542, 3.12, 0.261, 298, 249, CDK2 IN COMPLEX WITH 3 MOLECULES OF 8-ANILINO-1-NAPHTHALENE SULFONATE
4963, 2brbA, 0.7542, 3.33, 0.239, 272, 251, STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
4964, 5x3fB, 0.7541, 3.01, 0.198, 348, 252, CRYSTAL STRUCTURE OF THE YGJG-PROTEIN A-ZPA963-PKA CATALYTIC DOMAIN
4965, 5k72C, 0.7541, 2.98, 0.284, 277, 243, IRAK4 IN COMPLEX WITH COMPOUND 21
4966, 5d9kA, 0.7541, 2.90, 0.215, 280, 247, RSK2 N-TERMINAL KINASE IN COMPLEX WITH BI-D1870
4967, 5acbD, 0.7541, 3.29, 0.251, 319, 255, CRYSTAL STRUCTURE OF THE HUMAN CDK12-CYCLINK COMPLEX
4968, 4qp2A, 0.7541, 3.00, 0.185, 336, 248, CRYSTAL STRUCTURE OF ERKS IN COMPLEX WITH 5-CHLOROBENZO[D]OXAZOL-2- AMINE
4969, 3p86A, 0.7541, 2.51, 0.328, 250, 241, CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN MUTANT D676N IN COMPLEX WITH STAUROSPORINE
4970, 3en7A, 0.7541, 1.99, 0.310, 247, 232, TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH S1 A MULTITARGETED KINASE INHIBITOR
4971, 5csxA, 0.7540, 2.98, 0.302, 261, 248, CRYSTAL STRUCTURE OF B-RAF IN COMPLEX WITH BI 882370
4972, 1pmeA, 0.7540, 3.20, 0.203, 333, 251, STRUCTURE OF PENTA MUTANT HUMAN ERK2 MAP KINASE COMPLEXED WITH A SPECIFIC INHIBITOR OF HUMAN P38 MAP KINASE
4973, 5uiqA, 0.7539, 2.70, 0.276, 268, 239, CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 9
4974, 4d2tD, 0.7539, 2.97, 0.233, 319, 249, STRUCTURE OF MELK IN COMPLEX WITH INHIBITORS
4975, 3s00A, 0.7539, 3.01, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L4-14
4976, 3qzhA, 0.7539, 2.97, 0.256, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-124
4977, 5l2qC, 0.7538, 2.67, 0.196, 282, 245, SERINE/THREONINE-PROTEIN KINASE 40 (STK40) KINASE HOMOLOGY DOMAIN
4978, 4o6eA, 0.7538, 2.82, 0.204, 328, 245, DISCOVERY OF 5678-TETRAHYDROPYRIDO[34-D]PYRIMIDINE INHIBITORS OF ERK2
4979, 4kbcB, 0.7538, 3.18, 0.190, 277, 252, CK1D IN COMPLEX WITH {4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDIN-2- YL}METHANOL INHIBITOR
4980, 4bkyA, 0.7538, 2.53, 0.254, 311, 240, CRYSTAL STRUCTURE OF UNPHOSPHORYLATED MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (MELK) IN COMPLEX WITH PYRROLOPYRAZOLE INHIBITOR
4981, 3zfyB, 0.7538, 2.68, 0.325, 255, 240, CRYSTAL STRUCTURE OF EPHB3
4982, 3royA, 0.7538, 2.97, 0.256, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-154
4983, 2f49B, 0.7538, 2.94, 0.233, 337, 249, CRYSTAL STRUCTURE OF FUS3 IN COMPLEX WITH A STE5 PEPTIDE
4984, 5nzzH, 0.7537, 2.86, 0.215, 335, 247, CRYSTAL STRUCTURE OF PHOSPHORYLATED P38AMAPK IN COMPLEX WITH TAB1 
4985, 4xs2B, 0.7537, 2.84, 0.274, 278, 241, IRAK4-INHIBITOR CO-STRUCTURE
4986, 1wbpA, 0.7537, 3.52, 0.179, 350, 257, SRPK1 BOUND TO 9MER DOCKING MOTIF PEPTIDE
4987, 3r8pA, 0.7536, 3.03, 0.268, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-6
4988, 3lj0A, 0.7536, 2.65, 0.228, 404, 241, IRE1 COMPLEXED WITH ADP AND QUERCETIN
4989, 5wg4A, 0.7535, 3.15, 0.187, 621, 256, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG257284
4990, 5lw1H, 0.7535, 3.11, 0.210, 355, 252, CRYSTAL STRUCTURE OF DARPIN-DARPIN RIGID FUSION VARIANT DD_232_11_D12 IN COMPLEX JNK1A1 AND JIP1 PEPTIDE
4991, 4fv0A, 0.7535, 3.29, 0.194, 341, 253, CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK3
4992, 3r7vA, 0.7535, 3.01, 0.260, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-9
4993, 5t1tB, 0.7534, 2.61, 0.280, 280, 239, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
4994, 3r8mA, 0.7534, 2.95, 0.258, 286, 248, CDK2 IN COMPLEX WITH INHIBITOR L3-3
4995, 3qx4A, 0.7534, 3.02, 0.268, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-78
4996, 3py3A, 0.7534, 3.03, 0.212, 355, 250, CRYSTAL STRUCTURE OF PHOSPHORYLATED P38ALPHA MAP KINASE
4997, 3lj0B, 0.7534, 2.65, 0.228, 399, 241, IRE1 COMPLEXED WITH ADP AND QUERCETIN
4998, 4f0gA, 0.7533, 2.57, 0.282, 263, 241, CRYSTAL STRUCTURE OF THE ROCO4 KINASE DOMAIN FROM D. DISCOIDEUM
4999, 4e7wA, 0.7533, 3.48, 0.200, 359, 255, STRUCTURE OF GSK3 FROM USTILAGO MAYDIS
5000, 3r8uA, 0.7533, 3.05, 0.268, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-1-132
